0000896264-24-000093.txt : 20240227 0000896264-24-000093.hdr.sgml : 20240227 20240227162650 ACCESSION NUMBER: 0000896264-24-000093 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 100 CONFORMED PERIOD OF REPORT: 20231230 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 24687257 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-K 1 usna-20231230.htm 10-K usna-20231230
0000896264FYfalse2023P3Yhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent00008962642023-01-012023-12-3000008962642023-07-01iso4217:USD00008962642024-02-23xbrli:shares00008962642023-12-3000008962642022-12-31iso4217:USDxbrli:shares00008962642022-01-022022-12-3100008962642021-01-032022-01-010000896264us-gaap:CommonStockMember2021-01-020000896264us-gaap:AdditionalPaidInCapitalMember2021-01-020000896264us-gaap:RetainedEarningsMember2021-01-020000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-0200008962642021-01-020000896264us-gaap:RetainedEarningsMember2021-01-032022-01-010000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-032022-01-010000896264us-gaap:AdditionalPaidInCapitalMember2021-01-032022-01-010000896264us-gaap:CommonStockMember2021-01-032022-01-010000896264us-gaap:CommonStockMember2022-01-010000896264us-gaap:AdditionalPaidInCapitalMember2022-01-010000896264us-gaap:RetainedEarningsMember2022-01-010000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-0100008962642022-01-010000896264us-gaap:RetainedEarningsMember2022-01-022022-12-310000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-022022-12-310000896264us-gaap:AdditionalPaidInCapitalMember2022-01-022022-12-310000896264us-gaap:CommonStockMember2022-01-022022-12-310000896264us-gaap:CommonStockMember2022-12-310000896264us-gaap:AdditionalPaidInCapitalMember2022-12-310000896264us-gaap:RetainedEarningsMember2022-12-310000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000896264us-gaap:RetainedEarningsMember2023-01-012023-12-300000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-300000896264us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-300000896264us-gaap:CommonStockMember2023-01-012023-12-300000896264us-gaap:CommonStockMember2023-12-300000896264us-gaap:AdditionalPaidInCapitalMember2023-12-300000896264us-gaap:RetainedEarningsMember2023-12-300000896264us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-30usna:region0000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2023-12-300000896264us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMember2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-300000896264us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-300000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310000896264us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310000896264us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsNonrecurringMember2022-12-310000896264us-gaap:FairValueMeasurementsNonrecurringMember2023-12-300000896264usna:AmountsReceivableFromCreditCardProcessorsMember2023-12-300000896264usna:AmountsReceivableFromCreditCardProcessorsMember2022-12-310000896264usna:RestrictedCashDepositsInChinaMember2023-12-300000896264usna:RestrictedCashDepositsInChinaMember2022-12-310000896264srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-300000896264srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-300000896264us-gaap:OtherAssetsMember2021-01-02xbrli:pure0000896264us-gaap:ForeignExchangeOptionMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-010000896264us-gaap:ForeignExchangeOptionMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000896264us-gaap:ForeignExchangeOptionMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-12-300000896264us-gaap:ForeignExchangeOptionMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-022022-12-310000896264us-gaap:ForeignExchangeOptionMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-032022-01-010000896264us-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000896264us-gaap:DesignatedAsHedgingInstrumentMember2023-12-300000896264us-gaap:SubsequentEventMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-250000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-04-032022-07-020000896264us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-07-02usna:period0000896264us-gaap:PublicUtilitiesInventoryRawMaterialsMember2023-12-300000896264usna:FinishedGoodsMember2023-12-300000896264us-gaap:PublicUtilitiesInventoryRawMaterialsMember2022-12-310000896264usna:FinishedGoodsMember2022-12-310000896264us-gaap:ResearchMemberus-gaap:ForeignCountryMember2023-12-300000896264usna:MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember2023-12-300000896264us-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMemberusna:UtahStateTaxCommissionMember2023-12-300000896264us-gaap:DomesticCountryMemberus-gaap:ResearchMember2023-12-300000896264us-gaap:ForeignCountryMember2023-12-300000896264usna:ForeignOperatingLossCarryforwardsMember2023-12-300000896264usna:OtherForeignDeferredTaxAssetsMember2023-12-300000896264us-gaap:OtherNoncurrentLiabilitiesMember2023-12-300000896264us-gaap:OtherCurrentLiabilitiesMember2022-12-310000896264us-gaap:OtherNoncurrentLiabilitiesMember2022-12-310000896264us-gaap:BuildingMember2023-12-300000896264us-gaap:BuildingMember2022-12-310000896264srt:MinimumMemberusna:LaboratoryAndProductionEquipmentMember2023-12-300000896264srt:MaximumMemberusna:LaboratoryAndProductionEquipmentMember2023-12-300000896264usna:LaboratoryAndProductionEquipmentMember2023-12-300000896264usna:LaboratoryAndProductionEquipmentMember2022-12-310000896264us-gaap:AirTransportationEquipmentMember2023-12-300000896264us-gaap:AirTransportationEquipmentMember2022-12-310000896264srt:MinimumMemberus-gaap:ComputerEquipmentMember2023-12-300000896264srt:MaximumMemberus-gaap:ComputerEquipmentMember2023-12-300000896264us-gaap:ComputerEquipmentMember2023-12-300000896264us-gaap:ComputerEquipmentMember2022-12-310000896264srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2023-12-300000896264srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2023-12-300000896264us-gaap:FurnitureAndFixturesMember2023-12-300000896264us-gaap:FurnitureAndFixturesMember2022-12-310000896264srt:MinimumMemberus-gaap:AutomobilesMember2023-12-300000896264srt:MaximumMemberus-gaap:AutomobilesMember2023-12-300000896264us-gaap:AutomobilesMember2023-12-300000896264us-gaap:AutomobilesMember2022-12-310000896264us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2023-12-300000896264us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2023-12-300000896264us-gaap:LeaseholdImprovementsMember2023-12-300000896264us-gaap:LeaseholdImprovementsMember2022-12-310000896264us-gaap:LandImprovementsMember2023-12-300000896264us-gaap:LandImprovementsMember2022-12-310000896264us-gaap:LandMember2023-12-300000896264us-gaap:LandMember2022-12-310000896264usna:DepositsAndProjectsInProcessMember2023-12-300000896264usna:DepositsAndProjectsInProcessMember2022-12-310000896264us-gaap:TrademarksAndTradeNamesMember2023-12-300000896264us-gaap:TradeSecretsMember2023-12-300000896264us-gaap:CustomerRelationshipsMember2023-12-300000896264us-gaap:NoncompeteAgreementsMember2023-12-300000896264us-gaap:LicensingAgreementsMember2023-12-300000896264us-gaap:TrademarksAndTradeNamesMember2022-12-310000896264us-gaap:TradeSecretsMember2022-12-310000896264us-gaap:CustomerRelationshipsMember2022-12-310000896264us-gaap:NoncompeteAgreementsMember2022-12-310000896264us-gaap:LicensingAgreementsMember2022-12-310000896264us-gaap:LineOfCreditMember2023-12-300000896264us-gaap:LineOfCreditMemberusna:AmendedAndRestatedCreditAgreementMember2023-12-300000896264us-gaap:LineOfCreditMemberusna:AmendedAndRestatedCreditAgreementMember2023-01-012023-12-30utr:Y0000896264usna:LiabilityAwardMember2023-01-012023-12-300000896264usna:LiabilityAwardMember2022-01-022022-12-310000896264usna:LiabilityAwardMember2021-01-032022-01-010000896264usna:The2015PlanMember2023-12-300000896264us-gaap:StockAppreciationRightsSARSMemberusna:The2015PlanMember2023-01-012023-12-300000896264us-gaap:RestrictedStockMemberusna:The2015PlanMember2023-01-012023-12-300000896264us-gaap:EmployeeStockMemberusna:The2015PlanMember2023-01-012023-12-300000896264us-gaap:StockAppreciationRightsSARSMember2023-01-012023-12-300000896264us-gaap:StockAppreciationRightsSARSMember2021-01-032022-01-010000896264us-gaap:StockAppreciationRightsSARSMember2022-01-022022-12-310000896264us-gaap:StockAppreciationRightsSARSMemberusna:VestingAnnuallyMember2023-01-012023-12-300000896264us-gaap:StockAppreciationRightsSARSMember2023-12-300000896264us-gaap:StockAppreciationRightsSARSMember2022-01-010000896264us-gaap:StockAppreciationRightsSARSMember2022-12-310000896264us-gaap:StockAppreciationRightsSARSMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-300000896264us-gaap:StockAppreciationRightsSARSMemberus-gaap:AdditionalPaidInCapitalMember2022-01-022022-12-310000896264us-gaap:StockAppreciationRightsSARSMemberus-gaap:AdditionalPaidInCapitalMember2021-01-032022-01-010000896264us-gaap:RestrictedStockUnitsRSUMemberusna:VestingAnnuallyMember2023-01-012023-12-300000896264us-gaap:ShareBasedPaymentArrangementNonemployeeMemberusna:DeferredStockUnitsMemberusna:VestingEachQuarterMember2023-01-012023-12-300000896264us-gaap:RestrictedStockMember2023-12-300000896264us-gaap:RestrictedStockUnitsRSUMember2022-12-310000896264us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-300000896264us-gaap:RestrictedStockUnitsRSUMember2023-12-300000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-300000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2022-01-022022-12-310000896264us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AdditionalPaidInCapitalMember2021-01-032022-01-010000896264us-gaap:RestrictedStockUnitsRSUMember2022-01-022022-12-310000896264us-gaap:RestrictedStockUnitsRSUMember2021-01-032022-01-010000896264usna:CashSettledRestrictedStockUnitsMember2022-12-310000896264usna:CashSettledRestrictedStockUnitsMember2023-01-012023-12-300000896264usna:CashSettledRestrictedStockUnitsMember2023-12-300000896264usna:DeferredStockUnitsMember2023-01-012023-12-300000896264usna:DeferredStockUnitsMember2022-01-022022-12-310000896264usna:DeferredStockUnitsMember2021-01-032022-01-010000896264usna:PerformanceStockUnitsMember2023-01-012023-12-300000896264srt:MinimumMemberusna:PerformanceStockUnitsMember2023-01-012023-12-300000896264usna:PerformanceStockUnitsMembersrt:MaximumMember2023-01-012023-12-300000896264usna:PerformanceStockUnitsMember2022-01-022022-12-310000896264usna:PerformanceStockUnitsMember2021-01-032022-01-010000896264usna:PerformanceStockUnitsMember2023-12-300000896264usna:PerformanceStockUnitsMemberusna:A100OfTargetNumberUnitsMember2023-12-300000896264usna:PerformanceStockUnitsMemberusna:A100OfTargetNumberUnitsMember2023-01-012023-12-30usna:customer0000896264usna:PerformanceStockUnitsMemberusna:A150OfTargetNumberUnitsMember2023-12-300000896264usna:PerformanceStockUnitsMemberusna:A150OfTargetNumberUnitsMember2023-01-012023-12-300000896264usna:PerformanceStockUnitsMemberusna:A200OfTargetNumberUnitsMember2023-12-300000896264usna:PerformanceStockUnitsMemberusna:A200OfTargetNumberUnitsMember2023-01-012023-12-30usna:segment0000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-300000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2022-01-022022-12-310000896264usna:DirectSellingMemberus-gaap:OperatingSegmentsMember2021-01-032022-01-010000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-300000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2022-01-022022-12-310000896264usna:AllOtherMemberus-gaap:OperatingSegmentsMember2021-01-032022-01-010000896264usna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-300000896264usna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-022022-12-310000896264usna:USANANutritionalsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-032022-01-010000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:USANAFoodsMember2023-01-012023-12-300000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:USANAFoodsMember2022-01-022022-12-310000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:USANAFoodsMember2021-01-032022-01-010000896264usna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-300000896264usna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-022022-12-310000896264usna:PersonalCareAndSkincareMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-032022-01-010000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:AllOtherMember2023-01-012023-12-300000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:AllOtherMember2022-01-022022-12-310000896264us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMemberusna:AllOtherMember2021-01-032022-01-010000896264usna:GreaterChinaMember2023-01-012023-12-300000896264usna:GreaterChinaMember2022-01-022022-12-310000896264usna:GreaterChinaMember2021-01-032022-01-010000896264usna:SoutheastAsiaPacificMember2023-01-012023-12-300000896264usna:SoutheastAsiaPacificMember2022-01-022022-12-310000896264usna:SoutheastAsiaPacificMember2021-01-032022-01-010000896264usna:NorthAsiaMember2023-01-012023-12-300000896264usna:NorthAsiaMember2022-01-022022-12-310000896264usna:NorthAsiaMember2021-01-032022-01-010000896264srt:AsiaPacificMember2023-01-012023-12-300000896264srt:AsiaPacificMember2022-01-022022-12-310000896264srt:AsiaPacificMember2021-01-032022-01-010000896264usna:AmericasAndEuropeMember2023-01-012023-12-300000896264usna:AmericasAndEuropeMember2022-01-022022-12-310000896264usna:AmericasAndEuropeMember2021-01-032022-01-010000896264usna:GreaterChinaMember2023-12-300000896264usna:GreaterChinaMember2022-12-310000896264usna:SoutheastAsiaPacificMember2023-12-300000896264usna:SoutheastAsiaPacificMember2022-12-310000896264usna:NorthAsiaMember2023-12-300000896264usna:NorthAsiaMember2022-12-310000896264srt:AsiaPacificMember2023-12-300000896264srt:AsiaPacificMember2022-12-310000896264usna:AmericasAndEuropeMember2023-12-300000896264usna:AmericasAndEuropeMember2022-12-310000896264country:CN2023-01-012023-12-300000896264country:CN2022-01-022022-12-310000896264country:CN2021-01-032022-01-010000896264country:US2023-01-012023-12-300000896264country:US2022-01-022022-12-310000896264country:US2021-01-032022-01-010000896264country:KR2023-01-012023-12-300000896264country:KR2022-01-022022-12-310000896264country:KR2021-01-032022-01-010000896264country:US2023-12-300000896264country:US2022-12-310000896264country:US2022-01-010000896264country:CN2023-12-300000896264country:CN2022-12-310000896264country:CN2022-01-010000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-12-310000896264usna:SecSchedule1209AllowanceSalesReturnsMember2023-01-012023-12-300000896264usna:SecSchedule1209AllowanceSalesReturnsMember2023-12-300000896264us-gaap:AllowanceForCreditLossMember2022-12-310000896264us-gaap:AllowanceForCreditLossMember2023-01-012023-12-300000896264us-gaap:AllowanceForCreditLossMember2023-12-300000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-12-310000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2023-01-012023-12-300000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2023-12-300000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-01-010000896264usna:SecSchedule1209AllowanceSalesReturnsMember2022-01-022022-12-310000896264us-gaap:AllowanceForCreditLossMember2022-01-010000896264us-gaap:AllowanceForCreditLossMember2022-01-022022-12-310000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-010000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-022022-12-310000896264usna:SecSchedule1209AllowanceSalesReturnsMember2021-01-020000896264usna:SecSchedule1209AllowanceSalesReturnsMember2021-01-032022-01-010000896264us-gaap:AllowanceForCreditLossMember2021-01-020000896264us-gaap:AllowanceForCreditLossMember2021-01-032022-01-010000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-020000896264us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-032022-01-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM 10-K
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 30, 2023
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number: 001-35024
______________________________
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Utah87-0500306
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
3838 West Parkway Blvd., Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)
(801) 954-7100
(Registrant’s telephone number, including area code)
______________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 per shareUSNANew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
______________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Yes x No o
Large Accelerated Filer
xAccelerated filer o
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☑
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements
of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
The aggregate market value of common stock held by non-affiliates of the registrant as of July 1, 2023, was approximately $699,225,000 based on a closing market price of $63.04 per share.
There were 19,240,514 shares of the registrant’s common stock outstanding as of February 23, 2024.
DOCUMENTS INCORPORATED BY REFERENCE

The registrant incorporates by reference into Part III (Items 10, 11, 12, 13, and 14) of this report certain information contained in its Definitive Proxy Statement to be filed with the Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year ended December 30, 2023, in connection with the registrant’s 2024 Annual Meeting of Shareholders to be held May 6, 2024.
Auditor Name: KPMG LLP
Auditor Location: Salt Lake City, Utah
Auditor Firm ID: 185

USANA HEALTH SCIENCES, INC.
FORM 10-K
For the Fiscal Year Ended December 30, 2023
INDEX
Page

Item 11
Executive Compensation
Item 12
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13
Certain Relationships and Related Transactions, and Director Independence
Item 14
Principal Accounting Fees and Services

Cautionary Note Regarding Forward-Looking Statements and Certain Risks
This report contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include, but are not limited to, statements regarding future financial results, long-term value creation goals, productivity, raw material prices and related costs, supply chain, asset impairment, litigation, sustainability and environmental, social and governance (“ESG”) efforts, compliance with current or proposed international laws and regulations, the impact of COVID-19 or other pandemics, or geo-political tensions, conflicts or wars on our operations. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely unduly on forward-looking statements.
Although we believe that the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those we project or assume in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission (“SEC”). Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date hereof. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, the occurrence of unanticipated events or otherwise. Among the important factors that could cause our actual results, performance and achievements to differ materially from estimates or projections contained in our forward-looking statements in this report are the following:
•Our dependence upon the direct selling business model to distribute our products and the activities of our independent Associates;
•Extensive regulation of our business model and uncertainties relating to the interpretation and enforcement of applicable laws and regulations governing direct selling and anti-pyramiding in the United States, China, and other markets where we have operations;
•The operation and expansion of our business in China through our subsidiary, BabyCare Holdings, Ltd. (“BabyCare”), including risks related to (i) operating in China in general, (ii) engaging in direct selling in China, (iii) BabyCare’s business model in China, (iv) new and expanded data privacy and security laws and regulations in China, and (v) changes in the Chinese economy, marketplace or consumer environment;
•Unanticipated effects of changes to our Compensation Plan;
•Challenges associated with our planned expansion into new international markets, delays in commencement of sales or product offerings in such markets, delays in compliance with local marketing or other regulatory requirements, or changes in target markets;
•Macroeconomic conditions and other factors, including inflationary pressures, slower economic growth or recession, general conditions affecting consumer spending or discretionary income, or disruptions to our supply chain;
•Any resurgence of the COVID-19 pandemic and its impact, which is highly unpredictable and could be significant and could harm our business, operations, and financial results;
1
•Political events, natural disasters, pandemics, epidemics or other health crises including, and in addition to, COVID-19, or other events that may negatively affect economic conditions, consumer spending or consumer behavior;
•Changes in the legal and regulatory environment including environmental, health and safety regulations, data security and privacy, and trade policies and tariffs, the impact of customs, duties, taxation, and transfer pricing regulations, as well as regulations governing distinctions between and our responsibilities to employees and independent contractors;
•Geo-political tensions or conflicts, including impacts from the conflicts involving Russia and Ukraine, and Israel and Palestine, deterioration in foreign relations, as well as disputes or tensions among other countries around the world in general or among the United States, China, and other countries;
•Volatile fluctuation in the value of foreign currencies against the U.S. dollar;
•Noncompliance by us or our Associates with any data privacy or security laws or any security breach by us or a third party involving the misappropriation, loss, destruction or other unauthorized use or disclosure of confidential information;
•Shortages of raw materials, disruptions in the business of our contract manufacturers, significant price increases of key raw materials, and other disruptions to our supply chain;
•Our continued compliance with debt covenants in our Credit Facility;
•Litigation, tax, and legal compliance risk and costs, especially if materially different from the amount we expect to incur or have accrued for, and any disruptions caused by the same;
•Information technology system failures, data security breaches, data security and privacy compliance, network disruptions, and cybersecurity attacks; and
•Acquisition, divestiture, and investment-related risks, including risks associated with past or future acquisitions.
Unless otherwise indicated or otherwise required by the context, the terms “we,” “our,” “it,” “its,” “Company,” and “USANA” refer to USANA Health Sciences, Inc. and its wholly owned subsidiaries.
2
PART I
Item 1. Business
General
USANA Health Sciences, Inc. is a global direct-selling nutrition, personal health and wellness company. In 2023, we generated $921 million in net sales and finished the year with approximately 483,000 active Customers worldwide. We were founded in 1992 by Myron W. Wentz, Ph.D. and since that time, we have developed and manufactured high quality, science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 25 geographic markets worldwide, where we distribute and sell our products by way of direct selling. Mainland China (“China”) is our largest market and single largest source of revenue, representing approximately 46.4% of net sales and approximately 48.9% of active Customers. Late in the fourth quarter of 2023, we commenced operations in our newest market, India. We distribute our products through the direct selling channel, because we believe it is the most conducive sales channel to meeting our vision, which is improving the overall health and nutrition of individuals and families around the world. As a U.S.-based multi-national corporation with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we manufacture, and sell, and our method of distribution. We are a U.S. public company listed on the New York Stock Exchange ("NYSE") and subject to the rules of the SEC.
Our customer base is primarily comprised of two types of customers: “Associates” and “Preferred Customers” referred to collectively as “active Customers.” Our Associates also sell our products to retail customers. Associates share in our company vision by acting as independent distributors of our products, in addition to purchasing our products for their personal use. In 2023, we launched our Affiliate program in the United States, Canada, and Mexico and are evaluating introducing the program in other markets. This program offers another sales and compensation opportunity to individuals who are interested in selling USANA products. Affiliates are discussed and reported in this report as part of our Associates. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. We only count as active Customers those Associates and Preferred Customers who have purchased from us at any time during the most recent three-month period.
This “Item 1. Business” provides detailed information about our world-wide business, including who we are, what we do and where we are headed. Unless otherwise specified, current information reported in this Annual Report on Form 10-K for the fiscal year ended December 30, 2023 (this “report” or “Annual Report”) is as of or for the fiscal year ended December 30, 2023. We also discuss the development of our company and the geographic areas where we do business. For the year ended December 30, 2023, there were no material changes to our corporate structure or our method of conducting business.
Current Focus and Growth Strategy
In 2024, we plan to continue to execute our global growth strategy which remains focused on increasing the number of active Customers in each of our markets. We plan to do this by (i) increasing in-person and digital engagement with our Associates around the world; (ii) implementing and executing market specific promotional and incentive strategies; (iii) continuing to advance our digital commerce initiatives to support our business; (iv) introducing new products, and continuing to pursue product development and further leveraging our foods manufacturing facility; (v) focusing on our China market and our customer base in that market; (vi) pursuing growth in India and evaluating further international expansion; and (vii) advancing our business development strategy by evaluating new acquisition opportunities and growing the two companies we acquired in 2022. Further information on these strategies is set out below.
Associate Engagement
We will continue to offer, promote, and advance in-person engagement events, and incentive trips with our Associates. Our engagement efforts will include an increase in smaller meetings and events in our various markets, as well as continuing to promote and offer our large scale events like our China National Meeting and Asia Pacific Convention. Our objective continues to be increasing and improving collaboration amongst our management team, Associates and their customers. We will also continue to simplify and condense our promotional and marketing messaging by supporting our Associates in focusing on the science-based differentiation of USANA's products, which includes our proprietary
3
InCelligence Technology®. InCelligence™ is our patented technology that supports the body's natural ability to nourish, protect and renew itself.
Market-Specific Strategies
We will continue to pursue market-specific strategies to facilitate customer growth and strengthen our business around the world. While we plan to increase the cadence of promotional and incentive activity across our regions, we will continue to execute strategically timed, market- and region-specific incentives in lieu of larger, world-wide incentive offerings. We also plan to continue offering strategically timed product promotions to increase product demand and drive customer growth.
Digital Commerce Initiatives
We will continue to invest in, expand, and enhance our digital capabilities to increase our number of active Customers, increase Associate engagement and improve our overall customer experience. In particular, we will continue to enhance our digital tools surrounding the development of promotional and marketing assets for our Associates, our onboarding program, Affiliate program, shopping cart, and other key Associate resources.

Product Development
We will continue to invest in research and development and product innovation to ensure that USANA remains a leader in clinical nutrition. We also plan to introduce new science-based products in 2024 and over the next several years. Our foods plant ("USANA North" facility) in Salt Lake City, UT, houses the manufacturing for our foods-related products. In 2023, we moved more of the production of our Active Nutrition products to USANA North and plan to do the same in 2024. In 2023, we also moved the production of Rise Bar's products to USANA North to realize cost savings, increase production efficiency, and provide Rise Bar with increased capacity to grow its customer base. We plan to increase Rise Bar production in 2024. Overall, we believe our investment in USANA North allows us to be more agile and cost efficient in responding to both current and future opportunities.
China Strategy
We will continue to increase and execute our strategic initiatives in China, some of which include:
•Targeting a new customer demographic in China through simple, easy-to-use, digitally-based customer acquisition, fulfillment and service initiatives.
•Enhancing our digital capabilities, which entails continued digital investments to improve the overall customer experience. These investments continue to target improving our (i) onboarding process; (ii) shopping experience and app; and (iii) promotional, marketing and training assets.
•Expanding third-party research, collaborations, and partnerships, including those with the National Sports Training Bureau and Beijing University of Chinese Medicine (China).
India and International Expansion
Late in the fourth quarter of 2023, we commenced operations in India and are optimistic about the long-term growth potential of this new market. In 2024, we will continue to execute our post-launch market growth strategy by supporting our India team, expanding the portfolio of products we offer in India, and enhancing our promotional and marketing assets in the market. We continue to believe that growth opportunities exist in new international markets and will continue to evaluate new market opportunities for USANA's business.
Business Development
Our strong balance sheet and our willingness to invest in growth continues to allow us to pursue a wide-range of opportunities that are additive to our long-term success. We will continue to pursue acquisition opportunities in the health and wellness space that strengthen, diversify, and grow our world-wide business by focusing on: (i) overall nutrition, (ii) vertical integration, (iii) product and category expansion, and (iv) geographic expansion.
In 2022, we completed the acquisition of two companies, Rise Bar and Oola Global, LLC "(Oola"). Rise Bar manufactures and sells high-quality protein bars that are formulated to help customers achieve their health goals through clean and simple ingredients. Oola is an emerging direct selling company that offers a personal development framework
4
that helps individuals create a life of balance, growth, and purpose. As Rise Bar and Oola continue to operate and grow independently of USANA, we will continue to leverage their knowledge, experience, and technology to grow USANA’s core business. We will also continue to utilize USANA's assets and resources to support growth objectives for Rise Bar and Oola. For further details of these acquisitions, see Note B to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Products
The following table summarizes information concerning the principal product lines of our Direct-selling segment.
Product Line/CategoryDescriptionPercent of Product
Sales by Fiscal Year		Product examples
USANA® Nutritionals Optimizers
Consists of targeted supplements designed to meet individual health and nutritional needs. These products support needs such as cardiovascular health, skeletal/structural health, and digestive health and are intended to be used in conjunction with the Essentials/CellSentials
2023 – 71%
2022 – 70%
2021 – 68%
Proflavanol®
CoQuinone® 30
BiOmega-3™
Essentials/CellSentials®(1)
Includes core vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group beginning with children 13 months of age.
2023 – 16%
2022 – 17%
2021 – 18%
USANA CellSentials
Essentials
HealthPak 100™
Foods(2)
Includes meal replacement shakes, snack bars, and other related products that promote healthy weight management, digestive health, energy and hydration through a holistic approach. These products can be used along with Essentials and Optimizers to provide a complete and healthy diet and sustained energy throughout the day.
2023 – 7%
2022 – 7%
2021 – 7%
Nutrimeal
Fibergy
RESET™ weight-management program
Personal care and Skincare
Includes our premium science-based personal care products and Celavive, our innovative skincare system formulated with our USANA InCelligence Technology®. Celavive offers a comprehensive skincare regimen benefiting multiple skincare types and ethnicities, upgraded science, and more noticeable user benefits.
2023 – 5%
2022 – 5%
2021 – 6%
Vitalizing Serum
Protective Day Cream
Replenishing Night Cream
Protective Day Cream
Perfecting Toner
All OtherIncludes materials and online tools that are designed to assist our Associates in building their businesses and in marketing our products.
2023 – 1%
2022 – 1%
2021 – 1%
Associate Starter Kit
Product Brochures
Logo Merchandise
(1) Represents a product line consisting of multiple products.
(2) Includes our Active Nutrition line.
In addition to the products described above, we offer products designed specifically for prenatal, infant, and young-child age groups in China. As we continue to focus on innovation, we will look for innovative product opportunities such as our Celavive and Active Nutrition product lines.
5
Total product sales, as a percentage of net sales, represented by our top-selling products for the last three fiscal years is as follows:
Year Ended
202320222021
Key Product
USANA Essentials/CellSentials(1)
10 %11 %12 %
Proflavanol10 %10 %10 %
Probiotic9 %10 %9 %
(1) Represents specific products within the product line Essentials/CellSentials
Other top-selling products include our Hepasil, Soy Lecithin, and HealthPak™.
Geographic Presence
We have ongoing operations in the following markets, which are presented in two geographic regions: (1) Asia Pacific, and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia. The countries included in these regions and sub-regions are described below:
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India(2)
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
(2) We commenced operation in this market near the end of the fourth quarter of 2023
Impact of Foreign Currency Exchange
Because we have operations in multiple markets, with sales and expenses generated and incurred in multiple currencies, our reported U.S. dollar sales and earnings can be significantly affected by fluctuations in currency exchange rates. In general, our operating results are affected positively by a weakening of the U.S. dollar and negatively by a strengthening of the U.S. dollar. In 2023, net sales outside of the United States represented approximately 89.6% of consolidated net sales.
Research and Development
We focus our research and development (“R&D”) efforts on developing and bringing to market high quality, science-based products that promote long-term health and wellness. Our R&D activities include developing products that are new to USANA and new to the industry, updating existing USANA-brand formulas to keep them current with the latest science, and adapting existing formulas to meet ever-changing consumer preferences, and regulations in global markets.
When developing and manufacturing our products, we follow the highest applicable industry quality standards, as established by the U.S. Food and Drug Administration (“FDA”), U.S. Pharmacopeia (“USP”), and other leading non-governmental agencies (“NGO”). Our ingredients are selected to meet a number of criteria and our quality control is maintained through controlled sourcing of raw ingredients, manufacturing, packaging and labeling, with testing occurring at multiple stages throughout the manufacturing process.
6
Our scientific staff includes experts on human nutrition, cellular biology, biochemistry, genetics, the microbiome, natural product chemistry, foods and cosmetic science, and clinical research. These experts continually review the latest published research on nutrition, present their findings at scientific conferences, publish in scientific journals, and collaborate with third-party researchers and institutions to identify possible new products and product upgrade opportunities.
The R&D team is also involved in protecting our proprietary position with exclusive ingredients, proprietary formulations, product-specific scientific validation, and in some cases, patent protection. Research continues to support our proprietary InCelligence technology, advances in microbiome supplementation, immune system support, stress adaptation, healthy aging, and brain health. In 2023, our research team experienced growth as we dedicated more resources to explore ingredients with a specific emphasis on cell-signaling. This expansion aims to uncover new leads for developing proprietary formulas intended to positively impact cellular health.
Our in-house research team has established and maintained good working relationships with scientists at a number of universities and research institutes, including the University of Washington, the University of Utah, The Foods for Health Institute at The University of California Davis, Roseman University of Health Sciences, University of Memphis, Beijing University of Chinese Medicine (China) ("BUCM"), Peking University (China), Central Queensland University (Australia), University of Ghent (Belgium), and other academic institutions globally. These relationships help us continue to advance our knowledge, expertise and leadership in several areas of applied human nutrition. Working with these partners, we select products at all stages of development for preclinical and clinical studies, including funding multiple studies through BUCM. These preclinical and clinical studies are focused on cell-signaling and traditional Chinese medicine to serve as a pipeline of innovative ingredients. During 2023, we had seven clinical studies underway at multiple stages of completion. For completed studies, we published on manuscript, with the others currently under data analysis or manuscript preparation.
In fiscal years 2023, 2022, and 2021, we expended $11.4 million, $11.6 million, and $11.1 million, respectively, on product R&D activities. We expect to continue investing in R&D to advance our expertise and leadership in cellular nutrition, as well as overall health and wellness. In 2024, we plan to shift spending towards increased investments into early stage research and scientific investigations as we believe our trusted history of scientifically-supported products is a sustainable competitive advantage that provides a substantial barrier to entry for competitors who wish to enter our space.
Manufacturing and Quality Assurance
We conduct manufacturing, production and quality control operations for approximately 67% of our products in-house. We have established and maintain a manufacturing and quality control facility at our corporate headquarters in Salt Lake City, Utah. In 2019, we added a 54,000 square foot manufacturing facility located adjacent to our corporate headquarters, which expanded our manufacturing capabilities to allow us to manufacture our food products in-house. This adjacent facility started to produce product during the fourth quarter of 2020. BabyCare manufactures and produces the majority of its products in-house and maintains manufacturing and quality control facilities in Beijing, China and Tianjin, China.
7
Manufacturing
Our production process uses automatic and semi-automatic equipment and includes the following activities by type:
Tablet
Manufacturing		Foods
Manufacturing		Personal Care and Skincare
Manufacturing
Auditing and qualifying suppliers of raw materialsxxx
Acquiring raw materialsxxx
Analyzing raw material qualityxxx
Weighing or otherwise measuring raw materialsxxx
Mixing raw materials into batchesxxx
Forming mixtures into tabletsx
Converting batches into bars and/or finished powdersx
Coating and sorting the tabletsx
Analyzing tablet qualityx
Analyzing bars and/or finished powder qualityx
Analyzing liquid batch qualityx
Packaging finished productsxxx
Analyzing finished product qualityxxx
We conduct sample testing of raw materials, in-process materials, and finished products for purity, potency, and composition to determine whether our products conform to our internal specifications, and we maintain complete documentation for each of these tests. We employ a qualified staff of professionals to develop, implement and maintain a quality system designed to assure that our products are manufactured to our internal and applicable regulatory agency specifications.
Our Salt Lake City, Utah manufacturing facilities are registered, as required, with the FDA, Health Canada Natural Health Products Directorate, the Australian Therapeutic Goods Administration (“TGA”), and other governmental agencies. These and other various organizations and government agencies regularly audit this facility to assess, among other things, compliance with current Good Manufacturing Practices (“GMPs”) and with labeling claims. Additionally, our Salt Lake City, Utah manufacturing facilities are certified, through inspection and audits, with the Islamic Foods and Nutrition Counsel of America in compliance with Halal, The Organized Kashrus Laboratories in compliance with Kosher, NSF International in compliance with product testing and GMPs, and the TGA in compliance with the current Therapeutic Goods Act in Australia.
The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs and pharmaceutical GMPs, with additional requirements that are specific to dietary supplements. We are audited by the FDA, specifically for dietary supplements, and have historically been found to be in compliance with GMPs for dietary supplements. Although the FDA has not promulgated GMPs for personal care items, it has issued guidelines for manufacturing personal care products. We voluntarily maintain compliance with the guidance established by the FDA and the Personal Care Products Council.
Our Beijing, China manufacturing facility is registered with State Administration of Market Regulation (“SAMR”), which includes the China Food and Drug Administration. Our facility in Beijing is audited regularly by various organizations and government agencies to assess, among other things, compliance with applicable GMPs, and with labeling claims.
Third-Party Suppliers and Manufacturers
We contract with third-party suppliers and manufacturers for the production of certain of our products, which account for approximately 33% of our product sales. These third-party suppliers and manufacturers produce and, in most cases, package these products according to formulations that have been developed by or in conjunction with our in-house product development team. These products include most of our gelatin-capsulated supplements, Rev3 Energy® Drink,
8
Probiotics, and powdered drink mixes. In 2024, our intention is to continue transitioning the production of our powdered drink mixes to our USANA North facility.
Products manufactured by third-party suppliers at their locations must also pass through quality control and assurance procedures to ensure they are manufactured in conformance with our specifications. As noted above, with the expansion of our manufacturing facility in Salt Lake City, Utah, we are able to manufacture our foods product line. Additionally, we plan to increase the proportion of the personal care and skincare products that we manufacture. This will reduce our reliance on third-party suppliers and manufacturers and add to our operating strengths, which are described below in this Annual Report.
Quality Control and Assurance
We have in-house microbiology and analytical chemistry labs in which we conduct quality control processes. In our microbiology laboratory, scientists test for biological contamination of raw materials and finished goods. In our analytical chemistry laboratory, scientists test for chemical contamination and accurate levels of active ingredients in both raw materials and finished products. Scientists also identify and confirm all raw materials used in the manufacturing process through scientifically valid means. Both laboratories conduct stability tests on finished products to determine the shelf life of our products. Our Salt Lake City, Utah laboratory staff also performs chemical assays on vitamin and mineral constituents, using USP methods and other internally validated methods. In addition to our quality control and clinical laboratories, both our headquarters and China facilities also house a laboratory designated for R&D.
Raw Materials
Most of the raw ingredients used in the manufacture of our products are available from a number of suppliers. Our raw material suppliers must demonstrate stringent process and quality control before we use their products in our manufacturing process. When supplies of certain raw materials have tightened, we have been able to find alternative sources of raw materials, and believe we will be able to do so in the future, if the need arises.
Distribution and Marketing
General
We distribute our products internationally through direct selling, which entails person-to-person marketing and selling of products. Direct selling is based on the strength of personal relationships and recommendations that frequently come from friends, neighbors, relatives, and close acquaintances. We believe that direct selling is an effective way to distribute our products because it allows person-to-person product education, as well as higher levels of customer service, all of which are not as readily available through other distribution channels.
Structure of Direct Selling Program
Overview. Although our direct selling philosophy and strategy are generally consistent in our markets around the world, certain aspects of our business may differ from market to market as a result of different legal and regulatory regimes, operational requirements or other factors. These differences may include how individuals join USANA, the compensation they are paid, the products they sell, and other components of their relationship with USANA. For example, China has enacted and maintains unique business laws and regulations governing direct selling that differ materially from our other markets around the world. Consequently, we have adjusted our direct selling program in China to comply with these laws and regulations. To do this, we operate our business in China through BabyCare. BabyCare utilizes a business model in China that is consistent with the philosophy of our world-wide business model, but differs in structure from our other markets. These differences are explained below under “China Business.”
Associates. Outside of China, a person who wishes to sell USANA products must join our independent sales force as an Associate. A person becomes a USANA Associate by completing an application under the sponsorship of an existing Associate. The new Associate then becomes part of the sponsoring Associate’s sales organization. New Associates must agree to adhere to the USANA policies and procedures. Under our policies and procedures, Associates may not, among other things: (i) use deceptive or unlawful practices to sell USANA products; (ii) make deceptive or unlawful claims or representations concerning our products or Compensation Plan; or (iii) sell competitive products to other USANA Associates or solicit USANA Associates to participate in other direct selling opportunities. Associates who violate our policies are subject to discipline, which may include the termination of their purchase and distribution rights. New Associates are required to purchase a starter kit that includes a detailed manual describing our business and products, as well as our policies and procedures. We sell these kits at a nominal price averaging approximately $15 in each of our
9
markets and these kits are fully refundable under our return policy, which is described elsewhere in this report. No other direct investment is required to become an Associate.
Once a person becomes an Associate, she, he, or they may purchase products directly from us at wholesale prices for their personal use and for resale to customers. Our Associates are also entitled to build sales organizations by attracting, enrolling and selling product to new customers. Associates are not required to recruit or sponsor new Associates and we do not compensate Associates for sponsoring or recruiting Associates. The sponsoring of new Associates results in the creation of multiple levels within our direct selling structure. Sponsored Associates are referred to as part of the sales organization of the sponsoring Associate. New Associates in turn may sponsor new Associates and Preferred Customers, creating additional levels in their sales network, but also forming a part of the same sales organization as the original sponsoring Associate. As outlined below, Associates who are interested in earning income with USANA must successfully sell USANA products and establish a network of product consumers in order to qualify for commissions, including bonuses. Subject to payment of a minimal annual account renewal fee, Associates may continue to distribute or consume our products as long as they adhere to our policies and procedures.
Associate Compensation. This section describes our Associate Compensation Plan generally, except for our China operations, which are discussed separately below under the caption “China Business.” Our Compensation Plan provides several opportunities for Associates to earn compensation, provided they are willing to work consistently at (i) sharing, marketing and selling USANA products to consumers and (ii) building, training, and retaining their sales organizations. The purpose behind each form of compensation under our Compensation Plan is to reward committed Associates for generating product sales either directly or indirectly through their sales organization and network of product consumers.
Associates can earn compensation under the Compensation Plan in four ways:
•Commissions. The primary way an Associate is compensated is through earning commissions. Associates earn commissions by generating sales volume points, which are based on product sales of their sales organization. We have assigned each of our products a sales volume point value comprised of a certain percentage of the product price in U.S. dollars. To be eligible to earn commissions, an Associate must sell a certain amount of product each month. Associates do not earn commissions for simply recruiting and enrolling others in their organization. Commissions are paid only on the sale of products. In most markets, we pay Associates their commissions on a weekly basis.
•Bonuses. We offer Associates several bonus opportunities, including our leadership bonus, elite bonus, and lifetime matching bonus. These bonus opportunities are based on a pay-for-performance philosophy and, therefore, are paid out when the Associate achieves certain performance measures.
•Retail Mark-Ups. As discussed previously, in markets where retail mark-ups are permitted, our Associates purchase products from us at the Preferred Price and may resell them to consumers at higher retail prices. This allows the Associate to retain the retail mark-up as another form of compensation.
•Contests and Promotions. We regularly sponsor contests and promotions designed to incentivize Associates to generate sales, grow their active Customer base and ultimately increase the number of USANA product users. These promotions are also based on a pay-for-performance philosophy and, therefore, are only paid upon the achievement of certain objectives.
With the exception of our China market (discussed below), we endeavor to integrate our Compensation Plan across markets where legally permissible, allowing Associates to receive commissions for global product sales. This sales organization structure is designed to allow Associates to build a global network by establishing or expanding their sales organization in the markets where we operate. We believe our Compensation Plan significantly enhances our ability to expand internationally, and we intend to continue to integrate new markets, where permitted, into our Compensation Plan.
Preferred Customers and Retail Customers. We also sell products directly to Preferred Customers and retail customers who purchase the products only for their personal use. Preferred Customers enroll with USANA, generally through an introduction by an Associate, and purchase product directly from the Company. Retail customers, however, generally purchase directly from Associates. Neither Preferred Customers nor retail customers may resell or distribute our products, regardless of where they purchased them. To sell USANA products, a Preferred Customer or retail customer must become an Associate.
These various customer programs give us access to a customer market that would otherwise be missed, by targeting consumers who enjoy USANA products, but who prefer not to maintain a distribution relationship with us.
10
Although our policies prohibit Preferred Customers and retail customers from engaging in retail sales of products, they may enroll as Associates at any time in the future, if they desire.
Affiliate program. We offer an Affiliate Program where Affiliates receive unique links to share with others. Affiliates earn a commission on all orders placed through their links, with commission percentages ranging from 15-20% of the product sale amount based on the product category.
China Business. As explained above, the Chinese government maintains direct selling laws and regulations that differ materially from our other markets around the world. Although these laws and regulations permit direct selling, they impose a number of financial and operational restrictions, including a prohibition of pyramid selling and multi-level compensation systems. The Chinese government has also implemented a number of administrative and regulatory measures around direct selling to control these prohibited activities. To reduce the risk that the Chinese government might view BabyCare’s business model as conflicting with these laws and regulations, BabyCare utilizes a business model that is different from the model we use elsewhere in the world. BabyCare’s business model has been developed specifically for the China market and is based on, among other things: (i) BabyCare’s communications with the Chinese government, (ii) BabyCare’s interpretation of China's direct selling laws and regulations, as well as its understanding of how the government interprets and enforces these laws and regulations, and (iii) BabyCare’s understanding of how other multinational direct selling companies operate in China. Consequently, individuals who join BabyCare in China are compensated under BabyCare’s compensation plan, which has been established for China. Notwithstanding the foregoing, BabyCare has not received approval from the Chinese government that its business model, compensation plan or operations comply with applicable laws and regulations, including those pertaining to direct selling.
BabyCare sells products in China through a variety of methods, including: (a) online through its website; (b) at physical branch retail locations; (c) through direct sellers in provinces and municipalities where BabyCare has received a direct selling license granted by the local provincial government; and (d) through independent distributors who are considered independent business owners under Chinese law. Individuals who reside in China and who are interested in being part of our business in China may do so by enrolling with BabyCare. While the process for enrolling with BabyCare is similar to the process for joining our business in other markets, individuals must initially enroll with BabyCare as a China Preferred Customer ("CPC"). CPCs are similar to Preferred Customers in our other markets, but CPCs may also refer other CPCs in China and receive free product value from us on future product purchases based on the volume of product purchased by CPCs they have referred.
A CPC may become a direct seller or independent distributor (which we report collectively as Associates) in China by electing to do so and agreeing to adhere to BabyCare’s policies and procedures in China. Our direct sellers in China are permitted by our policies and the terms of our direct selling licenses to sell product away from fixed retail locations in the provinces and municipalities where BabyCare has been granted a local direct selling license. Direct sellers are compensated for their sales under BabyCare’s compensation plan and do not receive compensation for promotional, marketing, or sales services that independent distributors are eligible to receive (as described below). Independent distributors are independent business owners who sell BabyCare’s products in China and also provide promotional, marketing, and sales services for BabyCare in China. Under BabyCare’s compensation plan, independent distributors are compensated not only for their own product sales, but also for their productivity in providing promotional, marketing and sales services. BabyCare’s compensation to its independent distributors for these services is intended and designed to be business-to-business compensation under Chinese law. To calculate independent distributor compensation for these services, we (i) use our world-wide Compensation Plan to track sales volume, and other metrics for the group of CPCs, distributors and others in China to whom the independent distributor provides promotional, marketing and sales services on behalf of BabyCare; (ii) calculate the fee-based compensation for the various services performed by the distributor; and (iii) pay the corresponding service fee to the independent distributor in China on a monthly basis. The fee-based compensation we pay our China independent distributors is comparable to the compensation available to our Associates in other markets and competitive with other direct selling companies in China.
BabyCare’s business model, compensation plan, and operations in China involve certain risks and uncertainties, as discussed further in Item 1A. Risk Factors. We endeavor to mitigate these risks and uncertainties through various measures, including by seeking to understand and obey laws and regulations, training our employees and sales force, engaging in dialogue with government officials to better understand their goals and explain our plans, and cooperating in inquiries and other matters of interest to regulators. However, these efforts do not completely eliminate the significant risks associated with BabyCare’s operations in China.
Associate Training and Motivation. Initial training of Associates about USANA, our products and Compensation Plan, and global direct selling in general, is provided primarily by an Associate’s sponsor and others in the Associate’s
11
sales organization. We develop and provide training materials and sales tools to assist Associates in building their businesses, and we provide reprints from commercial publications that feature USANA that may be used as sales tools. We also sponsor and conduct regional, national, and international Associate events, as well as intensive leadership training seminars. Attendance at these sessions is voluntary, and we undertake no generalized effort to provide individualized training to Associates, although experience shows that the most effective and successful Associates tend to be those who participate in such training activities. Although we provide leadership training and sales tools, we ultimately rely on our Associates to sell our products, attract new customers to purchase our products, and to educate and train new Associates regarding our products and Compensation Plan.
Operating Strengths
Our principal objective is to improve the overall health and nutrition of individuals and families around the world. We do this through developing and manufacturing high-quality, science-based nutritional, and personal care and skincare products that promote long-term health, and providing a global direct selling opportunity for our Associates who desire to distribute our products and earn supplemental income. Our strategy is to capitalize on our operating strengths, which include (i) a strong R&D program; (ii) significant in-house manufacturing capability; (iii) high quality science-based products; (iv) an equitable Associate Compensation Plan; (v) a scalable business model; and (vi) an experienced management team.
Emphasis on Research and Development. We have a technical team of experienced scientists, including several holding doctoral degrees, quality engineers, and regulatory specialists who contribute to our R&D activities. In our R&D laboratories, our scientists and researchers:
•Investigate activities of natural extracts and formulated products in laboratory and clinical settings;
•Identify and research combinations of nutrients that may be candidates for new products;
•Develop new nutritional ingredients for use in supplements;
•Study the metabolic activities of existing and newly identified nutritional ingredients;
•Enhance existing USANA brand products, as new discoveries in nutrition, personal care and skincare are made;
•Formulate products to meet diverse regulatory requirements across all of our markets; and
•Investigate processes for improving the production of our formulated products.
Our in-house research team also conducts double-blind, placebo-controlled, clinical studies, which are intended to further evaluate the efficacy of our products. In addition, we collaborate with outside research organizations to further support various aspects of our R&D efforts. Our in-house research team has funded clinical research programs and works closely with scientists at a number of universities and research institutes, including those listed under the caption “Research and Development” above, to maintain our leadership in clinical research in nutrition, oxidative stress, glycemic stress, chronic inflammation and health implications of the microbiome. It is through our internal R&D efforts, as well as our relationships with outside research organizations and health care providers, that we can provide what we believe to be among the highest quality health products in the industry.
In-house Manufacturing. We manufacture products that account for approximately 67% of our product sales. We believe that our ability to manufacture our own products in-house is a significant competitive advantage for the following reasons:
•We can better control the quality of raw materials and finished products;
•We can more reliably monitor the manufacturing process to better guarantee potency and bioavailability and to reduce the risk of product contamination;
•We can better control production schedules to increase the likelihood of maintaining an uninterrupted supply of products for our customers;
•We are able to produce most of our own prototypes in the research phase of product development; and
12
•We are better able to manage the underlying costs associated with manufacturing our products.
Science-based Quality Products. As a result of our emphasis on R&D and our in-house manufacturing capabilities, we have developed a line of high quality products that we believe provide health benefits to our customers. Our products have been developed based on a combination of published research, in-house laboratory and third-party clinical studies, and sponsored research.
Equitable Associate Compensation Plan and Support. We are committed to increasing our product sales by providing a competitive compensation plan that attracts and retains Associates who constitute our sales force. We motivate our Associates by paying incentives on a weekly basis, in most markets. Where permissible, our Compensation Plan is implemented as a global-seamless plan, meaning that Associates can be compensated each week for their business success in any market in which they have product consumers and/or a sales organization where we conduct business. Our China operations maintain their own compensation plan, which is structured differently than our plan in other markets. In China, we pay Associates on a monthly basis.
To support our Associates, we sponsor virtual and in-person meetings and events throughout the year, where we offer information about our products and our global direct selling system. These meetings are designed to assist Associates in business development and to provide a forum for interaction with some of our Associate leaders and with members of our management team. Throughout the COVID-19 pandemic, we held meetings and events with our Associates using a predominantly virtual meeting strategy; however, in markets where health and safety best practices have allowed us to safely do so, we have held in-person meetings. Our strategy in 2024, and going forward, is to offer in-person meetings and events with our Associates to the extent health and safety practices make it possible. Our plan is to continue to leverage a virtual meeting element as a component of our in-person meetings. We also provide low-cost sales tools and resources, which we believe are an integral part of building and maintaining a successful home-based business for our Associates.
In addition to company-sponsored meetings, sales tools and resources, we maintain a website exclusively for our Associates, where they can access the latest USANA news, obtain training materials, manage their personal information, enroll new customers, shop for products, and register for company-sponsored events. Additionally, through this website, Associates can access other online services to which they may subscribe. For example, we offer an online business management service, which includes a tool that helps Associates track and manage their business activity, a personal webpage to which prospects or retail customers can be directed, and e-cards for advertising.
We also believe that recognition is an important factor in supporting and retaining our Associates. We understand that being a successful USANA Associate requires hard work and dedication, and we celebrate key achievements and rank advancements of our Associates. We believe that our recognition programs greatly contribute to our ability to retain our Associates.
Business Model. We believe that our direct-selling business model provides, among others, the following advantages:
•No requirement for a company-employed sales force to sell our products, with a relatively low incremental cost to add a new active Customer;
•Commissions paid to our Associates are tied to sales performance;
•Accounts receivable are minimal because payment is required at the time an active Customer purchases product;
•A stream of recurring revenue generated from our monthly product subscription program known as “Auto Order,” which we utilize in all of our markets (this program offers a 10% price discount and represented 65% of our product sales volume for the year ended December 30, 2023); and
•The ability to expand into new international markets with moderate investment because we generally maintain only warehouse facilities, customer support, and minimal administrative facilities in those international markets. Larger markets, including China, however, require more significant local investment.
Experienced Management Team. Our management team includes individuals with expertise in various scientific and managerial disciplines, including global direct selling, nutrition, product research and development, international development, marketing, sales, information technology, manufacturing, accounting and finance, legal, regulatory, and
13
operations. This team is responsible for supporting growth, R&D, international expansion, strengthening our financial condition, and improving our internal controls.
Competition
Our industry is very competitive and the barriers to entry are not significant. We compete with manufacturers, distributors, and retailers of nutritional products in many channels, including global direct selling, specialty retail stores, wholesale stores, and the internet generally. We also compete with other public and privately owned global network marketers for distributor talent, including for example Amway, Herbalife, and Nu Skin. On both fronts, compared to USANA, some of our competitors are significantly larger, have a longer operating history, higher visibility and name recognition, and greater financial resources. We compete with these entities by emphasizing to our Associates, Preferred Customers, and potential customers the strengths of our business, as described in the "Operating Strengths" section above.
Product Returns
Product returns have not been a material factor in our business, totaling approximately 0.6%, 0.7%, and 0.6% of net sales in 2023, 2022, and 2021, respectively. Customer satisfaction has always been and will continue to be a hallmark of our business. We believe that we have always offered a generous product return policy. Our standard return policy allows customers to receive a 100% refund on the purchase price on all product orders that are unused and returned within the first 30 days following purchase. Additionally, we offer a 100% refund of the sales price on all product orders that are unused and resalable up to one year from the date of purchase. This standard policy differs slightly in a few of our international markets due to applicable regulations in those markets. To avoid manipulation of our Compensation Plan, return of product when the purchase amount exceeds $100 and the product was not damaged at the time of receipt by the Associate may result in cancellation of an Associate’s distributorship.
Major Customers
We sell product to independent Associates, Preferred Customers, and retail customers. No single Associate or Preferred Customer accounted for 10% or more of net sales in any of the last three fiscal years. Notwithstanding the foregoing, the nature of our business model results in a significant amount of sales to several different Associate leaders and their sales organizations. Although no single Associate accounted for 10% or more of our annual net sales, the loss of a key Associate leader or that Associate’s sales organization could adversely affect our net sales and our overall operating results. See “Item 1A. Risk Factors.”
Associate Compliance
Our reputation depends upon the quality of our products and the integrity of our Associates. We continually monitor and review our Associates’ compliance with our policies and procedures as well as the laws and regulations applicable to our business around the world. Part of this review entails an assessment of our Associates’ sales activities to ensure that they are actually selling products to consumers. Our policies and procedures require Associates to present our products and the USANA opportunity ethically and honestly. Associates are not permitted to make claims about our products or Compensation Plan that are not consistent with our policies and procedures and applicable laws and regulations. The majority of our Associates use marketing and promotional materials provided by USANA. Associates are permitted to produce their own marketing and promotional materials. However, prior to doing so, Associates are required to complete an Advertising Certification to help educate them and prevent them from making unapproved product and business claims (with the exception of Mainland China where Associates are only allowed to use advertising material created by the Company).
In the ordinary course of our business, we encounter Associates who fail to adhere to our policies and procedures. We systematically review reports of alleged Associate misbehavior. Infractions of the policies and procedures are reported to our Ethics and Education group, who determine what, if any, disciplinary action is warranted in each case. More serious infractions are also reported to our Ethics Committee, which includes USANA executives. If we determine that an Associate has violated any of our policies and procedures, we may take a number of disciplinary actions, including warnings, fines or probation. Among other measures, we may also withdraw or deny awards, suspend privileges, withhold commissions until specific conditions are satisfied, or take other appropriate actions in our discretion, including termination of the Associate’s purchase and distribution rights.
Because we believe that Associate compliance is critical to the integrity of our business, we are aggressive in ensuring that our Associates comply with our policies and procedures. When an Associate fails to comply with our policies and procedures, we may terminate the Associate’s purchase and distribution rights. From time to time, we become involved
14
in litigation with Associates whose purchase and distribution rights have been terminated. We consider such litigation to be routine and incidental to our business and we will continue to be aggressive in ensuring that our Associates comply with our policies and procedures.
Information Technology
We believe that the ability to efficiently manage sales, active Customer data, distribution, compensation, manufacturing, inventory, accounting and finance, and communication functions through the use of secure, sophisticated, and dependable information processing systems is critical to our success. We continually evaluate changes in the information technology environment in connection with our efforts to capitalize on new technologies, keep pace with regulatory standards, and secure our systems and data. Over the last several years, we have meaningfully invested in technology systems and infrastructure to create a better overall customer experience for our customers and we will continue to invest in this area going forward.
Our information technology resources are maintained primarily by our in-house staff to optimally support our customer base and core business processes. Our IT staff manages an array of systems and processes that support our global operations 24 hours a day and 365 days a year. Below is a list of our most critical applications:
•A web-based application and native mobile applications that provide online services to Associates, such as training sessions, presentations, various communication tools, online shopping, enrollment, a real-time reporting engine, product information, web hosting, email, and other tools to help Associates effectively manage their business and sales organizations;
•A web-based order-entry system that handles order entry, customer information, compensation, Associate business structure, returns, invoices, and other transactional-based processes; and
•A fully integrated world-wide Enterprise Resource Planning (“ERP”) system that handles accounting, human resources, inventory management, production processes, quality assurance, and reporting requirements in a multinational environment.
Our web applications are supported by a clustered environment providing high availability. All systems vital to the functioning of our organization are fully backed up and stored off-site to mitigate the risk of significant interruption of our business in the event of a disaster at the locations of our primary servers.
For information regarding technology-related risks, see the information in “Item 1A: Risk Factors.”
Regulatory Matters
General. In every jurisdiction in which we operate, our business is subject to extensive governmental regulation. These regulations exist at various national and local levels and pertain to our products, direct selling, and other aspects of our business. In this section, we describe the material regulations that are applicable to our business.
Product Regulation. Numerous governmental agencies regulate the formulation, manufacturing, holding, packaging, labeling, advertising, promoting, importing, distributing, shipping, and selling of health supplements, cosmetics, and foods. In the United States, these agencies include the Federal Trade Commission (“FTC”) under the FTC Act, as amended, the FDA, under the Food, Drug, and Cosmetic Act, as amended (“FDCA”) and related regulations, the Consumer Product Safety Commission, the U.S. Department of Agriculture, the Environmental Protection Agency, the United States Customs and Border Patrol, and the United States Postal Service.
Our largest selling product group includes products that are regulated as dietary supplements under the FDCA. Dietary supplements are also regulated in the United States under the Dietary Supplement Health and Education Act of 1994, as amended (“DSHEA”), which we believe is generally favorable to the dietary supplement industry. Some of our powdered drink, food bar, and other nutrition products are regulated as foods under the Nutrition Labeling and Education Act of 1990, as amended (“NLEA”). The NLEA establishes requirements for ingredient and nutritional labeling including product labeling claims. The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs and Pharmaceutical GMPs, with additional requirements that are specific to dietary supplements. We are audited annually by the FDA, specifically for dietary supplements and have been found in compliance with GMPs for dietary supplements. The Dietary Supplement & Nonprescription Drug Consumer Protection Act requires manufacturers of dietary supplements and over-the-counter (“OTC”) products to notify the FDA when they receive reports of serious adverse events occurring within the United
15
States. We have an internal adverse event reporting system that has been in place for several years, and we believe that we comply with this law.
In general, our personal care and skincare products, which are regulated as cosmetic products by the FDA, are not subject to pre-market approval by that agency. Cosmetics, however, are subject to regulation by the FDA under the adulteration and misbranding provisions of the FDCA. Cosmetics also are subject to specific labeling regulations, including warning statements, if the safety of a cosmetic is not adequately substantiated or if the product may be hazardous, as well as ingredient statements and other packaging requirements under The Fair Packaging and Labeling Act. Cosmetics that meet the definition of a drug, such as sunscreens, are regulated as drugs. OTC drug products, including cosmetics, may be marketed if they conform to the requirements of the OTC monograph that is applicable to that drug. Drug products not conforming to monograph requirements require an approved New Drug Application (“NDA”) before marketing may begin. Under these provisions, if the agency were to find that a product or ingredient of one of our OTC drug products is not generally recognized as safe and effective or is not included in a final monograph that is applicable to one of our OTC drug products, we would be required to reformulate or cease marketing that product until it is the subject of an approved NDA or until the time, if ever, that the monograph is amended to include such product.
Advertising of our products in the United States is subject to regulation by the FTC under the FTC Act. Claims by us or our Associates about our products that cannot be adequately substantiated may be considered unfair or deceptive acts or practices and may expose us to liability under the FTC Act. In recent years, the FTC has initiated numerous investigations of and actions against companies that sell dietary supplement, weight-management, and cosmetic products. We believe that we have adequate substantiation for all material advertising claims that we make for our products in the United States, and we believe that we have organized the documentation to support our advertising and promotional practices. However, no assurance can be given that the FTC would reach the same conclusion if it were to review or question our substantiation for our advertising claims in the United States.
The FTC may enforce compliance with the law in a variety of ways both administratively and judicially, using compulsory process, cease and desist orders, and injunctions. FTC enforcement can result in orders requiring, among other things, limits on advertising, corrective advertising, consumer redress, divestiture of assets, rescission of contracts, and such other relief as the agency deems necessary to protect the public. During 2020, for example, the FTC sent warning letters to several nutrition companies and direct-selling companies in connection with advertising claims that the companies and/or their distributor sales people were making about the respective company's product's ability to prevent or treat COVID-19. Failure to adhere to FTC warning letters or other orders can result in substantial financial or other penalties. Although, to our knowledge, we have not been the subject of any action by the FTC, no assurance can be given that the FTC will not question our advertising or other operations in the United States in the future. Any action in the future by the FTC could materially and adversely affect our ability to market our products successfully in the United States.
The manufacturing, labeling, and advertising of our products are also regulated by various governmental agencies outside the United States in each country where they are distributed. In China, our nutritional products are typically classified as “health functional foods” and our personal care and skincare products are classified typically as “non-special use cosmetics.” The registration process for health functional foods in China is complex and can be unpredictable. It generally requires extensive analysis and approval by the SAMR. As a result, it can take several years to register a product as a health functional food in China. While all products currently sold by BabyCare in China have been registered with the SAMR, we continue to work through the registration process for other health functional food products, which we also hope to begin selling through BabyCare in the future. SAMR and other governmental agencies also enforce advertising and other regulations that restrict the ability of health product companies to advertise the benefits of their products in China.
In Australia, the TGA regulates product registration, labeling and manufacturing. In Japan, the Ministry of Health, Labor and Welfare regulates these activities. Upon entering a new market, prior to commencing operations or marketing products, we may be required to obtain approvals, licenses, or certifications from that country’s Food Administration, Ministry of Health or comparable agency. Approvals or licensing may be conditioned on reformulation of USANA products for the particular market or approval or licensing otherwise may be unavailable with respect to certain products or product ingredients in a given market.
We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, would have on our business. Future changes could include requirements for the reformulation of certain products to meet new standards, the recall or discontinuation of certain products that cannot be reformulated, additional record keeping, expanded documentation of the properties of certain products, expanded or different labeling, and additional scientific substantiation.
16
Any or all of these requirements could have a material adverse effect on our business, financial condition, and operating results.
Direct Selling Regulation. Various laws and regulations in all of our markets regulate direct selling. These laws and regulations exist at many levels of government in many different forms, including statutes, rules, regulations, judicial decisions, and administrative orders. Direct selling regulations are inherently fact-based and often do not include “bright line” rules. In most of our markets, these regulations are subject to discretionary interpretation by regulators and respective legal authorities. Consequently, the regulations, or a regulator’s interpretation and enforcement of the regulations, could change at any time. If that were to occur, we may be required to change our business model in the respective market in an effort to comply.
In the United States, the FTC has jurisdiction to regulate direct selling companies under the FTC Act. The FTC’s interpretation of the applicable direct selling laws and regulations has evolved over the last several years as represented in various consent orders between the FTC and certain direct selling companies, guidance issued by the FTC to the direct selling industry and informal communications from the FTC to the industry. The FTC, through these consent orders, guidance and communications, has addressed a variety of consumer protection issues, including misleading earnings representations by a company or its independent distributors, as well as the fairness and legal compliance of a company’s business model and distributor compensation plan. For example, in 2020, the FTC sent warning letters to several direct-selling companies in connection with income claims allegedly made by the companies and/or their distributor sales forces in the context of the respective company's business opportunity during the COVID-19 pandemic. The consent orders, guidance and communication from the FTC have also created a degree of ambiguity and uncertainty regarding how the FTC and other regulators will interpret the laws, regulations and judicial precedent applicable to direct selling in the United States. In October 2021, the FTC, pursuant to its Penalty Offense Authority under the FTC Act, sent letters to over 1,100 companies, including USANA, warning them that the FTC could seek penalties of up to $43,792 per violation for conduct determined to be unfair, deceptive, or otherwise unlawful in certain prior FTC actions. The letter did not accuse any recipient company, including USANA, of engaging in unlawful conduct. But if the FTC later alleges that we have engaged in acts or practices found to be unfair, deceptive, or unlawful in the actions referenced in the letters, we could be at risk of penalties and other potential liability.
As noted above, the Chinese government has adopted direct selling laws and regulations that contain a number of financial and operational restrictions on direct selling companies, as well as prohibitions on pyramid selling and multi-level compensation. These regulations are subject to discretionary interpretation and enforcement by various municipal, provincial and state officials in China. Departments within the Chinese government that regulate direct selling include the Ministry of Commerce (“MOFCOM”), the Ministry of Public Security (“MPS”) and their regional and local counterparts. BabyCare’s business model has been developed specifically for China based on, among other things: (i) BabyCare’s communications with the Chinese government, (ii) BabyCare’s interpretation of the direct selling laws and regulations, as well as its understanding of how the government interprets and enforces the regulations, and (iii) BabyCare’s understanding of how other multinational direct selling companies operate in China.
Notwithstanding the foregoing, the direct selling industry in China, as well as the regulatory environment for the industry, continues to evolve and receive significant attention and scrutiny from the Chinese government and the Chinese media. In 2019, following unfavorable media coverage of certain health product companies and direct selling companies, several departments of the Chinese government, including SAMR, MPS, and MOFCOM, initiated a review of health product and direct selling companies. This review required direct-selling companies in China such as BabyCare to conduct a self-assessment of the regulatory compliance of their business (including product regulatory compliance and direct selling regulatory compliance) and to provide information to the Chinese government regarding that assessment. The review also entailed a review of direct sellers' regulatory compliance by various departments of the Chinese government. During this review, the Chinese government, among other things, instructed direct selling companies not to hold large distributor meetings, and suspended its application review process for direct selling licenses and authorizations. The Chinese government has yet to re-open the application review process for direct selling licenses and authorizations or indicate if or when it plans to do so. The Chinese government's scrutiny of the direct selling industry has been higher following the 2019 review.
The Chinese government has taken action historically against direct selling companies that it believes have violated the government’s direct selling regulations and anti-pyramiding laws. The government’s action in this regard has entailed investigating direct selling companies and their distributors, imposing significant fines and, in some cases, shutting down companies it believed to be in violation. Historically, there have been instances when inquiries or complaints about BabyCare’s business resulted in warnings from the Chinese government, as well as the payment of fines by BabyCare or its distributors.
17
BabyCare has obtained direct selling licenses in certain provinces and municipalities in China, but must obtain others from additional provinces and municipalities if it is to continue to expand its direct selling business model in China. As of the date of this Annual Report, BabyCare has been granted licenses to engage in direct selling in the provinces and municipalities of Beijing, Jiangsu, Shaanxi, and Tianjin.
Direct selling companies, and the industry in general, continue to experience significant media and public scrutiny. Several companies similar to USANA recently have been scrutinized and penalized in several markets where we operate, including the United States, Canada, China, Japan, and South Korea. This scrutiny, along with the uncertainty of the laws and regulations pertaining to direct selling in many countries, can affect how a regulator or member of the public, including investors, perceives us. For instance, there has been significant media and short-seller attention given to the viability and legality of direct selling in the United States and China over the past few years. This attention has led to intense public scrutiny of our industry, as well as volatility in our stock price and the stock prices of other direct selling companies who operate in the same markets. We cannot predict the impact that this scrutiny may have on our business or industry in the future.
We detail more of the various risks associated with the regulation of our overall business, direct selling business model and Compensation Plan in this Annual Report in “Item 1A. “Risk Factors.”
Transfer Pricing Regulation. In the United States and many other countries, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported by our United States or international entities and taxed accordingly. We have adopted transfer prices, which are supported by formal transfer pricing studies for the sale of products to our subsidiaries in accordance with applicable transfer pricing laws. In addition, we have entered into agreements with our subsidiaries for services and other contractual obligations, such as the payment of Associate incentives that are also supported by the same formal transfer pricing studies. We have experienced instances in the past where international taxing authorities have successfully challenged our transfer pricing calculations and agreements and assessed us additional tax. Going forward, if the U.S. Internal Revenue Service (“IRS”) or the taxing authorities of any other jurisdiction successfully challenge these agreements or require changes in our standard transfer pricing practices for products, we could become subject to higher taxes and our earnings could be adversely affected. The tax treaties between the United States and most countries provide competent authority for relief to avoid any double taxation. We believe that we operate in compliance with all applicable transfer pricing regulations. There can be no assurance, however, that we will continue to be found to be operating in compliance with transfer pricing regulations or that those laws will not be modified, which may require that we change our operating procedures.
Intellectual Property
Trademarks. We have developed and use registered trademarks in our business, particularly relating to our product names. We own 30 trademarks that are registered with the U.S. Patent and Trademark Office. Federal registration of a trademark enables the registered owner of the mark to bar the unauthorized use of the registered mark by a third party in connection with a similar product in similar channels of trade anywhere in the United States, regardless of whether the registered owner has ever used the trademark in the area where the unauthorized use occurs. We have filed applications and own trademark registrations, and we intend to register additional trademarks in countries outside the United States where USANA products are or may be sold in the future. Protection of registered trademarks in some jurisdictions may not be as extensive as the protection in the United States.
We also claim ownership and protection of certain product names, unregistered trademarks, and service marks under common law. Common law trademark rights do not provide the same level of protection that is afforded by the registration of a trademark. In addition, common law trademark rights are limited to the geographic area in which the trademark is actually used. We believe these trademarks, whether registered or claimed under common law, constitute valuable assets, adding to recognition of USANA and the effective marketing of USANA products. Trademark registration once obtained is essentially perpetual, subject to the payment of a renewal fee and continued usage of the trademark. We therefore believe that these proprietary rights have been and will continue to be important in enabling us to compete.
Patent. We own U.S. Patent 10,632,101 for our InCelligence complex formula. This patent was issued in 2020.
Trade Secrets. We own certain intellectual property, including trade secrets that we seek to protect, in part, through operational protections and confidentiality agreements with employees, consultants, vendors and other parties. Even where these agreements exist, there can be no assurance that these agreements will not be breached, that we would have adequate remedies for any breach, or that our trade secrets will not otherwise become known to or independently developed by competitors. Our proprietary product formulations are generally considered trade secrets, but are not otherwise protected under intellectual property laws.
18
We intend to protect our legal rights concerning intellectual property by taking all appropriate legal action. Consequently, we may become involved from time to time in litigation to determine the enforceability, scope, and validity of any of the foregoing proprietary rights. Any intellectual property litigation could result in substantial cost and divert the efforts of management and technical personnel.
Seasonality
We experience variations in the activity of our customers in many of our markets in the first and fourth quarters around major cultural events such as Lunar New Year and Christmas.
Backlog
Our products are typically shipped within 72 hours after receipt of an order. As of February 23, 2024, we had no significant backlog of orders.
Working Capital Practices
Due to our dual role as manufacturer and distributor, we require substantial inventories, as such, we strive to maintain sufficient amounts of inventory in order to provide a high level of service to our customers. At times we may strategically choose to carry a greater amount of inventory for various reasons, such as promotional activity, product launches, and uncertainty in supply and distribution channels. We also watch seasonal commodity markets and may buy ahead of normal demand to hedge against cost increases and supply risks.
Environment Laws
We are not aware of any instance in which we have contravened federal, state, or local laws relating to protection of the environment or in which we otherwise may be subject to liability for environmental conditions that could materially affect operations.
Our Values and Culture
Our business is driven by our four Core Values:
•Excellence: We rely on scientific research to provide innovative, healthy living solutions, and we empower all individuals to continually improve each day.
•Community: We support, care for, and encourage one another, and the world, to live happier, healthier lives.
•Integrity: We demonstrate honesty, responsibility, and accountability through our individual actions and corporate decision-making.
•Health: We cultivate a holistic view of wellness that supports a healthy body and a strong mind.
Corporate Sustainability
The Sustainability Committee of the Board of Directors oversees and advises on all matters related to corporate sustainability, including ESG. The Sustainability Committee is composed of directors Peggie Pelosi, Chair; John Fleming; Frederic Winssinger; Tim Wood; and J. Scott Nixon. In the United States and abroad there are an increasing number of sustainability-related rules and regulations that have been adopted or proposed. Such regulations may subject us to new disclosure requirements, which could result in risks to our reputation or consumer demand for our products if we do not meet increasingly demanding stakeholder expectations and standards. We will continue to incorporate and advance sustainability-related best practices across all of our markets as part of our commitment to improving the health and wellness of individuals, families and communities around the world.
19
Our ESG strategy centers on three main pillars - products, people, and planet - that encompass where we are focusing our sustainability efforts now and in the future. To achieve our goals, we plan to continue fortifying each pillar, to deliver meaningful progress while evolving our efforts to ensure our business becomes more sustainable day by day.
Strategic PillarsTier One TopicsTier Two Topics
Products
•Product quality and safety
•Responsible sourcing
•Health and nutrition
•Affordable and accessible products
People
•Talent management and development
•Employee health, safety, and well-being
•Diversity, equity, and inclusion
•Human rights
Planet
•Sustainable packaging
•Waste management
•Greenhouse gas management
•Biodiversity and environmental conservation
•Energy management
•Water management
We encourage you to review our most recent Sustainability Report available on our investor relations website https://ir.usana.com/ for more detailed information regarding our human capital programs and initiatives. Nothing on our website, including our Sustainability Report or sections thereof, is deemed incorporated by reference into this Report.
Human Capital
We believe that "creating the healthiest family on earth by empowering the individual" starts with our employees. Key to our ambition is giving our employees the skills and development they need to build a meaningful career and tools to support their total health and wellness and enhancing our diverse and inclusive workplace culture to help employees thrive. We also believe that the manner in which we address issues related to workforce demographics, diversity, equity, and inclusion, community involvement, talent management, compensation and benefits, and employee health and safety directly correlates to our success as a business.
As of February 23, 2024, we had approximately 1,800 employees working in 22 countries worldwide, as measured by full-time equivalency. The majority of our employee population resides in the United States (46%) and China (28%). Approximately 58% of our world-wide employee population is female. We are actively working through initiatives such as our Women in Leadership Program, along with formal and informal mentorship programs, to continue promoting and hiring talented and capable women into management roles. We have also increased the number of women in senior leadership roles over the past several years.
Our employees are not currently represented by a collective bargaining agreement, and we have not experienced work stoppages as a result of labor disputes. We believe that we have a good relationship with our employees.
We are committed to fostering a diverse, inclusive and equitable workplace. Our diversity, equity and inclusion (“DEI”) program is designed to promote representation and engagement at all levels of the organization. Through our mentorship program and Women in Leadership initiative, we are working to increase representation of underrepresented groups in leadership positions. Our DEI council focuses on education and awareness, access to developmental programs, and community engagement.

One of the key elements of our DEI program is our commitment to volunteerism and charitable action. In 2023, we spent more than 2,900 hours volunteering, working with local organizations to help promote diversity, equity and inclusion in the communities where we operate. Additionally, we continued our support of programs that foster career development and help to ensure that all employees have the opportunity to reach their full potential.

In addition to these internal initiatives, we also partner with other organizations to help achieve our DEI goals. By working together with other companies, community groups, and non-profits, we are able to amplify our impact and create a more inclusive and equitable society for all.

Our DEI program is a key component of our company culture. By fostering diversity, equity, and inclusion, we are able to create a more vibrant and innovative workplace that benefits all of our employees, customers, and stakeholders. We will continue to invest in this program, and strive to make our company an inclusive, equitable and welcoming place for all.
20
We understand the value of developing employees at every level. Our leaders actively participate in leadership development programs that include mentorship and coaching, online learning, and regular company and industry specific training programs. Additionally, our global employee population is engaged in online learning platforms and, more than 400 participants have completed our mentorship and coaching program. All employees are encouraged to attend training specific to their role, as well as, utilize our tuition reimbursement program, which has provided additional monetary support to employees at all levels as they pursue bachelor and advanced college degrees.
The health and safety of employees is also a key element in providing return to all stakeholders. In addition to following mandatory government requirements for health and safety, we have established a wellness program that includes free nutritional products to employees.
Employees in our corporate headquarters have access to an on-site gym, exercise classes, free access to massages, and chiropractic care. A health clinic located on the campus of our corporate headquarters provides medical and mental health care, and is actively engaged in the health of about 52% of our eligible employees.
We recognize that a strong commitment to community is essential to all stakeholders. We utilize the USANA Foundation, which operates independently of the Company, to provide philanthropic nutrition to underserved children and families worldwide. In 2023, the USANA Foundation:
•Provided over 30 million meals;
•Provided aid and grants to partner charities around the world;
•Distributed backpacks of food for at risk children in local schools to take home on the weekend and during long holiday breaks; and
•Gifted bottles of children's vitamins to some of the most malnourished children around the world.
A discussion of the risks relating to our ability to attract and retain active Associates and Preferred Customers, and the loss of key management, is included in Item 1A. Risk Factors.
Information About Our Executive Officers and Directors
Executive Officers
The following table sets forth certain information regarding our Executive Officers as of the date of this Annual Report.
NameAgePosition
Jim H. Brown(1)
55
Chief Executive Officer and President
Kevin G. Guest(1)
61
Executive Chairman of the Board
G. Douglas Hekking54Chief Financial Officer
Paul A. Jones60Chief People Officer
P. Joshua Foukas48Chief Legal Officer, General Counsel and Corporate Secretary
Daniel A. Macuga54Chief Communications and Marketing Officer
Robert Sinnott59Chief Scientific Officer
Walter Noot58Chief Operating Officer
David Mulham63Chief Sales Officer
Brent Neidig40
Chief Commercial Officer
(1) As announced on February 13, 2023, effective July 1, 2023, Jim H. Brown was appointed as the Company's Chief Executive Officer, at which time Kevin Guest transitioned to Executive Chairman of the Board.
Jim H. Brown was appointed President in 2016 and Chief Executive Officer in July 2023. From 2016 to 2019 Mr. Brown also served as Chief Operating Officer. Mr. Brown received a bachelor’s degree with a double major in computer science and math, and an M.B.A. from Francis Marion University in Florence, South Carolina.
21
Kevin G. Guest was appointed Executive Chairman of the Board in July 2023. From 2020 to July 2023 Mr. Guest served as Chairman of the Board and Chief Executive Officer. From 2016 to 2020 Mr. Guest served as Chief Executive Officer. Mr. Guest's important role as the leading force of our management and sales efforts, and his talent as a motivating leader, qualify him to serve as a member of the Board. Mr. Guest earned a B.A. in Communications from Brigham Young University.
G. Douglas Hekking became our Chief Financial Officer in May 2017. Mr. Hekking received a B.S. in accounting from the University of Utah and an M.B.A. from Brigham Young University.
Paul A. Jones has been our Chief People Officer since 2021. From 2015 to 2021, Mr. Jones was Chief Leadership Development Officer. Mr. Jones received a B.S. in finance from Utah State University and M.A. in organizational management from the University of Phoenix.
P. Joshua Foukas has served as our Chief Legal Officer and Corporate Secretary since 2018. Mr. Foukas received a B.A. from the University of Utah and a J.D. from the University of Idaho.
Daniel A. Macuga, Jr. became Chief Communications and Marketing Officer of USANA in 2017. Mr. Macuga received a B.A. in communications from the University of California, San Diego.
Robert A. Sinnott, M.N.S., Ph.D. joined USANA as Chief Scientific Officer in August 2016. Dr. Sinnott holds a B.S. in Biological Sciences, an M.S. in Natural Science, and a Ph.D. in Plant Sciences from Arizona State University, in Tempe, Arizona. His focus was on applied biological sciences, including biotechnology and plant medicinal chemistry.
Walter Noot joined USANA as Chief Information Officer in December 2016 and served in that role until he was promoted to Chief Operating Officer in October 2019. He holds a B.S. in mechanical engineering from Brigham Young University.
David Mulham was appointed Chief Field Development Officer in 2017. Mr. Mulham has a postgraduate diploma from Macquarie Graduate School of Management, Sydney.
Brent L. Neidig was appointed Chief Commercial Officer in July 2023. Mr. Neidig was appointed Executive Vice President of China in February 2017, and in April 2019 was named Chief Officer and Managing Director of China. Mr. Neidig received a B.S. in accounting and M.B.A. from the University of Utah.
Board of Directors
The following table sets forth certain information regarding our Directors as of the date of this Annual Report.
NameAgePosition
Kevin Guest61Executive Chairman of the Board
Gilbert A. Fuller83Director
Xia Ding53Director
Peggie J. Pelosi 68Director
Frederic J. Winssinger55Director
Timothy Wood75Director
John T. Fleming80Director
J. Scott Nixon64Director
Additional Available Information
We maintain our corporate headquarters, executive offices, and principal facilities at 3838 West Parkway Boulevard, Salt Lake City, Utah 84120. Our telephone number is (801) 954-7100. Our website address is www.usana.com. The information on our website should not be considered part of and is not incorporated into this Annual Report by reference.
We make available, free of charge at our corporate website, copies of our reports filed with the SEC under the Exchange Act, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements, and all amendments to such reports, as soon as reasonably practicable after such reports or other
22
material have been electronically filed with or furnished to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act. This information may also be obtained from the SEC via its on-line database, which is located at www.sec.gov.
You may also obtain, free of charge on our website, a copy of our Corporate Governance Guidelines, our Code of Ethics for Directors and Employees, and the charters of the Audit Committee, Governance, Risk and Nominating Committee, Compensation Committee, and Sustainability Committee of our Board of Directors.
Item 1A. Risk Factors
We have listed below the most material risk factors applicable to us. These risk factors are not necessarily in the order of importance or probability of occurrence: You should consider the following risk factors, in addition to the information presented elsewhere in this Annual Report, particularly under the heading “Cautionary Note Regarding Forward-Looking Statements,” on page 1, and the disclosures contained in Part I, “Item 1. Business,” and Part II, “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this report, as well as in the other filings we make from time to time with the SEC, in evaluating us, our business and an investment in our securities.
Risk Associated with Direct Selling
Direct selling is subject to intense government scrutiny, and regulation and changes in the law, or the interpretation and enforcement of the law, might adversely affect our business.
Various laws and regulations in the United States and other countries regulate direct selling. These laws and regulations exist at many levels of government in many different forms, are inherently fact-based, and often do not include “bright line” rules. We are also subject to the risk that the laws and regulations, or a regulator’s interpretation and enforcement of the laws and regulations, could change.
In the United States, the FTC is one of many regulators who regulate direct selling. The FTC has actively warned various direct selling companies and the industry as a whole about certain business practices associated with direct selling and entered into settlements with several direct selling companies that required those companies to modify their compensation plans and business models. Those settlements resulted from enforcement actions brought by the FTC involving a variety of alleged violations of consumer protection laws, including misleading earnings representations and legal compliance of those companies’ business models and distributor compensation plans. For example, in 2016, the FTC entered into a settlement with another direct selling company following an enforcement action in which the FTC alleged that the company’s distributors were making misleading earnings representations and that the company was utilizing an illegal business model. Also in 2016, the FTC entered into a settlement with another direct selling company following an enforcement action in which the FTC alleged that the company’s distributors had made misleading income representations and that the company was utilizing an unfair and deceptive compensation plan.
In 2019, the FTC entered into a settlement with a direct selling company following an FTC enforcement action, which included the alleged violations noted above. Pursuant to this settlement, the company is permanently prohibited from using a multilevel compensation plan in the United States. Following this settlement, the FTC initiated litigation with another direct selling company for similar alleged violations and pursued similar claims and remedies, including a prohibition of multilevel compensation in the United States. Although the court ruled in favor of the defendant company in this case, settlements such as those described in the other cases above may require a direct selling company to pay a significant fine, revise its U.S. business model and compensation plan to comply with various restrictions on how it can compensate distributors and change its marketing practices to avoid misleading product or income representations, among other things. Although a settlement between the FTC and a specific company does not generally have force of law or binding effect on other companies, FTC officials have indicated that the direct selling industry should look to these settlements, and the principles contained therein, for guidance.
In 2020, the FTC sent warning letters to several direct-selling companies regarding product and/or income claims that the companies and/or their distributors were making related to the COVID-19 pandemic. In 2021, the FTC, pursuant to its Penalty Offense Authority under the FTC Act, sent letters to over 1,100 companies, including USANA, warning them that the FTC could seek penalties of up to $43,792 per violation for conduct determined to be unfair, deceptive, or otherwise unlawful in certain prior FTC actions. The letter did not accuse any recipient company, including USANA, of engaging in unlawful conduct. But if the FTC later alleges that we have engaged in acts or practices found to be unfair, deceptive, or unlawful in the actions referenced in the letters, we could be at risk of penalties and other potential liability.
The FTC is currently advocating and considering certain legal and regulatory changes that, if implemented, could have a material adverse effect on our business. For example, in 2022 the FTC issued an Advanced Notice of Proposed
23
Rulemaking for a proposed rule concerning deceptive earnings claims that would further regulate how companies like USANA advertise and represent their business. The FTC is also currently reviewing the Business Opportunity Rule, which requires business opportunity sellers to give prospective buyers specific information to help them evaluate a business opportunity or work-at-home program. Direct sellers like USANA are currently exempt from the Business Opportunity Rule, but the FTC could include direct sellers within the scope of the rule as a result of the review. If direct sellers become subject to the rule, we will have to comply with disclosure requirements that could significantly increase the cost of doing business and have other material adverse effects on our business.
We regularly analyze our business model in response to settlements between the FTC and other direct selling companies, as well as guidance and other communications issued by the FTC, and from time to time we refine aspects of our business model where appropriate. Although we strive to ensure that our business model and compensation plan are compliant with applicable laws and regulations, as well as regulatory guidance, in each of our markets, we cannot assure you that a regulator, if it were to review our business, would agree with our assessment and would not require us to change one or more aspects of our operations. Any action against us in the future by the FTC or another regulator could materially and adversely affect our operations.
We are also subject to various direct selling laws and regulations in our other markets, including China (as explained below). We cannot predict the nature of any future law, regulation, or guidance, nor can we predict what effect additional governmental regulations, judicial decisions, or administrative orders would have on our business. Failure by us, or our Associates, to comply with these laws, regulations, or guidance, could have a material adverse effect on our business in a particular market or in general. Finally, the continuation of regulatory challenges, investigations and litigation against other direct selling companies could harm our business and industry if the laws and regulations are interpreted in a way that results in additional restrictions on direct selling companies in general.
The violation of marketing or advertising laws by Associates in connection with the sale of our products or the improper promotion of our Compensation Plan could adversely affect our business.
All Associates contractually agree to adhere to our policies. Although these policies prohibit Associates from making false, misleading and other improper claims regarding products or income potential from the sale of the products, from time to time Associates, without our knowledge and in violation of our policies, create promotional materials or otherwise provide information that does not accurately describe USANA, our products or the Compensation Plan. They also may make statements regarding potential earnings, product claims, or other matters in violation of our policies or applicable laws and regulations concerning these matters. These violations may result in legal action against us in our various markets by regulatory agencies, state attorneys general, or private parties. Legal actions against us or our Associates or others who are associated with us could lead to increased regulatory scrutiny of our business, including our business model. We take what we believe to be commercially reasonable steps to (i) regularly train our Associates, and (ii) monitor the activities of our Associates to guard against misrepresentation and other illegal or unethical conduct by Associates and to assure compliance with our policies. There can be no assurance, however, that our efforts in this regard will be sufficient to accomplish this objective. In the past, we have experienced adverse publicity both within and outside of our sales force for enforcing our Associate policies and procedures. This type of adverse publicity has made, and will continue to make, it difficult for us to attract and retain Associates and Preferred Customers and may have an adverse effect on our business, financial condition, and results of operations.
We may have or could incur obligations relating to the activities of our Associates.
Our Associates are subject to taxation, and, in some instances, legislation or governmental agencies may impose an obligation on us to collect taxes, such as sales taxes or value added taxes, and to maintain appropriate records of such transactions. In addition, we are subject to the risk in some jurisdictions of being responsible for social security and similar taxes as well as employee benefits with respect to our Associates. In particular, the laws regarding independent contractor status in certain jurisdictions, including the United States, continue to evolve and, in some cases, authorities have sought to apply these laws unfavorably against gig economy, platform and direct selling companies, including USANA. In 2020, we were named as a defendant in a private lawsuit in California by a plaintiff’s firm that is seeking to reclassify our California Associates from independent contractors to employees under California state law. Although we prevailed in this litigation and continue to believe we have legally and appropriately classified our Associates as independent contractors, it is possible that future lawsuits or potential future laws, could negatively impact the independent contractor status of our Associates or distributors in direct selling companies in general. For example, in January 2024, the Department of Labor (DOL) issued a final rule regarding the classification of workers as employees vs. independent contractors under the Fair Labor Standards Act. The final rule, which becomes effective March 11, 2024, is significantly different from the 2021 rule
24
issued by the DOL and requires companies and courts to consider the totality of six economic factors when deciding whether a worker is an employee or independent contractor.
If the 2024 DOL final rule or other federal, state or local laws and regulations or the interpretation of such laws and regulations require us to treat our Associates as employees, or if our Associates are deemed by local regulatory authorities in one or more of the jurisdictions in which we operate to be our employees rather than independent contractors, under existing laws and interpretations, we may be deemed to be responsible for a variety of obligations that are imposed upon employers relating to their employees, including social security and related taxes in those jurisdictions, wages, employee benefits, plus any related assessments and penalties, which could harm our financial condition and operating results.
Our Associate Compensation Plan, or changes we make to it, may be viewed negatively by some Associates, could fail to achieve our desired objectives, and could have a negative impact on our business.
From time to time, we modify our Compensation Plan to (i) keep it competitive and attractive, (ii) cause or address a change in Associate behavior, (iii) conform to legal and regulatory requirements, or (iv) address other business needs. It is difficult to predict how any changes to the plan will be viewed by Associates and whether such changes will achieve their desired results. For example, in 2023 we launched our Affiliate program in three markets and this program creates a new and different element of our Compensation Plan. There can be no assurance that changes to our Associate Compensation Plan will allow us to successfully attract new Associates or retain existing Associates, nor can we assure that any changes we make to our Compensation Plan will achieve our desired results. Additionally, the payment of Associate incentives under our Compensation Plan is our most significant expense. Modifying our Compensation Plan directly affects the incentives we pay as a percentage of net sales. There can be no assurance that changes to the Compensation Plan will be successful in achieving target levels of Associate incentives as a percentage of net sales. Furthermore, such changes may make it difficult to attract and retain qualified and motivated Associates.
Changes we are required to make to our Associate Compensation Plan in certain markets, including limits on the amount of Associate compensation we can pay, may hurt our ability to attract and retain Associates, result in regulatory risk and affect our operating results.
We have been required to modify our Associate Compensation Plan in certain markets to comply with the laws and regulations in these markets or the interpretation of the same by authorities in these markets. For example, we have been required to use a different compensation plan for our BabyCare operations in China (as noted elsewhere in this report) and have been required to modify our Compensation Plan in India, South Korea, Malaysia, and Indonesia to comply with applicable laws and regulations. We obtain regulatory approval of our Compensation Plan when required or, when not required, we may seek a legal opinion regarding compliance. We may also be prohibited from distributing products through direct selling or paying multilevel compensation in some countries. Several markets, including China, South Korea, and Indonesia also impose limits on the amount of compensation we can pay to our Associate sales force.

If we fail to comply with the legal requirements for our Compensation Plan in our various markets, including the limits on compensation we are legally permitted to pay, we may incur fines or other sanctions, including the loss of applicable licenses to conduct our business. These required changes to Compensation Plan, including compensation limits, may also be viewed as limiting the incentive for people to join our Associate sales force and may reduce the competitive advantage of our Associate Compensation Plan.
Risks Related to Our China Business
Our Greater China region accounts for a significant part of our business and expected growth. A decline in sales or customers in this region would harm our business, financial condition and results of operations.
Our Greater China region consists of China, Hong Kong, and Taiwan and has been our largest region for sales over the last several years and China has been our largest market. Our international growth strategy has focused largely on growing our China business. For the last three years, health officials in Greater China have responded to the COVID-19 pandemic, which has created a challenging operating environment for our business in China and has negatively impacted our sales and customer results. Additionally, in 2019, our sales and active Customer counts in both the Greater China region and our China market declined, largely because of a challenging operating environment in China, following the China’s governments inquiry into and review of the health foods industry in China. If we are not successful in growing BabyCare’s sales and customer base in China, our consolidated growth as a company will be negatively affected and our business, financial condition, results of operations and cash flows may be harmed.
25
BabyCare must comply with significant operational, financial, and other regulatory requirements to engage in direct selling in China. Although we believe that we will be successful in growing BabyCare’s business in China, it is difficult to assess the extent to which BabyCare’s business model and compensation plan will be successful or deemed to be compliant with applicable Chinese laws and regulations. In light of the factors listed above, and the other risks to our business, there can be no assurance that we will be successful in increasing sales and customers in China through BabyCare.
Our operations in China are subject to significant government regulation, as well as a variety of legal, political, and economic risks. If the Chinese government modifies its direct selling laws and regulations, or interprets and enforces these laws and regulations in a manner that is adverse to our business in China, our consolidated business and results of operations may be materially harmed.
Our operations in China are conducted by BabyCare, our China subsidiary. BabyCare operates in China pursuant to direct selling laws and regulations that are uncertain and evolving. These regulations contain a number of financial and operational restrictions for direct selling companies, including prohibitions on pyramid selling and multi-level compensation. The laws and regulations are also subject to discretionary interpretation and enforcement by various state, provincial and municipal level officials in China. Regulators in China may modify current direct selling laws and regulations or change how they interpret and enforce them. As a result, there can be no assurance that the Chinese government’s current or future interpretation and application of existing and new regulations will not negatively impact our business in China, result in regulatory investigations or lead to fines or penalties against us or our Associates.
The Chinese government also exercises significant control over the Chinese economy, including through controlling capital, foreign currency exchange, foreign exchange rates, and tax regulations, providing preferential treatment to certain industry segments or companies and issuing required licenses to conduct business. We also face additional risks resulting from new and expanded China data privacy and security laws and regulations. Accordingly, any adverse change in the Chinese governmental, economic or other policies could have a material adverse effect on BabyCare’s business in China and our consolidated results of operations.
In addition to BabyCare's direct selling business in China, we periodically offer and sell certain U.S. products in China through a cross-border e-commerce sales channel by utilizing one of our separate China subsidiaries that is registered to engage in cross-border e-commerce. This cross-border e-commerce channel is legally required to be separate from BabyCare's direct selling business in China. The products that we offer and sell through this channel are neither registered for retail sale in China nor registered as direct selling products under BabyCare's direct selling license. Consequently, products sold via our cross-border e-commerce channel can only be sold to China customers for their personal consumption and cannot be sold through BabyCare's direct selling channel. BabyCare's direct selling business in China could be negatively impacted if China regulatory authorities (i) attribute our cross-border e-commerce sales and related product claims to BabyCare's direct selling business, and (ii) make a determination that the same are in violation of direct selling or other applicable laws and regulations.
Although BabyCare utilizes a business model that has been developed specifically for China’s laws and regulations, the Chinese government has not approved BabyCare’s model, compensation plan, and operations.
BabyCare’s business model has been designed specifically for China’s laws and regulations based on, among other things, BabyCare’s (i) communications with the Chinese government, (ii) interpretation of the direct selling laws and regulations, as well as its understanding of how the government interprets and enforces the regulations, and (iii) understanding of how other multinational direct selling companies operate in China. Many of the components of BabyCare’s business model are unique to China and are not part of our business model in our markets outside of China. For example, BabyCare sells products in China through a variety of methods, including: (a) online through its website; (b) at physical branch retail locations in China; (c) through direct sellers in provinces and municipalities where BabyCare has received a direct selling license; and (d) through independent distributors who are considered independent business owners under Chinese law. BabyCare has not received confirmation from the Chinese government that its business model and operations in China comply with applicable laws and regulations, including those pertaining to direct selling. We cannot assure that Chinese regulatory authorities would deem BabyCare's business model, compensation plan or the activities of its employees, direct sellers or independent distributors to be compliant with current or future laws and regulations. If BabyCare’s model were deemed to be in violation of applicable regulations, as they are now or may in the future be interpreted or enforced, BabyCare could be subject to fines, penalties or suspension of its business in China or, ultimately, have its direct selling license revoked by the Chinese government, all of which could have a material adverse impact on our business in China.
26
BabyCare’s operations in China, and direct selling companies in general, are subject to significant government oversight, scrutiny and monitoring.
Chinese regulators regularly monitor and make inquiries about the business activities of direct sellers in China and have done so with BabyCare. For example, following adverse media coverage of certain health product companies and direct selling companies in 2019, several departments of the Chinese government, including SAMR, MPS, and MOFCOM, initiated a review of health product and direct selling companies in China. The review required applicable companies such as BabyCare to conduct a self-assessment of the regulatory compliance of their business and to provide information to the government regarding the same. The review also entailed a review of a company’s regulatory compliance by various departments of the Chinese government. During this review, the Chinese government, among other things, (i) instructed direct selling companies not to hold large distributor meetings, and (ii) suspended its application review process for direct selling licenses and authorizations. The Chinese government has yet to re-open the application review process for direct selling licenses and authorizations or indicate if or when it plans to do so.
Direct selling regulations in China prevent persons who are not Chinese nationals from engaging in direct selling in China. We have implemented internal policies that are designed to promote our Associates’ compliance with these regulations, however, we cannot guarantee that any of our Associates residing outside of China or any of BabyCare’s Associates in China have not engaged or will not engage in activities that violate our policies in this market or that violate Chinese law or other applicable laws and regulations, which might result in regulatory action and adverse publicity and potential harm to our business in China.
The Chinese government has investigated and imposed significant fines on companies and their distributors believed to have violated direct selling and anti-pyramiding regulations. In some cases, it has even shut such companies down. There have been instances where inquiries or complaints about BabyCare’s business have resulted in warnings from the Chinese government as well as the payment of fines by BabyCare or its distributors. We expect that BabyCare will continue to face the risk of government inquiries, complaints or investigations. Any determination that BabyCare’s business or the activities of its Associates are not in compliance with applicable regulations could result in additional fines, disruption of business, or the suspension or termination of BabyCare’s licenses, including its direct selling licenses, all of which could have a material adverse effect on our business and operations. There can be no assurance that the Chinese government’s interpretation and enforcement of applicable laws and regulations will not negatively impact BabyCare’s business, result in regulatory investigations or lead to fines or penalties against BabyCare, USANA or our Associates in China.
BabyCare must apply for and receive government approval to expand its business in China and the failure to obtain such approvals could negatively impact its ability to expand and grow its business.
BabyCare has obtained direct selling licenses in certain provinces and municipalities and it must obtain various licenses and approvals from additional municipalities and provinces within China if it is to operate its direct selling business model in China. Although direct selling licenses are centrally issued, the licenses are generally valid only in the jurisdictions within which related approvals have been obtained. Those approvals are generally awarded on local and provincial bases, and the approval process requires involvement of multiple ministries at each level.
BabyCare also will be required to obtain licenses from municipalities and provinces within China where it currently does not hold a license. The Chinese government has not reopened its application review process for direct selling licenses and approvals since suspending the process in 2019. If BabyCare is unable to obtain additional direct selling licenses and approvals as quickly as we would like, or at all, it would negatively impact our ability to expand and grow our business in China. Ultimately, there can be no assurance that BabyCare will be successful in maintaining its current direct selling licenses or obtaining additional direct selling licenses or the required approvals to expand into additional locations in China that are important to its business.
Risk Associated with Our International Operations
Risks associated with operating in international markets could restrict our ability to expand globally and harm our business and prospects.
We currently conduct our business in various foreign countries, and we expect to expand the number of countries in which we operate in the future. Economic conditions, including those resulting from wars, civil unrest, political unrest, acts of terrorism and other conflicts or volatility in the global markets, may adversely affect our customers, their demand for our products and their ability to pay for our products. In addition, there are numerous risks inherent in conducting our business internationally, including, but not limited to, potential instability in international markets, changes in regulatory
27
requirements applicable to international operations, currency fluctuations in foreign countries, political, economic and social conditions in foreign countries and complex U.S. and foreign laws and treaties.
We believe that our ability to achieve future growth is dependent in part on our ability to continue our international expansion efforts. There can be no assurance, however, that we will be able to grow in our existing international markets or enter new international markets on a timely basis, or that new markets will be profitable. We must overcome significant regulatory and legal barriers before we can begin marketing in any international market. In addition, before marketing commences in a new country or market, it is difficult to assess the extent to which our products and sales techniques will be accepted or successful in any given country. In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures and legal systems from those encountered elsewhere. We may be required to reformulate certain of our products before commencing sales in a given country. Once we have entered a market, we must adhere to the regulatory and legal requirements of that market. No assurance can be given that we will be able to successfully reformulate our products in any of our current or potential international markets to meet local regulatory requirements or to attract local customers. Our failure to do so could have a material adverse effect on our business, financial condition, or results of operations.
In many market areas, other direct selling companies already have significant market penetration, the effect of which could be to desensitize the local population to a new opportunity, such as USANA, or to make it more difficult for us to attract qualified Associates or sell to customers generally. Even if we are able to commence operations in new markets, there may not be a sufficient population of persons who are interested in our business.
Trade policies, disputes, tariffs or other international disputes could harm our business and operating results.
Trade policies and actions which have been, or in the future may be, implemented by the United States against other countries, including China, relating to the import and export of certain products, and negotiations with respect thereto, may have a negative effect on our business, financial condition, and results of operations in China and other markets. There have been consistent, ongoing discussions and activities that raise concern in this regard.
Additionally, any actions taken by the Chinese government, or the government in our other markets, to implement further trade policy changes, financial restrictions, or increased regulatory scrutiny on U.S. companies could negatively impact our business, financial condition, and results of operations. For instance, China has previously taken or threatened to take trade and other actions in retaliation against U.S. policies, and is likely to continue to do so. Past or future developments in this regard may have a material adverse effect on the economies, financial markets, and currency exchange rates in China and the United States.
Tensions between the United States and China have increased over the past few years as a result of disputes in areas including trade policy, intellectual property, cybersecurity and data privacy. China is our largest market and the United States is one of our largest markets and the location of our corporate headquarters. Our business could be harmed if relations between the United States and China worsen or if either government imposes additional policies, tariffs or sanctions and our business could encounter increased regulatory scrutiny in China, as well as adverse media or public attention in China, as a result of the deteriorating bilateral relationship.
Fluctuation in the value of currency exchange rates with the U.S. dollar affects our operations and our net sales and earnings.
For the year ended December 30, 2023, 89.6% of our total net sales were generated in markets outside of the United States. Consequently, exchange rate fluctuations have, and will continue to have, a significant effect on our sales and earnings. If exchange rates fluctuate dramatically, it may become uneconomical for us to establish or to continue activities in certain countries. For instance, changes in currency exchange rates may affect the relative prices at which we and our competitors sell similar products in the same market. As our business expands outside the United States, an increasing share of our net sales and operating costs is transacted in currencies other than the U.S. dollar. Accounting practices require that our non-U.S. financial results be converted to U.S. dollars for reporting purposes. Consequently, our reported net earnings may be significantly affected by fluctuations in currency exchange rates, with earnings generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar.
Currently our strategy for reducing our exposure to currency fluctuation includes the timely and efficient repatriation of earnings from international markets where such earnings are not considered to be indefinitely reinvested, and settlement of intercompany transactions. We also enter into currency exchange contracts to offset foreign currency exposure in various international markets. We do not use derivative instruments for speculative purposes. A foreign government may impose, and some have imposed, foreign currency remittance restrictions. For example, several markets
28
in which we conduct business, including China, require that we file the necessary statutory financial statements for the relevant period as a prerequisite to repatriating cash in the form of a dividend. Any government restrictions on transfers of cash out of the country and control of exchange rates may have a materially adverse effect on our business, financial condition, liquidity and cash flows. There can be no assurance that we will be successful in protecting our operating results or cash flows from potentially adverse effects of currency exchange fluctuations. Any such adverse effects could also adversely affect our business, financial condition, or results of operations.
Inflationary pressures and persistently high prices and uncertain availability of commodities, raw materials or other inputs used by us and our suppliers, or instability in logistics and related costs, could negatively impact our profitability.
Increases in prices, including as a result of inflation and rising interest rates, for commodities, raw materials or other inputs that we and our suppliers use in manufacturing products, systems, components and ingredients or other similar raw materials, or increases in logistics and related costs, have led and may continue to lead to higher production costs for our products. In addition, any increase in the cost, or reduced availability, of critical materials for our products could lead to higher production costs and could impede our ability to successfully deliver on business strategy. Further, increasing global demand for, and uncertain supply of, such materials could disrupt us or our suppliers’ ability to obtain such materials in a timely manner and/or could lead to increased costs. Geopolitical risk, fluctuations in supply and demand, fluctuations in interest rates, any weakening of the U.S. dollar and other economic and political factors have created and may continue to create pricing pressure for commodities, raw materials and other inputs. These inflationary pressures could, in turn, negatively impact our profitability because we may not be able to pass all of those costs on to our customers or require our suppliers to absorb such costs. Additionally, any price increases we impose on our products as a result of the inflationary environment may result in decreased demand of our products, which could adversely affect our business, financial condition, or results of operations.
Risks Related to Our Products, Manufacturing and Operations
Our products and manufacturing activities are subject to extensive government regulation, which could limit or prevent the sale of our products in some markets.
The manufacture, packaging, labeling, advertising, promotion, distribution, and sale of our products are subject to regulation by numerous national and local governmental agencies in the United States and other countries, including the FDA and the FTC. Failure to comply with FDA regulatory requirements may result in, among other things, injunctions, product withdrawals, recalls, product seizures, fines, and criminal prosecutions. Any action of this type by the FDA could materially adversely affect our ability to market our products successfully. The manufacture of nutritional or dietary supplements and related products in the United States requires compliance with dietary supplement GMPs, which are based on the food-model GMPs, with additional requirements that are specific to dietary supplements. We believe our manufacturing processes comply with these GMPs for dietary supplements. Nevertheless, any FDA action determining that our processes were non-compliant with dietary supplement GMPs, could materially adversely affect our ability to manufacture and market our products. In addition, the Dietary Supplement & Nonprescription Drug Consumer Protection Act requires manufacturers of dietary supplement and over-the-counter products to notify the FDA when they receive reports of serious adverse events occurring within the United States. Potential FDA responses to any such report could include injunctions, product withdrawals, recalls, product seizures, fines, or criminal prosecutions. We have an internal adverse event reporting system that has been in place for several years and believe that we comply with this new law. Nevertheless, any action by the FDA in response to a serious adverse event report that may be filed by us could materially and adversely affect our ability to market our products successfully.
In markets outside the United States, prior to commencing operations or marketing our products, we may be required to obtain approvals, licenses, or certifications from a country’s ministry of health or a comparable agency. Approvals or licensing may be conditioned on reformulation of products or may be unavailable with respect to certain products or product ingredients. We must also comply with product labeling and packaging regulations that vary from country to country. These activities are also subject to regulation by various agencies of the countries in which our products are sold.
We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, could have on our business. These potential effects could include, however, requirements for the reformulation of certain products to meet new standards, the recall or discontinuance of certain products, additional record keeping and reporting requirements, expanded documentation of the properties of certain products, expanded or different labeling, or additional scientific
29
substantiation. Any or all of these requirements could have a material adverse effect on our business, financial condition, or results of operations.
Our in-house manufacturing activity is subject to certain risks.
We manufacture approximately 67% of the products sold to our customers. Additionally, over the past several years we have increased self-manufacturing of our foods, personal care and skincare products, which has increased the percentage of products we manufacture in-house. Because of our self-manufacturing practices, we are dependent upon the uninterrupted and efficient operation of our manufacturing facilities. Those operations are subject to power failures, the breakdown, failure, or substandard performance of equipment, the improper installation or operation of equipment, natural or other disasters, and the need to comply with the requirements or directives of government agencies, including the FDA and CFDA. There can be no assurance that the occurrence of these or any other operational problems at our facilities would not have a material adverse effect on our business, financial condition, or results of operations.
We are subject to a variety of environmental laws relating to the storage, discharge, handling, emission, generation, manufacture, use and disposal of chemicals, solid and hazardous waste, and other toxic and hazardous materials. Our manufacturing operations presently do not result in the generation of material amounts of hazardous or toxic substances. Nevertheless, complying with new or more stringent laws or regulations, or more vigorous enforcement of current or future policies of regulatory agencies, could require substantial expenditures by us that could have a material adverse effect on our business, financial condition, or results of operations. Environmental laws and regulations require us to maintain and comply with a number of permits, authorizations, and approvals and to maintain and update training programs and safety data regarding materials used in our processes. Violations of those requirements could result in financial penalties and other enforcement actions and could require us to halt one or more portions of our operations until a violation is cured. The combined costs of curing incidents of non-compliance, resolving enforcement actions that might be initiated by government authorities, or of satisfying new legal requirements could have a material adverse effect on our business, financial condition, or results of operations.
Our reliance on third parties to manufacture and supply certain of our products may harm our business, financial condition and operating results.
We contract with third-party suppliers and manufacturers for the production of certain of our products, which accounted for approximately 33% of our product sales for the year ended December 30, 2023. These third-party suppliers and manufacturers produce and, in most cases, package the products according to formulations and specifications that have been developed by or in conjunction with our in-house product development team. These products include most of our gelatin-capsulated supplements, Rev3 Energy Drink, Probiotic, our powdered drink mixes, foods, and certain of our personal care products, including our Celavive line for markets outside of China. Products manufactured by third-party suppliers at their locations must also pass through quality control and assurance procedures to ensure they are manufactured in conformance with our specifications. We cannot assure you that our outside contract manufacturers will continue to reliably supply products to us at the levels of quality, or the quantities, we require, and in compliance with our specifications or applicable laws, including under the FDA’s GMP regulations. We have encountered situations in the past where we have had disagreements with contract manufacturers about the overall quality of products they have produced for us, and specifically whether such products conform to our specifications. We have also suspended and terminated relationships with contract manufacturers for quality issues and non-conforming products. While our business continuation plan contemplates events such as these, identifying and obtaining acceptable replacement manufacturing sources, on a timely basis or at all, is challenging. Additionally, transferring our third-party manufacturing business to another contract manufacturer can be expensive, time-consuming, result in delays in our production or shipping, reduce our net sales, damage our relationship with customers and damage our reputation in the marketplace.
The inability to obtain adequate supplies of raw materials for products at favorable prices, or at all, could have a material adverse effect on our business, financial condition, or operating results.
We acquire all of our raw materials for the manufacture of our products from third-party suppliers. Materials used in manufacturing our products are purchased through purchase order, often invoking pre-negotiated annual supply agreements. We have very few long-term agreements for the supply of these materials. There is a risk that any of our suppliers could discontinue selling raw materials to us. Although we believe that we could establish alternate sources for most of our products, any delay in locating and establishing relationships with other sources could result in product shortages or back orders for products, with a resulting loss of net sales. In certain situations, we may be required to alter our products or to substitute different products from another source. There can be no assurance that suppliers will provide the raw materials that are needed by us in the quantities that we request or at the prices that we are willing to pay. Because
30
we do not control the actual production of certain raw materials, we are also subject to delays caused by any interruption in the production of these materials, based on conditions not within our control, including those related to the COVID-19 pandemic, weather, crop conditions, transportation interruptions, strikes by supplier employees, and natural disasters (the nature and severity of which may be impacted by climate change) or other catastrophic events.
In the past, we have experienced temporary shortages of the raw materials used in certain of our nutritional products. Although we had identified multiple sources to supply such raw material ingredients, quantities of the materials we purchased during these shortages were at higher prices, which had a negative impact on our gross margins for those products. While we periodically experience price increases due to unexpected raw material shortages and other unanticipated events, we have been able to manage this by increasing the price at which we sell our products, therefore, this has historically not resulted in a material effect on our gross margin. Supply chain interruptions, including as a result of shortages and transportation issues or unexpected increases in demand, and price increases can adversely affect us as well as our suppliers and Associates, whose performance may have a significant impact on our results. Such shortages or disruptions could be caused by factors beyond the control of our suppliers, Associates or us. Any of these events, if they were to occur, could harm our business, results of operations and financial condition.
Delays and disruptions to transporting and distributing our products may adversely affect our results.
We may experience delays and disruptions in shipping, transporting and otherwise distributing our products, including increased airport and shipping port congestion, a lack of transportation capacity, increased expenses, import or export controls or delays, and labor disputes or shortages. Disruptions in transportation and shipments may result in increased costs, including the additional use of airfreight to meet demand. Congestion to ports can affect previously negotiated contracts with shipping companies, resulting in unexpected increases in shipping costs and reduction in our profitability. For example, the COVID-19 pandemic resulted in several delays, cost increases, and disruptions in our global distribution channel.
We may incur liability with respect to our products.
As a manufacturer and a distributor of products for human consumption and topical application, we could become exposed to product liability claims and litigation. Additionally, the manufacture and sale of these products involves the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. To date, we have not been a party to any product liability litigation, although, like any dietary supplement company, we have received reports from individuals who have asserted that they suffered adverse consequences as a result of using our products. The number of reports we have received to date is nominal. These matters historically have been settled to our satisfaction and have not resulted in material payments. We are aware of no instance in which any of our products are or have been defective in any way that could give rise to material losses or expenditures related to product liability claims. Although we maintain product liability insurance, which we believe to be adequate for our needs, there can be no assurance that we will not be subject to such claims in the future or that our insurance coverage will be adequate.
Nutritional supplement products may be supported by only limited availability of conclusive clinical studies.
Our products include nutritional supplements that are made from vitamins, minerals, herbs, and other substances for which there is a long history of human consumption. Some of our products contain innovative ingredients or combinations of ingredients. Although we believe that all of our products are safe when taken as directed, there is little long-term experience with human consumption of certain of these product ingredients or combinations of ingredients in concentrated form. We conduct research and test the formulation and production of our products, but we have performed or sponsored only limited clinical studies. Furthermore, because we are highly dependent on consumers’ perception of the efficacy, safety, and quality of our products, as well as similar products distributed by other companies, we could be adversely affected in the event that those products prove or are asserted to be ineffective or harmful to consumers or in the event of adverse publicity associated with any illness or other adverse effects resulting from consumers’ use or misuse of our products or similar products of our competitors.
Legal, Regulatory, Compliance and Tax Risks
Legal action by former Associates or third parties against us could harm our business.
We continually monitor and review our Associates’ compliance with our policies and procedures as well the laws and regulations applicable to our business. In the ordinary course of our business, Associates occasionally fail to adhere to our policies and procedures. If this happens, we may take disciplinary action against the breaching Associate. This disciplinary action is based on the facts and circumstances of the particular case and may include anything from warnings
31
for minor violations to termination of the Associate’s purchase and distribution rights for more serious violations. From time to time, we become involved in litigation with an Associate whose purchase and distribution rights have been terminated. We consider this type of litigation to be routine and incidental to our business. While neither the existence nor the outcome of this type of litigation is typically material to our business, in the past we have been involved in litigation of this nature that resulted in a large cash award against us.
Our competitors have also been involved in this type of litigation, and more and more of these cases have resulted in class action litigation, where the result has been a large cash award against the competitor or a large cash settlement by the competitor. These types of challenges, awards or settlements could provide incentives for similar actions by other former Associates against us in the future, which could result in class action litigation against us. Any such challenge involving others in our industry or us, could harm our business by resulting in fines or damages against us, creating adverse publicity about us or our industry, or hurting our ability to attract and retain customers.
We believe that Associate compliance is critical to the integrity of our business, and, therefore, we will continue to be assertive in ensuring that our Associates comply with our policies and procedures. As such, there can be no assurance that this type of litigation will not occur again in the future or result in an award or settlement that has a materially adverse effect on our business. We could also be subject to challenges by private parties in civil actions. We are aware of recent civil litigation against various direct selling companies in the United States, which have already resulted in settlements and may result in additional significant settlements in the future by these companies. There can be no assurance that we will not be challenged by private parties in litigation.
We may incur liability under our “Athlete Guarantee” program.
We believe that our nutritional supplement products are free from substances that have been banned by world-class training and competitive athletic programs. We retain independent testing agencies to conduct periodic checks for banned substances. We further believe that, while our products promote good health, they are not otherwise considered “performance enhancing” as that term has been used in defining substances that are banned from use in international competition by the World Anti-Doping Agency (“WADA”). For many years, we have been a sponsor of Olympic level athletes and professional competitors around the world. These athletes have been tested on many occasions and have never tested positive for banned substances as a result of taking USANA nutritional products. To back up our claim that athletes who use USANA products as part of their training regimen will not be consuming banned substances, we have offered to enter into agreements with select athletes, some of whom have high-profiles and are highly compensated. These agreements provide that, during the term of the agreement, should the athlete test positive for a banned substance included in the WADA, and should such positive result be caused by taking USANA nutritional products, we will compensate that athlete at an amount equal to two times their current annual earnings, up to $1.0 million, based on the athlete’s personal level of competition, endorsement, and other income, as well as other factors. Although we believe that the pool of current and potential participants in the program is small and that the procedures and safeguards implemented by us in connection with the program are sound, there is no guarantee that an athlete who is accepted in the program will not successfully make a claim against us. We currently have no insurance to protect us from potential claims under this program.
Failure to comply with anti-corruption laws could adversely affect our business.
We currently conduct our business in various foreign countries and expect to expand the number of countries in which we operate in the future. Our international business is subject to various anti-corruption laws, including principally the U.S. Foreign Corrupt Practices Act. In recent years, there have been an increasing number of investigations and other enforcement activities under these laws, including a voluntary investigation we concluded several years ago concerning our China operations. The FCPA prohibits U.S.-based companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business. Other anti-corruption laws prohibit both domestic and international bribery as well as bribery across both public and private sectors. We pursue opportunities in certain parts of the world that experience government corruption and in certain circumstances compliance with anti-bribery laws may conflict with local customs and practices. Our policies mandate compliance with all applicable anti-bribery laws. Further, we require our partners, subcontractors, agents and others who work for us or on our behalf to comply with these and other anti-bribery laws.
Although we have policies and procedures and a compliance program designed to ensure that we comply with the FCPA and other anti-bribery laws, there is no assurance that such policies or procedures will protect us against liability under the FCPA or other laws for actions taken by our agents, employees and intermediaries. If we are found to be liable for violations of these acts (either due to our own acts or our inadvertence or due to the acts or inadvertence of others), we could incur severe criminal or civil penalties or other sanctions, which could have a material adverse effect on our
32
reputation, business, results of operations or cash flows. In addition, detecting, investigating and resolving actual or alleged violations of these acts is expensive and could consume significant time and attention of our senior management.
We could be subject to adverse changes in tax laws, regulations and interpretations or challenges to our tax positions.
We are subject to tax laws and regulations in the United States and numerous other foreign jurisdictions. Tax laws, regulations, and interpretations in various jurisdictions may change, with or without notice, due to social, economic, political and other considerations. As a result, our evaluation and estimates for our provision for income taxes may change perhaps negatively. Our future effective tax rates could be affected by numerous factors, including changes in the market mix for our net sales, the amount of our earnings and where earned, intercompany transactions, the inability to realize tax benefits, changes in currency exchange rates, tax positions, allocation and apportionment of state taxes, changes in our deferred tax assets and liabilities and their valuation, changes in our business operations, acquisitions, and entry into new markets. There can be no assurance that additional changes in tax laws or regulations, both within the United States and the other jurisdictions in which we operate, will not materially and adversely affect our effective tax rate, tax payments, financial condition and results of operations. Similarly, changes in tax laws and regulations that impact our customers and counterparties or the economy generally may also impact our financial condition and results of operations.
We are also subject to examination by tax authorities, including state revenue agencies and foreign governments. While we regularly assess the likelihood of favorable or unfavorable outcomes resulting from examinations by tax authorities to determine the adequacy of our provision for income taxes, there can be no assurance that the actual outcome resulting from these examinations will not materially adversely affect our financial condition and operating results. The IRS and several foreign tax authorities have also increasingly focused attention on intercompany transfer pricing. Tax authorities, in certain instances, have disagreed with our transfer pricing calculations and agreements and assessed us with additional taxes. Going forward, tax authorities could continue to disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. If we do not prevail in any such disagreements, our profitability may be affected. Tax laws and regulations are complex and subject to varying interpretations and any significant failure to comply with applicable tax laws and regulations in all relevant jurisdictions could give rise to substantial penalties and liabilities. Any changes in enacted tax laws, rules or regulatory or judicial interpretations; any adverse outcome in connection with tax audits in any jurisdiction; or any change in the pronouncements relating to accounting for income taxes could materially and adversely impact our effective tax rate, tax payments, financial condition and results of operations.
We have identified material weaknesses in our internal control over financial reporting. If we fail to properly remediate the material weaknesses or to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud.
As more fully disclosed in Item 9A. “Controls and Procedures,” we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures and internal control over financial reporting. Based on that evaluation, we have concluded that our disclosure controls and procedures were not effective as of December 30, 2023, due to material weaknesses in internal control over financial reporting.
The material weaknesses resulted from an insufficient complement of trained resources with specialized skills and knowledge in information technology general controls (ITGCs), or an alternative contingency plan, to timely respond to the impacts of turnover in key personnel with responsibility for ITGCs that occurred during 2023. As a result, we did not maintain effective ITGCs in the areas of user access, program change management, and computer operations over the information technology (IT) systems that support our financial reporting processes. Process-level automated controls that are dependent on the affected ITGCs and manual controls that rely on the integrity of data or reports from the affected systems across substantially all of our processes were also deemed ineffective because they could have been adversely impacted. Although these material weaknesses did not result in any errors to the financial statements, and there were no changes to previously released financial results, the applicable control deficiencies were not remediated as of December 30, 2023, and, consequently, there was a reasonable possibility that it could have resulted in a material misstatement in the Company's financial statements that would not have been detected.
While the Company’s management, under the oversight of the Audit Committee, has begun taking steps to implement our remediation plan as described more fully in Item 9A. “Controls and Procedures,” these material weaknesses will not be considered remediated until the enhanced controls operate for a sufficient period of time and management has concluded, that the related controls are effective. There is no assurance that the measures we take will remediate these material weaknesses. If we fail to maintain effective internal controls, we could be required to take costly and time-consuming corrective measures, to remedy any number of deficiencies, significant deficiencies or material
33
weaknesses, be required to restate the affected historical financial statements, be subjected to investigations and/or sanctions by federal and state securities regulators and be subjected to civil lawsuits by security holders. Any of the foregoing could also cause investors to lose confidence in our reported financial information and in our company and would likely result in a decline in the market price of our stock and in our ability to raise additional financing if needed in the future.
ESG issues may have an adverse effect on our reputation, business, financial condition or results of operations.
Companies across all industries are facing increasing scrutiny relating to their ESG policies. If we are unable to meet our ESG goals or evolving regulator, investor, industry or stakeholder expectations and standards, or if we are perceived to have not responded appropriately to the growing concern for ESG issues, customers may choose to stop purchasing our products and our reputation, business or financial condition may be adversely affected. In particular, these constituencies are increasingly focusing on environmental issues, including climate change, water use, plastic waste, and other sustainability concerns. These factors could cause us to incur additional costs, to make changes to our operations to make additional commitments, set targets or establish additional goals and take actions to meet them, which could expose us to market, operational and execution costs or risk.
In addition to environmental issues these constituencies are also focused on social and other governance issues, including matters such as, but not limited to, human capital and social issues. We also have established diversity, equity and inclusion goals as part of our ESG initiative.
Concern over climate change, including plastics and packaging materials, in particular, may result in new or increased legal and regulatory requirements, including, for example, two climate disclosure laws adopted by California in 2023 . Increased regulatory requirements related to environmental causes, and related ESG disclosure rules, including the new California laws and the SEC's recent disclosure proposal on climate change, may result in increased compliance costs or increased costs of energy, raw materials or compliance with emissions standards, which may cause disruptions in the manufacture of our products or an increase in operating costs. Any failure to achieve our ESG goals or a perception (whether or not valid) of our failure to act responsibly with respect to the environmental, human capital, or social issues, or to effectively respond to new, or changes in, legal or regulatory requirements concerning environmental or other ESG matters, or increased operating or manufacturing costs due to increased regulation or environmental causes could adversely affect our business and reputation and increase risk of litigation.
Risk Associated with Information Technology, Data Security and Data Privacy
A failure or interruption of our information technology systems would harm our business.
The global nature of our business, shopping and our global compensation plan requires the development and implementation of robust and efficiently functioning information technology systems. Such systems are vulnerable to a variety of potential risks, including damage or interruption resulting from natural disasters, power outages, certain aging system architecture, systems failures, hardware or software corruption, human error or hacking, malware, ransomware, phishing or other similar acts. We rely on both self-developed and third-party developed and supported information technology systems. Although we have adopted and implemented a business continuity and disaster recovery plan and a variety of other operational safeguards, the occurrence of any of these events could result in costly interruptions or failures adversely affecting our business and the results of our operations.
We rely on information technology to support our operations and reporting environments. A data breach involving that technology or the data stored in it, could disrupt our ability to operate our businesses effectively, adversely affect our reported financial results and our reputation, and expose us to significant potential liability, government investigations, fines or litigation.
In the ordinary course of our global business, we collect and store in our data centers and on our networks, including cloud systems, significant amounts of data, including personally identifiable information (PII), intellectual property, and our proprietary business information The secure collection, storage and other processing of this information is critical to our operations, regulatory compliance and business strategy. Although we strive to frequently analyze and improve our data security measures, our information technology and infrastructure are subject to persistent attacks of varying degrees and types and we may be vulnerable to attacks by hackers. Such attacks could include viruses, ransomware attacks, computer denial of service attacks, or phishing schemes. In some instances, despite our reasonable efforts, it could take us some time to discover that our networks have been breached.
34
Any such breach of our networks and the information and PII stored therein could cause such information and PII to be accessed, publicly disclosed, altered, damaged, held ransom, lost or stolen. In any such event, we could suffer significant loss or incur significant liability, including: damage to our reputation; increased cyber insurance premiums; loss of customer confidence or goodwill; and significant expenditures of time and money to address and remediate the resulting damage (including notification and credit monitoring costs, as well as fines and penalties imposed by regulators) to affected individuals or business partners, or to defend ourselves in resulting litigation or other legal proceedings, by affected individuals, business partners or regulators.
Likewise, a failure to adhere to the payment card industry’s data security standards could lead to significant penalties from payment card associations, termination of our ability to receive credit or debit card payments, any of which could have a material adverse effect on our business and financial condition. Furthermore, such data breach could result in significant disruption of our operations, which could adversely affect our business, revenues and competitive position.
We are subject to data privacy and security laws and regulations, and our actual or perceived failure to comply with them could adversely affect our business and operating results.
Compliance with data privacy and security laws and regulations is a significant effort for us in all of our markets because we collect, store and otherwise process significant amounts of customer and employee personal information for business (including for transactional and marketing purposes) and legal purposes. The governments of our various markets have adopted, or are adopting, complex and strict laws and regulations governing data privacy and security, and these areas are still rapidly evolving. These laws and regulations have resulted in greater compliance risk and cost for us.
These laws and regulations often require us to take a variety of actions, including: implementing new data privacy and security policies; granting individuals a wide variety of rights with respect to their PII, including access, correction and deletion rights; informing individuals of security breaches that affect their PII; disclosing to individuals how we process their PII and obtaining their written consent to such processing; and localizing individuals' PII within national borders and complying with cross border PII transfer assessments and requirements, among other things. Examples of significant, recent data privacy and security laws affecting our various markets include the European Union General Data Protection Regulation, ("GDPR"), China’s national Data Privacy Law and Personal Information Protection Law, China's Cybersecurity Law, the California Consumer Privacy Act, ("CCPA"), and the California Privacy Rights Act. Virginia, Colorado, Connecticut, Utah, Iowa, Indiana, Tennessee, Montana, Texas, Florida, Delaware, and Oregon all have adopted laws introducing new privacy obligations and many other states are considering similar legislation. A broad range of legislative measures also have been introduced at the federal level. There also is a wide range of enforcement agencies at both the state and federal levels that can review companies for privacy and data security concerns based on general consumer protection laws. The FTC and state Attorneys General all are aggressive in reviewing privacy and data security protections for consumers.
We have incurred, and will continue to incur, substantial costs in striving to comply with these various data privacy and security laws and regulations. Compliance with these laws and regulations may limit our ability to provide products and services to our customers that they may find valuable or otherwise require us to change our business practices in a manner that is ultimately adverse to our business objectives. As such, we cannot assure ongoing compliance with all such laws or regulations, industry standards, contractual obligations and other legal obligations. Any failure or perceived failure by us to comply with data security and privacy laws and regulations may result in governmental enforcement actions and prosecutions, private litigation, significant fines and penalties, adverse publicity, or reputation damage, which could have an adverse effect our business and operating results.
Human Capital Risks Associated with our Business
If we are unable to attract and retain active Associates and Preferred Customers, our business may be harmed.
Our consumer base includes Associates who personally consume and sell our products, Preferred Customers who join USANA and simply consume our products, and retail customers who do not join USANA but purchase products directly from us or one of our Associates and consume our products. We refer to Associates, and Preferred Customers in this Annual Report together as active Customers. We rely largely on our Associates to market and sell our products and to generate active Customer growth. Our ability to maintain and increase sales in the future will depend in large part upon our success in increasing our number of active Customers. Our success will also depend on our ability to retain and motivate our existing Associates and attract new Associates to sell our products. Associates typically market and sell our products on a part-time basis and often engage in other business activities, some of which may compete with us. Our ability to continue to attract and retain active Customers can be affected by a number of factors, some of which are beyond our control, including each of the other risks identified in this Annual Report. Our Associates may terminate their services at any time
35
and, like most direct selling companies, we experience a high turnover among new active Customers from year to year. Customers may also stop buying from us at any time and it is challenging to determine why a customer actually stops buying. In 2023 most of our markets, including China, experienced active Customer declines. If our strategies, including our customer experience strategy, do not generate growth in our active Customer base, our operating results could be harmed.
We also rely on the successful efforts of our Associates who become leaders with our Company. Our Compensation Plan is designed to permit Associates to sponsor new Associates and Preferred Customers, thereby creating sales organizations. As a result, Associates develop business and personal relationships with other Associates and Preferred Customers. The loss of a key Associate or group of Associates, large turnover or decreases in the size of the key Associate force, seasonal or other decreases in product purchases, sales volume reduction, the costs associated with training new Associates, and other related expenses may adversely affect our business, financial condition, or results of operations.
The loss of key management personnel could adversely affect our business.
Our executive officers are primarily responsible for our day-to-day operations, and we believe our success depends in part on our ability to retain our executive officers, to compensate our executive officers at attractive levels, and to continue to attract additional qualified individuals to our management team. We depend upon the services of our Executive Chairman, Kevin Guest; our Chief Executive Officer and President, Jim H. Brown; and our Chief Financial Officer, Douglas Hekking, as well as other key members of our executive team. We cannot guarantee continued service by our key executive officers. We do not maintain key man life insurance on any of our executive officers, nor do we have an employment agreement with any of our executive officers. The loss or limitation of the services of any of our executive officers or the inability to attract additional qualified management personnel could have a material adverse effect on our business, financial condition, or results of operations.
Risks Associated with Business Development Activities and Acquisitions
In 2022, we acquired two businesses and our growth strategy contemplates acquiring additional businesses in the future to the extent that we find prospects that meet our acquisition criteria. Our acquisition criteria includes, but is not limited to: vertical integration; product and category expansion; geographic expansion; and other opportunities that strengthen, diversify and grow our world-wide business. Our completed and potential future acquisitions entail a variety of risks and uncertainties, including: (i) potential disruption to our direct selling business; (ii) failure to achieve our strategic objectives, efficiencies, and growth strategies for the acquisition; (iii) potential loss of key employees, customers, or other stakeholders of acquired businesses, particularly given that our strategy contemplates our acquired businesses operating and growing independently of USANA; (iv) general risks associated with owning and overseeing businesses and industries where we have limited or no prior experience; (v) expense and indebtedness, including unanticipated liabilities and litigation; (vi) shareholder dilution; (vii) difficulty in implementing an effective control environment for acquired companies, in a timely and efficient manner; or (viii) the failure to consummate transactions in a timely or efficient manner or at all.
The occurrence of any of the foregoing risks or others, or our inability to effectively execute our business development strategy, could have a material adverse effect on our business, financial condition and operating results. We cannot assure you that we will be able to identify suitable acquisition prospects, consummate acquisitions on favorable terms or at all, or accomplish the objectives of an acquisition.
General Economic, Publicity, Competitive, and Intellectual Property Risks Associated with our Business
Difficult economic conditions may adversely affect our business.
Over the past few years, economic conditions in many of the markets where we sell our products have resulted in challenges to our business and economies around the world have been negatively impacted by the COVID-19 pandemic. We cannot predict whether world or market-specific economies will improve or deteriorate in the future. If difficult economic conditions continue or worsen as a result of the COVID-19 pandemic, or otherwise, we could experience declines in net sales, profitability and cash flow due to lower demand for our products or other factors caused by economic challenges faced by our customers, potential customers or suppliers. Additionally, these conditions may result in a material adverse effect on our liquidity and capital resources or otherwise negatively impact our operations or overall financial condition.
36
Our business is subject to the effects of adverse publicity and negative public perception.
Our ability to attract and retain active Customers and to sustain and enhance sales through our Associates can be affected by adverse publicity or negative public perception regarding our industry, our competition, or our business generally. Our business prospects, financial condition and results of operations could be adversely affected if our public image or reputation were tarnished by negative publicity. This negative public perception may include publicity regarding the legality of direct selling, the quality or efficacy of nutritional supplement products or ingredients in general or our products or ingredients specifically, data privacy or security concerns, and regulatory investigations, regardless of whether those investigations involve us or our Associates or the business practices or products of our competitors or other direct selling companies.
There has been significant media and short-seller attention regarding the viability and legality of direct selling in the United States, China, and internationally over the past several years. This attention has led to intense public scrutiny of the industry, as well as volatility in our stock price and the stock price of companies similar to ours. There can be no assurance that we will not be subject to adverse publicity or negative public perception in the future or that such adverse publicity will not have a material adverse effect on our business, financial condition, or results of operations.
Our business is subject to the risks associated with intense competition from larger, wealthier, and more established competitors.
We face intense competition in the business of distributing and marketing nutritional supplements, vitamins and minerals, personal care products, and other nutritional products, as described in greater detail in “Business — Competition.” Numerous manufacturers, distributors, and retailers compete actively for consumers and, in the case of other direct selling companies, for Associates. There can be no assurance that we will be able to compete in this intensely competitive environment. In addition, nutrition and personal care products can be purchased in a wide variety of channels of distribution, including retail stores. Entry to market is not particularly capital intensive or otherwise subject to high barriers and as a result, new competitors can enter easily and compete with us for customers and distributors, including our Associates. Our product offerings in each product category are also relatively small, compared to the wide variety of products offered by many of our competitors.
Our business is subject to particular intellectual property risks.
Most of our products are not protected by patents. The labeling regulations governing our nutritional supplements require that we indicate ingredients of such products precisely and accurately on product containers. Accordingly, patent protection for nutritional supplements often is impractical given the large number of manufacturers who produce nutritional supplements having many active ingredients in common. Additionally, the nutritional supplement industry is characterized by rapid change and frequent reformulations of products, as the body of scientific research and literature refines current understanding of the application and efficacy of certain substances and the interactions among various substances. We protect our investment in research, as well as the techniques we use to improve the purity and effectiveness of our products, by relying on trade secret laws. We have also entered into confidentiality agreements with certain of our employees involved in research and development activities. Additionally, we endeavor to seek, to the fullest extent permitted by applicable law, trademark and trade dress protection for our products, which protection has been sought in many of our existing and potential future markets. Notwithstanding our efforts, there can be no assurance that our efforts to protect our trade secrets and trademarks will be successful. Nor can there be any assurance that third parties will not assert claims against us for infringement of their intellectual proprietary rights. If an infringement claim is asserted, we may be required to obtain a license of such rights, pay royalties on a retrospective or prospective basis, or terminate our manufacturing and marketing of our infringing products. Litigation with respect to such matters could result in substantial costs and diversion of management and other resources and could have a material adverse effect on our business, financial condition, or operating results.
Global Pandemic
Pandemics, epidemics, disease outbreaks and other public health crises, such as the COVID-19 pandemic, have disrupted our business and operations, and future public health crises could materially adversely impact our business, financial condition, liquidity and results of operations.
Pandemics, epidemics or disease outbreaks in the United States or globally, including the COVID-19 pandemic, have disrupted, and may in the future disrupt, our business, which could materially affect our results of operations, financial condition, liquidity and future expectations. Any such events may adversely impact our global supply chain and global manufacturing operations and cause us to again limit or suspend our operations in the United States, China and
37
elsewhere. To address the pandemic, many governments issued various restrictive orders that affected businesses and consumers. During the pandemic, government-imposed restrictions, health and safety mandated best practices, and public hesitance regarding in-person gatherings reduced our ability and the ability of our Associates to hold sales meetings, required our Associates to share and sell our products in a predominantly virtual environment, resulted in cancellations of key Company events and trips, required us to utilize a work-from-home strategy for all non-manufacturing and non-distribution employees, and required us to temporarily close our walk-in and fulfillment locations we maintain in some markets. The pandemic also affected the availability and cost of several of our raw materials, packaging materials and shipping resources to transport our product to our various markets around the world. Our supply chain and logistics have incurred some disruption and we could experience more significant disruptions or face more significant closures in the future.
These factors and others related to the COVID-19 pandemic, including the spread of new variants of the virus, will likely continue to negatively affect our business and our financial results in a number of ways. Any new pandemic or other public health crises, or future public health crises, could have a material impact on our business, financial condition and results of operations going forward.
Risks Related to Our Common Stock
The beneficial ownership of a significant percentage of our common stock gives our founder and parties related to or affiliated with him effective control, and limits the influence of other shareholders on important policy and management issues.
Gull Global, Ltd., an entity that is solely owned and controlled by our founder, Dr. Myron Wentz, owned approximately 41.7% of our outstanding common stock at December 30, 2023. Dr. Wentz is no longer active in the management of USANA and is an emeritus member of our Board of Directors. By virtue of this stock ownership, Dr. Wentz is able to exert significant influence and control over the election of the members of our Board of Directors and our business affairs. This concentration of ownership could also have the effect of delaying, deterring, or preventing a change in control that might otherwise be beneficial to shareholders. There can be no assurance that conflicts of interest will not arise with respect to these relationships or that conflicts will be resolved in a manner favorable to our other shareholders.
Sales by our shareholders of a substantial number of shares of our common stock in the public market could adversely affect the market price of our common stock.
A large number of outstanding shares of our common stock are held by several of our principal shareholders, including Gull Global, Ltd. If any of these principal shareholders were to decide to sell large amounts of stock over a short period of time such sales could cause the market price of our common stock to decline.
The market price of our common stock may be influenced by many factors, some of which are beyond our control.
There can be no assurance that an active market in our stock will be sustained. We have a relatively small public float compared to the number of our shares outstanding. Accordingly, we cannot predict the extent to which investors’ interest in our common stock will provide an active and liquid trading market. We are also vulnerable to investors taking a “short position” in our common stock, which has the effect of depressing the price of our common stock and adding volatility to our trading market. The price of our common stock also may fluctuate in the future in response to quarter-to-quarter variations in operating results, material announcements by us or our competitors, governmental regulatory action, conditions in the nutritional supplement industry, negative publicity, or other events or factors, many of which are beyond our control. In addition, the stock market has historically experienced significant price and volume fluctuations, which have particularly affected the market prices of many dietary and nutritional supplement companies and which have not had a strong correlation in certain cases to the operating performance of these companies. Our operating results in future quarters may be below the expectations of securities analysts and investors. If that were to occur, the price of our common stock, and accordingly, the value of a shareholder’s investment in our company, would likely decline, perhaps substantially.
Item 1B. Unresolved Staff Comments
There are no unresolved comments that were received from the SEC staff relating to our periodic or current reports under the Securities Exchange Act of 1934.
38
Item 1C. Cybersecurity

Overview.
We have implemented and maintain a cybersecurity risk management program, which consists of, among other things, comprehensive processes to identify, assess, manage, and mitigate material cybersecurity threats as part of our broader enterprise risk management program. We utilize an internal team of cybersecurity professionals and, to some extent, data privacy professionals to oversee this program. Where appropriate, we obtain input from external experts on our program, including with respect to prevailing cybersecurity practices and the latest cyber threat trends.

Cybersecurity Team.
Our internal team of cybersecurity and data privacy professionals oversee, among other things, our cybersecurity risk management and mitigation, incident prevention, detection, and remediation. The leadership of these teams is comprised of various professionals with cybersecurity expertise, including our Vice President of Information Security and Disaster Recovery, who reports to our Chief Operating Officer. Our Vice President of Information Security and Disaster Recovery has a bachelor’s degree in computer information systems, multiple university certifications in advanced cybersecurity, and over 30 years’ experience in cybersecurity and technology roles at various companies. Our executive leadership team, with input from the above teams, is responsible for our overall enterprise risk management system and associated processes, and regularly considers cybersecurity risks in the context of other material risks to the Company.

Risk Management Program Components, Training, and Incident Response.
As part of our cybersecurity risk management program, our incident response team tracks and logs cybersecurity and data privacy incidents across the Company to identify, assess, mitigate, remediate, and resolve any such incidents. Prior to forming a contractual relationship with a material vendor or third-party service provider that will have access to our information systems or data, we perform due diligence on their cybersecurity and data privacy posture. We conduct annual reviews and tests of our information security program and we periodically review and update our cybersecurity policies. We also periodically utilize qualified third parties to evaluate and assess our cybersecurity risk management program, including through conducting cybersecurity maturity assessments. We utilize cybersecurity user awareness trainings with our employees, cybersecurity insurance, business continuity mechanisms, tabletop exercises, penetration testing, and vulnerability scanning to evaluate the effectiveness of our information security program and improve our security measures and planning. The material results of these assessments are reported to our executive leadership team and the Governance, Risk and Nominating Committee of the Company’s Board of Directors (the “Board”).
We have adopted a cybersecurity and data privacy incident response plan that provides a framework for identifying, classifying, documenting, and responding to cybersecurity and data privacy incidents and determining whether reporting of an incident is appropriate or required under regulatory standards. The plan also includes a materiality assessment framework to assist us in determining whether a security incident is “material” under the federal securities laws. A cross-functional working group reviews significant cybersecurity incidents under this framework to assess the incident and, among other things, determine whether further assessment and escalation of the incident within USANA is appropriate. Any incident assessed as being or potentially becoming material is immediately escalated to designated members of our executive leadership team. We consult with outside cybersecurity and data privacy consultants and legal counsel as appropriate, including on cyber incident significance and/or materiality analysis and disclosure matters, and designated members of our management team make the final materiality determinations and disclosure and other compliance decisions. Our management apprises the Governance Risk and Nominating Committee and, where necessary, our independent registered public accounting firm, of cybersecurity matters and relevant developments, as appropriate.

Governance.
Our Board is actively involved in the assessment, oversight and management of the material risks that could affect the Company. The Board carries out its risk oversight and management responsibilities by monitoring risk directly as a full Board and, where appropriate, through its committees. The Board has delegated to the Governance, Risk and Nominating Committee the ultimate oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements, cooperation with law enforcement, and related effects on financial and other risks, and it reports any findings and recommendations, as appropriate, to the full Board for consideration. Our cybersecurity and data privacy professionals regularly discuss cyber risks and trends and, should they arise, any material incidents with management and the Governance, Risk and Nominating Committee.

Material Risks from Cybersecurity Threats.
39
As a global company with operations and customers in 25 markets, we encounter a variety of cybersecurity threats. However, our business strategy, results of operations and financial condition have not been materially affected by risks from cybersecurity threats. Nevertheless, we cannot provide assurance that they will not be materially affected in the future by such risks or any future material incidents. For more information on our cybersecurity related risks, see “Item 1A. Risk Factors.” of this Annual Report on Form 10-K.

Item 2. Properties
Corporate Headquarters
Our world-wide corporate headquarters is a 354,000 square foot company-owned facility located in Salt Lake City, Utah. In addition to executive offices, this facility includes space for manufacturing and quality control, distribution, administrative functions, and research and development. This facility manufactures inventories for all global markets, excluding China. Additionally, we own a 54,000 square foot manufacturing facility, located adjacent to the corporate headquarters facility, where we began in-house manufacturing of our foods product line during the fourth quarter of 2020.
China Manufacturing
We own a 350,000 square foot state-of-the-art facility in Beijing, China similar in potential capacity and nature to our corporate headquarters to manufacture products sold in China. Additionally, we own a 31,000 square foot manufacturing facility in Tianjin, China, where we manufacture our skincare products for sale in China.
Other Office and Distribution Warehouse Facilities
We own a 45,000 square foot office and warehouse building in Sydney, Australia.
In other markets, we lease regional offices and distribution warehouses. Additionally, we lease retail centers for our operations in China.
We believe that the facilities referenced above are in good condition and are adequately utilized. Further, we believe that our current and planned manufacturing facilities provide for the productive capacity to meet our foreseeable needs.
Item 3. Legal Proceedings
We are a party to litigation and other proceedings that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters.
Information with respect to legal proceedings may be found in Note K to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated herein by reference.
Item 4. Mine Safety Disclosures
Not applicable.
40
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our common stock trades on the NYSE under the symbol “USNA.” As of February 23, 2024, we had approximately 237 holders of record of our common stock. We have never declared or paid cash dividends on our common stock. Future cash dividends, if any, will be determined by our Board of Directors and will be based on earnings, available capital, our financial condition, and other factors that the Board of Directors deems to be relevant.
Information regarding securities authorized for issuance under equity compensation plans is included in Item 12. “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”
Share Repurchases
Our share repurchase plan has been ongoing since the fourth quarter of 2000, with our Board of Directors periodically approving additional dollar amounts for share repurchases under the plan. There were no share repurchases made during the quarter ended December 30, 2023. As of December 30, 2023, the remaining authorized repurchase amount under the stock repurchase plan was $71.2 million inclusive of accrued excise tax. There is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Stock Performance Graph
The following graph and table compare the performance of our common stock to the Russell 2000 Index ("Index") and to a market-weighted index of six companies selected in good faith from our industry (the “Peer Group”) over the last five years. The data shown assumes an investment on December 31, 2018, of $100 in our common stock and each of the other equities and reinvestment of all dividends into additional shares of the same class of equity, if applicable to the stock or index.
Each of the companies included in the Peer Group markets or manufactures products similar to our products or markets its products through a similar marketing channel. The Peer Group includes the following companies: Nu Skin Enterprises, Inc., Herbalife Nutrition Ltd., LifeVantage Corporation, Medifast, Inc., Nature's Sunshine Products, Inc., and Mannatech, Inc.
2273
41
USNARussell 2000Peer Group
Dec 2018$100$100$100
Dec 2019$67$124$100
Dec 2020$65$146$80
Dec 2021$86$166$111
Dec 2022$45$131$114
Dec 2023$46$150$65
Item 6. Reserved
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of USANA’s financial condition and results of operations is presented in nine sections:
•Overview
•Customers
•Presentation
•Non-GAAP Financial Measures
•Results of Operations
•Liquidity and Capital Resources
•Contractual Obligations and Commercial Contingencies
•Inflation
•Critical Accounting Policies and Estimates
This discussion and analysis from management's perspective should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing elsewhere in this report.
Overview
We develop and manufacture high quality, science-based nutritional and personal care and skincare products that are distributed internationally primarily through direct selling. We use this distribution method because we believe it is more conducive to meeting our vision as a company, which is to improve the overall health and nutrition of individuals and families around the world. Our customer base is primarily comprised of two types of customers: “Associates” and “Preferred Customers,” referred to together as “active Customers.” Our Associates also sell our products to retail customers. Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. In 2023, we launched our Affiliate program in the United States, Canada, and Mexico and are evaluating introducing the program in other markets. This program offers another sales and compensation opportunity to individuals who are interested in selling USANA products. Affiliates are discussed and reported in this report with Associates. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. We only count as active Customers those Associates and Preferred Customers who have purchased from us at any time during the most recent three-month period. As of December 30, 2023, we had approximately 483,000 active Customers worldwide.
Customers
Because we sell our products to a customer base of independent Associates and Preferred Customers, we increase our sales by increasing the number of our active Customers, the amount they spend on average, or both. Our primary focus continues to be increasing the number of active Customers. We believe this focus is consistent with our vision of improving the overall health and nutrition of individuals and families around the world. Sales to Associates account for approximately 52% of Direct-selling segment product sales during 2023, with the remainder of our sales being to Preferred Customers. Increases or decreases in product sales are typically the result of variations in the volume of product sold relating to fluctuations in the number of active Customers purchasing our products. The number of active Associates and
42
Preferred Customers is therefore used by management as a key non-financial indicator to evaluate our operational performance.
The table below summarizes the change in our active Customer base by geographic region, rounded to the nearest thousand, as of the dates indicated.
Total Active Customers by RegionChange from
Prior Year		Percent
Change
As of
December 30, 2023		As of
December 31, 2022
Asia Pacific:
Greater China255,00052.8 %244,00049.8 %11,0004.5 %
Southeast Asia Pacific80,00016.6 %87,00017.8 %(7,000)(8.0 %)
North Asia48,0009.9 %53,00010.8 %(5,000)(9.4 %)
Asia Pacific Total383,00079.3 %384,00078.4 %(1,000)(0.3 %)
Americas and Europe100,00020.7 %106,00021.6 %(6,000)(5.7 %)
483,000100.0 %490,000100.0 %(7,000)(1.4 %)
Presentation
Product sales along with the shipping and handling fees billed to our customers are recorded as revenue net of applicable sales discounts when, or as control of, the promised product is transferred to the customer, which is at the time of delivery to the third party carrier for shipment. Payments received for unshipped products are recorded as deferred revenue and are included in the "Other current liabilities" line item in the consolidated balance sheet. Also reflected in net sales is a provision for a refund liability for sales returns, which is estimated based on our historical experience. Additionally, other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
Cost of sales primarily consists of expenses related to raw materials, labor, quality assurance, and overhead costs that are all directly associated with the production and distribution of our products and sales materials, as well as duties and taxes that are associated with the import and export of our products. As international sales increase as a percentage of net sales, cost of sales are increasingly affected by additional duties, freight, and other factors, such as changes in currency exchange rates.
Associate incentives expense includes all forms of commissions, and other incentives paid to our Associates. Incentives paid to Associates include bonuses earned, rewards from contests and promotions, and base commissions, which makes up the majority of our Associate incentives expense. We pay bonuses to Associates based on certain business-related criteria, total base commission earnings, and leadership level. Contests and promotions are offered as an incentive and reward to our Associates and are typically paid out only after an Associate achieves specific criteria. Base commissions are paid out on the sale of products. Associates earn their commissions based on sales volume points that are generated in their sales organization. Sales volume points are assigned to each commissionable product and comprise a certain percent of the product price. Items such as our starter kits and sales tools have no sales volume point value, and commissions are not paid on the sale of these items. Although insignificant to our financial statements, an Associate may earn commissions on sales volume points that are generated from personal purchases that are not considered part of their “Qualifying Sales.” To be eligible to earn commissions, an Associate must reach a certain level of Qualifying Sales each month, which may include product that they use personally or that they resell to consumers. Associates do not earn commissions on their Qualifying Sales. Commissions paid to Associates on personal purchases are considered a sales discount and are reported as a reduction to our net sales.
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, lease costs and utilities, Associate event costs, advertising, professional fees, marketing, and research and development expenses. Wages and benefits represent the largest component of selling, general and administrative expenses. Significant depreciation and amortization expense is incurred as a result of investments in physical facilities, computer and information technology infrastructure to support our international operations.
43
Sales to customers outside the United States are transacted in the respective local currencies and translated to U.S. dollars at weighted-average currency exchange rates for each monthly accounting period to which they relate. With the exception of China, our raw material purchases from suppliers and product purchases from third-party manufacturers are transacted in U.S. dollars. Consequently, our net sales and earnings are affected by changes in currency exchange rates. In general, our operating results are affected positively by a weakening U.S. dollar and negatively by a strengthening U.S. dollar. In our net sales discussions that follow, we approximate the impact of currency fluctuations on net sales by translating current year net sales at the average exchange rates in effect during the comparable prior-year periods.
Non-GAAP Financial Measures
We believe that presentation of certain non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations. Management believes these measures reflect an additional way of viewing aspects of our business that, when viewed with our U.S. GAAP results, provide a more complete understanding of factors and trends affecting our business. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes. We provide such non-GAAP financial information for informational purposes only. Readers should consider the information in addition but not instead of or superior to, our Consolidated Financial Statements prepared in accordance with U.S. GAAP, accompanying this report.
In analyzing business trends and performance, management uses “constant currency” net sales, “local currency” net sales, and other currency-related financial information terms to discuss our financial results in a way we believe is helpful in understanding the impact of fluctuations in foreign-currency exchange rates and facilitating period-to-period comparisons of results of operations and providing investors an additional perspective on trends and underlying business results. Changes in our reported revenue and profits in this report include the impacts of changes in foreign currency exchange rates. As additional information to the reader, we provide constant currency assessments in the tables and the narrative information in this MD&A to remove or quantify the impact of the fluctuation in foreign exchange rates and utilize constant currency results in our analysis of performance. Our constant currency financial results are calculated by translating the current period’s financial results at the same average exchange rates in effect during the applicable prior-year period and then comparing this amount to the prior-year period’s financial results.
Results of Operations
Summary of 2023 Financial Results
Our discussion and analysis is focused on our 2023 and 2022 financial results, including comparisons of our year-over-year performance between these years. Discussion and analysis of our 2021 fiscal year specifically, as well as the year-over-year comparison of our 2022 financial performance to 2021, are located in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on February 28, 2023, which is available on our investor relations website at https://ir.usana.com or the SEC’s website at www.sec.gov. That information is incorporated by reference into this report.
Net sales in 2023 decreased 7.8%, or $77.6 million, to $921.0 million, compared with 2022. The decrease in net sales was primarily the result of a challenging economic environment in many of our key markets, which had varying degrees of impact on attracting new customers as well as consumer purchasing behavior of our products throughout the year. In some markets, we recognized our consumers were faced with an increasingly challenging economic environment. Consequently, we experienced a decline in active Customers of 1.4% compared to the prior year. Additionally, unfavorable changes in currency exchange rates decreased net sales for the year by an estimated $27.8 million.
Net earnings decreased 8.0% to $63.8 million in 2023, when compared with 2022. The decrease in net earnings was primarily the result of decreased sales and higher relative operating expenses.
44
Fiscal Year 2023 compared to Fiscal Year 2022
Net Sales
The following table summarizes the changes in our net sales by geographic region for the fiscal years ended December 30, 2023, and December 31, 2022:
Net Sales by Region
(in thousands)		Change from prior
year		Percent changeCurrency impact on
sales		Percent change
excluding currency
impact
Twelve Months Ended
December 30, 2023December 31, 2022
Asia Pacific
Greater China$475,099 51.6 %$502,486 50.3 %$(27,387)(5.5)%$(22,498)(1.0)%
Southeast Asia Pacific163,890 17.8 %190,478 19.1 %(26,588)(14.0)%(4,376)(11.7)%
North Asia101,446 11.0 %108,952 10.9 %(7,506)(6.9)%(1,774)(5.3)%
Asia Pacific Total740,435 80.4 %801,916 80.3 %(61,481)(7.7)%(28,648)(4.1)%
Americas and Europe180,575 19.6 %196,685 19.7 %(16,110)(8.2)%882 (8.6)%
$921,010 100.0 %$998,601 100.0 %$(77,591)(7.8)%$(27,766)(5.0)%
Asia Pacific: The decrease in constant currency net sales in Greater China was primarily the result of a sales decline in China and Taiwan where local currency net sales decreased 0.6% and 3.9%, respectively. There were local currency declines in all markets in the Southeast Asia Pacific sub-region, most notable in the Philippines and Australia, which had local currency net sales declines of 25.7% and 8.4%, respectively. The decrease in constant currency net sales in North Asia was most notable in South Korea, which had a local currency net sales decline of 5.6%.
Americas and Europe: There were local currency sales declines in all markets in this region. The decrease in constant currency net sales is largely the result of sales declines in the United States and Canada, which had local currency net sales declines of 12.1%, and 7.2%, respectively
Gross Profit
Gross profit increased 20 basis points to 80.8% of net sales, up from 80.6% in 2022. The increase in gross profit margin can be attributed to decreased inventory valuation adjustments, and the impact of modest price increases that occurred throughout the year. These increases were partially offset by higher material costs, unfavorable changes in currency exchange rates, and loss of leverage on lower sales.
Associate Incentives
Associate incentives decreased 70 basis points to 42.8% of net sales in 2023, compared with 43.5% in the prior year. The relative decrease can primarily be attributed to decreased spend on promotional and program incentives, as well as modest price increases that occurred throughout the year.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased 160 basis points relative to net sales and decreased $5.3 million in absolute terms. The relative increase can be attributed to leverage lost on lower net sales. The decreased expense in absolute terms can be primarily attributed to a decrease in variable operating expenses as well as the capitalization of expenses associated with our digital commerce initiatives.
Income Taxes
Income taxes increased to 37.7% of pre-tax earnings in 2023, up from 36.2% of pre-tax earnings in 2022. The effective tax rate increase is due primarily to a change in the market mix of pre-tax book income.
45
Diluted Earnings Per Share
Diluted EPS decreased to $3.30 in 2023 from $3.59 in 2022. This decrease can be attributed to lower net earnings.
Liquidity and Capital Resources
We have historically met our working capital and capital expenditure requirements by using net cash flow from operations and by drawing on our line of credit. Our principal source of liquidity is our operating cash flow. Although we are required to maintain cash deposits with banks in certain of our markets, there are currently no material restrictions on our ability to transfer and remit funds among our international markets. In China, however, our compliance with Chinese accounting and tax regulations promulgated by the State Administration of Foreign Exchange (“SAFE”) results in transfer and remittance of our profits and dividends from China to the United States on a delayed basis. If SAFE or other Chinese regulators introduce new regulations or change existing regulations which allow foreign investors to remit profits and dividends earned in China to other countries, our ability to remit profits or pay dividends from China to the United States may be limited in the future.
We believe our current liquidity is adequate to meet our cash requirements and sustain our operations through cash flow from operations. Maintaining a capital structure that emphasizes sufficient liquidity and adaptability in the prevailing economic climate is our top priority. We actively assess potential acquisition opportunities and investments in complementary ventures. While we continuously aim to preserve ample liquidity and ensure business continuity amid uncertainties, we also explore initiatives such as stock repurchases. These strategic decisions have the potential to impact our liquidity, enabling us to navigate these challenging times effectively.
Cash and Cash Equivalents
Cash and cash equivalents increased to $330.4 million at December 30, 2023, from $288.4 million at December 31, 2022. Cash flow provided by operating activities was $70.6 million partially offset by cash used in financing activities of $14.2 million, and cash used in investing activities of $12.0 million. Additionally, unfavorable changes in currency exchange rates, have impacted cash and cash equivalents, and restricted cash by an estimated $2.5 million.
The following table below presents concentrations of cash and cash equivalents by market for the periods indicated:
Cash and cash equivalents
(in Millions)
As of
December 30, 2023		As of
December 31, 2022
United States$169.9 $114.1 
China$111.0 $129.8 
All other markets$49.5 $44.5 
Total Cash and cash equivalents$330.4 $288.4 
Cash Flows Provided by Operations and Significant Uses of Cash
As discussed above, our principal source of liquidity comes from cash flows from operations. Net cash flow provided by operating activities totaled $70.6 million in 2023. Net earnings combined with adjustments of non-cash items contributed positively to our net cash flow provided by operating activities, partially offset by changes in working capital.
Other significant uses of cash included an investment of $14.5 million to purchase property and equipment primarily related to our digital commerce initiatives and our India operations. Additionally, cash used to repurchase and retire shares totaled $11.6 million for 2023.
Net cash flow provided by operating activities totaled $103.9 million in 2022. Net earnings combined with adjustments of non-cash items contributed positively to our net cash flow provided by operating activities, partially offset by cash used to payout the annual employee bonus, reduce accruals related to inventories, and a reduction in trade payables. Additionally, cash used to repurchase and retire shares was $25.4 million for 2022.
46
Line of Credit
Information with respect to our line of credit may be found in Note J to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Share Repurchase
Information with respect to our share repurchases may be found in Note N to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Off-Balance Sheet Arrangements
None.
Summary
We believe our current cash balances, future cash provided by operations, and amounts available under our line of credit will be sufficient to cover our operating and capital needs in the ordinary course of business for the foreseeable future. If we experience an adverse operating environment or unanticipated and unusual capital expenditure requirements, additional financing may be required. No assurance can be given, however, that additional financing, if required, would be available to us at all or on favorable terms. We might also require or seek additional financing for the purpose of expanding into new markets, growing our existing markets, mergers and acquisitions, or for other reasons. Such financing may include the use of debt or the sale of additional equity securities. Any financing which involves the sale of equity securities or instruments that are convertible into equity securities could result in immediate and possibly significant dilution to our existing shareholders.
Contractual Obligations and Commercial Contingencies
The following table summarizes our contractual obligations and commitments as of December 30, 2023, and the effect such obligations and commitments are expected to have on our liquidity and cash flow in future periods:
Payments Due By Period
(in thousands)
Contractual ObligationsTotalLess than 1 year1 - 3 years3 - 5 yearsMore than 5 years
Operating Leases$12,900 $7,609 $5,170 $121 $— 
Other Commitments31,771 21,438 10,282 51 — 
Total Contractual Obligations$44,671 $29,047 $15,452 $172 $— 
“Operating Leases” generally provide that property taxes, insurance, and maintenance expenses are our responsibility. Such expenses are not included in the operating lease amounts in the table above. Information with respect to our Operating Leases may be found in Note G to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
“Other Commitments” generally include consulting- and IT-related services, investments in brand awareness through corporate and athlete sponsorships, facility maintenance, services related to the events that we hold for our Associates both locally and internationally, and local lines of credit. Additionally, throughout the year we will enter into various short-term contracts, mostly for services related to events that we hold for our Associates. Information with respect to our Unconditional Purchase Obligations may be found in Note K to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report, which is incorporated by reference.
Inflation
Like many other global companies, we are facing significant inflationary pressures in the world economy. Inflationary pressures are growing as we renew pricing arrangements, notably for certain direct materials, wages, energy, and transportation costs. These inflationary pressures, including margin pressure from inflation as well as the cost of capital could continue to grow in 2024.
47
Critical Accounting Policies and Estimates
Our Consolidated Financial Statements included in this report have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Our significant accounting policies are described in the Consolidated Financial Statements included herein. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Those estimates and assumptions are derived and are continually evaluated based on our historical experiences, current facts and circumstances, and on changes in the business environment. Actual results, however, may sometimes differ materially from estimates under different conditions. Critical accounting estimates are defined as both those that are material to the portrayal of our financial condition and results of operations and those that require management’s most subjective judgments. We believe that our most critical accounting policies and estimates are described in this section.
Revenue Recognition. Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those products or services. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
A majority of our sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third-party carrier for shipment. We receive payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. Our product sales contracts include terms that could cause variability in the transaction price for items such as discounts, credits, or sales returns. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, we estimate a refund liability for the variable consideration based on historical experience.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under our initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid and include all forms of commissions, and other incentives paid to our Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, the incentives are paid for distinct services related to our product sales and are recorded as an expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third-party carrier for shipment. We account for these activities as fulfillment costs. Therefore, we recognize the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the “Other current liabilities” line item in the consolidated balance sheet. Deferred revenue is recognized when or as the related performance obligation is satisfied. On the occasion that will-call orders are not picked up by customers, we periodically assess the likelihood that customers will exercise their contractual right to pick up orders and recognize revenue when the likelihood that customers will pick up orders becomes remote.
Inventory Valuation. Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. The forecasted future product demand for excess or slow-moving inventories is based on judgment
48
and available information. A change in any valuation assumptions could result in an adjustment to inventory. However, the reported carrying value of inventory is not highly sensitive to reasonable changes in individual assumptions.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Our earnings, cash flows, and financial position are affected by fluctuations in currency exchange rates, interest rates, and other uncertainties that are inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks that are associated with changes in social, political, and economic conditions in our international operations. This includes changes in the laws and policies that govern investment in international countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment.
Foreign Currency Risks. Because a significant portion of our sales are generated outside the United States, currency exchange rate fluctuations may have a significant effect on our sales and earnings. The local currency of each international subsidiary is considered the functional currency, with all revenue and expenses being translated at weighted-average currency exchange rates for the applicable periods. In general, our reported sales and gross profit are affected positively by a weakening of the U.S. dollar and negatively by a strengthening of the U.S. dollar because we manufacture the majority of our products in the United States and sell them to our international subsidiaries in their respective functional currencies. Currency fluctuations, however, have the opposite effect on our Associate incentives and selling, general and administrative expenses. We are unable to reasonably estimate the effect that currency fluctuations may have on our future business, results of operations, or financial condition. This is due to the uncertainty in, and the varying degrees and type of exposure that we face from, fluctuation of various currencies.
Currently our strategy for reducing our exposure to currency fluctuation includes the timely and efficient repatriation of earnings from international markets, and settlement of intercompany transactions. Additionally, we may enter into short-term foreign currency credit arrangements in our international markets, primarily as a way to reduce our exposure to negative effects of changes in foreign currency exchange rates. We also enter into currency exchange contracts to offset foreign currency exposure in various international markets. We do not use derivative financial instruments for trading or speculative purposes. There can be no assurance that our practices will be successful in eliminating all or substantially all of the risks that we may encounter in connection with our currency transactions.
Interest Rate Risks. As of December 30, 2023, we had an immaterial amount of outstanding debt on a local line of credit and no outstanding debt on our credit facility. Based on this limited activity our exposure to interest rate risk is immaterial. It may become necessary to borrow in the future in order to meet our financing needs. In the event that it becomes necessary to borrow, there can be no assurance that we will be able to borrow, or at favorable rates.
Item 8. Financial Statements and Supplementary Data
The Financial Statements and Supplementary Data required by this Item are set forth at the pages indicated at Part IV, Item 15, below.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Not applicable.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information that is required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods that are specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), as appropriate, to allow timely decisions regarding any required disclosure. In designing and evaluating these disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
As of the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as a result of
49
material weaknesses in internal control over financial reporting as described below, the disclosure controls and procedures were not effective as of December 30, 2023.
Nevertheless, based on the performance of additional procedures by management designed to ensure reliability of financial reporting, our Chief Executive Officer and Chief Financial Officer have concluded that, notwithstanding the material weaknesses described below, the consolidated financial statements, included in this Form 10-K, fairly present, in all material respects, the Company’s financial position, results of operations, and cash flows as of the dates, and for the periods, presented in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP).
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). The Company’s internal control over financial reporting is a process designed by, or under the supervision of, the Company's Chief Executive Officer and Chief Financial Officer and effected by the Company's Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:
•Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
•Provide reasonable assurance that transactions are recorded as necessary to permit preparation of the consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
•Provide reasonable assurance regarding the prevention or timely detection of any unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim consolidated financial statements will not be prevented or detected on a timely basis.
Our management, including our Chief Executive Officer and our Chief Financial Officer, under the oversight of our Board of Directors, assessed the effectiveness of our internal control over financial reporting as of December 30, 2023. In making this assessment, management used the criteria that have been set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Based on its assessment, using those criteria, management concluded that, as of December 30, 2023, our internal control over financial reporting was not effective due to the following control deficiencies:
The Company did not have a sufficient complement of trained resources with specialized skills and knowledge in information technology general controls (ITGCs), or an alternative contingency plan, to timely respond to the impacts of turnover in key personnel with responsibility for ITGCs that occurred during 2023. As a result, the Company did not maintain effective ITGCs in the areas of user access, program change management, and computer operations over the information technology (IT) systems that support the Company’s financial reporting processes. Process-level automated controls that are dependent on the affected ITGCs and manual controls that rely on the integrity of data or reports from the affected systems across substantially all the Company’s processes were also deemed ineffective because they could have been adversely impacted.
The control deficiencies did not result in any identified misstatements to the consolidated financial statements, and there were no changes to previously released financial results. However, these control deficiencies create a reasonable
50
possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis and, therefore, we concluded that the deficiencies represent material weaknesses in the Company's internal control over financial reporting.
Our independent registered public accounting firm, KPMG LLP, who audited the consolidated financial statements included in this Annual Report on Form 10-K issued an adverse opinion on the effectiveness of the Company’s internal control over financial reporting, which is included at the end of Part II, Item 9A of this form 10-K.
Remediation Efforts to Address Material Weaknesses
Management is implementing and will continue to implement measures designed to ensure that the control deficiencies contributing to the material weaknesses are remediated, such that the relevant controls are designed, implemented, and operating effectively. The remediation actions include:
•Enhancing our IT organization that is responsible for the development, monitoring, and testing of the ITGCs to ensure sufficiency of resources with the appropriate knowledge, experience, and training; and
•Developing a training program addressing ITGCs and related policies, to educate control owners on the principles and requirements of internal control activities, including maintaining adequate evidence of the controls’ operation and ensuring timely and consistent performance of the controls as designed.
We believe that these actions will remediate the material weaknesses, however, as we continue to evaluate and enhance our internal control over financial reporting, we may determine that additional measures to address the material weaknesses or adjustments to the remediation plan may be required. The material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect that the remediation of these material weaknesses will be completed prior to the end of fiscal year 2024.
Changes in Internal Control over Financial Reporting
Other than with respect to identification of the material weaknesses described above, there were no changes in our internal control over financial reporting during the fiscal quarter ended December 30, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
51
Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors
USANA Health Sciences, Inc.:

Opinion on Internal Control Over Financial Reporting

We have audited USANA Health Sciences, Inc. and subsidiaries' (the Company) internal control over financial reporting as of December 30, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 30, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 30, 2023 and December 31, 2022, the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 30, 2023, and the related notes and financial statement schedule II - valuation and qualifying accounts (collectively, the consolidated financial statements), and our report dated February 27, 2024 expressed an unqualified opinion on those consolidated financial statements.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management’s assessment: The Company did not have a sufficient complement of trained resources with specialized skills and knowledge in information technology general controls (ITGCs), or an alternative contingency plan, to timely respond to the impacts of turnover in key personnel with responsibility for ITGCs that occurred during 2023. As a result, the Company did not maintain effective ITGCs in the areas of user access, program change management, and computer operations over the information technology (IT) systems that support the Company’s financial reporting processes. Process-level automated controls that are dependent on the affected ITGCs and manual controls that rely on the integrity of data or reports from the affected systems across substantially all the Company’s processes were also deemed ineffective because they could have been adversely impacted. The material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2023 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
52
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP
Salt Lake City, Utah
February 27, 2024
Item 9B. Other Information
During the fiscal quarter ended December 30, 2023, none of our directors or officers informed us of the adoption, modification or termination of a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as those terms are defined in Regulation S-K, Item 408
Item 9C. Disclosure regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
PART III
Items 10, 11, 12, 13 and 14
Information required by Items 10, 11, 12, 13, and 14 of this Form 10-K is incorporated by reference from our definitive Proxy Statement for our 2024 Annual Meeting of Shareholders, which will be filed with the SEC, pursuant to Regulation 14A, not later than 120 days after the end of the 2023 fiscal year, all of which information is hereby incorporated by reference in, and made part of, this Form 10-K, except disclosure of certain information related to our executive officers, which is included in Part I, Item 1 of this report under the heading "Information About Our Executive Officers and Directors."
PART IV
Item 15. Exhibits, Financial Statement Schedules
(a)The following documents are filed as part of this report:
1.Financial Statements
2.Financial Statement Schedules.
For the years ended December 30, 2023, December 31, 2022, and January 1, 2022
Schedule II – Valuation and Qualifying Accounts
53
3.Exhibits.
The exhibits identified below are filed or incorporated by reference as part of this Annual Report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). We have identified below each management contract and compensation plan filed as an exhibit to this Annual Report in response to Item 15(a)(3) of Form 10-K.

Exhibit
Number
Description
3.1
3.2
4.1
4.6
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
10.18
10.19
10.20
10.21
10.22
54
14
21
23.1
31.1
31.2
32.1
32.2
97
101.INSInline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________
*Denotes a management contract or compensatory plan or arrangement.
55
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
USANA Health Sciences, Inc.
By:
/s/ Jim H. Brown
Jim H. Brown
Chief Executive Officer and President
Date: February 27, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
SignatureTitleDate
/s/ Jim H. Brown
Chief Executive Officer and President
February 27, 2024
Jim H. Brown
(Principal Executive Officer)
/s/ G. Douglas HekkingChief Financial OfficerFebruary 27, 2024
G. Douglas Hekking(Principal Financial and Accounting Officer)
/s/ Kevin G. Guest
Executive Chairman of the Board
February 27, 2024
Kevin G. Guest
/s/ Gilbert A. FullerDirectorFebruary 27, 2024
Gilbert A. Fuller
/s/ John T. FlemingDirectorFebruary 27, 2024
John T. Fleming
/s/ J. Scott Nixon
DirectorFebruary 27, 2024
J. Scott Nixon
/s/ Frederic J. WinssingerDirectorFebruary 27, 2024
Frederic J. Winssinger
/s/ Xia DingDirectorFebruary 27, 2024
Xia Ding
/s/ Timothy E. WoodDirectorFebruary 27, 2024
Timothy E. Wood
/s/ Peggie PelosiDirectorFebruary 27, 2024
Peggie Pelosi
56
Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors
USANA Health Sciences, Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of USANA Health Sciences, Inc. and subsidiaries (the Company) as of December 30, 2023 and December 31, 2022, the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 30, 2023, and the related notes and financial statement schedule II - valuation and qualifying accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 30, 2023 and December 31, 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 30, 2023, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 30, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 27, 2024 expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Assessment of lower of cost or net realizable value of certain inventories

As discussed in Notes A and C to the consolidated financial statements, inventories of $61,454,000 in current assets and noncurrent inventories of $3,128,000 in other assets as of December 30, 2023 are stated at the lower of cost or net realizable value. The Company performs analyses to identify and estimate the net realizable value of excess or slow-moving inventories, which includes the evaluation of inventory that does not conform to product specifications, expiration dates, current and future product demand, production planning and market conditions. The Company manufactures inventories in the United States for all global markets, excluding China.

F-1
We identified the assessment of lower of cost or net realizable value of inventories, excluding inventories manufactured and held in China, as a critical audit matter. The forecasted future product demand for excess or slow-moving inventories is difficult to assess and results in the application of greater auditor judgment.

The following are the primary procedures we performed to address the critical audit matter. We evaluated the design of certain internal controls over the Company’s inventory valuation process, including controls related to the assessment of the lower of cost or net realizable value and the determination of the forecasted future product demand. We performed a retrospective review to assess the Company’s ability to accurately forecast. We evaluated the Company’s determination of lower of cost or net realizable value of excess or slow-moving inventories utilizing current year sales by product and comparing it to product inventory on hand as of December 30, 2023. We also analyzed a sample of inventory items to evaluate the forecasted future product demand by comparison of that forecast to historical demand and any known changes that would impact future demand.

/s/ KPMG LLP
We have served as the Company’s auditor since 2013.
Salt Lake City, Utah
February 27, 2024
F-2
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)

As of
December 30,
2023		As of
December 31,
2022
ASSETS
Current assets
Cash and cash equivalents$330,420 $288,420 
Inventories61,454 67,089 
Prepaid expenses and other current assets25,872 28,873 
Total current assets417,746 384,382 
Property and equipment, net99,814 97,773 
Goodwill17,102 17,368 
Intangible assets, net29,919 32,432 
Deferred tax assets13,284 9,799 
Other assets54,892 54,795 
$632,757 $596,549 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable$10,070 $11,049 
Line of credit - short term786 — 
Other current liabilities107,989 132,784 
Total current liabilities118,845 143,833 
Deferred tax liabilities4,552 4,071 
Other long-term liabilities12,158 14,173 
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 2022
19 19 
Additional paid-in capital65,661 55,604 
Retained earnings445,217 391,636 
Accumulated other comprehensive income (loss)(13,695)(12,787)
Total stockholders' equity497,202 434,472 
$632,757 $596,549 
The accompanying notes are an integral part of these statements.
F-3
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except per share data)

Fiscal Year
202320222021
Net sales$921,010 $998,601 $1,186,464 
Cost of sales176,693 193,890 217,898 
Gross profit744,317 804,711 968,566 
Operating expenses:
Associate incentives394,257 434,793 519,267 
Selling, general and administrative256,989 262,304 279,107 
Total operating expenses651,246 697,097 798,374 
Earnings from operations93,071 107,614 170,192 
Other income (expense):
Interest income9,637 3,789 2,515 
Interest expense(262)(192)(57)
Other, net7 (2,590)(2,008)
Other income (expense), net9,382 1,007 450 
Earnings before income taxes102,453 108,621 170,642 
Income taxes38,665 39,271 54,137 
Net earnings$63,788 $69,350 $116,505 
Earnings per common share
Basic$3.31 $3.60 $5.78 
Diluted$3.30 $3.59 $5.73 
Weighted average common shares outstanding
Basic19,250 19,254 20,146 
Diluted19,345 19,310 20,343 
Comprehensive income:
Net earnings$63,788 $69,350 $116,505 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment(1,298)(15,126)2,203 
Tax benefit (expense) related to foreign currency translation adjustment390 1,881 1,880 
Other comprehensive income (loss), net of tax(908)(13,245)4,083 
Comprehensive income$62,880 $56,105 $120,588 
The accompanying notes are an integral part of these statements.
F-4
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

Common StockAdditional
Paid-in
Capital		Retained
Earnings		Accumulated
Other
Comprehensive
Income (Loss)		Total
SharesValue
Balance at January 2, 202121,038$21 $62,460 $382,794 $(3,625)$441,650 
Net earnings116,505 116,505 
Other comprehensive income (loss), net of tax4,083 4,083 
Equity-based compensation expense14,298  14,298 
Common stock repurchased and retired(1,844)(2)(23,173)(154,662)(177,837)
Common stock issued under equity award plans199—  — 
Tax withholding for net-share settled equity awards(3,575)(3,575)
Balance at January 1, 202219,39319 50,010 344,637 458 395,124 
Net earnings69,350 69,350 
Other comprehensive income (loss), net of tax(13,245)(13,245)
Equity-based compensation expense13,331 13,331 
Common stock repurchased and retired(288)— (3,031)(22,351)(25,382)
Common stock issued under equity award plans101—   — 
Tax withholding for net-share settled equity awards(4,706) (4,706)
Balance at December 31, 202219,20619 55,604 391,636 (12,787)434,472 
Net earnings63,788 63,788 
Other comprehensive income (loss), net of tax(908)(908)
Equity-based compensation expense14,595 14,595 
Common stock repurchased and retired(180)— (1,446)(10,207)(11,653)
Common stock issued under equity award plans104—  — 
Tax withholding for net-share settled equity awards (3,092)(3,092)
Balance at December 30, 202319,130$19 $65,661 $445,217 $(13,695)$497,202 
The accompanying notes are an integral part of these statements.
F-5
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Year Ended
202320222021
Cash flows from operating activities
Net earnings$63,788 $69,350 $116,505 
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization12,702 13,393 13,036 
Right-of-use asset amortization7,693 8,017 9,157 
(Gain) loss on sale of property and equipment10 141 61 
Equity-based compensation expense14,595 13,331 14,298 
Deferred income taxes(2,749)(7,183)(2,970)
Inventory write-down2,601 6,082 4,200 
Changes in operating assets and liabilities, net of acquisitions:
Inventories2,353 15,797 (14,701)
Prepaid expenses and other assets110 (3,304)(2,331)
Accounts payable(428)(2,656)(4,572)
Other liabilities(30,034)(9,066)(11,456)
Net cash provided by (used in) operating activities70,641 103,902 121,227 
Cash flows from investing activities
Receipts on notes receivable— — 116 
Proceeds from the settlement of net investment hedges3,775 4,555 — 
Payments for net investment hedge(1,271)— (1,555)
Payments to acquire businesses— (6,532)— 
Proceeds from sale of property and equipment15 7 15 
Purchases of property and equipment(14,494)(10,400)(12,763)
Net cash provided by (used in) investing activities(11,975)(12,370)(14,187)
Cash flows from financing activities
Repurchase of common stock(11,599)(25,382)(177,837)
Borrowings on line of credit1,542 11,000 — 
Payments on line of credit(750)(11,000)— 
Payments related to tax withholding for net-share settled equity awards(3,092)(4,706)(3,575)
Payments for contingent consideration(338)— — 
Net cash provided by (used in) financing activities(14,237)(30,088)(181,412)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(2,503)(13,777)2,088 
Net increase (decrease) in cash, cash equivalents, and restricted cash41,926 47,667 (72,284)
Cash, cash equivalents, and restricted cash at beginning of period291,320 243,653 315,937 
Cash, cash equivalents, and restricted cash at end of period$333,246 $291,320 $243,653 
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents$330,420 $288,420 $239,832 
Restricted cash included in other assets2,826 2,900 3,821 
F-6
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
(in thousands)
Year Ended
202320222021
Total cash, cash equivalents, and restricted cash$333,246 $291,320 $243,653 
Supplemental disclosures of cash flow information
Cash paid during the period for:
Interest$68 $49 $10 
Income taxes44,247 45,863 59,524 
Cash received during the period for:
Income tax refund1,922 113 191 
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations5,699 5,641 5,322 
Accrued purchases of property and equipment117 679 383 
Contingent consideration given to acquire businesses— 886 — 
Accrued excise tax for repurchase of common stock54 — — 
The accompanying notes are an integral part of these statements.
F-7
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)

NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India(1)
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
(1) We commenced operations in this market near the end of the fourth quarter of 2023.
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the consolidated statements of cash flows.
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2023, 2022, and 2021 were 52-week years. Fiscal year 2023 covered the period January 1, 2023 to December 30, 2023 (hereinafter 2023). Fiscal year 2022 covered the period January 2, 2022 to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021).
F-8
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
As of December 30, 2023 and December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 30,
2023		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$258,319 $258,319 $— $— 
Foreign currency contracts included in other current liabilities(62)— (62)— 
Deferred compensation liabilities
(3,137)— (3,137)— 
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.
The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 30, 2023 and December 31, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.
Fair Value of Financial Instruments
As of December 30, 2023 and December 31, 2022, the Company’s financial instruments include cash equivalents and restricted cash. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
F-9
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 30, 2023 and December 31, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 30, 2023 and December 31, 2022 totaled $9,379 and $8,904, respectively.
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,826 as of December 30, 2023, and $2,900 as of December 31, 2022. This deposit is required for the application of direct selling licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.

Noncurrent inventories are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventories are classified in the "Other assets" line item in the Company's consolidated balance sheets. Noncurrent inventories are anticipated to be consumed beyond our normal operating cycle, but prior to obsolescence.
F-10
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for credit losses regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
The Company capitalizes certain internal-use software development costs, consisting primarily of employee salaries and contractor costs, during the application development stage. Costs incurred for upgrades and enhancements that are expected to result in additional functionalities are also capitalized. These development costs are amortized using the straight-line method over an estimated useful life of three to five years, and are reflected as part of Property and equipment, net on our consolidated balance sheets.
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
F-11
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the unpaid lease payments over the lease term at the commencement date for leases exceeding 12 months. Unpaid lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill
Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2023, 2022, and 2021, no impairment of goodwill was recorded.
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable.
F-12
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2023, 2022, and 2021, no impairment of indefinite-lived intangible assets was recorded.
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are remeasured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2023, the Company evaluated an observable price change related to equity securities without readily determinable fair values. No adjustment to the carrying value of the securities was necessary based on the observable price change. During 2022, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2023, 2022, and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation
In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the consolidated balance sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the consolidated statements of comprehensive income. As
F-13
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
of December 30, 2023 and December 31, 2022, the trustee held total assets of $2,962 and $1,622, and deferred compensation liabilities of $3,137, and, $1,632, respectively.
Self-Insurance
The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance for the United States markets on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,292. A liability is accrued for all unpaid claims. Total self-insurance expense was $14,501, $13,413, and $12,349 in 2023, 2022, and 2021, respectively.
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
During 2023 and 2021, the Company entered into and settled a European option with notional amounts of $81,343 and $98,684, respectively. During 2022 the Company entered into and settled a forward contract with a notional amount of $98,930. Both the forward contract and the European options were designated as net investment hedges. The Company realized gains of $2,504 and $4,555 in 2023 and 2022, respectively, and realized a loss of $1,555 in 2021. These gains and loss were recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 30, 2023 and December 31, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting.
Subsequent to December 30, 2023, on January 25, 2024 the Company entered into an option contract designated as a net investment hedge with a notional amount of $77,345.
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 30, 2023, $71,186, inclusive of accrued excise tax, is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on
F-14
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders becomes remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
F-15
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
The following table presents Other Revenue for the periods indicated:
Year Ended
202320222021
Other Revenue$3,177 $3,452 $3,825 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 30, 2023 and December 31, 2022.
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 30,
2023		December 31,
2022
Contract liabilities at beginning of period$20,875 $19,635 
Increase due to deferral of revenue at period end13,910 20,875 
Decrease due to beginning contract liabilities recognized as revenue(20,875)(19,635)
Contract liabilities at end of period$13,910 $20,875 
Product Return Policy
All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.6%, 0.7%, and 0.6% of net sales in 2023, 2022, and 2021, respectively.
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
F-16
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. The grant date fair value of each performance share unit is based upon a Monte-Carlo simulation in order to incorporate market conditions. Equity-based compensation expense for restricted stock units and stock-settled stock appreciation rights are recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Equity-based compensation expense for performance stock units is recognized based on the achievement of certain performance and market conditions by specified target dates, subject to continued service through the applicable vesting dates. The probability of the awards meeting the performance condition is not included in the grant date fair value, but is estimated quarterly for expense recognition. The Company recognizes an adjustment to compensation expense based on revisions in probability assessments. The Company accounts for forfeitures as they occur. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising
Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $4,756, $5,053, and $12,399, in 2023, 2022, and 2021, respectively.
Research and Development
Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,446, $11,563, and $11,112 in 2023, 2022, and 2021, respectively.
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. The Company adopted the provisions of ASU 2021-08 during the first quarter of 2023 and the adoption of the standard did not have an impact on its consolidated financial statements.
Issued Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is intended to provide financial statement users with more disaggregated expense information about a public entity’s reportable segments. ASU 2023-07 requires incremental disclosures related to a public entity’s reportable segments including allowing the disclosure of multiple measures of segment profit or loss,
F-17
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
requiring the disclosure of significant segment expenses, and requiring the qualitative disclosure of other segment items. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024, and should be adopted retrospectively unless impracticable. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard is intended to benefit investors by providing more detailed income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
No other recent accounting pronouncements had, or are expected to have, a material impact on the Company's consolidated financial statements.
NOTE B— BUSINESS COMBINATIONS
In the second quarter of 2022, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The final purchase price allocations were $771 to tangible assets, $6,065 to intangible assets, and $582 to goodwill. The primary reasons for the business combinations are to augment and expand the Company's core competencies.
The contingent consideration liability associated with the business combinations in 2022 was based on the achievement of certain milestones over a three-year period, and the seller's continued employment with the business. Under the terms of the purchase agreement, the contingent consideration consisted of three earn-out periods capped at $500 per earn-out period. The maximum earn-out was $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy.
As of December 31, 2022, the contingent consideration had a fair value of $886. During 2023, the employee resigned from the business, which consequently terminated the employment relationship and the remaining contingent consideration of $548 was forfeited. This non-cash gain on contingent consideration is included in the change in "Other liabilities" line item on the Company’s consolidated statements of cash flows. Contingent consideration is included in Fair Value Measures above.
Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Financial Statements.
F-18
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE C—INVENTORIES
December 30,
2023		December 31,
2022
Raw materials$19,848 $21,776 
Work in progress4,707 4,285 
Finished goods36,899 41,028 
$61,454 $67,089 
Noncurrent inventories$3,128 $3,479 
As of December 30, 2023, noncurrent inventories consisted of $2,051 of raw materials and $1,077 of finished goods inventory. As of December 31, 2022, noncurrent inventories consisted of $1,711 of raw materials and $1,768 of finished goods inventory. Noncurrent inventories are included in the “Other assets” line item on the Company’s consolidated balance sheets.
NOTE D—PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consists of the following:
December 30,
2023		December 31,
2022
Other prepaid expenses$9,069 $9,089 
Miscellaneous receivables, net6,172 5,183 
Other current assets6,096 7,121 
Prepaid insurance2,325 2,293 
Deferred commissions1,181 3,157 
Income taxes receivable1,029 2,030 
$25,872 $28,873 
NOTE E—INCOME TAXES
Consolidated earnings before income taxes consists of the following for 2023, 2022, and 2021:
Year Ended
202320222021
United States$(19,988)$(23,996)$13,017 
Foreign122,441 132,617 157,625 
Total earnings before income taxes$102,453 $108,621 $170,642 
F-19
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202320222021
Current
Federal$(42)$42 $(264)
State469 297 567 
Foreign40,913 45,869 56,668 
Total Current41,340 46,208 56,971 
Deferred
Federal(4,031)(9,180)(4,088)
State(59)(331)(40)
Foreign1,415 2,574 1,294 
Total Deferred(2,675)(6,937)(2,834)
$38,665 $39,271 $54,137 
The effective tax rate for 2023, 2022, and 2021 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202320222021
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.5 0.4 0.4 
Permanent tax differences0.7 0.3 0.1 
Excess foreign tax credits(16.4)(16.6)(10.9)
Net increase in valuation allowance13.0 11.9 10.6 
Foreign income tax rate differences8.7 9.5 1.8 
Foreign withholding taxes10.6 9.7 7.9 
Uncertain tax position reserve(0.4)0.5 (0.3)
All other, net— (0.5)1.1 
37.7 %36.2 %31.7 %
The effective tax rate for the year ended December 30, 2023 increased compared to the year ended December 31, 2022. The effective tax rate increase is due primarily to an unfavorable foreign currency impact on withholding tax accruals and the change in the market mix of pre-tax book income.
F-20
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
The significant categories of deferred taxes are as follows:
December 30,
2023		December 31,
2022
Deferred tax assets
Inventory$5,588 $5,872 
Accruals not currently deductible6,680 8,627 
Equity-based compensation expense2,580 2,746 
Property and equipment771 922 
Intangible assets6,359 6,680 
Foreign currency translation1,760 1,448 
Capitalized R&D expenses13,537 9,618 
Tax credit carry forwards134,205 115,539 
Net operating losses1,956 1,720 
Other3,237 3,223 
Gross deferred tax assets176,673 156,395 
Valuation allowance(137,252)(118,136)
Net deferred tax assets39,421 38,259 
Deferred tax liabilities
Property and equipment(5,897)(5,723)
Prepaid expenses(1,819)(2,990)
Intangible assets(6,359)(6,680)
Withholding tax on unremitted earnings(11,673)(11,639)
Other(4,941)(5,499)
Gross deferred tax liabilities(30,689)(32,531)
Net deferred taxes$8,732 $5,728 
The components of net deferred taxes on a jurisdiction basis are as follows:
December 30,
2023		December 31,
2022
Net deferred tax assets$13,284 $9,799 
Net deferred tax liabilities(4,552)(4,071)
Net deferred taxes$8,732 $5,728 
As of December 30, 2023, the Company had foreign tax credit carryforwards of approximately $128,695. If unused, these carryforwards will expire between 2026 and 2033. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances.
F-21
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
The Company recorded a $1,591 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates.
The Company also had $1,908 of Utah research credit carryforwards, and $3,602 of Federal research credit carryforwards as of December 30, 2023. If unused, the Utah research credit carryforwards expire between 2027 and 2037, and the Federal research credits expire between 2036 and 2043. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards.
In addition, the Company had $6,100 of foreign operating loss carry forwards, $1,627 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,893 and a valuation allowance of $1,423 has been applied against this deferred tax asset. The 2023 deferred tax asset for state-tax-loss carryforwards was $63. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2042 and others can be carried forward indefinitely.
The total combined valuation allowance was $137,252 as of December 30, 2023. The 2023 valuation allowance represents a $19,116 net increase from 2022. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced.
As of December 30, 2023, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.
As of December 30, 2023, the Company reported $1,074 in "Other long-term liabilities" in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 reported as of December 31, 2022.
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202320222021
Beginning balance of unrecognized tax benefits$1,450 $1,008 $1,528 
Increases related to prior year tax positions30 107 21 
Decreases related to prior year tax positions(363)— (330)
Increases related to current year tax positions409 468 424 
Decreases for settlements with taxing authorities(452)(133)(635)
Ending balance of unrecognized tax benefits$1,074 $1,450 $1,008 
The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 30, 2023 and December 31, 2022, the Company reported $66 and $201, respectively, as income tax expense related to interest and penalties. As of December 30, 2023, the Company recorded $180 of "Other long-term liabilities" associated with interest and penalties for unrecognized tax benefits. This compares to $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties reported as of December 31, 2022.
F-22
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE E—INCOME TAXES - CONTINUED
The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2019. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.
NOTE F—PROPERTY AND EQUIPMENT
Cost of property and equipment and their estimated useful lives is as follows:
Useful life (years)December 30,
2023		December 31,
2022
Buildings39.5$77,803 $78,071 
Laboratory and production equipment
5-7
54,502 50,679 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
52,302 53,436 
Furniture and fixtures
3-5
6,323 6,198 
Automobiles
3-5
744 722 
Leasehold improvements
3-5
14,337 14,388 
Land improvements153,263 3,271 
212,226 209,717 
Less accumulated depreciation and amortization128,939 124,748 
83,287 84,969 
Land6,720 6,723 
Deposits and projects in process9,807 6,081 
$99,814 $97,773 
Depreciation of property and equipment was $10,904, $11,351, and $11,661, for the years ended 2023, 2022, and 2021, respectively.
NOTE G—OPERATING LEASES
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 30,
2023		December 31,
2022
Assets
ROU operating lease assets, netOther assets$17,671 $19,997 
Total ROU assets$17,671 $19,997 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$7,278 $6,892 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities5,141 7,680 
Total lease liabilities$12,419 $14,572 
F-23
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE G—OPERATING LEASES - CONTINUED
The components of lease expense were as follows:
Year Ended
202320222021
Operating lease expense$8,042 $8,606 $9,585 
Total lease expense$8,042 $8,606 $9,585 
These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,755, $8,258, and $9,830 for the years ended 2023, 2022, and 2021, respectively.
The following table presents supplemental lease information:
Year Ended
202320222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$8,227 $7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,699 $5,641 $5,322 
The following table presents weighted-average remaining lease term and weighted-average discount rate for the Company's operating leases:
Year Ended
20232022
Weighted-average remaining lease term—operating leases
1.99 yrs.
2.39 yrs.
Weighted-average discount rate—operating leases3.97 %3.04 %
The following table presents the maturity of the Company’s lease liabilities as of December 30, 2023:
Year ending
2024$7,609 
20253,858 
20261,312 
2027121 
2028 and Thereafter— 
12,900 
Less: imputed interest(481)
Present value$12,419 

NOTE H—INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test during the third quarter of 2023. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2023 and 2022.
F-24
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE H—INTANGIBLE ASSETS - CONTINUED
The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2023. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2023 and 2022.
The changes in the carrying amount of goodwill are as follows:
December 30,
2023		December 31,
2022
Balance at beginning of year:
Gross goodwill$17,368 $17,668 
Goodwill as of beginning of year17,368 17,668 
  
Goodwill acquired during the year— 582 
Currency translation adjustment(266)(882)
Balance as of end of year
Gross goodwill17,102 17,368 
Goodwill as of end of year$17,102 $17,368 
Intangible assets consist of the following:
As of December 30, 2023
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(343)$1,942 10
Product formulas8,480 (8,426)54 8
Customer relationships3,314 (1,243)2,071 4
Non-compete agreements467 (184)283 4
Indefinite-lived intangible assets
Direct selling license25,569 25,569 
$40,115 $29,919 
Estimated Amortization Expense: 
2024$1,223 
20251,154 
2026692 
2027253 
2028229 
Thereafter799 
$4,350 
F-25
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE H—INTANGIBLE ASSETS - CONTINUED
As of December 31, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct selling license26,238 26,238 
$41,004 $32,432 
Aggregate amortization of intangible assets was $1,835, $1,723, and $1,182 for the years ended 2023, 2022, and 2021, respectively.
NOTE I—OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
December 30,
2023		December 31,
2022
Associate incentives$45,665 $55,688 
Accrued employee compensation16,198 17,334 
Deferred revenue13,910 20,875 
Sales taxes9,231 11,234 
Operating lease liabilities7,278 6,892 
Income taxes3,297 4,973 
All other12,410 15,788 
$107,989 $132,784 
NOTE J—LINE OF CREDIT
On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the Bloomberg Short-Term Bank Yield Index rate ("BSBY").
The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.
There was no outstanding debt on the Credit Facility as of December 30, 2023. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement.
F-26
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE J—LINE OF CREDIT - CONTINUED
Interest on revolving borrowings under the Credit Facility is computed at BSBY, adjusted by features specified in the Credit Agreement. The covenants require the Company’s rolling four-quarter consolidated EBITDA (as defined in the Credit Agreement) to be $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA to be equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms.
The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.
The Company maintains local lines of credit across different markets to secure sufficient working capital. As of December 30, 2023, the balance on these local lines of credit was $786.
NOTE K—COMMITMENTS AND CONTINGENCIES
Unconditional Purchase Obligations
The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $8,018 and $7,163, as of December 30, 2023 and December 31, 2022, respectively that are generally paid within one year.
Contingencies
The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future.
Employee Benefit Plan
In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,451, $2,589, and $2,509 for the years ended 2023, 2022, and 2021, respectively.
The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.
NOTE L—EQUITY-BASED COMPENSATION
Total equity-based compensation expense was $14,965, $13,485, and $14,706 for fiscal years 2023, 2022, and 2021, of which, $370, $154, and $408, was related to liability-classified awards, respectively. The related tax benefit for these periods was $2,507, $2,556, and $2,813, respectively.
F-27
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 30, 2023. This table does not include an estimate for future grants that may be issued.
2024$11,697 
20257,934 
20264,426 
2027531 
$24,588 
The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.
The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock appreciation rights, stock options, and restricted stock awards which include restricted stock units, deferred stock units, performance stock units, (collectively "restricted stock awards") and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.
Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 30, 2023, 4,267 awards had been granted under the 2015 Plan, of which 2,942 were stock-settled stock appreciation rights, and 1,325 were restricted stock awards. Also, as of December 30, 2023, a total of 1,174 options and grants had been forfeited, of which 73 awards have been added back to the number of shares available for issuance under the 2015 Plan.
Stock-Settled Stock Appreciation Rights
The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. The weighted-average fair value of stock-settled stock appreciation rights granted in 2023 and 2021 were $19.92 and $27.12, respectively. There were no stock-settled stock appreciation rights granted in 2022.
Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.
The following table includes the weighted-average assumptions the Company used to calculate the fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202320222021
Expected volatility (1)39.89 %N/A43.28 %
Risk-free interest rate (2)3.78 %N/A0.33 %
Expected life (3)
3.5 yrs.
N/A
3.5 yrs.
Expected dividend yield (4)0.00 %N/A0.00 %
Weighted-average exercise price (5)$58.79 N/A$85.19 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
F-28
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at December 31, 2022147 $82.16 1.3$— 
Granted18 58.79 
Exercised— — 
Forfeited(4)81.59 
Expired(49)115.45 
Outstanding at December 30, 2023112 $63.88 1.2$— 
Exercisable at December 30, 202365 $64.84 0.7$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 30, 2023 and December 31, 2022 was $53.60 and $53.20, respectively.
The total intrinsic value of stock-settled stock appreciation rights exercised was $0, $50, and $10,337, for the years ended 2023, 2022, and 2021, respectively. The total fair value of stock-settled stock appreciation rights that vested was $1,009, $983, and $3,868, for the years ended 2023, 2022, and 2021, respectively.
During the year ended 2023, there were no exercises of stock-settled stock appreciation rights. During the years ended 2022 and 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years ended 2023, 2022, and 2021.
Restricted Stock Awards
Restricted stock awards include stock-settled and cash-settled restricted stock units, performance stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of units held, valued at the closing market price on the vest date. The fair value of restricted stock units is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock units are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates. Performance stock units are granted to officers and key employees. The ultimate number of shares to be earned depends on the achievement of certain market and performance conditions, and continued service through the applicable vesting date, and do not have expiration dates.
F-29
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at December 31, 2022385$85.80 
Granted27459.23 
Vested(155)59.94 
Forfeited(14)79.23 
Outstanding at December 30, 2023490$71.35 
During the year ended 2023, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capital of $3,092, $4,706, and $3,575 for the years ended 2023, 2022, and 2021, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows.
The total fair value of restricted stock units that vested was $9,293, $12,808, and $11,378, for the years ended 2023, 2022, and 2021, respectively.
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at December 31, 202212$84.72 
Granted1459.82 
Vested(4)61.09 
Forfeited— — 
Nonvested at December 30, 202322$68.71 
The weighted-average fair value of liability-classified awards outstanding was $69, $85, and $79 for the years ended 2023, 2022, and 2021, respectively.
The number of deferred stock units vested and unreleased totaled 8, for the years ended 2023, and 2022, and 19 for the year ended 2021, respectively. There were no deferred stock units that vested in 2023, 2022, and 2021.
During 2023, the Company granted 84 performance stock units to officers and key employees. The performance stock units are subject to a cliff vesting at the end of a three-year period. The number of units that vest will vary between 0% - 200% based on the achievement of market and performance conditions, over the three-year service period. The fair value of the performance stock units is determined using a Monte-Carlo simulation model. A Monte-Carlo simulation model uses stock price volatility and other assumptions to estimate the probability of satisfying the market conditions and the resulting fair value of the award.
The weighted-average grant date fair value of performance stock units granted in 2023 was $40.05. There were no performance stock units granted in 2022 or 2021. In 2023, there was unrecognized compensation expense of $913 related to unvested performance stock units that are not probable of achieving the performance condition.
The following table includes the weighted-average assumptions the Company used to calculate the fair value of performance stock units that were granted during the periods indicated.
F-30
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE L—EQUITY-BASED COMPENSATION - CONTINUED
Year Ended
2023
Expected volatility (1)37.84 %
Risk-free interest rate (2)4.09 %
Expected dividend yield (3)
N/A
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)The Company historically has not paid and currently has no plan to pay dividends.
The market condition is met if the Company achieves the target closing stock price on December 31, 2025, of $59.84. If the market condition is met, the number of earned performance stock units, as a percentage of the target number of performance stock units, is calculated based on the compound annual growth rate ("CAGR") of the Company's active Customers from fiscal year-end 2022 to fiscal year-end 2025. The payout as a percent of target shares will be determined based on the active Customer growth rate achieved by the Company as of fiscal year-end 2025, as illustrated in the table below. If the active Customer CAGR growth rate does not meet the performance condition according to the table below, the corresponding payout will be zero.
Market condition
Performance condition
Target share price
active Customer CAGR
Fiscal year-end 2025 active Customers(1)
Payout as % of target number of shares
$59.846%584,000100%
$59.849%635,000150%
$59.8412%688,000200%
(1) Based on active Customer count of 490,000 at December 31, 2022. For purposes of this performance condition, "active Customer" is defined as active Customer in the Company’s Direct-selling operating segment (discussed further in Note M – Segment Information below), excluding customers from mergers and acquisitions.

NOTE M—SEGMENT INFORMATION

The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products.
The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment.
As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s consolidated statements of comprehensive income.
F-31
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE M—SEGMENT INFORMATION - CONTINUED

Year Ended
202320222021
Net sales:
Direct-selling$915,211 $995,043 $1,186,464 
All other5,799 3,558 — 
Consolidated Total$921,010 $998,601 $1,186,464 
No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue for our Direct-selling segment that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202320222021
USANA Nutritionals87%87%86%
USANA Foods (1)
7%7%7%
Personal care and Skincare5%5%6%
All Other1%1%1%
______________________________
(1)Includes the Company’s Active Nutrition line
Selected Financial Information
Financial information, presented by geographic region is listed below:
Year Ended
202320222021
Net Sales to External Customers
Asia Pacific
Greater China$475,099 $502,486 $563,469 
Southeast Asia Pacific163,890 190,478 269,803 
North Asia101,446 108,952 129,920 
Asia Pacific Total740,435 801,916 963,192 
Americas and Europe180,575 196,685 223,272 
Consolidated Total$921,010 $998,601 $1,186,464 
F-32
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE M—SEGMENT INFORMATION - CONTINUED
December 30,
2023		December 31,
2022
Long-lived Assets
Asia Pacific
Greater China$79,418 $86,051 
Southeast Asia Pacific17,504 15,226 
North Asia2,235 3,617 
Asia Pacific Total99,157 104,894 
Americas and Europe96,480 92,373 
Consolidated Total$195,637 $197,267 
Total Assets
Asia Pacific
Greater China$219,781 $250,786 
Southeast Asia Pacific57,820 51,880 
North Asia21,807 22,952 
Asia Pacific Total299,408 325,618 
Americas and Europe333,349 270,931 
Consolidated Total$632,757 $596,549 
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202320222021
Net sales:
China$427,265 $453,134 $506,103 
South Korea$99,108 $106,391 $125,835 
United States$95,906 $106,087 $110,379 
Long-lived Assets:
United States$93,181 $89,150 
China$77,767 $83,938 
F-33
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share data)
NOTE N—COMMON STOCK AND EARNINGS PER SHARE
Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202320222021
Net earnings available to common shareholders$63,788 $69,350 $116,505 
Weighted average common shares outstanding - basic19,250 19,254 20,146 
Dilutive effect of in-the-money equity awards95 56 197 
Weighted average common shares outstanding - diluted19,345 19,310 20,343 
Earnings per common share from net earnings - basic$3.31 $3.60 $5.78 
Earnings per common share from net earnings - diluted$3.30 $3.59 $5.73 
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202320222021
31935460
During the year ended 2023, the Company repurchased and retired 180 shares for $11,653 including accrued excise tax of $54. During the years ended 2022 and 2021, the Company repurchased and retired 288 shares, and 1,844 shares for an aggregate price of $25,382 and $177,837, respectively.
F-34

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
DescriptionBalance at beginning of periodCharged to costs and expensesDeductionsBalance at end of period
December 30, 2023
Allowance for sales returns$572 $5,552 $5,704 $420 
Allowance for credit losses$363 $112 $54 $421 
Valuation allowance - deferred tax assets$118,136 $19,116 $— $137,252 
December 31, 2022
Allowance for sales returns$547 $6,562 $6,537 $572 
Allowance for credit losses$504 $6 $147 $363 
Valuation allowance - deferred tax assets$99,958 $18,178 $— $118,136 
January 1, 2022
Allowance for sales returns$819 $7,213 $7,485 $547 
Allowance for credit losses$372 $148 $16 $504 
Valuation allowance - deferred tax assets$81,401 $18,557 $— $99,958 
F-35
 EX-21 2 subsidiaries-exhibit21.htm EX-21 Document
EXHIBIT 21
SUBSIDIARIES

Set forth below is a list of all active subsidiaries of the Registrant, the state or other jurisdiction of incorporation or organization of each, and the names under which subsidiaries do business as of February 23, 2024.

Name
Jurisdiction of Incorporation
USANA Canada Holding, Inc.
Delaware
USANA Health Sciences, China, Inc.
Delaware
USANA Health Sciences, New Zealand, Inc.
Delaware
International Holdings, Inc.
Delaware
UHS Essential Health Philippines, Inc.
Utah
Pet Lane Inc.
Delaware
USANA Canada Co.
Canada
USANA Australia Pty, Ltd.
Australia
USANA Health Sciences (NZ) Corporation
New Zealand
USANA Hong Kong Limited
Hong Kong
USANA Health Sciences Japan, LLC.
Japan
USANA Health Sciences Korea Ltd.
South Korea
USANA Health Sciences Singapore Pte, Ltd.
Singapore
USANA Mexico S.A. de C.V.
Mexico
Mercadotecnia Nutricional S de R.L. de C.V.
Mexico
UHS Essential Health Malaysia SND BHD
Malaysia
BabyCare Holdings Ltd.
Utah / Cayman Islands
BabyCare Ltd.
People’s Republic of China
Tianjin BabyCare Biological Science and Technology Ltd
People’s Republic of China
Tianjin Health Resources Sales Co., Ltd
People’s Republic of China
USANA Health Sciences (Thailand) Ltd
Thailand
USANA Health Sciences (France) SAS
France
USANA Asia Holding Ltd.
Singapore
USANA Health Sciences (Colombia) SAS
Colombia
PT. USANA Health Sciences Indonesia
Indonesia
PT. USANA International Indonesia
Indonesia
USANA Air LLC
Utah
USANA Europe GmbH Germany
OOLA Life, Inc.
Utah
Rise Bar Wellness, Inc.
Utah
USANA Health Sciences India Private LimitedIndia

Except as noted above, each subsidiary listed above is doing business under its corporate name.


 EX-23.1 3 usna-20231230xexhibit231.htm EX-23.1 Document
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-96645, 333-128103, 333-133385, 333-174695, and 333-206070) on Form S-8 and (No. 333-169946) on Form S-3 of our reports dated February 27, 2024, with respect to the consolidated financial statements and financial statement schedule II of USANA Health Sciences, Inc. and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
Salt Lake City, Utah
February 27, 2024

 EX-31.1 4 usna-20231230xex311.htm EX-31.1 Document
EXHIBIT 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Jim H. Brown, certify that:
1.I have reviewed this Annual Report on Form 10-K of USANA Health Sciences, Inc. (the “Registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: February 27, 2024
/s/ Jim H. Brown
 Jim H. Brown
 Chief Executive Officer
(Principal Executive Officer)

 EX-31.2 5 usna-20231230xex312.htm EX-31.2 Document
EXHIBIT 31.2
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, G. Douglas Hekking, certify that:
1.I have reviewed this Annual Report on Form 10-K of USANA Health Sciences, Inc. (the “Registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: February 27, 2024
/s/ G. Douglas Hekking
 G. Douglas Hekking
 Chief Financial Officer
(Principal Accounting and Financial Officer)

 EX-32.1 6 usna-20231230xex321.htm EX-32.1 Document
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies that the Annual Report on Form 10-K of USANA Health Sciences, Inc. for the period ended December 30, 2023 as filed February 27, 2024 with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of The Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of USANA Health Sciences, Inc.

Date: February 27, 2024
/s/ Jim H. Brown
 Jim H. Brown
 Chief Executive Officer
(Principal Executive Officer)

 EX-32.2 7 usna-20231230xex322.htm EX-32.2 Document
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies that the Annual Report on Form 10-K of USANA Health Sciences, Inc. for the period ended December 30, 2023 as filed February 27, 2024 with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of The Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of USANA Health Sciences, Inc.

Date: February 27, 2024
/s/ G. Douglas Hekking
 G. Douglas Hekking
 Chief Financial Officer
(Principal Accounting and Financial Officer)



 EX-97 8 ex-97usanaxclawbackpolicy.htm EX-97 Document
EXHIBIT 97
CLAWBACK POLICY

1.Introduction. The Board of Directors (the “Board”) of USANA Health Sciences, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has therefore adopted this policy (the “Policy”) to provide for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws. This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the “Exchange Act”).
2.Administration. This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee, in which case references herein to the Board shall be deemed references to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.
3.Covered Executives. This Policy applies to the Company’s current and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act and the listing standards of the national securities exchange on which the Company’s securities are listed (“Covered Executives”).
4.Recoupment; Accounting Restatement. If the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, the Board will require reimbursement or forfeiture of any excess Incentive Compensation (as defined below) received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement.
5.Incentive Compensation. For purposes of this Policy, “Incentive Compensation” means compensation that is granted, earned, or vested based wholly or in part on the attainment of a Financial Reporting Measure (as defined below), including, without limitation, the following: (a) annual bonuses and other short- and long-term cash incentives; (b) stock options; (c) stock appreciation rights; (d) restricted stock; (e) restricted stock units; (f) performance shares; or (g) performance units. For purposes of this Policy, “Financial Reporting Measures” include: (a) company stock price; (b) total shareholder return; (c) revenues; (d) net income; (e) earnings before interest, taxes, depreciation, and amortization (EBITDA); (f) funds from operations; (g) liquidity measures such as working capital or operating cash flow; (h) return measures such as return on invested capital or return on assets; and (i) earnings measures such as earnings per share.
6.Excess Incentive Compensation: Amount Subject to Recovery. The amount to be recovered will be the excess of the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have been paid to the Covered Executive had it been based on the restated results, as determined by the Board. If the Board cannot determine the amount of excess Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make its determination based on a reasonable estimate of the effect of the accounting restatement. For the avoidance of doubt, any Incentive Compensation awarded to a Covered Executive before such person became a Covered Executive is not subject to this Policy.
7.Method of Recoupment. The Board will determine, in its sole discretion, the method for recouping Incentive Compensation hereunder, which may include, without limitation:
a.requiring reimbursement of cash Incentive Compensation previously paid;
b.seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;
c.offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive;

EXHIBIT 97
d.cancelling outstanding vested or unvested equity awards; and/or
e.taking any other remedial and recovery action permitted by law, as determined by the Board.
8.No Indemnification. The Company shall not indemnify any Covered Executives against the loss of any incorrectly awarded Incentive Compensation.
9.Interpretation. The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act and any applicable rules or standards adopted by the Securities and Exchange Commission or any national securities exchange on which the Company’s securities are listed.
10.Effective Date. This Policy shall be effective as of the date it is adopted by the Board (the “Effective Date”) and shall apply to Incentive Compensation that is approved, awarded or granted to Covered Executives on or after that date.
11.Amendment; Termination. The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect any regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with any rules or standards adopted by a national securities exchange on which the Company’s securities are listed. The Board may terminate this Policy at any time.
12.Other Recoupment Rights. The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.
13.Impracticability. The Board shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Rule 10D-1 of the Exchange Act and the listing standards of the national securities exchange on which the Company’s securities are listed.
14.Successors. This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.

Adopted: October 23, 2023

 EX-101.SCH 9 usna-20231230.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Operating Leases link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Line of Credit link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Equity-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Common Stock and Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Operating Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Equity-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Common Stock and Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Business Combinations (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Property and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Operating Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Operating Leases - Supplemental Lease Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Line of Credit - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Equity-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 usna-20231230_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 usna-20231230_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 usna-20231230_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Deferred income taxes Deferred Income Taxes and Tax Credits Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Share-based Payment Arrangement, Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Entity Voluntary Filers Entity Voluntary Filers Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Business Combination, Separately Recognized Transactions [Line Items] Business Combination, Separately Recognized Transactions [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development expense, total Research and Development Expense Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Share-based compensation arrangement by share-based payment award, expiration period (year) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Proceeds from the settlement of net investment hedges Proceeds from Hedge, Investing Activities Product return, percentage refunded Product Return Percentage Refunded The percentage of refund on product returns. Revenue from External Customers by Products and Services Revenue from External Customers by Products and Services [Table Text Block] Award Type [Domain] Award Type [Domain] Schedule of Stock-Settled Appreciation Right Activity Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block] Beginning balance outstanding, shares (in shares) Ending balance outstanding, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Expired, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Cash paid for amounts included in the measurement of lease liabilities Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract] Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Line of Credit Debt Disclosure [Text Block] Other Current Liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Payments to acquire businesses Payments to Acquire Businesses, Gross Research and Development Research and Development Expense, Policy [Policy Text Block] Deferred tax liabilities Net deferred tax liabilities Deferred Income Tax Liabilities, Net Foreign Exchange Option Foreign Exchange Option [Member] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Computer equipment and software Computer Equipment [Member] Tax benefit (expense) related to foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Withholding tax on unremitted earnings Deferred Tax Liabilities Withholding Tax On Unremitted Earnings Amount of deferred tax liability attributable to taxable temporary differences from withholding tax on unremitted earnings. Other income (expense), net Nonoperating Income (Expense) Statutory U.S. federal income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Impairment of intangible assets, indefinite-lived (excluding goodwill) Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Personal care and Skincare Personal Care And Skincare [Member] Related to personal care and skincare. Deferred revenue Deferred Revenue, Current Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Geographical [Axis] Geographical [Axis] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Associate Incentives Associate Incentives [Policy Text Block] Disclosure of accounting policy for associate incentives. Inventory write-down Inventory Write-down Product Return Policy Product Return [Policy Text Block] Disclosure of accounting policy for product returns. Income Taxes Income Tax Disclosure [Text Block] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Restricted cash included in other assets Restricted cash and cash equivalents, noncurrent, total Restricted Cash and Cash Equivalents, Noncurrent Leases Lessee, Leases [Policy Text Block] Current liabilities Liabilities, Current [Abstract] Incremental taxes Incremental Taxes The amount of incremental taxes for the reporting period. Federal Deferred Federal Income Tax Expense (Benefit) Associate incentives Associate Incentives Expenses related to commissions and other incentives earned by independent associates. Commissions are earned based on direct and indirect commissionable product sales. Other incentives including bonuses and contests and promotions are based on pay-for-performance and earned when associates achieve the required performance measures. Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Payments for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Cash paid during the period for: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract] Earnings per share, diluted (in dollars per share) Earnings per common share from net earnings - diluted (in dollars per share) Earnings Per Share, Diluted Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Foreign currency contracts included in other current liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Goodwill [Roll Forward] Goodwill [Roll Forward] Prepaid Expense and Other Assets, Current [Abstract] Payments for net investment hedge Payments for Hedge, Investing Activities Level 3 Fair Value, Inputs, Level 3 [Member] Line of Credit Line of Credit [Member] Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage Accrued excise tax for repurchase of common stock Excise and Sales Taxes Weighted average exercise price, outstanding (in dollars per share) Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Per share or unit weighted-average exercise price of award under share-based payment arrangement. Excludes share and unit options. SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Trading Symbol Trading Symbol Non-compete agreements Noncompete Agreements [Member] 2027 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Four Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year four. Net earnings Net earnings Net Income (Loss) Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Translation of Foreign Currencies Foreign Currency Transactions and Translations Policy [Policy Text Block] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Operating Leases Lessee, Operating Leases [Text Block] Intangible assets, gross (excluding goodwill) Intangible Assets, Gross (Excluding Goodwill) LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Employee Stock Employee Stock [Member] Expired, weighted-average exercise price (in dollars per share) Expired, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award expired during the period under share-based payment arrangement. Excludes share and unit options. Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stockholders' equity Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule of Unrecognized Tax Benefits Reconciliation Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Contract liabilities at beginning of period Contract liabilities at end of period Contract with Customer, Liability United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Equity securities without readily determinable fair value, impairment loss, annual amount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Income Tax Contingency [Table] Income Tax Contingency [Table] Share-based compensation arrangement by share-based payment award, award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Excess foreign tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USANA Foods USANA Foods [Member] Related to USANA Foods. Level 1 Fair Value, Inputs, Level 1 [Member] Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Goodwill Goodwill as of beginning of year Goodwill as of end of year Goodwill Increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Weighted-average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Schedule of Revenue by Geographic Region Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Derivative assets (liabilities), at fair value, net, total Derivative Assets (Liabilities), at Fair Value, Net 2024 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year One Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year one Entity Small Business Entity Small Business Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions Cash received during the period for: Income Taxes Paid, Net [Abstract] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Defined benefit plan, cliff vesting period (year) Defined Benefit Plan Cliff Vesting Period Minimum amount of service time before matching contributions will cliff vest. Movement in Contract Liabilities [Roll Forward] Movement In Contract Liabilities [Roll Forward] Movement In Contract Liabilities Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Payout as % of target number of shares Share-Based Payment Arrangement, Payout, Percentage of Target Number Of Shares Share-Based Payment Arrangement, Payout, Percentage of Target Number Of Shares Derivative, notional amount Derivative, Notional Amount Business Combination, Separately Recognized Transactions [Table] Business Combination, Separately Recognized Transactions [Table] Product return, first time order, duration of return (day) Product Return First Time Order Duration Of Return The duration of the return on first-time product orders. Measurement Frequency [Axis] Measurement Frequency [Axis] Operating lease liabilities Operating Lease, Liability, Noncurrent Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Leases, Operating [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Depreciation Depreciation 2025 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Two Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year two. Line of Credit Facility [Table] Line of Credit Facility [Table] Tax withholding for net-share settled equity awards Share-based payment arrangement, decrease for tax withholding obligation Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Deferred Stock Units Deferred Stock Units [Member] Represents deferred stock units. Schedule of Maturity of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Income taxes Accrued Income Taxes, Current Prepaid expenses Deferred Tax Liabilities, Prepaid Expenses Number of sub geographical regions Number Of Sub-Geographical Regions The number of sub-geographical regions the company operates in. Product and Service [Domain] Product and Service [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Accruals not currently deductible Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Grantee Status [Axis] Grantee Status [Axis] Schedule of Supplemental Lease Information Lease, Cost [Table Text Block] Inventories Increase (Decrease) in Inventories Investment in Equity Securities Equity Securities without Readily Determinable Fair Value [Policy Text Block] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Forfeited, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Number of geographic regions Number Of Geographic Regions The number of geographic regions in which the company operates. Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Income taxes receivable Income Taxes Receivable, Current Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Interest expense Interest Expense Accrued purchases of property and equipment Capital Expenditures Incurred but Not yet Paid Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Hedging Designation [Axis] Hedging Designation [Axis] Property, plant and equipment, gross Property, Plant and Equipment, Gross Adjustments to additional paid in capital Adjustments to Additional Paid in Capital, Other ROU assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Raw Materials Raw Materials [Member] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating lease liabilities Operating Lease, Liability, Current Schedule of Stock-Settled Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of Market-Based and Performance-Based Condition Schedule of Market-Based and Performance-Based Conditions [Table Text Block] Schedule of Market-Based and Performance-Based Conditions Other Foreign Deferred Tax Assets Other Foreign Deferred Tax Assets [Member] Represents other foreign deferred tax assets. Decreases related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Auditor Firm ID Auditor Firm ID Amortization of intangible assets, total Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Total estimated amortization expense Finite-Lived Intangible Assets, Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Uncertain tax position reserve Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Valuation allowance - deferred tax assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Increases related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Other liabilities Increase (Decrease) in Other Operating Liabilities Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Total ROU assets Lease Right Of Use Asset Amount of lessee's right to use underlying asset under lease. Schedule of Consolidated Income Before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Interest income Investment Income, Interest Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Operating lease expense Operating Lease, Cost Common stock, shares, issued (in shares) Common Stock, Shares, Issued Vested, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Gross profit Gross Profit Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Equity-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Selling, general and administrative Selling, General and Administrative Expense Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Share-based compensation arrangement by share-based payment award, award vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Schedule of Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Defined contribution plan, employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Accounting Policies [Table] Accounting Policies [Table] Accounting Policies Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Share-based payment arrangement, nonvested award, cost not yet recognized, amount Total remaining unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Cash equivalents, at carrying value, total Cash Equivalents, at Carrying Value Document Type Document Type Goodwill acquired during the year Goodwill, Acquired During Period Beginning balance outstanding, shares (in shares) Ending balance outstanding, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Domestic Tax Authority Domestic Tax Authority [Member] Entity Address, Address Line One Entity Address, Address Line One Inventories Inventory, Policy [Policy Text Block] Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities [Member] Represents mirrored deferred tax assets recorded in the U.S. to offset deferred tax liabilities of foreign disregarded entities. Equity-Based Compensation Share-Based Payment Arrangement [Text Block] Federal Current Federal Tax Expense (Benefit) Weighted-average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Nonqualified Deferred Compensation Nonqualified Deferred Compensation Plan Policy [Policy Text Block] Disclosure of accounting policy related to the Company's nonqualified deferred compensation plan. Exercisable, aggregate intrinsic value Exercisable, Aggregate Intrinsic Value Intrinsic value of exercisable award under share-based payment arrangement. Excludes share and unit options. Business Acquisition [Axis] Business Acquisition [Axis] Trade name and trademarks Trademarks and Trade Names [Member] Subsequent Event Subsequent Event [Member] Unrecognized tax benefits, income tax penalties and interest accrued, total Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Operating loss carryforwards, total Operating Loss Carryforwards Self-Insurance Self Insurance Reserve [Policy Text Block] State Deferred State and Local Income Tax Expense (Benefit) Other current liabilities Total other current liabilities Other Liabilities, Current Income Statement [Abstract] Income Statement [Abstract] Inventory [Line Items] Inventory [Line Items] Raw materials Inventory, Raw Materials, Net of Reserves Title of 12(b) Security Title of 12(b) Security Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Exercises In Period Intrinsic Value The intrinsic value of award exercised under share-based payment arrangement. Excludes share and unit options. Gross goodwill Gross goodwill Goodwill, Gross Money market funds included in cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Business Combinations Business Combination Disclosure [Text Block] Common Stock Share Repurchases Stockholders' Equity, Policy [Policy Text Block] Indefinite-lived intangible assets (excluding goodwill), direct sales license Indefinite-Lived Intangible Assets (Excluding Goodwill) Operating Segments Operating Segments [Member] Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value (in dollars per share) Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) Ending balance outstanding, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Other current assets Other Assets, Current Common stock issued under equity award plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Income Tax Disclosure [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Inventories Total inventory, net Inventory, Net Total lease expense Lease, Cost Inventory Deferred Tax Assets, Inventory Share-based payment arrangement, amount capitalized Share-Based Payment Arrangement, Amount Capitalized Land Land [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Noncurrent inventories Inventory, Noncurrent Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Advertising Advertising Cost [Policy Text Block] Contingent consideration milestone period Contingent Consideration Milestone Period Contingent Consideration Milestone Period Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Repurchase of common stock Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Foreign Deferred Foreign Income Tax Expense (Benefit) Payments to acquire businesses Payments to Acquire Assets, Investing Activities Inventory Disclosure [Abstract] Other Assets Other Assets [Member] Segments [Domain] Segments [Domain] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Weighted-average remaining contractual term Weighted-Average Remaining Contractual Term [Abstract] Weighted-Average Remaining Contractual Term Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets Assets, Current [Abstract] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Advertising expense Advertising Expense Schedule of Deferred Taxes Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Entity Address, State or Province Entity Address, State or Province Derivatives Financial Instruments Derivatives, Policy [Policy Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows from operating leases Operating Lease, Payments Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares) Share-based Compensation Arrangement By Share-based Payment Award Shares Issued Per Award Exercised The number of shares issued per each one award upon exercise of award under share based payment arrangement. Common stock, shares, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Series of Individually Immaterial Business Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Auditor Location Auditor Location Forfeited, weighted-average exercise price (in dollars per share) Forfeited, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award forfeited during the period under share-based payment arrangement. Excludes share and unit options. Deferred tax assets, operating loss carryforwards, foreign Deferred Tax Assets, Operating Loss Carryforwards, Foreign Common stock, par or stated value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Defined contribution plan, maximum annual contributions per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent All other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Contingent consideration given to acquire businesses Noncash or Part Noncash Acquisition, Value of Assets Acquired Net earnings available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Common stock repurchased and retired Stock repurchased and retired during period, value Stock Repurchased and Retired During Period, Value Total effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Total lease liabilities Present value Operating Lease, Liability Deferred tax liabilities Deferred Tax Liabilities, Gross [Abstract] Accounting Policies [Line Items] Accounting Policies [Line Items] Accounting Policies Credit Facility [Axis] Credit Facility [Axis] Total Current Current Income Tax Expense (Benefit) Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Vesting [Domain] Vesting [Domain] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Charged to costs and expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Property and equipment, net, excluding non-depreciable Property Plant And Equipment Net Excluding Nondepreciable Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale, excluding non-depreciable amounts. Measurement Frequency [Domain] Measurement Frequency [Domain] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] The Company The Company [Policy Text Block] The Company Product formulas Trade Secrets [Member] Unrecorded unconditional purchase obligation, to be paid, year one Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Plan Name [Axis] Plan Name [Axis] Capitalized R&D expenses Deferred Tax Assets, in Process Research and Development Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Share-based payment arrangement, expense, tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Number of reportable segments Number of Reportable Segments Liability Award Liability Award [Member] Represents liability award. Earnings per common share Earnings Per Share [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 2022 Common Stock, Value, Issued Product return, percentage of net sales Product Return Percentage Of Net Sales The percentage of net sales that had product returns during the period. China CHINA Non-qualified deferred compensation plan, salary deferred, percentage Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage Exercisable, weighted-average remaining contractual term (years) Exercisable, Weighted-Average Remaining Contractual Term (Year) Weighted average remaining contractual term for equity-based awards excluding options that are exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Life insurance, corporate or bank owned, amount Life Insurance, Corporate or Bank Owned, Amount Right-of-use asset amortization Operating Lease, Right-of-Use Asset, Periodic Reduction Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] State Current State and Local Tax Expense (Benefit) Deferred tax assets, operating loss carryforwards, state and local Deferred Tax Assets, Operating Loss Carryforwards, State and Local Total current assets Assets, Current Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548) Contingent consideration Business Combination, Contingent Consideration, Liability Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Other, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category 2028 and Thereafter Lessee, Operating Lease, Liability, to be Paid, Year Five And After Year Five Lessee, Operating Lease, Liability, to be Paid, Year Five And After Year Five Statement [Table] Statement [Table] Business combination, contingent consideration, liability, noncurrent Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Sales taxes Sales and Excise Tax Payable, Current Schedule of Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Unrecognized tax benefits Beginning balance of unrecognized tax benefits Ending balance of unrecognized tax benefits Unrecognized Tax Benefits 150% Of Target Number Units 150% Of Target Number Units [Member] 150% Of Target Number Units Income Tax Authority [Axis] Income Tax Authority [Axis] Concentration risk, percentage Concentration Risk, Percentage All other Other Sundry Liabilities, Current Asia Pacific Total Asia Pacific [Member] Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Foreign withholding taxes Foreign Withholding Taxes Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax withholdings. Defined contribution plan, employer contribution amount Defined Contribution Plan Employer Contribution Amount Amount of contributions made by an employer to a defined contribution plan. State income taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Granted, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five Buildings Building [Member] Prepaid insurance Prepaid Insurance Schedule of Goodwill Schedule of Goodwill [Table Text Block] Tax credit carry forwards Deferred Tax Assets, Tax Credit Carryforwards Schedule of Prepaid Expenses Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Accounts Receivable Accounts Receivable [Policy Text Block] Right-of-use assets obtained in exchange for lease obligations Right-Of-Use Assets Obtained In Exchange For Lease Obligations The amount of right of use asset obtained in exchange for operating lease liability classified as a noncash transaction. Equity-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Business combination, contingent consideration, liability, current Business Combination, Contingent Consideration, Liability, Current Fair Value, Nonrecurring Fair Value, Nonrecurring [Member] Other Revenue Other Income SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Product Concentration Risk Product Concentration Risk [Member] Line of credit - short term Line of Credit, Current Southeast Asia Pacific [Member] Southeast Asia Pacific [Member] Related to Southeast Asia Pacific. Deferred commissions Deferred Costs, Current Depreciation and amortization Depreciation, Depletion and Amortization Deferred tax assets Deferred Tax Assets, Gross [Abstract] Furniture and fixtures Furniture and Fixtures [Member] Restricted Cash Deposits in China Restricted Cash Deposits in China [Member] Represents restricted cash deposits in China. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] 2026 Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Three Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year three. Allowance for credit losses SEC Schedule, 12-09, Allowance, Credit Loss [Member] Business Combination and Asset Acquisition [Abstract] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Long-lived Assets Long-Lived Assets Goodwill, impairment loss Goodwill, Impairment Loss Restricted Stock Restricted Stock [Member] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Decrease due to beginning contract liabilities recognized as revenue Contract with Customer, Liability, Revenue Recognized SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Gross deferred tax assets Deferred Tax Assets, Gross Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Utah State Tax Commission Utah State Tax Commission [Member] Represents the Utah state tax commission. Document Fiscal Period Focus Document Fiscal Period Focus Finite-lived intangible asset, weighted-average amortization period (years) Finite-Lived Intangible Asset, Useful Life 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Granted, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Rent expense Operating Lease, Expense Equity-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Foreign Tax Authority Foreign Tax Authority [Member] Income tax refund Proceeds from Income Tax Refunds SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Line of credit facility, additional increase in maximum borrowing capacity Line Of Credit Facility Additional Increase In Maximum Borrowing Capacity Maximum borrowing capacity due to additional increase under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility Common Stock and Earnings Per Share Earnings Per Share [Text Block] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Schedule of Cash-Settled Restricted Stock Unit Activity Schedule of Nonvested Share Activity [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Associate incentives Associate Incentives Payable Carrying value as of the balance sheet date of liabilities incurred and payable for associate incentives. Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Defined contribution plan, requisite service period (month) Defined Contribution Plan Requisite Service Period The requisite service period of the defined contribution plan. Amounts Receivable from Credit Card Processors Amounts Receivable From Credit Card Processors [Member] Represents amounts receivable from credit card processors. Inventory [Domain] Inventory [Domain] Software and Software Development Costs Software and Software Development Costs [Member] Income tax expense related to interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Minimum Minimum [Member] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property and equipment, net Property, Plant and Equipment, Net Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Land improvements Land Improvements [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Maximum amount of earnouts total Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Line of Credit Facility [Abstract] ASSETS Assets Assets [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Payments related to tax withholding for net-share settled equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Fiscal Year Fiscal Period, Policy [Policy Text Block] Schedule II - Valuation And Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Liabilities Liabilities [Abstract] Other Deferred Tax Assets, Other Minimum amount of projected aggregate claims before insurance reimbursement Minimum Amount Of Projected Aggregate Claims Before Insurance Reimbursement The minimum amount of projected aggregate claims required before insurance will reimburse. Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax assets Net deferred tax assets Deferred Income Tax Assets, Net Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Retained Earnings Retained Earnings [Member] Total liabilities and equity Liabilities and Equity Amended and Restated Credit Agreement Amended And Restated Credit Agreement [Member] Related to amended and restated credit agreement. Other income (expense): Nonoperating Income (Expense) [Abstract] Other assets Other Assets, Noncurrent Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate ROU operating lease assets, net Operating Lease, Right-of-Use Asset Earnings per share, basic (in dollars per share) Earnings per common share from net earnings - basic (in dollars per share) Earnings Per Share, Basic Accounting Policies [Abstract] Accounting Policies [Abstract] The 2015 Plan The 2015 Plan [Member] Represents the 2015 Equity Incentive Award Plan. Foreign Current Foreign Tax Expense (Benefit) Allowance for sales returns SEC Schedule, 12-09, Allowance, Sales Returns [Member] Allowance for sales returns. Net deferred taxes Deferred Tax Assets, Net Undistributed earnings Undistributed Earnings, Basic Performance Payout [Domain] Performance Payout [Domain] Performance Payout [Domain] Entity Address, City or Town Entity Address, City or Town Schedule of Segment Reporting Information, by Operating Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory, Current [Table] Inventory, Current [Table] Income taxes Income Taxes Paid Principles of Consolidation and Basis of Presentation Consolidation, Policy [Policy Text Block] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Increase due to deferral of revenue at period end Increase Due To Deferral Of Revenue At Period End The amount of increase (decrease) in contract with customer liability due to deferred revenue. Document Transition Report Document Transition Report Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Receipts on notes receivable Proceeds from Collection of Notes Receivable Payments on line of credit Repayments of Lines of Credit Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] South Korea KOREA, REPUBLIC OF Entity Public Float Entity Public Float Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised (in shares) Exercised, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Direct-selling Direct Selling [Member] Direct Selling Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Property, Plant and Equipment [Abstract] Other Liabilities Disclosure [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Valuation allowance, deferred tax asset, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Adjustments to reconcile net earnings to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Intangible Assets Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block] Tabular disclosure for finite lived and indefinite lived intangible assets. Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Americas and Europe Americas And Europe [Member] Related to Americas and Europe. Performance Stock Units Performance Stock Units [Member] Performance Stock Units Deposits and projects in process Deposits and Projects In Process [Member] Represents deposits and projects in process. Automobiles Automobiles [Member] Laboratory and production equipment Laboratory And Production Equipment [Member] Represents laboratory and production equipment. Purchase price allocations to tangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Performance Payout [Axis] Performance Payout [Axis] Performance Payout Noncurrent: Other Liabilities, Noncurrent [Abstract] Inventory [Axis] Inventory [Axis] Forfeited, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Total Deferred Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] North Asia North Asia [Member] Related to north Asia. Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Total prepaid expense and other current assets Prepaid Expense and Other Assets, Current Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Aggregate intrinsic value, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Forfeited, shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Finished Goods Finished Goods [Member] Finished Goods Defined contribution plan, employer matching contribution, percent of employees' gross pay Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Nonfinancial assets, fair value disclosure Nonfinancial Assets Fair Value Disclosure The amount of nonfinancial assets measured at fair value. Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization Debt Instrument Covenant Ratio Of Consolidated Funded Debt To Adjusted Earnings Before Interest Taxes Depreciation And Amortization The covenant ratio of consolidated debt to adjusted earnings before interest, taxes, depreciation, and amortization for a debt instrument. Prepaid Expenses And Other Current Assets Other Current Assets [Text Block] Share price (in dollars per share) Target share price (in dollars per share) Share Price Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Common stock issued under entity award plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Greater China Greater China [Member] Related to Greater China. Current: Other Liabilities, Current [Abstract] Entity Registrant Name Entity Registrant Name Dilutive effect of in-the-money equity awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Foreign Operating Loss Carryforwards Foreign Operating Loss Carryforwards [Member] Represents foreign operating loss carryforwards. Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Foreign income tax rate differences Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Permanent tax differences Permanent Tax Differences Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to permanent tax differences. Schedule of Remaining Unrecognized Compensation Expense Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares) Share-based Compensation Arrangement By Share-based Payment Award Grants In Period Gross Gross number of awards granted during the period. Other comprehensive income (loss), net of tax: Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Auditor Name Auditor Name Document Period End Date Document Period End Date Borrowings on line of credit Proceeds from Lines of Credit Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Derivative, gain (loss) on derivative, net Derivative, Gain (Loss) on Derivative, Net (Gain) loss on sale of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Finite-lived intangible assets, gross carrying amount Finite-Lived Intangible Assets, Gross Income taxes Total income tax expense (benefit) Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Deferred compensation liabilities Deferred Compensation Liability, Current and Noncurrent Weighted-average remaining contractual term, outstanding (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Deferred compensation liability, classified, noncurrent, total Deferred Compensation Liability, Classified, Noncurrent Designated as Hedging Instrument Designated as Hedging Instrument [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] active Customer CAGR Share-Based Payment Arrangement, Performance Condition, Active Customer Growth Rate, Percentage Share-Based Payment Arrangement, Performance Condition, Active Customer Growth Rate, Percentage Accrued employee compensation Employee-related Liabilities, Current Maximum amount per earnout Business Combination, Contingent Consideration Arrangements, Range Of Outcomes, Value Per Arrangement, High Amount of maximum earn-out per period. Vesting [Axis] Vesting [Axis] Revenue Benchmark Revenue Benchmark [Member] Product return, first time order, percentage refunded Product Return First Time Order Percentage Refunded The percentage refunded on first-time orders for product returns. Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares) Share-based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased In Period The number of shares vested and unreleased in the period of non-option equity instruments under share based payment arrangement. Exercised, weighted-average exercise price (in dollars per share) Exercised, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award exercised in period under share-based payment arrangement. Excludes share and unit options. Inventories Inventory Disclosure [Text Block] Weighted-average remaining lease term—operating leases Operating Lease, Weighted Average Remaining Lease Term Granted, weighted-average exercise price (in dollars per share) Granted, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of award granted during the period under share-based payment arrangement. Excludes share and unit options. Miscellaneous receivables, net Other Receivables, Net, Current Net sales Net Sales to External Customers Revenue from Contract with Customer, Excluding Assessed Tax Exercisable, shares (in shares) Exercisable, Shares (In Shares) Number of equity instruments other than options exercisable. Amendment Flag Amendment Flag Amortized intangible assets Finite-Lived Intangible Assets, Net [Abstract] Money Market Funds Money Market Funds [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Share-based compensation arrangement by share-based payment award, forfeitures (in shares) Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Number of shares under equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Tax credit carryforward, amount Tax Credit Carryforward, Amount Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Direct selling license Licensing Agreements [Member] Weighted-average discount rate—operating leases Operating Lease, Weighted Average Discount Rate, Percent SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Vesting Annually Vesting Annually [Member] Represents vesting annually. Credit Facility [Domain] Credit Facility [Domain] Common stock repurchased and retired (in shares) Stock repurchased and retired during period, shares (in shares) Stock Repurchased and Retired During Period, Shares Business Combinations Business Combinations Policy [Policy Text Block] Useful life Property, Plant and Equipment, Useful Life Leasehold improvements Leasehold Improvements [Member] Net increase in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Diluted (in shares) Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Grantee Status [Domain] Grantee Status [Domain] Purchase price allocations to intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Contract with Customer, Contract Asset, Contract Liability, and Receivable Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Operating expenses: Operating Expenses [Abstract] Decreases for settlements with taxing authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Foreign currency translation Deferred Tax Assets, Unrealized Currency Losses Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Document Annual Report Document Annual Report Cash-settled Restricted Stock Units Cash-Settled Restricted Stock Units [Member] Represents cash-settled restricted stock units. Balance Sheet Location [Axis] Balance Sheet Location [Axis] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Total assets Total Assets Assets Defined contribution plan, employer matching contribution, match percent exceeding initial match Defined Contribution Plan Employer Matching Contribution Match Percent Exceeding Initial Match The percent exceeding the initial matching percent that the employer matches contributions under the defined contribution plan. Self-insurance expense Self Insurance Expense The expense in the period incurred for claims for which no insurance coverage exists. Cover [Abstract] Equity-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other prepaid expenses Other Prepaid Expense, Current China UNITED STATES Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Fair Value, Recurring Fair Value, Recurring [Member] Other Current Liabilities Other Liabilities Disclosure [Text Block] Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] Other long-term liabilities Other Liabilities, Noncurrent Vested, weighted-average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vesting Each Quarter Vesting Each Quarter [Member] Represents vesting each quarter. Total operating lease, liability Lessee, Operating Lease, Liability, to be Paid Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization Debt Instrument Covenant Adjusted Earnings Before Interest Taxes Depreciation And Amortization The amount of debt instrument covenant for adjusted earnings before interest taxes, depreciation, and amortization. Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] 200% Of Target Number Units 200% Of Target Number Units [Member] 200% Of Target Number Units Total operating expenses Operating Expenses Segment Information Segment Reporting Disclosure [Text Block] Number of earnout periods Number Of Earnout Periods Number of earn-out periods. Air transportation equipment Air Transportation Equipment [Member] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Fiscal year-end 2025 active Customers Number Of Active Customers Number Of Active Customers Exercisable, weighted-average exercise price (in dollars per share) Exercisable, Weighted-Average Exercise Price (In Dollars Per Share) Per share or unit weighted-average exercise price of exercisable award under share-based payment arrangement. Excludes share and unit options. Equity Component [Domain] Equity Component [Domain] State and Local Jurisdiction State and Local Jurisdiction [Member] Work in progress Inventory, Work in Process, Net of Reserves Defined contribution plan, minimum age of employee Defined Contribution Plan Minimum Age Of Employee The minimum age of employee required to participate in the defined contribution plan Other Deferred Tax Liabilities, Other Net operating losses Deferred Tax Assets, Operating Loss Carryforwards Contract with customer, asset, after allowance for credit loss, total Contract with Customer, Asset, after Allowance for Credit Loss Schedule of Classification of ROU Assets and Lease Liabilities Assets And Liabilities, Lessee [Table Text Block] Tabular disclosure of lessee's assets and liabilities. Basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic 100% Of Target Number Units 100% Of Target Number Units [Member] 100% Of Target Number Units Property and equipment Deferred Tax Assets, Property, Plant and Equipment Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Earnings from operations Operating Income (Loss) Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Gross deferred tax liabilities Deferred Tax Liabilities, Gross Comprehensive income: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Minimum amount of individual claims before insurance reimbursement Minimum Amount Of Individual Claims Before Insurance Reimbursement The minimum amount of individual claims required before insurance will reimburse. Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Operating loss carryforwards, not subject to expiration Operating Loss Carryforwards Not Subject To Expiration Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws, that are not subject to expiration. USANA Nutritionals USANA Nutritionals [Member] Related to USANA Nutritionals. Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Intangible assets Deferred Tax Liabilities, Intangible Assets Long-term line of credit, total Long-Term Line of Credit Customer relationships Customer Relationships [Member] All Other All Other [Member] Related to all other. Equity based compensation expense Equity Based Compensation Expense The value of equity based compensation expenses under share-based payment arrangement. Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] EX-101.PRE 13 usna-20231230_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 usna-20231230_g1.jpg CUMULITIVE SHAREHOLDER RETURN begin 644 usna-20231230_g1.jpg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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 30, 2023
Feb. 23, 2024
Jul. 01, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 30, 2023    
Current Fiscal Year End Date --12-30    
Document Transition Report false    
Entity File Number 001-35024    
Entity Registrant Name USANA HEALTH SCIENCES, INC.    
Entity Incorporation, State or Country Code UT    
Entity Tax Identification Number 87-0500306    
Entity Address, Address Line One 3838 West Parkway Blvd.    
Entity Address, City or Town Salt Lake City    
Entity Address, State or Province UT    
Entity Address, Postal Zip Code 84120    
City Area Code 801    
Local Phone Number 954-7100    
Title of 12(b) Security Common Stock, Par Value $0.001 per share    
Trading Symbol USNA    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 699,225,000
Entity Common Stock, Shares Outstanding   19,240,514  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE

The registrant incorporates by reference into Part III (Items 10, 11, 12, 13, and 14) of this report certain information contained in its Definitive Proxy Statement to be filed with the Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year ended December 30, 2023, in connection with the registrant’s 2024 Annual Meeting of Shareholders to be held May 6, 2024.
    
Auditor Name KPMG LLP    
Auditor Location Salt Lake City, Utah    
Auditor Firm ID 185    
Entity Central Index Key 0000896264    
Document Fiscal Period Focus FY    
Amendment Flag false    
Document Fiscal Year Focus 2023    

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 330,420 $ 288,420
Inventories 61,454 67,089
Prepaid expenses and other current assets 25,872 28,873
Total current assets 417,746 384,382
Property and equipment, net 99,814 97,773
Goodwill 17,102 17,368
Intangible assets, net 29,919 32,432
Deferred tax assets 13,284 9,799
Other assets 54,892 54,795
Total assets 632,757 596,549
Current liabilities    
Accounts payable 10,070 11,049
Line of credit - short term 786 0
Other current liabilities 107,989 132,784
Total current liabilities 118,845 143,833
Deferred tax liabilities 4,552 4,071
Other long-term liabilities 12,158 14,173
Stockholders' equity    
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 2022 19 19
Additional paid-in capital 65,661 55,604
Retained earnings 445,217 391,636
Accumulated other comprehensive income (loss) (13,695) (12,787)
Total stockholders' equity 497,202 434,472
Total liabilities and equity $ 632,757 $ 596,549
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
shares in Thousands
Dec. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000 50,000
Common stock, shares, issued (in shares) 19,130 19,206
Common stock, shares, outstanding (in shares) 19,130 19,206
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Income Statement [Abstract]      
Net sales $ 921,010 $ 998,601 $ 1,186,464
Cost of sales 176,693 193,890 217,898
Gross profit 744,317 804,711 968,566
Operating expenses:      
Associate incentives 394,257 434,793 519,267
Selling, general and administrative 256,989 262,304 279,107
Total operating expenses 651,246 697,097 798,374
Earnings from operations 93,071 107,614 170,192
Other income (expense):      
Interest income 9,637 3,789 2,515
Interest expense (262) (192) (57)
Other, net 7 (2,590) (2,008)
Other income (expense), net 9,382 1,007 450
Earnings before income taxes 102,453 108,621 170,642
Income taxes 38,665 39,271 54,137
Net earnings $ 63,788 $ 69,350 $ 116,505
Earnings per common share      
Earnings per share, basic (in dollars per share) $ 3.31 $ 3.60 $ 5.78
Earnings per share, diluted (in dollars per share) $ 3.30 $ 3.59 $ 5.73
Weighted average common shares outstanding      
Basic (in shares) 19,250 19,254 20,146
Diluted (in shares) 19,345 19,310 20,343
Comprehensive income:      
Net earnings $ 63,788 $ 69,350 $ 116,505
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustment (1,298) (15,126) 2,203
Tax benefit (expense) related to foreign currency translation adjustment 390 1,881 1,880
Other comprehensive income (loss), net of tax (908) (13,245) 4,083
Comprehensive income $ 62,880 $ 56,105 $ 120,588
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Cash flows from operating activities      
Net earnings $ 63,788 $ 69,350 $ 116,505
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 12,702 13,393 13,036
Right-of-use asset amortization 7,693 8,017 9,157
(Gain) loss on sale of property and equipment 10 141 61
Equity-based compensation expense 14,595 13,331 14,298
Deferred income taxes (2,749) (7,183) (2,970)
Inventory write-down 2,601 6,082 4,200
Changes in operating assets and liabilities, net of acquisitions:      
Inventories 2,353 15,797 (14,701)
Prepaid expenses and other assets 110 (3,304) (2,331)
Accounts payable (428) (2,656) (4,572)
Other liabilities (30,034) (9,066) (11,456)
Net cash provided by (used in) operating activities 70,641 103,902 121,227
Cash flows from investing activities      
Receipts on notes receivable 0 0 116
Proceeds from the settlement of net investment hedges 3,775 4,555 0
Payments for net investment hedge (1,271) 0 (1,555)
Payments to acquire businesses 0 (6,532) 0
Proceeds from sale of property and equipment 15 7 15
Purchases of property and equipment (14,494) (10,400) (12,763)
Net cash provided by (used in) investing activities (11,975) (12,370) (14,187)
Cash flows from financing activities      
Repurchase of common stock (11,599) (25,382) (177,837)
Borrowings on line of credit 1,542 11,000 0
Payments on line of credit (750) (11,000) 0
Payments related to tax withholding for net-share settled equity awards (3,092) (4,706) (3,575)
Payments for contingent consideration (338) 0 0
Net cash provided by (used in) financing activities (14,237) (30,088) (181,412)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,503) (13,777) 2,088
Net increase (decrease) in cash, cash equivalents, and restricted cash 41,926 47,667 (72,284)
Cash, cash equivalents, and restricted cash at beginning of period 291,320 243,653 315,937
Cash, cash equivalents, and restricted cash at end of period 333,246 291,320 243,653
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 330,420 288,420 239,832
Restricted cash included in other assets 2,826 2,900 3,821
Total cash, cash equivalents, and restricted cash 333,246 291,320 243,653
Cash paid during the period for:      
Interest 68 49 10
Income taxes 44,247 45,863 59,524
Cash received during the period for:      
Income tax refund 1,922 113 191
Non-cash investing and financing activities:      
Right-of-use assets obtained in exchange for lease obligations 5,699 5,641 5,322
Accrued purchases of property and equipment 117 679 383
Contingent consideration given to acquire businesses 0 886 0
Accrued excise tax for repurchase of common stock $ 54 $ 0 $ 0
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jan. 02, 2021   21,038      
Beginning balance at Jan. 02, 2021 $ 441,650 $ 21 $ 62,460 $ 382,794 $ (3,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 116,505     116,505  
Other comprehensive income (loss), net of tax 4,083       4,083
Equity-based compensation expense $ 14,298   14,298    
Common stock repurchased and retired (in shares) (1,844) (1,844)      
Common stock repurchased and retired $ (177,837) $ (2) (23,173) (154,662)  
Common stock issued under entity award plans (in shares)   199      
Common stock issued under equity award plans 0        
Tax withholding for net-share settled equity awards (3,575)   (3,575)    
Ending balance (in shares) at Jan. 01, 2022   19,393      
Ending balance at Jan. 01, 2022 395,124 $ 19 50,010 344,637 458
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 69,350     69,350  
Other comprehensive income (loss), net of tax (13,245)       (13,245)
Equity-based compensation expense $ 13,331   13,331    
Common stock repurchased and retired (in shares) (288) (288)      
Common stock repurchased and retired $ (25,382) $ 0 (3,031) (22,351)  
Common stock issued under entity award plans (in shares)   101      
Common stock issued under equity award plans 0        
Tax withholding for net-share settled equity awards $ (4,706)   (4,706)    
Ending balance (in shares) at Dec. 31, 2022 19,206 19,206      
Ending balance at Dec. 31, 2022 $ 434,472 $ 19 55,604 391,636 (12,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 63,788     63,788  
Other comprehensive income (loss), net of tax (908)       (908)
Equity-based compensation expense $ 14,595   14,595    
Common stock repurchased and retired (in shares) (180) (180)      
Common stock repurchased and retired $ (11,653)   (1,446) (10,207)  
Common stock issued under entity award plans (in shares)   104      
Common stock issued under equity award plans 0        
Tax withholding for net-share settled equity awards $ (3,092)   (3,092)    
Ending balance (in shares) at Dec. 30, 2023 19,130 19,130      
Ending balance at Dec. 30, 2023 $ 497,202 $ 19 $ 65,661 $ 445,217 $ (13,695)
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India(1)
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
(1) We commenced operations in this market near the end of the fourth quarter of 2023.
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the consolidated statements of cash flows.
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2023, 2022, and 2021 were 52-week years. Fiscal year 2023 covered the period January 1, 2023 to December 30, 2023 (hereinafter 2023). Fiscal year 2022 covered the period January 2, 2022 to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021).
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
As of December 30, 2023 and December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 30,
2023		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$258,319 $258,319 $— $— 
Foreign currency contracts included in other current liabilities(62)— (62)— 
Deferred compensation liabilities
(3,137)— (3,137)— 
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.
The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 30, 2023 and December 31, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.
Fair Value of Financial Instruments
As of December 30, 2023 and December 31, 2022, the Company’s financial instruments include cash equivalents and restricted cash. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 30, 2023 and December 31, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 30, 2023 and December 31, 2022 totaled $9,379 and $8,904, respectively.
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,826 as of December 30, 2023, and $2,900 as of December 31, 2022. This deposit is required for the application of direct selling licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.

Noncurrent inventories are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventories are classified in the "Other assets" line item in the Company's consolidated balance sheets. Noncurrent inventories are anticipated to be consumed beyond our normal operating cycle, but prior to obsolescence.
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for credit losses regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
The Company capitalizes certain internal-use software development costs, consisting primarily of employee salaries and contractor costs, during the application development stage. Costs incurred for upgrades and enhancements that are expected to result in additional functionalities are also capitalized. These development costs are amortized using the straight-line method over an estimated useful life of three to five years, and are reflected as part of Property and equipment, net on our consolidated balance sheets.
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the unpaid lease payments over the lease term at the commencement date for leases exceeding 12 months. Unpaid lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill
Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2023, 2022, and 2021, no impairment of goodwill was recorded.
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable.
Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2023, 2022, and 2021, no impairment of indefinite-lived intangible assets was recorded.
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are remeasured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2023, the Company evaluated an observable price change related to equity securities without readily determinable fair values. No adjustment to the carrying value of the securities was necessary based on the observable price change. During 2022, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2023, 2022, and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation
In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the consolidated balance sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the consolidated statements of comprehensive income. As
of December 30, 2023 and December 31, 2022, the trustee held total assets of $2,962 and $1,622, and deferred compensation liabilities of $3,137, and, $1,632, respectively.
Self-Insurance
The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance for the United States markets on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,292. A liability is accrued for all unpaid claims. Total self-insurance expense was $14,501, $13,413, and $12,349 in 2023, 2022, and 2021, respectively.
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
During 2023 and 2021, the Company entered into and settled a European option with notional amounts of $81,343 and $98,684, respectively. During 2022 the Company entered into and settled a forward contract with a notional amount of $98,930. Both the forward contract and the European options were designated as net investment hedges. The Company realized gains of $2,504 and $4,555 in 2023 and 2022, respectively, and realized a loss of $1,555 in 2021. These gains and loss were recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 30, 2023 and December 31, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting.
Subsequent to December 30, 2023, on January 25, 2024 the Company entered into an option contract designated as a net investment hedge with a notional amount of $77,345.
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 30, 2023, $71,186, inclusive of accrued excise tax, is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on
revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders becomes remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
The following table presents Other Revenue for the periods indicated:
Year Ended
202320222021
Other Revenue$3,177 $3,452 $3,825 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 30, 2023 and December 31, 2022.
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 30,
2023		December 31,
2022
Contract liabilities at beginning of period$20,875 $19,635 
Increase due to deferral of revenue at period end13,910 20,875 
Decrease due to beginning contract liabilities recognized as revenue(20,875)(19,635)
Contract liabilities at end of period$13,910 $20,875 
Product Return Policy
All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.6%, 0.7%, and 0.6% of net sales in 2023, 2022, and 2021, respectively.
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. The grant date fair value of each performance share unit is based upon a Monte-Carlo simulation in order to incorporate market conditions. Equity-based compensation expense for restricted stock units and stock-settled stock appreciation rights are recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Equity-based compensation expense for performance stock units is recognized based on the achievement of certain performance and market conditions by specified target dates, subject to continued service through the applicable vesting dates. The probability of the awards meeting the performance condition is not included in the grant date fair value, but is estimated quarterly for expense recognition. The Company recognizes an adjustment to compensation expense based on revisions in probability assessments. The Company accounts for forfeitures as they occur. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising
Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $4,756, $5,053, and $12,399, in 2023, 2022, and 2021, respectively.
Research and Development
Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,446, $11,563, and $11,112 in 2023, 2022, and 2021, respectively.
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. The Company adopted the provisions of ASU 2021-08 during the first quarter of 2023 and the adoption of the standard did not have an impact on its consolidated financial statements.
Issued Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is intended to provide financial statement users with more disaggregated expense information about a public entity’s reportable segments. ASU 2023-07 requires incremental disclosures related to a public entity’s reportable segments including allowing the disclosure of multiple measures of segment profit or loss,
requiring the disclosure of significant segment expenses, and requiring the qualitative disclosure of other segment items. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024, and should be adopted retrospectively unless impracticable. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard is intended to benefit investors by providing more detailed income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
No other recent accounting pronouncements had, or are expected to have, a material impact on the Company's consolidated financial statements.
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Combinations
 12 Months Ended
Dec. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combinations BUSINESS COMBINATIONS
In the second quarter of 2022, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The final purchase price allocations were $771 to tangible assets, $6,065 to intangible assets, and $582 to goodwill. The primary reasons for the business combinations are to augment and expand the Company's core competencies.
The contingent consideration liability associated with the business combinations in 2022 was based on the achievement of certain milestones over a three-year period, and the seller's continued employment with the business. Under the terms of the purchase agreement, the contingent consideration consisted of three earn-out periods capped at $500 per earn-out period. The maximum earn-out was $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy.
As of December 31, 2022, the contingent consideration had a fair value of $886. During 2023, the employee resigned from the business, which consequently terminated the employment relationship and the remaining contingent consideration of $548 was forfeited. This non-cash gain on contingent consideration is included in the change in "Other liabilities" line item on the Company’s consolidated statements of cash flows. Contingent consideration is included in Fair Value Measures above.
Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Financial Statements.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventories
 12 Months Ended
Dec. 30, 2023
Inventory Disclosure [Abstract]  
Inventories INVENTORIES
December 30,
2023		December 31,
2022
Raw materials$19,848 $21,776 
Work in progress4,707 4,285 
Finished goods36,899 41,028 
$61,454 $67,089 
Noncurrent inventories$3,128 $3,479 
As of December 30, 2023, noncurrent inventories consisted of $2,051 of raw materials and $1,077 of finished goods inventory. As of December 31, 2022, noncurrent inventories consisted of $1,711 of raw materials and $1,768 of finished goods inventory. Noncurrent inventories are included in the “Other assets” line item on the Company’s consolidated balance sheets.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid Expenses and Other Current Assets
 12 Months Ended
Dec. 30, 2023
Prepaid Expense and Other Assets, Current [Abstract]  
Prepaid Expenses And Other Current Assets PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consists of the following:
December 30,
2023		December 31,
2022
Other prepaid expenses$9,069 $9,089 
Miscellaneous receivables, net6,172 5,183 
Other current assets6,096 7,121 
Prepaid insurance2,325 2,293 
Deferred commissions1,181 3,157 
Income taxes receivable1,029 2,030 
$25,872 $28,873 
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
 12 Months Ended
Dec. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
Consolidated earnings before income taxes consists of the following for 2023, 2022, and 2021:
Year Ended
202320222021
United States$(19,988)$(23,996)$13,017 
Foreign122,441 132,617 157,625 
Total earnings before income taxes$102,453 $108,621 $170,642 
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202320222021
Current
Federal$(42)$42 $(264)
State469 297 567 
Foreign40,913 45,869 56,668 
Total Current41,340 46,208 56,971 
Deferred
Federal(4,031)(9,180)(4,088)
State(59)(331)(40)
Foreign1,415 2,574 1,294 
Total Deferred(2,675)(6,937)(2,834)
$38,665 $39,271 $54,137 
The effective tax rate for 2023, 2022, and 2021 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202320222021
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.5 0.4 0.4 
Permanent tax differences0.7 0.3 0.1 
Excess foreign tax credits(16.4)(16.6)(10.9)
Net increase in valuation allowance13.0 11.9 10.6 
Foreign income tax rate differences8.7 9.5 1.8 
Foreign withholding taxes10.6 9.7 7.9 
Uncertain tax position reserve(0.4)0.5 (0.3)
All other, net— (0.5)1.1 
37.7 %36.2 %31.7 %
The effective tax rate for the year ended December 30, 2023 increased compared to the year ended December 31, 2022. The effective tax rate increase is due primarily to an unfavorable foreign currency impact on withholding tax accruals and the change in the market mix of pre-tax book income.
The significant categories of deferred taxes are as follows:
December 30,
2023		December 31,
2022
Deferred tax assets
Inventory$5,588 $5,872 
Accruals not currently deductible6,680 8,627 
Equity-based compensation expense2,580 2,746 
Property and equipment771 922 
Intangible assets6,359 6,680 
Foreign currency translation1,760 1,448 
Capitalized R&D expenses13,537 9,618 
Tax credit carry forwards134,205 115,539 
Net operating losses1,956 1,720 
Other3,237 3,223 
Gross deferred tax assets176,673 156,395 
Valuation allowance(137,252)(118,136)
Net deferred tax assets39,421 38,259 
Deferred tax liabilities
Property and equipment(5,897)(5,723)
Prepaid expenses(1,819)(2,990)
Intangible assets(6,359)(6,680)
Withholding tax on unremitted earnings(11,673)(11,639)
Other(4,941)(5,499)
Gross deferred tax liabilities(30,689)(32,531)
Net deferred taxes$8,732 $5,728 
The components of net deferred taxes on a jurisdiction basis are as follows:
December 30,
2023		December 31,
2022
Net deferred tax assets$13,284 $9,799 
Net deferred tax liabilities(4,552)(4,071)
Net deferred taxes$8,732 $5,728 
As of December 30, 2023, the Company had foreign tax credit carryforwards of approximately $128,695. If unused, these carryforwards will expire between 2026 and 2033. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances.
The Company recorded a $1,591 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates.
The Company also had $1,908 of Utah research credit carryforwards, and $3,602 of Federal research credit carryforwards as of December 30, 2023. If unused, the Utah research credit carryforwards expire between 2027 and 2037, and the Federal research credits expire between 2036 and 2043. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards.
In addition, the Company had $6,100 of foreign operating loss carry forwards, $1,627 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,893 and a valuation allowance of $1,423 has been applied against this deferred tax asset. The 2023 deferred tax asset for state-tax-loss carryforwards was $63. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2042 and others can be carried forward indefinitely.
The total combined valuation allowance was $137,252 as of December 30, 2023. The 2023 valuation allowance represents a $19,116 net increase from 2022. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced.
As of December 30, 2023, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.
As of December 30, 2023, the Company reported $1,074 in "Other long-term liabilities" in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 reported as of December 31, 2022.
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202320222021
Beginning balance of unrecognized tax benefits$1,450 $1,008 $1,528 
Increases related to prior year tax positions30 107 21 
Decreases related to prior year tax positions(363)— (330)
Increases related to current year tax positions409 468 424 
Decreases for settlements with taxing authorities(452)(133)(635)
Ending balance of unrecognized tax benefits$1,074 $1,450 $1,008 
The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 30, 2023 and December 31, 2022, the Company reported $66 and $201, respectively, as income tax expense related to interest and penalties. As of December 30, 2023, the Company recorded $180 of "Other long-term liabilities" associated with interest and penalties for unrecognized tax benefits. This compares to $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties reported as of December 31, 2022.
The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2019. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment
 12 Months Ended
Dec. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment PROPERTY AND EQUIPMENT
Cost of property and equipment and their estimated useful lives is as follows:
Useful life (years)December 30,
2023		December 31,
2022
Buildings39.5$77,803 $78,071 
Laboratory and production equipment
5-7
54,502 50,679 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
52,302 53,436 
Furniture and fixtures
3-5
6,323 6,198 
Automobiles
3-5
744 722 
Leasehold improvements
3-5
14,337 14,388 
Land improvements153,263 3,271 
212,226 209,717 
Less accumulated depreciation and amortization128,939 124,748 
83,287 84,969 
Land6,720 6,723 
Deposits and projects in process9,807 6,081 
$99,814 $97,773 
Depreciation of property and equipment was $10,904, $11,351, and $11,661, for the years ended 2023, 2022, and 2021, respectively.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases
 12 Months Ended
Dec. 30, 2023
Leases, Operating [Abstract]  
Operating Leases OPERATING LEASES
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 30,
2023		December 31,
2022
Assets
ROU operating lease assets, netOther assets$17,671 $19,997 
Total ROU assets$17,671 $19,997 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$7,278 $6,892 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities5,141 7,680 
Total lease liabilities$12,419 $14,572 
The components of lease expense were as follows:
Year Ended
202320222021
Operating lease expense$8,042 $8,606 $9,585 
Total lease expense$8,042 $8,606 $9,585 
These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,755, $8,258, and $9,830 for the years ended 2023, 2022, and 2021, respectively.
The following table presents supplemental lease information:
Year Ended
202320222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$8,227 $7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,699 $5,641 $5,322 
The following table presents weighted-average remaining lease term and weighted-average discount rate for the Company's operating leases:
Year Ended
20232022
Weighted-average remaining lease term—operating leases
1.99 yrs.
2.39 yrs.
Weighted-average discount rate—operating leases3.97 %3.04 %
The following table presents the maturity of the Company’s lease liabilities as of December 30, 2023:
Year ending
2024$7,609 
20253,858 
20261,312 
2027121 
2028 and Thereafter— 
12,900 
Less: imputed interest(481)
Present value$12,419 
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets
 12 Months Ended
Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test during the third quarter of 2023. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2023 and 2022.
The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2023. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2023 and 2022.
The changes in the carrying amount of goodwill are as follows:
December 30,
2023		December 31,
2022
Balance at beginning of year:
Gross goodwill$17,368 $17,668 
Goodwill as of beginning of year17,368 17,668 
  
Goodwill acquired during the year— 582 
Currency translation adjustment(266)(882)
Balance as of end of year
Gross goodwill17,102 17,368 
Goodwill as of end of year$17,102 $17,368 
Intangible assets consist of the following:
As of December 30, 2023
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(343)$1,942 10
Product formulas8,480 (8,426)54 8
Customer relationships3,314 (1,243)2,071 4
Non-compete agreements467 (184)283 4
Indefinite-lived intangible assets
Direct selling license25,569 25,569 
$40,115 $29,919 
Estimated Amortization Expense: 
2024$1,223 
20251,154 
2026692 
2027253 
2028229 
Thereafter799 
$4,350 
As of December 31, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct selling license26,238 26,238 
$41,004 $32,432 
Aggregate amortization of intangible assets was $1,835, $1,723, and $1,182 for the years ended 2023, 2022, and 2021, respectively.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Other Current Liabilities
 12 Months Ended
Dec. 30, 2023
Other Liabilities Disclosure [Abstract]  
Other Current Liabilities OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
December 30,
2023		December 31,
2022
Associate incentives$45,665 $55,688 
Accrued employee compensation16,198 17,334 
Deferred revenue13,910 20,875 
Sales taxes9,231 11,234 
Operating lease liabilities7,278 6,892 
Income taxes3,297 4,973 
All other12,410 15,788 
$107,989 $132,784 
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Line of Credit
 12 Months Ended
Dec. 30, 2023
Line of Credit Facility [Abstract]  
Line of Credit LINE OF CREDIT
On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the Bloomberg Short-Term Bank Yield Index rate ("BSBY").
The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.
There was no outstanding debt on the Credit Facility as of December 30, 2023. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement.
Interest on revolving borrowings under the Credit Facility is computed at BSBY, adjusted by features specified in the Credit Agreement. The covenants require the Company’s rolling four-quarter consolidated EBITDA (as defined in the Credit Agreement) to be $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA to be equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms.
The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.
The Company maintains local lines of credit across different markets to secure sufficient working capital. As of December 30, 2023, the balance on these local lines of credit was $786.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies
 12 Months Ended
Dec. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies COMMITMENTS AND CONTINGENCIES
Unconditional Purchase Obligations
The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $8,018 and $7,163, as of December 30, 2023 and December 31, 2022, respectively that are generally paid within one year.
Contingencies
The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future.
Employee Benefit Plan
In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,451, $2,589, and $2,509 for the years ended 2023, 2022, and 2021, respectively.
The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation
 12 Months Ended
Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation EQUITY-BASED COMPENSATION
Total equity-based compensation expense was $14,965, $13,485, and $14,706 for fiscal years 2023, 2022, and 2021, of which, $370, $154, and $408, was related to liability-classified awards, respectively. The related tax benefit for these periods was $2,507, $2,556, and $2,813, respectively.
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 30, 2023. This table does not include an estimate for future grants that may be issued.
2024$11,697 
20257,934 
20264,426 
2027531 
$24,588 
The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.
The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock appreciation rights, stock options, and restricted stock awards which include restricted stock units, deferred stock units, performance stock units, (collectively "restricted stock awards") and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.
Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 30, 2023, 4,267 awards had been granted under the 2015 Plan, of which 2,942 were stock-settled stock appreciation rights, and 1,325 were restricted stock awards. Also, as of December 30, 2023, a total of 1,174 options and grants had been forfeited, of which 73 awards have been added back to the number of shares available for issuance under the 2015 Plan.
Stock-Settled Stock Appreciation Rights
The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. The weighted-average fair value of stock-settled stock appreciation rights granted in 2023 and 2021 were $19.92 and $27.12, respectively. There were no stock-settled stock appreciation rights granted in 2022.
Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.
The following table includes the weighted-average assumptions the Company used to calculate the fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202320222021
Expected volatility (1)39.89 %N/A43.28 %
Risk-free interest rate (2)3.78 %N/A0.33 %
Expected life (3)
3.5 yrs.
N/A
3.5 yrs.
Expected dividend yield (4)0.00 %N/A0.00 %
Weighted-average exercise price (5)$58.79 N/A$85.19 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at December 31, 2022147 $82.16 1.3$— 
Granted18 58.79 
Exercised— — 
Forfeited(4)81.59 
Expired(49)115.45 
Outstanding at December 30, 2023112 $63.88 1.2$— 
Exercisable at December 30, 202365 $64.84 0.7$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 30, 2023 and December 31, 2022 was $53.60 and $53.20, respectively.
The total intrinsic value of stock-settled stock appreciation rights exercised was $0, $50, and $10,337, for the years ended 2023, 2022, and 2021, respectively. The total fair value of stock-settled stock appreciation rights that vested was $1,009, $983, and $3,868, for the years ended 2023, 2022, and 2021, respectively.
During the year ended 2023, there were no exercises of stock-settled stock appreciation rights. During the years ended 2022 and 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years ended 2023, 2022, and 2021.
Restricted Stock Awards
Restricted stock awards include stock-settled and cash-settled restricted stock units, performance stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of units held, valued at the closing market price on the vest date. The fair value of restricted stock units is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock units are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates. Performance stock units are granted to officers and key employees. The ultimate number of shares to be earned depends on the achievement of certain market and performance conditions, and continued service through the applicable vesting date, and do not have expiration dates.
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at December 31, 2022385$85.80 
Granted27459.23 
Vested(155)59.94 
Forfeited(14)79.23 
Outstanding at December 30, 2023490$71.35 
During the year ended 2023, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capital of $3,092, $4,706, and $3,575 for the years ended 2023, 2022, and 2021, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows.
The total fair value of restricted stock units that vested was $9,293, $12,808, and $11,378, for the years ended 2023, 2022, and 2021, respectively.
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at December 31, 202212$84.72 
Granted1459.82 
Vested(4)61.09 
Forfeited— — 
Nonvested at December 30, 202322$68.71 
The weighted-average fair value of liability-classified awards outstanding was $69, $85, and $79 for the years ended 2023, 2022, and 2021, respectively.
The number of deferred stock units vested and unreleased totaled 8, for the years ended 2023, and 2022, and 19 for the year ended 2021, respectively. There were no deferred stock units that vested in 2023, 2022, and 2021.
During 2023, the Company granted 84 performance stock units to officers and key employees. The performance stock units are subject to a cliff vesting at the end of a three-year period. The number of units that vest will vary between 0% - 200% based on the achievement of market and performance conditions, over the three-year service period. The fair value of the performance stock units is determined using a Monte-Carlo simulation model. A Monte-Carlo simulation model uses stock price volatility and other assumptions to estimate the probability of satisfying the market conditions and the resulting fair value of the award.
The weighted-average grant date fair value of performance stock units granted in 2023 was $40.05. There were no performance stock units granted in 2022 or 2021. In 2023, there was unrecognized compensation expense of $913 related to unvested performance stock units that are not probable of achieving the performance condition.
The following table includes the weighted-average assumptions the Company used to calculate the fair value of performance stock units that were granted during the periods indicated.
Year Ended
2023
Expected volatility (1)37.84 %
Risk-free interest rate (2)4.09 %
Expected dividend yield (3)
N/A
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)The Company historically has not paid and currently has no plan to pay dividends.
The market condition is met if the Company achieves the target closing stock price on December 31, 2025, of $59.84. If the market condition is met, the number of earned performance stock units, as a percentage of the target number of performance stock units, is calculated based on the compound annual growth rate ("CAGR") of the Company's active Customers from fiscal year-end 2022 to fiscal year-end 2025. The payout as a percent of target shares will be determined based on the active Customer growth rate achieved by the Company as of fiscal year-end 2025, as illustrated in the table below. If the active Customer CAGR growth rate does not meet the performance condition according to the table below, the corresponding payout will be zero.
Market condition
Performance condition
Target share price
active Customer CAGR
Fiscal year-end 2025 active Customers(1)
Payout as % of target number of shares
$59.846%584,000100%
$59.849%635,000150%
$59.8412%688,000200%
(1) Based on active Customer count of 490,000 at December 31, 2022. For purposes of this performance condition, "active Customer" is defined as active Customer in the Company’s Direct-selling operating segment (discussed further in Note M – Segment Information below), excluding customers from mergers and acquisitions.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information
 12 Months Ended
Dec. 30, 2023
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products.
The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment.
As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s consolidated statements of comprehensive income.
Year Ended
202320222021
Net sales:
Direct-selling$915,211 $995,043 $1,186,464 
All other5,799 3,558 — 
Consolidated Total$921,010 $998,601 $1,186,464 
No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue for our Direct-selling segment that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202320222021
USANA Nutritionals87%87%86%
USANA Foods (1)
7%7%7%
Personal care and Skincare5%5%6%
All Other1%1%1%
______________________________
(1)Includes the Company’s Active Nutrition line
Selected Financial Information
Financial information, presented by geographic region is listed below:
Year Ended
202320222021
Net Sales to External Customers
Asia Pacific
Greater China$475,099 $502,486 $563,469 
Southeast Asia Pacific163,890 190,478 269,803 
North Asia101,446 108,952 129,920 
Asia Pacific Total740,435 801,916 963,192 
Americas and Europe180,575 196,685 223,272 
Consolidated Total$921,010 $998,601 $1,186,464 
December 30,
2023		December 31,
2022
Long-lived Assets
Asia Pacific
Greater China$79,418 $86,051 
Southeast Asia Pacific17,504 15,226 
North Asia2,235 3,617 
Asia Pacific Total99,157 104,894 
Americas and Europe96,480 92,373 
Consolidated Total$195,637 $197,267 
Total Assets
Asia Pacific
Greater China$219,781 $250,786 
Southeast Asia Pacific57,820 51,880 
North Asia21,807 22,952 
Asia Pacific Total299,408 325,618 
Americas and Europe333,349 270,931 
Consolidated Total$632,757 $596,549 
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202320222021
Net sales:
China$427,265 $453,134 $506,103 
South Korea$99,108 $106,391 $125,835 
United States$95,906 $106,087 $110,379 
Long-lived Assets:
United States$93,181 $89,150 
China$77,767 $83,938 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Earnings Per Share
 12 Months Ended
Dec. 30, 2023
Earnings Per Share [Abstract]  
Common Stock and Earnings Per Share COMMON STOCK AND EARNINGS PER SHARE
Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202320222021
Net earnings available to common shareholders$63,788 $69,350 $116,505 
Weighted average common shares outstanding - basic19,250 19,254 20,146 
Dilutive effect of in-the-money equity awards95 56 197 
Weighted average common shares outstanding - diluted19,345 19,310 20,343 
Earnings per common share from net earnings - basic$3.31 $3.60 $5.78 
Earnings per common share from net earnings - diluted$3.30 $3.59 $5.73 
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202320222021
31935460
During the year ended 2023, the Company repurchased and retired 180 shares for $11,653 including accrued excise tax of $54. During the years ended 2022 and 2021, the Company repurchased and retired 288 shares, and 1,844 shares for an aggregate price of $25,382 and $177,837, respectively.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 30, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation And Qualifying Accounts
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
DescriptionBalance at beginning of periodCharged to costs and expensesDeductionsBalance at end of period
December 30, 2023
Allowance for sales returns$572 $5,552 $5,704 $420 
Allowance for credit losses$363 $112 $54 $421 
Valuation allowance - deferred tax assets$118,136 $19,116 $— $137,252 
December 31, 2022
Allowance for sales returns$547 $6,562 $6,537 $572 
Allowance for credit losses$504 $6 $147 $363 
Valuation allowance - deferred tax assets$99,958 $18,178 $— $118,136 
January 1, 2022
Allowance for sales returns$819 $7,213 $7,485 $547 
Allowance for credit losses$372 $148 $16 $504 
Valuation allowance - deferred tax assets$81,401 $18,557 $— $99,958 
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 30, 2023
Accounting Policies [Abstract]  
The Company
The Company
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products.
The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.
Asia Pacific
(1)Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:
(i)Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare
(ii)Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India(1)
(iii)North Asia – Japan and South Korea
Americas and Europe
(2)Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)
(1) We commenced operations in this market near the end of the fourth quarter of 2023.
Principles of Consolidation and Basis of Presentation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the consolidated statements of cash flows.
Use of Estimates
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Fiscal Year
Fiscal Year
The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2023, 2022, and 2021 were 52-week years. Fiscal year 2023 covered the period January 1, 2023 to December 30, 2023 (hereinafter 2023). Fiscal year 2022 covered the period January 2, 2022 to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021).
Fair Value Measurements
Fair Value Measurements
The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
•Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
•Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
As of December 30, 2023 and December 31, 2022, the Company’s financial instruments include cash equivalents and restricted cash. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature.
Translation of Foreign Currencies
Translation of Foreign Currencies
The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.
Business Combinations
Business Combinations
The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 30, 2023 and December 31, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.
Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction.
Restricted Cash
Restricted Cash
The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,826 as of December 30, 2023, and $2,900 as of December 31, 2022. This deposit is required for the application of direct selling licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.
Inventories
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.

Noncurrent inventories are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventories are classified in the "Other assets" line item in the Company's consolidated balance sheets. Noncurrent inventories are anticipated to be consumed beyond our normal operating cycle, but prior to obsolescence.
Accounts Receivable
Accounts Receivable
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for credit losses regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.
Income Taxes
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.
The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.
Property and Equipment
Property and Equipment
Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.
The Company capitalizes certain internal-use software development costs, consisting primarily of employee salaries and contractor costs, during the application development stage. Costs incurred for upgrades and enhancements that are expected to result in additional functionalities are also capitalized. These development costs are amortized using the straight-line method over an estimated useful life of three to five years, and are reflected as part of Property and equipment, net on our consolidated balance sheets.
Leases
Leases
With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.
At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.
Lease liabilities are recognized based on the present value of the unpaid lease payments over the lease term at the commencement date for leases exceeding 12 months. Unpaid lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.
Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.
Goodwill
Goodwill
Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill.
Intangible Assets
Intangible Assets
Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable.
Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.
Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset.
Investment in Equity Securities
Investment in Equity Securities
Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.
The value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are remeasured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2023, the Company evaluated an observable price change related to equity securities without readily determinable fair values. No adjustment to the carrying value of the securities was necessary based on the observable price change. During 2022, no such observable price changes occurred.
At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2023, 2022, and 2021, no impairment of securities was recorded.
Nonqualified Deferred Compensation
Nonqualified Deferred Compensation
In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the consolidated balance sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the consolidated statements of comprehensive income.
Self-Insurance
Self-Insurance
The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance for the United States markets on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,292. A liability is accrued for all unpaid claims.
Derivatives Financial Instruments
Derivative Financial Instruments
The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.
The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.
Common Stock Share Repurchases
Common Stock Share Repurchases
The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 30, 2023, $71,186, inclusive of accrued excise tax, is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.
Revenue Recognition
Revenue Recognition
Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on
revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:
1)identification of the contract with a customer;
2)identification of the performance obligations in the contract;
3)determination of the transaction price;
4)allocation of the transaction price to the performance obligations in the contract; and
5)recognition of revenue when or as a performance obligation is satisfied.
Product Revenue
A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.
The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.
Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.
Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.
Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.
With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders becomes remote.
Other Revenue
Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.
The following table presents Other Revenue for the periods indicated:
Year Ended
202320222021
Other Revenue$3,177 $3,452 $3,825 
Revenue Disaggregation
Disaggregation of revenue by geographical region and major product line is included in Note M – Segment Information.
Contract Balances
When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).
Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets.
Product Return Policy
Product Return Policy
All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies.
Associate Incentives
Associate Incentives
Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.
Selling, General and Administrative
Selling, General and Administrative
Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.
Equity-Based Compensation
Equity-Based Compensation
The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. The grant date fair value of each performance share unit is based upon a Monte-Carlo simulation in order to incorporate market conditions. Equity-based compensation expense for restricted stock units and stock-settled stock appreciation rights are recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Equity-based compensation expense for performance stock units is recognized based on the achievement of certain performance and market conditions by specified target dates, subject to continued service through the applicable vesting dates. The probability of the awards meeting the performance condition is not included in the grant date fair value, but is estimated quarterly for expense recognition. The Company recognizes an adjustment to compensation expense based on revisions in probability assessments. The Company accounts for forfeitures as they occur. Further information regarding equity awards can be found in Note L – Equity-Based Compensation.
Advertising
Advertising
Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item.
Research and Development
Research and Development
Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item.
Earnings Per Share
Earnings Per Share
Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Adopted Accounting Pronouncements
In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. The Company adopted the provisions of ASU 2021-08 during the first quarter of 2023 and the adoption of the standard did not have an impact on its consolidated financial statements.
Issued Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is intended to provide financial statement users with more disaggregated expense information about a public entity’s reportable segments. ASU 2023-07 requires incremental disclosures related to a public entity’s reportable segments including allowing the disclosure of multiple measures of segment profit or loss,
requiring the disclosure of significant segment expenses, and requiring the qualitative disclosure of other segment items. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024, and should be adopted retrospectively unless impracticable. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard is intended to benefit investors by providing more detailed income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact adoption of the standard will have on its consolidated financial statements.
No other recent accounting pronouncements had, or are expected to have, a material impact on the Company's consolidated financial statements.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 30, 2023
Accounting Policies [Abstract]  
Fair Value Measurements, Recurring and Nonrecurring
As of December 30, 2023 and December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
December 30,
2023		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$258,319 $258,319 $— $— 
Foreign currency contracts included in other current liabilities(62)— (62)— 
Deferred compensation liabilities
(3,137)— (3,137)— 
December 31,
2022		Fair Value Measurements Using
Inputs
Level 1Level 2Level 3
Money market funds included in cash equivalents$211,539 $211,539 $— $— 
Foreign currency contracts included in other current liabilities(3,150)— (3,150)— 
Deferred compensation liabilities(1,632)— (1,632)— 
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)
(886)— — (886)
Disaggregation of Revenue
The following table presents Other Revenue for the periods indicated:
Year Ended
202320222021
Other Revenue$3,177 $3,452 $3,825 
Contract with Customer, Contract Asset, Contract Liability, and Receivable
The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.
December 30,
2023		December 31,
2022
Contract liabilities at beginning of period$20,875 $19,635 
Increase due to deferral of revenue at period end13,910 20,875 
Decrease due to beginning contract liabilities recognized as revenue(20,875)(19,635)
Contract liabilities at end of period$13,910 $20,875 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventories (Tables)
 12 Months Ended
Dec. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory
December 30,
2023		December 31,
2022
Raw materials$19,848 $21,776 
Work in progress4,707 4,285 
Finished goods36,899 41,028 
$61,454 $67,089 
Noncurrent inventories$3,128 $3,479 
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid Expenses and Other Current Assets (Tables)
 12 Months Ended
Dec. 30, 2023
Prepaid Expense and Other Assets, Current [Abstract]  
Schedule of Prepaid Expenses
Prepaid expenses and other current assets consists of the following:
December 30,
2023		December 31,
2022
Other prepaid expenses$9,069 $9,089 
Miscellaneous receivables, net6,172 5,183 
Other current assets6,096 7,121 
Prepaid insurance2,325 2,293 
Deferred commissions1,181 3,157 
Income taxes receivable1,029 2,030 
$25,872 $28,873 
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 30, 2023
Income Tax Disclosure [Abstract]  
Schedule of Consolidated Income Before Income Taxes
Consolidated earnings before income taxes consists of the following for 2023, 2022, and 2021:
Year Ended
202320222021
United States$(19,988)$(23,996)$13,017 
Foreign122,441 132,617 157,625 
Total earnings before income taxes$102,453 $108,621 $170,642 
Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations
Income tax expense (benefit) included in income from continuing operations consists of the following:
Year Ended
202320222021
Current
Federal$(42)$42 $(264)
State469 297 567 
Foreign40,913 45,869 56,668 
Total Current41,340 46,208 56,971 
Deferred
Federal(4,031)(9,180)(4,088)
State(59)(331)(40)
Foreign1,415 2,574 1,294 
Total Deferred(2,675)(6,937)(2,834)
$38,665 $39,271 $54,137 
Schedule of Effective Income Tax Rate
The effective tax rate for 2023, 2022, and 2021 reconciled to the statutory U.S. Federal tax rate is as follows:
Year Ended
202320222021
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit0.5 0.4 0.4 
Permanent tax differences0.7 0.3 0.1 
Excess foreign tax credits(16.4)(16.6)(10.9)
Net increase in valuation allowance13.0 11.9 10.6 
Foreign income tax rate differences8.7 9.5 1.8 
Foreign withholding taxes10.6 9.7 7.9 
Uncertain tax position reserve(0.4)0.5 (0.3)
All other, net— (0.5)1.1 
37.7 %36.2 %31.7 %
Schedule of Deferred Taxes
The significant categories of deferred taxes are as follows:
December 30,
2023		December 31,
2022
Deferred tax assets
Inventory$5,588 $5,872 
Accruals not currently deductible6,680 8,627 
Equity-based compensation expense2,580 2,746 
Property and equipment771 922 
Intangible assets6,359 6,680 
Foreign currency translation1,760 1,448 
Capitalized R&D expenses13,537 9,618 
Tax credit carry forwards134,205 115,539 
Net operating losses1,956 1,720 
Other3,237 3,223 
Gross deferred tax assets176,673 156,395 
Valuation allowance(137,252)(118,136)
Net deferred tax assets39,421 38,259 
Deferred tax liabilities
Property and equipment(5,897)(5,723)
Prepaid expenses(1,819)(2,990)
Intangible assets(6,359)(6,680)
Withholding tax on unremitted earnings(11,673)(11,639)
Other(4,941)(5,499)
Gross deferred tax liabilities(30,689)(32,531)
Net deferred taxes$8,732 $5,728 
The components of net deferred taxes on a jurisdiction basis are as follows:
December 30,
2023		December 31,
2022
Net deferred tax assets$13,284 $9,799 
Net deferred tax liabilities(4,552)(4,071)
Net deferred taxes$8,732 $5,728 
Schedule of Unrecognized Tax Benefits Reconciliation
The following reconciliation provides the changes in unrecognized tax benefits for the years presented:
Year Ended
202320222021
Beginning balance of unrecognized tax benefits$1,450 $1,008 $1,528 
Increases related to prior year tax positions30 107 21 
Decreases related to prior year tax positions(363)— (330)
Increases related to current year tax positions409 468 424 
Decreases for settlements with taxing authorities(452)(133)(635)
Ending balance of unrecognized tax benefits$1,074 $1,450 $1,008 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment (Tables)
 12 Months Ended
Dec. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment
Cost of property and equipment and their estimated useful lives is as follows:
Useful life (years)December 30,
2023		December 31,
2022
Buildings39.5$77,803 $78,071 
Laboratory and production equipment
5-7
54,502 50,679 
Air transportation equipment52,952 2,952 
Computer equipment and software
3-5
52,302 53,436 
Furniture and fixtures
3-5
6,323 6,198 
Automobiles
3-5
744 722 
Leasehold improvements
3-5
14,337 14,388 
Land improvements153,263 3,271 
212,226 209,717 
Less accumulated depreciation and amortization128,939 124,748 
83,287 84,969 
Land6,720 6,723 
Deposits and projects in process9,807 6,081 
$99,814 $97,773 
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases (Tables)
 12 Months Ended
Dec. 30, 2023
Leases, Operating [Abstract]  
Schedule of Classification of ROU Assets and Lease Liabilities
The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:
LeasesClassificationDecember 30,
2023		December 31,
2022
Assets
ROU operating lease assets, netOther assets$17,671 $19,997 
Total ROU assets$17,671 $19,997 
Liabilities
Current:
Operating lease liabilitiesOther current liabilities$7,278 $6,892 
Noncurrent:
Operating lease liabilitiesOther long-term liabilities5,141 7,680 
Total lease liabilities$12,419 $14,572 
Schedule of Supplemental Lease Information
The components of lease expense were as follows:
Year Ended
202320222021
Operating lease expense$8,042 $8,606 $9,585 
Total lease expense$8,042 $8,606 $9,585 
These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,755, $8,258, and $9,830 for the years ended 2023, 2022, and 2021, respectively.
The following table presents supplemental lease information:
Year Ended
202320222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$8,227 $7,924 $9,506 
ROU assets obtained in exchange for new operating lease liabilities$5,699 $5,641 $5,322 
The following table presents weighted-average remaining lease term and weighted-average discount rate for the Company's operating leases:
Year Ended
20232022
Weighted-average remaining lease term—operating leases
1.99 yrs.
2.39 yrs.
Weighted-average discount rate—operating leases3.97 %3.04 %
Schedule of Maturity of Lease Liabilities
The following table presents the maturity of the Company’s lease liabilities as of December 30, 2023:
Year ending
2024$7,609 
20253,858 
20261,312 
2027121 
2028 and Thereafter— 
12,900 
Less: imputed interest(481)
Present value$12,419 
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets (Tables)
 12 Months Ended
Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill are as follows:
December 30,
2023		December 31,
2022
Balance at beginning of year:
Gross goodwill$17,368 $17,668 
Goodwill as of beginning of year17,368 17,668 
  
Goodwill acquired during the year— 582 
Currency translation adjustment(266)(882)
Balance as of end of year
Gross goodwill17,102 17,368 
Goodwill as of end of year$17,102 $17,368 
Schedule of Intangible Assets
Intangible assets consist of the following:
As of December 30, 2023
Gross carrying
amount		Accumulated
 amortization		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(343)$1,942 10
Product formulas8,480 (8,426)54 8
Customer relationships3,314 (1,243)2,071 4
Non-compete agreements467 (184)283 4
Indefinite-lived intangible assets
Direct selling license25,569 25,569 
$40,115 $29,919 
As of December 31, 2022
Gross carrying
amount		Accumulated
amortization 		Net carrying
amount		Weighted-average
amortization
period (years)
Amortized intangible assets
Trade name and trademarks$2,285 $(114)$2,171 10
Product formulas8,701 (7,983)718 8
Customer relationships3,313 (414)2,899 4
Non-compete agreements467 (61)406 4
Indefinite-lived intangible assets
Direct selling license26,238 26,238 
$41,004 $32,432 
Schedule of Amortization Expense
Estimated Amortization Expense: 
2024$1,223 
20251,154 
2026692 
2027253 
2028229 
Thereafter799 
$4,350 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Other Current Liabilities (Tables)
 12 Months Ended
Dec. 30, 2023
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
December 30,
2023		December 31,
2022
Associate incentives$45,665 $55,688 
Accrued employee compensation16,198 17,334 
Deferred revenue13,910 20,875 
Sales taxes9,231 11,234 
Operating lease liabilities7,278 6,892 
Income taxes3,297 4,973 
All other12,410 15,788 
$107,989 $132,784 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation (Tables)
 12 Months Ended
Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Remaining Unrecognized Compensation Expense
The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 30, 2023. This table does not include an estimate for future grants that may be issued.
2024$11,697 
20257,934 
20264,426 
2027531 
$24,588 
Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights
The following table includes the weighted-average assumptions the Company used to calculate the fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
Year Ended
202320222021
Expected volatility (1)39.89 %N/A43.28 %
Risk-free interest rate (2)3.78 %N/A0.33 %
Expected life (3)
3.5 yrs.
N/A
3.5 yrs.
Expected dividend yield (4)0.00 %N/A0.00 %
Weighted-average exercise price (5)$58.79 N/A$85.19 
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)Depending upon the terms of the award, one of two methods will be used to calculate expected life:
(i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.
(4)The Company historically has not paid and currently has no plan to pay dividends.
(5)Exercise price is the closing price of the Company's common stock on the date of grant.
Schedule of Stock-Settled Appreciation Right Activity
A summary of the Company’s stock-settled stock appreciation right activity is as follows:
Shares Weighted-average exercise priceWeighted-average remaining
contractual term		Aggregate intrinsic value*
Outstanding at December 31, 2022147 $82.16 1.3$— 
Granted18 58.79 
Exercised— — 
Forfeited(4)81.59 
Expired(49)115.45 
Outstanding at December 30, 2023112 $63.88 1.2$— 
Exercisable at December 30, 202365 $64.84 0.7$— 
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 30, 2023 and December 31, 2022 was $53.60 and $53.20, respectively.
Schedule of Stock-Settled Restricted Stock Unit Activity
A summary of the Company’s stock-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Outstanding at December 31, 2022385$85.80 
Granted27459.23 
Vested(155)59.94 
Forfeited(14)79.23 
Outstanding at December 30, 2023490$71.35 
Schedule of Cash-Settled Restricted Stock Unit Activity
A summary of the Company’s cash-settled restricted stock unit activity is as follows:
Shares Weighted-average grant date fair value
Nonvested at December 31, 202212$84.72 
Granted1459.82 
Vested(4)61.09 
Forfeited— — 
Nonvested at December 30, 202322$68.71 
Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions
The following table includes the weighted-average assumptions the Company used to calculate the fair value of performance stock units that were granted during the periods indicated.
Year Ended
2023
Expected volatility (1)37.84 %
Risk-free interest rate (2)4.09 %
Expected dividend yield (3)
N/A
(1)The Company utilizes historical volatility of the trading price of its common stock.
(2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
(3)The Company historically has not paid and currently has no plan to pay dividends.
Schedule of Market-Based and Performance-Based Condition
Market condition
Performance condition
Target share price
active Customer CAGR
Fiscal year-end 2025 active Customers(1)
Payout as % of target number of shares
$59.846%584,000100%
$59.849%635,000150%
$59.8412%688,000200%
(1) Based on active Customer count of 490,000 at December 31, 2022. For purposes of this performance condition, "active Customer" is defined as active Customer in the Company’s Direct-selling operating segment (discussed further in Note M – Segment Information below), excluding customers from mergers and acquisitions.
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information (Tables)
 12 Months Ended
Dec. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Operating Segment These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s consolidated statements of comprehensive income.
Year Ended
202320222021
Net sales:
Direct-selling$915,211 $995,043 $1,186,464 
All other5,799 3,558 — 
Consolidated Total$921,010 $998,601 $1,186,464 
Revenue from External Customers by Products and Services The table below summarizes the approximate percentage of total product revenue for our Direct-selling segment that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated.
Year Ended
202320222021
USANA Nutritionals87%87%86%
USANA Foods (1)
7%7%7%
Personal care and Skincare5%5%6%
All Other1%1%1%
______________________________
(1)Includes the Company’s Active Nutrition line
Schedule of Revenue by Geographic Region
Financial information, presented by geographic region is listed below:
Year Ended
202320222021
Net Sales to External Customers
Asia Pacific
Greater China$475,099 $502,486 $563,469 
Southeast Asia Pacific163,890 190,478 269,803 
North Asia101,446 108,952 129,920 
Asia Pacific Total740,435 801,916 963,192 
Americas and Europe180,575 196,685 223,272 
Consolidated Total$921,010 $998,601 $1,186,464 
December 30,
2023		December 31,
2022
Long-lived Assets
Asia Pacific
Greater China$79,418 $86,051 
Southeast Asia Pacific17,504 15,226 
North Asia2,235 3,617 
Asia Pacific Total99,157 104,894 
Americas and Europe96,480 92,373 
Consolidated Total$195,637 $197,267 
Total Assets
Asia Pacific
Greater China$219,781 $250,786 
Southeast Asia Pacific57,820 51,880 
North Asia21,807 22,952 
Asia Pacific Total299,408 325,618 
Americas and Europe333,349 270,931 
Consolidated Total$632,757 $596,549 
Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
Year Ended
202320222021
Net sales:
China$427,265 $453,134 $506,103 
South Korea$99,108 $106,391 $125,835 
United States$95,906 $106,087 $110,379 
Long-lived Assets:
United States$93,181 $89,150 
China$77,767 $83,938 
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Earnings Per Share (Tables)
 12 Months Ended
Dec. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:
Year Ended
202320222021
Net earnings available to common shareholders$63,788 $69,350 $116,505 
Weighted average common shares outstanding - basic19,250 19,254 20,146 
Dilutive effect of in-the-money equity awards95 56 197 
Weighted average common shares outstanding - diluted19,345 19,310 20,343 
Earnings per common share from net earnings - basic$3.31 $3.60 $5.78 
Earnings per common share from net earnings - diluted$3.30 $3.59 $5.73 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive:
Year Ended
202320222021
31935460
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Narrative (Details)
 12 Months Ended
Dec. 30, 2023
USD ($)
region
Dec. 31, 2022
USD ($)
Jan. 01, 2022
USD ($)
Jan. 25, 2024
USD ($)
Jan. 02, 2021
USD ($)
Accounting Policies [Line Items]          
Number of geographic regions | region 2        
Number of sub geographical regions | region 3        
Restricted cash and cash equivalents, noncurrent, total $ 2,826,000 $ 2,900,000 $ 3,821,000    
Goodwill, impairment loss 0 0 0    
Impairment of intangible assets, indefinite-lived (excluding goodwill) 0 0 0    
Equity securities without readily determinable fair value, amount 0 0      
Equity securities without readily determinable fair value, impairment loss, annual amount $ 0 0 0    
Non-qualified deferred compensation plan, salary deferred, percentage 0.50        
Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage 0.80        
Life insurance, corporate or bank owned, amount $ 2,962,000 1,622,000      
Deferred compensation liability, classified, noncurrent, total 3,137,000 1,632,000      
Minimum amount of individual claims before insurance reimbursement 175,000        
Minimum amount of projected aggregate claims before insurance reimbursement 13,292,000        
Self-insurance expense 14,501,000 13,413,000 $ 12,349,000    
Derivative, notional amount 81,343,000        
Stock repurchase program, remaining authorized repurchase amount 71,186,000        
Contract with customer, asset, after allowance for credit loss, total $ 0 $ 0      
Product return, first time order, duration of return (day) 30 days        
Product return, first time order, percentage refunded 100.00%        
Product return, percentage refunded 100.00%        
Product return, percentage of net sales 0.60% 0.70% 0.60%    
Advertising expense $ 4,756,000 $ 5,053,000 $ 12,399,000    
Research and development expense, total $ 11,446,000 11,563,000 11,112,000    
Minimum | Software and Software Development Costs          
Accounting Policies [Line Items]          
Useful life 3 years        
Maximum | Software and Software Development Costs          
Accounting Policies [Line Items]          
Useful life 5 years        
Designated as Hedging Instrument          
Accounting Policies [Line Items]          
Derivative assets (liabilities), at fair value, net, total $ 0 0      
Designated as Hedging Instrument | Subsequent Event          
Accounting Policies [Line Items]          
Derivative, notional amount       $ 77,345,000  
Foreign Exchange Option | Designated as Hedging Instrument          
Accounting Policies [Line Items]          
Derivative, notional amount   98,930,000 98,684,000    
Derivative, gain (loss) on derivative, net 2,504,000 4,555,000 $ (1,555,000)    
Other Assets          
Accounting Policies [Line Items]          
Equity securities without readily determinable fair value, amount         $ 20,000,000
Amounts Receivable from Credit Card Processors          
Accounting Policies [Line Items]          
Cash equivalents, at carrying value, total 9,379,000 8,904,000      
Restricted Cash Deposits in China          
Accounting Policies [Line Items]          
Restricted cash and cash equivalents, noncurrent, total 2,826,000 2,900,000      
Fair Value, Nonrecurring          
Accounting Policies [Line Items]          
Nonfinancial assets, fair value disclosure $ 0 $ 0      
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Business combination, contingent consideration, liability, current   $ (338)
Business combination, contingent consideration, liability, noncurrent   (548)
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency contracts included in other current liabilities $ (62) (3,150)
Deferred compensation liabilities (3,137) (1,632)
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)   (886)
Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency contracts included in other current liabilities 0 0
Deferred compensation liabilities 0 0
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)   0
Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency contracts included in other current liabilities (62) (3,150)
Deferred compensation liabilities (3,137) (1,632)
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)   0
Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency contracts included in other current liabilities 0 0
Deferred compensation liabilities 0 0
Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)   (886)
Fair Value, Recurring | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds included in cash equivalents 258,319 211,539
Fair Value, Recurring | Money Market Funds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds included in cash equivalents 258,319 211,539
Fair Value, Recurring | Money Market Funds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds included in cash equivalents 0 0
Fair Value, Recurring | Money Market Funds | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds included in cash equivalents $ 0 $ 0
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Accounting Policies [Abstract]      
Other Revenue $ 3,177 $ 3,452 $ 3,825
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Movement in Contract Liabilities [Roll Forward]    
Contract liabilities at beginning of period $ 20,875 $ 19,635
Increase due to deferral of revenue at period end 13,910 20,875
Decrease due to beginning contract liabilities recognized as revenue (20,875) (19,635)
Contract liabilities at end of period $ 13,910 $ 20,875
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Combinations (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Jul. 02, 2022
USD ($)
period
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jan. 01, 2022
USD ($)
Business Combination, Separately Recognized Transactions [Line Items]        
Goodwill   $ 17,102 $ 17,368 $ 17,668
Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability   $ (548)    
Series of Individually Immaterial Business Acquisitions        
Business Combination, Separately Recognized Transactions [Line Items]        
Payments to acquire businesses $ 6,532      
Contingent consideration 886      
Purchase price allocations to tangible assets 771      
Purchase price allocations to intangible assets 6,065      
Goodwill $ 582      
Contingent consideration milestone period 3 years      
Number of earnout periods | period 3      
Maximum amount of earnouts total $ 1,500      
Maximum amount per earnout $ 500      
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 19,848 $ 21,776
Work in progress 4,707 4,285
Finished goods 36,899 41,028
Total inventory, net 61,454 67,089
Noncurrent inventories $ 3,128 $ 3,479
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventories - Narrative (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Inventory [Line Items]    
Noncurrent inventories $ 3,128 $ 3,479
Raw Materials    
Inventory [Line Items]    
Noncurrent inventories 2,051,000 1,711,000
Finished Goods    
Inventory [Line Items]    
Noncurrent inventories $ 1,077,000 $ 1,768,000
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]    
Other prepaid expenses $ 9,069 $ 9,089
Miscellaneous receivables, net 6,172 5,183
Other current assets 6,096 7,121
Prepaid insurance 2,325 2,293
Deferred commissions 1,181 3,157
Income taxes receivable 1,029 2,030
Total prepaid expense and other current assets $ 25,872 $ 28,873
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Consolidated Earnings Before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Income Tax Disclosure [Abstract]      
United States $ (19,988) $ (23,996) $ 13,017
Foreign 122,441 132,617 157,625
Earnings before income taxes $ 102,453 $ 108,621 $ 170,642
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Current      
Federal $ (42) $ 42 $ (264)
State 469 297 567
Foreign 40,913 45,869 56,668
Total Current 41,340 46,208 56,971
Deferred      
Federal (4,031) (9,180) (4,088)
State (59) (331) (40)
Foreign 1,415 2,574 1,294
Total Deferred (2,675) (6,937) (2,834)
Total income tax expense (benefit) $ 38,665 $ 39,271 $ 54,137
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Effective Tax Rate Reconciliation (Details)
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Income Tax Disclosure [Abstract]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefit 0.50% 0.40% 0.40%
Permanent tax differences 0.70% 0.30% 0.10%
Excess foreign tax credits (16.40%) (16.60%) (10.90%)
Net increase in valuation allowance 13.00% 11.90% 10.60%
Foreign income tax rate differences 8.70% 9.50% 1.80%
Foreign withholding taxes 10.60% 9.70% 7.90%
Uncertain tax position reserve (0.40%) 0.50% (0.30%)
All other, net 0.00% (0.50%) 1.10%
Total effective income tax rate reconciliation, percent 37.70% 36.20% 31.70%
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Significant Categories of Deferred Taxes (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Deferred tax assets    
Inventory $ 5,588 $ 5,872
Accruals not currently deductible 6,680 8,627
Equity-based compensation expense 2,580 2,746
Property and equipment 771 922
Intangible assets 6,359 6,680
Foreign currency translation 1,760 1,448
Capitalized R&D expenses 13,537 9,618
Tax credit carry forwards 134,205 115,539
Net operating losses 1,956 1,720
Other 3,237 3,223
Gross deferred tax assets 176,673 156,395
Valuation allowance (137,252) (118,136)
Net deferred tax assets 39,421 38,259
Deferred tax liabilities    
Property and equipment (5,897) (5,723)
Prepaid expenses (1,819) (2,990)
Intangible assets (6,359) (6,680)
Withholding tax on unremitted earnings (11,673) (11,639)
Other (4,941) (5,499)
Gross deferred tax liabilities (30,689) (32,531)
Net deferred taxes 8,732 5,728
Net deferred tax assets 13,284 9,799
Net deferred tax liabilities $ (4,552) $ (4,071)
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Income Tax Contingency [Line Items]        
Valuation allowance $ 137,252 $ 118,136    
Deferred tax assets, operating loss carryforwards, foreign 1,893      
Deferred tax assets, operating loss carryforwards, state and local 63      
Valuation allowance, deferred tax asset, increase (decrease), amount 19,116      
Undistributed earnings 4,000      
Incremental taxes 400      
Unrecognized tax benefits 1,074 1,450 $ 1,008 $ 1,528
Income tax expense related to interest and penalties 66 201    
Other Current Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits   66    
Unrecognized tax benefits, income tax penalties and interest accrued, total   64    
Other Noncurrent Liabilities        
Income Tax Contingency [Line Items]        
Unrecognized tax benefits 1,074 1,384    
Unrecognized tax benefits, income tax penalties and interest accrued, total 180 $ 239    
Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities        
Income Tax Contingency [Line Items]        
Valuation allowance 1,591      
Foreign Operating Loss Carryforwards        
Income Tax Contingency [Line Items]        
Valuation allowance 1,423      
Other Foreign Deferred Tax Assets        
Income Tax Contingency [Line Items]        
Valuation allowance 137,252      
Foreign Tax Authority        
Income Tax Contingency [Line Items]        
Operating loss carryforwards, total 6,100      
Operating loss carryforwards, not subject to expiration 1,627      
Research Tax Credit Carryforward | Foreign Tax Authority        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount 128,695      
Research Tax Credit Carryforward | State and Local Jurisdiction | Utah State Tax Commission        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount 1,908      
Research Tax Credit Carryforward | Domestic Tax Authority        
Income Tax Contingency [Line Items]        
Tax credit carryforward, amount $ 3,602      
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning balance of unrecognized tax benefits $ 1,450 $ 1,008 $ 1,528
Increases related to prior year tax positions 30 107 21
Decreases related to prior year tax positions (363) 0 (330)
Increases related to current year tax positions 409 468 424
Decreases for settlements with taxing authorities (452) (133) (635)
Ending balance of unrecognized tax benefits $ 1,074 $ 1,450 $ 1,008
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 212,226 $ 209,717
Less accumulated depreciation and amortization 128,939 124,748
Property and equipment, net, excluding non-depreciable 83,287 84,969
Property and equipment, net $ 99,814 97,773
Buildings    
Property, Plant and Equipment [Line Items]    
Useful life 39 years 6 months  
Property, plant and equipment, gross $ 77,803 78,071
Laboratory and production equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 54,502 50,679
Laboratory and production equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Laboratory and production equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 7 years  
Air transportation equipment    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Property, plant and equipment, gross $ 2,952 2,952
Computer equipment and software    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 52,302 53,436
Computer equipment and software | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Computer equipment and software | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 6,323 6,198
Furniture and fixtures | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Furniture and fixtures | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Automobiles    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 744 722
Automobiles | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Automobiles | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 14,337 14,388
Leasehold improvements | Minimum    
Property, Plant and Equipment [Line Items]    
Useful life 3 years  
Leasehold improvements | Maximum    
Property, Plant and Equipment [Line Items]    
Useful life 5 years  
Land improvements    
Property, Plant and Equipment [Line Items]    
Useful life 15 years  
Property, plant and equipment, gross $ 3,263 3,271
Land    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 6,720 6,723
Deposits and projects in process    
Property, Plant and Equipment [Line Items]    
Property and equipment, net $ 9,807 $ 6,081
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Property, Plant and Equipment [Abstract]      
Depreciation $ 10,904 $ 11,351 $ 11,661
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Leases, Operating [Abstract]      
Rent expense $ 8,755 $ 8,258 $ 9,830
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Assets    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
ROU operating lease assets, net $ 17,671 $ 19,997
Total ROU assets $ 17,671 $ 19,997
Current:    
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Operating lease liabilities $ 7,278 $ 6,892
Noncurrent:    
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other long-term liabilities Other long-term liabilities
Operating lease liabilities $ 5,141 $ 7,680
Total lease liabilities $ 12,419 $ 14,572
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases - Supplemental Lease Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Leases, Operating [Abstract]      
Operating lease expense $ 8,042 $ 8,606 $ 9,585
Total lease expense 8,042 8,606 9,585
Cash paid for amounts included in the measurement of lease liabilities      
Operating cash flows from operating leases 8,227 7,924 9,506
ROU assets obtained in exchange for new operating lease liabilities $ 5,699 $ 5,641 $ 5,322
Weighted-average remaining lease term—operating leases 1 year 11 months 26 days 2 years 4 months 20 days  
Weighted-average discount rate—operating leases 3.97% 3.04%  
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Leases - Maturity of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Leases, Operating [Abstract]    
2024 $ 7,609  
2025 3,858  
2026 1,312  
2027 121  
2028 and Thereafter 0  
Total operating lease, liability 12,900  
Less: imputed interest (481)  
Present value $ 12,419 $ 14,572
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]      
Goodwill, impairment loss $ 0 $ 0 $ 0
Impairment of intangible assets, indefinite-lived (excluding goodwill) 0 0 0
Amortization of intangible assets, total $ 1,835,000 $ 1,723,000 $ 1,182,000
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Goodwill [Roll Forward]    
Gross goodwill $ 17,368 $ 17,668
Goodwill as of beginning of year 17,368 17,668
Goodwill acquired during the year 0 582
Currency translation adjustment (266) (882)
Gross goodwill 17,102 17,368
Goodwill as of end of year $ 17,102 $ 17,368
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets - Estimated Amortization Expense (Details)
$ in Thousands
Dec. 30, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 1,223
2025 1,154
2026 692
2027 253
2028 229
Thereafter 799
Total estimated amortization expense $ 4,350
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets - Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Amortized intangible assets    
Total estimated amortization expense $ 4,350  
Indefinite-lived intangible assets    
Intangible assets, gross (excluding goodwill) 40,115 $ 41,004
Intangible assets, net 29,919 32,432
Direct selling license    
Indefinite-lived intangible assets    
Indefinite-lived intangible assets (excluding goodwill), direct sales license 25,569 26,238
Trade name and trademarks    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount 2,285 2,285
Finite-lived intangible assets, accumulated amortization (343) (114)
Total estimated amortization expense $ 1,942 $ 2,171
Finite-lived intangible asset, weighted-average amortization period (years) 10 years 10 years
Product formulas    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 8,480 $ 8,701
Finite-lived intangible assets, accumulated amortization (8,426) (7,983)
Total estimated amortization expense $ 54 $ 718
Finite-lived intangible asset, weighted-average amortization period (years) 8 years 8 years
Customer relationships    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 3,314 $ 3,313
Finite-lived intangible assets, accumulated amortization (1,243) (414)
Total estimated amortization expense $ 2,071 $ 2,899
Finite-lived intangible asset, weighted-average amortization period (years) 4 years 4 years
Non-compete agreements    
Amortized intangible assets    
Finite-lived intangible assets, gross carrying amount $ 467 $ 467
Finite-lived intangible assets, accumulated amortization (184) (61)
Total estimated amortization expense $ 283 $ 406
Finite-lived intangible asset, weighted-average amortization period (years) 4 years 4 years
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Other Current Liabilities - Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Other Liabilities Disclosure [Abstract]    
Associate incentives $ 45,665 $ 55,688
Accrued employee compensation 16,198 17,334
Deferred revenue 13,910 20,875
Sales taxes 9,231 11,234
Operating lease liabilities 7,278 6,892
Income taxes 3,297 4,973
All other 12,410 15,788
Total other current liabilities $ 107,989 $ 132,784
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Line of Credit - Narrative (Details)
 12 Months Ended
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Line of Credit Facility [Line Items]    
Line of credit - short term $ 786,000 $ 0
Line of Credit    
Line of Credit Facility [Line Items]    
Line of credit facility, maximum borrowing capacity 75,000,000  
Line of credit facility, additional increase in maximum borrowing capacity 200,000,000  
Long-term line of credit, total 0  
Line of Credit | Amended and Restated Credit Agreement    
Line of Credit Facility [Line Items]    
Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization $ 100,000,000  
Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization 2.0  
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
USD ($)
yr
Dec. 31, 2022
USD ($)
Jan. 01, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]      
Unrecorded unconditional purchase obligation, to be paid, year one $ 8,018 $ 7,163  
Defined contribution plan, minimum age of employee | yr 18    
Defined contribution plan, requisite service period (month) 1 month    
Defined contribution plan, employer matching contribution, percent of match 100.00%    
Defined contribution plan, employer matching contribution, percent of employees' gross pay 1.00%    
Defined contribution plan, employer matching contribution, match percent exceeding initial match 50.00%    
Defined contribution plan, maximum annual contributions per employee, percent 6.00%    
Defined benefit plan, cliff vesting period (year) 2 years    
Defined contribution plan, employer contribution amount $ 2,451 $ 2,589 $ 2,509
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Equity based compensation expense $ 14,965,000 $ 13,485,000 $ 14,706,000
Share-based payment arrangement, expense, tax benefit $ 2,507,000 $ 2,556,000 2,813,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year) 1 year 8 months 12 days    
Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares) 4,267,000    
Share price (in dollars per share) $ 53.60 $ 53.20  
Share-based payment arrangement, decrease for tax withholding obligation $ 3,092,000 $ 4,706,000 $ 3,575,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value (in dollars per share) $ 69 $ 85 $ 79
Share-based payment arrangement, nonvested award, cost not yet recognized, amount $ 24,588,000    
Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, decrease for tax withholding obligation $ 3,092,000 $ 4,706,000 $ 3,575,000
The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares) 1,750,000    
Liability Award      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, amount capitalized $ 370,000 $ 154,000 $ 408,000
Stock Appreciation Rights (SARs)      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, weighted-average grant date fair value (in dollars per share) $ 19.92 $ 0 $ 27.12
Share-based compensation arrangement by share-based payment award, expiration period (year) 4 years 6 months    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value $ 0 $ 50,000 $ 10,337,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value $ 1,009,000 983,000 3,868,000
Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised (in shares) 0    
Stock Appreciation Rights (SARs) | Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, decrease for tax withholding obligation $ 0 0 0
Stock Appreciation Rights (SARs) | Vesting Annually      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Stock Appreciation Rights (SARs) | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 2,942,000    
Deferred Stock Units      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value $ 0 $ 0 $ 0
Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares) 8,000 8,000 19,000
Deferred Stock Units | Vesting Each Quarter | Share-based Payment Arrangement, Nonemployee      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Restricted Stock      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares) 1    
Restricted Stock | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 1,325,000    
Restricted Stock Units (RSUs)      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 274,000    
Granted, weighted-average grant date fair value (in dollars per share) $ 59.23    
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value $ 9,293,000 $ 12,808,000 $ 11,378,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value (in dollars per share) $ 71.35 $ 85.80  
Restricted Stock Units (RSUs) | Additional Paid-in Capital      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Adjustments to additional paid in capital $ 3,092,000 $ 4,706,000 $ 3,575,000
Restricted Stock Units (RSUs) | Vesting Annually      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage 25.00%    
Employee Stock | The 2015 Plan      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, forfeitures (in shares) 1,174,000    
Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares) 73,000    
Performance Stock Units      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Granted, shares (in shares) 84,000 0 0
Granted, weighted-average grant date fair value (in dollars per share) $ 40.05    
Share price (in dollars per share) $ 59.84    
Share-based compensation arrangement by share-based payment award, award vesting period 3 years    
Share-based payment arrangement, nonvested award, cost not yet recognized, amount $ 913,000    
Performance Stock Units | Minimum      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Payout as % of target number of shares 0.00%    
Performance Stock Units | Maximum      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Payout as % of target number of shares 200.00%    
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)
$ in Thousands
Dec. 30, 2023
USD ($)
Share-Based Payment Arrangement [Abstract]  
2024 $ 11,697
2025 7,934
2026 4,426
2027 531
Total remaining unrecognized compensation expense $ 24,588
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Weighted-average Assumptions (Details) - Stock Appreciation Rights (SARs) - $ / shares
 12 Months Ended
Dec. 30, 2023
Jan. 01, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility 39.89% 43.28%
Risk-free interest rate 3.78% 0.33%
Expected life 3 years 6 months 3 years 6 months
Expected dividend yield 0.00% 0.00%
Weighted-average exercise price (in dollars per share) $ 58.79 $ 85.19
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Shares    
Beginning balance outstanding, shares (in shares) 147,000  
Granted, shares (in shares) 18,000  
Exercised, shares (in shares) 0  
Forfeited, shares (in shares) (4,000)  
Expired, shares (in shares) (49,000)  
Ending balance outstanding, shares (in shares) 112,000 147,000
Exercisable, shares (in shares) 65,000  
Weighted-average exercise price    
Weighted average exercise price, outstanding (in dollars per share) $ 63.88 $ 82.16
Granted, weighted-average exercise price (in dollars per share) 58.79  
Exercised, weighted-average exercise price (in dollars per share) 0  
Forfeited, weighted-average exercise price (in dollars per share) 81.59  
Expired, weighted-average exercise price (in dollars per share) 115.45  
Exercisable, weighted-average exercise price (in dollars per share) $ 64.84  
Weighted-average remaining contractual term    
Weighted-average remaining contractual term, outstanding (years) 1 year 2 months 12 days 1 year 3 months 18 days
Exercisable, weighted-average remaining contractual term (years) 8 months 12 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding $ 0 $ 0
Exercisable, aggregate intrinsic value $ 0  
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Shares    
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) $ 85 $ 79
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) $ 69 $ 85
Restricted Stock Units (RSUs)    
Shares    
Beginning balance outstanding, shares (in shares) 385  
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) $ 85.80  
Granted, shares (in shares) 274  
Granted, weighted-average grant date fair value (in dollars per share) $ 59.23  
Vested, shares (in shares) (155)  
Vested, weighted-average grant date fair value (in dollars per share) $ 59.94  
Forfeited, shares (in shares) (14)  
Forfeited, weighted-average grant date fair value (in dollars per share) $ 79.23  
Ending balance outstanding, shares (in shares) 490 385
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) $ 71.35 $ 85.80
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Shares    
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) $ 85 $ 79
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) $ 69 $ 85
Cash-settled Restricted Stock Units    
Shares    
Beginning balance outstanding, shares (in shares) 12  
Beginning balance outstanding, weighted-average grant date fair value (in dollars per share) $ 84.72  
Granted, shares (in shares) 14  
Granted, weighted-average grant date fair value (in dollars per share) $ 59.82  
Vested, shares (in shares) (4)  
Vested, weighted-average grant date fair value (in dollars per share) $ 61.09  
Forfeited, shares (in shares) 0  
Forfeited, weighted-average grant date fair value (in dollars per share) $ 0  
Ending balance outstanding, shares (in shares) 22 12
Ending balance outstanding, weighted-average grant date fair value (in dollars per share) $ 68.71 $ 84.72
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details) - Performance Stock Units
 12 Months Ended
Dec. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected volatility 37.84%
Risk-free interest rate 4.09%
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details)
customer in Thousands
 12 Months Ended
Dec. 30, 2023
customer
$ / shares
Dec. 31, 2022
customer
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Target share price (in dollars per share) $ 53.60 $ 53.20
Fiscal year-end 2025 active Customers | customer   490
Performance Stock Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Target share price (in dollars per share) 59.84  
Performance Stock Units | 100% Of Target Number Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Target share price (in dollars per share) $ 59.84  
active Customer CAGR 6.00%  
Fiscal year-end 2025 active Customers | customer 584  
Payout as % of target number of shares 100.00%  
Performance Stock Units | 150% Of Target Number Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Target share price (in dollars per share) $ 59.84  
active Customer CAGR 9.00%  
Fiscal year-end 2025 active Customers | customer 635  
Payout as % of target number of shares 150.00%  
Performance Stock Units | 200% Of Target Number Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Target share price (in dollars per share) $ 59.84  
active Customer CAGR 12.00%  
Fiscal year-end 2025 active Customers | customer 688  
Payout as % of target number of shares 200.00%  
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Additional Information (Details)
 12 Months Ended
Dec. 30, 2023
segment
Segment Reporting [Abstract]  
Number of reportable segments 1
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Segment Reporting Information [Line Items]      
Net sales $ 921,010 $ 998,601 $ 1,186,464
Operating Segments | Direct-selling      
Segment Reporting Information [Line Items]      
Net sales 915,211 995,043 1,186,464
Operating Segments | All Other      
Segment Reporting Information [Line Items]      
Net sales $ 5,799 $ 3,558 $ 0
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Schedule of Revenue Percentage By Product (Details) - Product Concentration Risk - Revenue Benchmark
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
USANA Nutritionals      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 87.00% 87.00% 86.00%
USANA Foods      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 7.00% 7.00% 7.00%
Personal care and Skincare      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 5.00% 5.00% 6.00%
All Other      
Segment Reporting Information [Line Items]      
Concentration risk, percentage 1.00% 1.00% 1.00%
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Consolidated Net Sales and Long Lived Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Segment Reporting Information [Line Items]      
Net Sales to External Customers $ 921,010 $ 998,601 $ 1,186,464
Long-lived Assets 195,637 197,267  
Total Assets 632,757 596,549  
Asia Pacific Total      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 740,435 801,916 963,192
Long-lived Assets 99,157 104,894  
Total Assets 299,408 325,618  
Greater China      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 475,099 502,486 563,469
Long-lived Assets 79,418 86,051  
Total Assets 219,781 250,786  
Southeast Asia Pacific [Member]      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 163,890 190,478 269,803
Long-lived Assets 17,504 15,226  
Total Assets 57,820 51,880  
North Asia      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 101,446 108,952 129,920
Long-lived Assets 2,235 3,617  
Total Assets 21,807 22,952  
Americas and Europe      
Segment Reporting Information [Line Items]      
Net Sales to External Customers 180,575 196,685 $ 223,272
Long-lived Assets 96,480 92,373  
Total Assets $ 333,349 $ 270,931  
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Segment Reporting Information [Line Items]      
Net sales $ 921,010 $ 998,601 $ 1,186,464
Long-lived Assets 195,637 197,267  
China      
Segment Reporting Information [Line Items]      
Net sales 427,265 453,134 506,103
Long-lived Assets 77,767 83,938
South Korea      
Segment Reporting Information [Line Items]      
Net sales 95,906 106,087 110,379
China      
Segment Reporting Information [Line Items]      
Net sales 99,108 106,391 125,835
Long-lived Assets $ 93,181 $ 89,150
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Earnings Per Share [Abstract]      
Net earnings available to common shareholders $ 63,788 $ 69,350 $ 116,505
Weighted average common shares outstanding - basic (in shares) 19,250 19,254 20,146
Dilutive effect of in-the-money equity awards (in shares) 95 56 197
Weighted average common shares outstanding - diluted (in shares) 19,345 19,310 20,343
Earnings per common share from net earnings - basic (in dollars per share) $ 3.31 $ 3.60 $ 5.78
Earnings per common share from net earnings - diluted (in dollars per share) $ 3.30 $ 3.59 $ 5.73
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 319 354 60
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Earnings Per Share - Narrative (Details) - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Stock repurchased and retired during period, shares (in shares) 180 288 1,844
Stock repurchased and retired during period, value $ 11,653 $ 25,382 $ 177,837
Accrued excise tax for repurchase of common stock $ 54 $ 0 $ 0
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Allowance for sales returns      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period $ 572 $ 547 $ 819
Charged to costs and expenses 5,552 6,562 7,213
Deductions 5,704 6,537 7,485
Balance at end of period 420 572 547
Allowance for credit losses      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 363 504 372
Charged to costs and expenses 112 6 148
Deductions 54 147 16
Balance at end of period 421 363 504
Valuation allowance - deferred tax assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 118,136 99,958 81,401
Charged to costs and expenses 19,116 18,178 18,557
Deductions 0 0 0
Balance at end of period $ 137,252 $ 118,136 $ 99,958
EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 94 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 97 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 254 440 1 false 84 0 false 9 false false R1.htm 0000001 - Document - Document And Entity Information Sheet http://www.usana.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 0000002 - Statement - Consolidated Balance Sheets Sheet http://www.usana.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.usana.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 0000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.usana.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 0000008 - Disclosure - Business Combinations Sheet http://www.usana.com/role/BusinessCombinations Business Combinations Notes 8 false false R9.htm 0000009 - Disclosure - Inventories Sheet http://www.usana.com/role/Inventories Inventories Notes 9 false false R10.htm 0000010 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 10 false false R11.htm 0000011 - Disclosure - Income Taxes Sheet http://www.usana.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 0000012 - Disclosure - Property and Equipment Sheet http://www.usana.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 0000013 - Disclosure - Operating Leases Sheet http://www.usana.com/role/OperatingLeases Operating Leases Notes 13 false false R14.htm 0000014 - Disclosure - Intangible Assets Sheet http://www.usana.com/role/IntangibleAssets Intangible Assets Notes 14 false false R15.htm 0000015 - Disclosure - Other Current Liabilities Sheet http://www.usana.com/role/OtherCurrentLiabilities Other Current Liabilities Notes 15 false false R16.htm 0000016 - Disclosure - Line of Credit Sheet http://www.usana.com/role/LineofCredit Line of Credit Notes 16 false false R17.htm 0000017 - Disclosure - Commitments and Contingencies Sheet http://www.usana.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 0000018 - Disclosure - Equity-Based Compensation Sheet http://www.usana.com/role/EquityBasedCompensation Equity-Based Compensation Notes 18 false false R19.htm 0000019 - Disclosure - Segment Information Sheet http://www.usana.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 0000020 - Disclosure - Common Stock and Earnings Per Share Sheet http://www.usana.com/role/CommonStockandEarningsPerShare Common Stock and Earnings Per Share Notes 20 false false R21.htm 0000021 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 21 false false R22.htm 9954471 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.usana.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.usana.com/role/SummaryofSignificantAccountingPolicies 22 false false R23.htm 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.usana.com/role/SummaryofSignificantAccountingPolicies 23 false false R24.htm 9954473 - Disclosure - Inventories (Tables) Sheet http://www.usana.com/role/InventoriesTables Inventories (Tables) Tables http://www.usana.com/role/Inventories 24 false false R25.htm 9954474 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets 25 false false R26.htm 9954475 - Disclosure - Income Taxes (Tables) Sheet http://www.usana.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.usana.com/role/IncomeTaxes 26 false false R27.htm 9954476 - Disclosure - Property and Equipment (Tables) Sheet http://www.usana.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.usana.com/role/PropertyandEquipment 27 false false R28.htm 9954477 - Disclosure - Operating Leases (Tables) Sheet http://www.usana.com/role/OperatingLeasesTables Operating Leases (Tables) Tables http://www.usana.com/role/OperatingLeases 28 false false R29.htm 9954478 - Disclosure - Intangible Assets (Tables) Sheet http://www.usana.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.usana.com/role/IntangibleAssets 29 false false R30.htm 9954479 - Disclosure - Other Current Liabilities (Tables) Sheet http://www.usana.com/role/OtherCurrentLiabilitiesTables Other Current Liabilities (Tables) Tables http://www.usana.com/role/OtherCurrentLiabilities 30 false false R31.htm 9954480 - Disclosure - Equity-Based Compensation (Tables) Sheet http://www.usana.com/role/EquityBasedCompensationTables Equity-Based Compensation (Tables) Tables http://www.usana.com/role/EquityBasedCompensation 31 false false R32.htm 9954481 - Disclosure - Segment Information (Tables) Sheet http://www.usana.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.usana.com/role/SegmentInformation 32 false false R33.htm 9954482 - Disclosure - Common Stock and Earnings Per Share (Tables) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareTables Common Stock and Earnings Per Share (Tables) Tables http://www.usana.com/role/CommonStockandEarningsPerShare 33 false false R34.htm 9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 34 false false R35.htm 9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details) Details 35 false false R36.htm 9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails Summary of Significant Accounting Policies - Schedule of Other Revenue (Details) Details 36 false false R37.htm 9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) Sheet http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details) Details 37 false false R38.htm 9954487 - Disclosure - Business Combinations (Details) Sheet http://www.usana.com/role/BusinessCombinationsDetails Business Combinations (Details) Details http://www.usana.com/role/BusinessCombinations 38 false false R39.htm 9954488 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.usana.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 39 false false R40.htm 9954489 - Disclosure - Inventories - Narrative (Details) Sheet http://www.usana.com/role/InventoriesNarrativeDetails Inventories - Narrative (Details) Details 40 false false R41.htm 9954490 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) Details 41 false false R42.htm 9954491 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details) Sheet http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails Income Taxes - Consolidated Earnings Before Income Taxes (Details) Details 42 false false R43.htm 9954492 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) Sheet http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details) Details 43 false false R44.htm 9954493 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) Sheet http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails Income Taxes - Effective Tax Rate Reconciliation (Details) Details 44 false false R45.htm 9954494 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details) Sheet http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails Income Taxes - Significant Categories of Deferred Taxes (Details) Details 45 false false R46.htm 9954495 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.usana.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 46 false false R47.htm 9954496 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes - Unrecognized Tax Benefits (Details) Details 47 false false R48.htm 9954497 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) Sheet http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details) Details 48 false false R49.htm 9954498 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://www.usana.com/role/PropertyandEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 49 false false R50.htm 9954499 - Disclosure - Operating Leases - Narrative (Details) Sheet http://www.usana.com/role/OperatingLeasesNarrativeDetails Operating Leases - Narrative (Details) Details 50 false false R51.htm 9954500 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) Sheet http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails Operating Leases - Classification of Lease Assets and Lease Liabilities (Details) Details 51 false false R52.htm 9954501 - Disclosure - Operating Leases - Supplemental Lease Information (Details) Sheet http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails Operating Leases - Supplemental Lease Information (Details) Details 52 false false R53.htm 9954502 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details) Sheet http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails Operating Leases - Maturity of Lease Liabilities (Details) Details 53 false false R54.htm 9954503 - Disclosure - Intangible Assets - Narrative (Details) Sheet http://www.usana.com/role/IntangibleAssetsNarrativeDetails Intangible Assets - Narrative (Details) Details 54 false false R55.htm 9954504 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) Sheet http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails Intangible Assets - Changes in Carrying Amounts of Goodwill (Details) Details 55 false false R56.htm 9954505 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details) Sheet http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails Intangible Assets - Estimated Amortization Expense (Details) Details 56 false false R57.htm 9954506 - Disclosure - Intangible Assets - Intangible Assets (Details) Sheet http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails Intangible Assets - Intangible Assets (Details) Details 57 false false R58.htm 9954507 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details) Sheet http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails Other Current Liabilities - Other Current Liabilities (Details) Details 58 false false R59.htm 9954508 - Disclosure - Line of Credit - Narrative (Details) Sheet http://www.usana.com/role/LineofCreditNarrativeDetails Line of Credit - Narrative (Details) Details 59 false false R60.htm 9954509 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 60 false false R61.htm 9954510 - Disclosure - Equity-Based Compensation - Narrative (Details) Sheet http://www.usana.com/role/EquityBasedCompensationNarrativeDetails Equity-Based Compensation - Narrative (Details) Details 61 false false R62.htm 9954511 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) Sheet http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details) Details 62 false false R63.htm 9954512 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details) Sheet http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails Equity-Based Compensation - Weighted-average Assumptions (Details) Details 63 false false R64.htm 9954513 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) Details 64 false false R65.htm 9954514 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details) Details 65 false false R66.htm 9954515 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) Sheet http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details) Details 66 false false R67.htm 9954516 - Disclosure - Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details) Sheet http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details) Details 67 false false R68.htm 9954517 - Disclosure - Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details) Sheet http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details) Details 68 false false R69.htm 9954518 - Disclosure - Segment Information - Additional Information (Details) Sheet http://www.usana.com/role/SegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 69 false false R70.htm 9954519 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) Sheet http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details) Details 70 false false R71.htm 9954520 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details) Sheet http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails Segment Information - Schedule of Revenue Percentage By Product (Details) Details 71 false false R72.htm 9954521 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details) Sheet http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails Segment Information - Consolidated Net Sales and Long Lived Assets (Details) Details 72 false false R73.htm 9954522 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) Sheet http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details) Details 73 false false R74.htm 9954523 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details) Details 74 false false R75.htm 9954524 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details) Details 75 false false R76.htm 9954525 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details) Sheet http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails Common Stock and Earnings Per Share - Narrative (Details) Details 76 false false R77.htm 9954526 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Sheet http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Details 77 false false All Reports Book All Reports usna-20231230.htm usna-20231230.xsd usna-20231230_cal.xml usna-20231230_def.xml usna-20231230_lab.xml usna-20231230_pre.xml usna-20231230_g1.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 100 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "usna-20231230.htm": { "nsprefix": "usna", "nsuri": "http://www.usana.com/20231230", "dts": { "inline": { "local": [ "usna-20231230.htm" ] }, "schema": { "local": [ "usna-20231230.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "usna-20231230_cal.xml" ] }, "definitionLink": { "local": [ "usna-20231230_def.xml" ] }, "labelLink": { "local": [ "usna-20231230_lab.xml" ] }, "presentationLink": { "local": [ "usna-20231230_pre.xml" ] } }, "keyStandard": 375, "keyCustom": 65, "axisStandard": 31, "axisCustom": 1, "memberStandard": 53, "memberCustom": 30, "hidden": { "total": 11, "http://xbrl.sec.gov/dei/2023": 4, "http://fasb.org/us-gaap/2023": 7 }, "contextCount": 254, "entityCount": 1, "segmentCount": 84, "elementCount": 673, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1033, "http://xbrl.sec.gov/dei/2023": 38, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://www.usana.com/role/DocumentAndEntityInformation", "longName": "0000001 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.usana.com/role/ConsolidatedBalanceSheets", "longName": "0000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R3": { "role": "http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "0000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income", "shortName": "Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R5": { "role": "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "longName": "0000005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R6": { "role": "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPolicies", "longName": "0000007 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.usana.com/role/BusinessCombinations", "longName": "0000008 - Disclosure - Business Combinations", "shortName": "Business Combinations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.usana.com/role/Inventories", "longName": "0000009 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets", "longName": "0000010 - Disclosure - Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.usana.com/role/IncomeTaxes", "longName": "0000011 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.usana.com/role/PropertyandEquipment", "longName": "0000012 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.usana.com/role/OperatingLeases", "longName": "0000013 - Disclosure - Operating Leases", "shortName": "Operating Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.usana.com/role/IntangibleAssets", "longName": "0000014 - Disclosure - Intangible Assets", "shortName": "Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.usana.com/role/OtherCurrentLiabilities", "longName": "0000015 - Disclosure - Other Current Liabilities", "shortName": "Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.usana.com/role/LineofCredit", "longName": "0000016 - Disclosure - Line of Credit", "shortName": "Line of Credit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.usana.com/role/CommitmentsandContingencies", "longName": "0000017 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.usana.com/role/EquityBasedCompensation", "longName": "0000018 - Disclosure - Equity-Based Compensation", "shortName": "Equity-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.usana.com/role/SegmentInformation", "longName": "0000019 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.usana.com/role/CommonStockandEarningsPerShare", "longName": "0000020 - Disclosure - Common Stock and Earnings Per Share", "shortName": "Common Stock and Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts", "longName": "0000021 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.usana.com/role/SignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "usna:TheCompanyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "usna:TheCompanyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.usana.com/role/InventoriesTables", "longName": "9954473 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables", "longName": "9954474 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.usana.com/role/IncomeTaxesTables", "longName": "9954475 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.usana.com/role/PropertyandEquipmentTables", "longName": "9954476 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.usana.com/role/OperatingLeasesTables", "longName": "9954477 - Disclosure - Operating Leases (Tables)", "shortName": "Operating Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.usana.com/role/IntangibleAssetsTables", "longName": "9954478 - Disclosure - Intangible Assets (Tables)", "shortName": "Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.usana.com/role/OtherCurrentLiabilitiesTables", "longName": "9954479 - Disclosure - Other Current Liabilities (Tables)", "shortName": "Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.usana.com/role/EquityBasedCompensationTables", "longName": "9954480 - Disclosure - Equity-Based Compensation (Tables)", "shortName": "Equity-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.usana.com/role/SegmentInformationTables", "longName": "9954481 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.usana.com/role/CommonStockandEarningsPerShareTables", "longName": "9954482 - Disclosure - Common Stock and Earnings Per Share (Tables)", "shortName": "Common Stock and Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "usna:NumberOfGeographicRegions", "unitRef": "region", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "usna:TheCompanyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "usna:NumberOfGeographicRegions", "unitRef": "region", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "usna:TheCompanyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails", "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Assets And Liabilities Measured At Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails", "longName": "9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Revenue (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Other Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails", "longName": "9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Contract Liabilities From Contract With Customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R38": { "role": "http://www.usana.com/role/BusinessCombinationsDetails", "longName": "9954487 - Disclosure - Business Combinations (Details)", "shortName": "Business Combinations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R39": { "role": "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails", "longName": "9954488 - Disclosure - Inventories - Schedule of Inventories (Details)", "shortName": "Inventories - Schedule of Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.usana.com/role/InventoriesNarrativeDetails", "longName": "9954489 - Disclosure - Inventories - Narrative (Details)", "shortName": "Inventories - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:InventoryNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R41": { "role": "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails", "longName": "9954490 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details)", "shortName": "Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OtherPrepaidExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:OtherPrepaidExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails", "longName": "9954491 - Disclosure - Income Taxes - Consolidated Earnings Before Income Taxes (Details)", "shortName": "Income Taxes - Consolidated Earnings Before Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails", "longName": "9954492 - Disclosure - Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details)", "shortName": "Income Taxes - Income Tax Expense (Benefit) Included in Income from Continuing Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails", "longName": "9954493 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)", "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails", "longName": "9954494 - Disclosure - Income Taxes - Significant Categories of Deferred Taxes (Details)", "shortName": "Income Taxes - Significant Categories of Deferred Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsInventory", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsInventory", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "longName": "9954495 - Disclosure - Income Taxes - Narrative (Details)", "shortName": "Income Taxes - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R47": { "role": "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails", "longName": "9954496 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)", "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R48": { "role": "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "longName": "9954497 - Disclosure - Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details)", "shortName": "Property and Equipment - Cost of Property and Equipment and Estimated Useful Lives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.usana.com/role/PropertyandEquipmentNarrativeDetails", "longName": "9954498 - Disclosure - Property and Equipment - Narrative (Details)", "shortName": "Property and Equipment - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.usana.com/role/OperatingLeasesNarrativeDetails", "longName": "9954499 - Disclosure - Operating Leases - Narrative (Details)", "shortName": "Operating Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "longName": "9954500 - Disclosure - Operating Leases - Classification of Lease Assets and Lease Liabilities (Details)", "shortName": "Operating Leases - Classification of Lease Assets and Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "usna:AssetsAndLiabilitiesLesseeTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails", "longName": "9954501 - Disclosure - Operating Leases - Supplemental Lease Information (Details)", "shortName": "Operating Leases - Supplemental Lease Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails", "longName": "9954502 - Disclosure - Operating Leases - Maturity of Lease Liabilities (Details)", "shortName": "Operating Leases - Maturity of Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "longName": "9954503 - Disclosure - Intangible Assets - Narrative (Details)", "shortName": "Intangible Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R55": { "role": "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails", "longName": "9954504 - Disclosure - Intangible Assets - Changes in Carrying Amounts of Goodwill (Details)", "shortName": "Intangible Assets - Changes in Carrying Amounts of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:GoodwillGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:GoodwillGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R56": { "role": "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails", "longName": "9954505 - Disclosure - Intangible Assets - Estimated Amortization Expense (Details)", "shortName": "Intangible Assets - Estimated Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails", "longName": "9954506 - Disclosure - Intangible Assets - Intangible Assets (Details)", "shortName": "Intangible Assets - Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "usna:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R58": { "role": "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails", "longName": "9954507 - Disclosure - Other Current Liabilities - Other Current Liabilities (Details)", "shortName": "Other Current Liabilities - Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-4", "name": "usna:AssociateIncentivesPayable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "usna:AssociateIncentivesPayable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.usana.com/role/LineofCreditNarrativeDetails", "longName": "9954508 - Disclosure - Line of Credit - Narrative (Details)", "shortName": "Line of Credit - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LinesOfCreditCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-127", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R60": { "role": "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails", "longName": "9954509 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "longName": "9954510 - Disclosure - Equity-Based Compensation - Narrative (Details)", "shortName": "Equity-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "usna:EquityBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "usna:EquityBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails", "longName": "9954511 - Disclosure - Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)", "shortName": "Equity-Based Compensation - Remaining Unrecognized Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-4", "name": "usna:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "usna:ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails", "longName": "9954512 - Disclosure - Equity-Based Compensation - Weighted-average Assumptions (Details)", "shortName": "Equity-Based Compensation - Weighted-average Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-137", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-137", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "longName": "9954513 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)", "shortName": "Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-143", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-137", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R65": { "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "longName": "9954514 - Disclosure - Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details)", "shortName": "Equity-Based Compensation - Summary of Stock-settled Restricted Stock Unit Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-151", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R66": { "role": "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "longName": "9954515 - Disclosure - Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details)", "shortName": "Equity-Based Compensation - Summary of Cash-settled Restricted Stock Unit Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-159", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R67": { "role": "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "longName": "9954516 - Disclosure - Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details)", "shortName": "Equity-Based Compensation - Schedule of Performance Stock Units Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-164", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-164", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "longName": "9954517 - Disclosure - Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details)", "shortName": "Equity-Based Compensation - Schedule of Market-Based and Performance-Based Conditions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:SharePrice", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "usna:NumberOfActiveCustomers", "unitRef": "customer", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "usna:ScheduleOfMarketBasedAndPerformanceBasedConditionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R69": { "role": "http://www.usana.com/role/SegmentInformationAdditionalInformationDetails", "longName": "9954518 - Disclosure - Segment Information - Additional Information (Details)", "shortName": "Segment Information - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails", "longName": "9954519 - Disclosure - Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details)", "shortName": "Segment Information - Schedule of Segment Reporting Information, by Operating Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-176", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R71": { "role": "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "longName": "9954520 - Disclosure - Segment Information - Schedule of Revenue Percentage By Product (Details)", "shortName": "Segment Information - Schedule of Revenue Percentage By Product (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-182", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-182", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "longName": "9954521 - Disclosure - Segment Information - Consolidated Net Sales and Long Lived Assets (Details)", "shortName": "Segment Information - Consolidated Net Sales and Long Lived Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-203", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R73": { "role": "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "longName": "9954522 - Disclosure - Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details)", "shortName": "Segment Information - Markets Representing Ten Percent Or More Of Consolidated Net Sales and Long-Lived Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-219", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } }, "R74": { "role": "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "longName": "9954523 - Disclosure - Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details)", "shortName": "Common Stock and Earnings Per Share - Schedule of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails", "longName": "9954524 - Disclosure - Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details)", "shortName": "Common Stock and Earnings Per Share - Schedule of Shares not Included in the Computation of Diluted EPS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "longName": "9954525 - Disclosure - Common Stock and Earnings Per Share - Narrative (Details)", "shortName": "Common Stock and Earnings Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails", "longName": "9954526 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details)", "shortName": "Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-234", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-249", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "usna-20231230.htm", "unique": true } } }, "tag": { "usna_A100OfTargetNumberUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "A100OfTargetNumberUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "100% Of Target Number Units", "label": "100% Of Target Number Units [Member]", "documentation": "100% Of Target Number Units" } } }, "auth_ref": [] }, "usna_A150OfTargetNumberUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "A150OfTargetNumberUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "150% Of Target Number Units", "label": "150% Of Target Number Units [Member]", "documentation": "150% Of Target Number Units" } } }, "auth_ref": [] }, "usna_A200OfTargetNumberUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "A200OfTargetNumberUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "200% Of Target Number Units", "label": "200% Of Target Number Units [Member]", "documentation": "200% Of Target Number Units" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "usna_AccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AccountingPoliciesLineItems", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Line Items]", "label": "Accounting Policies [Line Items]", "documentation": "Accounting Policies" } } }, "auth_ref": [] }, "usna_AccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AccountingPoliciesTable", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Table]", "label": "Accounting Policies [Table]", "documentation": "Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33", "r776" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r124", "r184" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "parentTag": "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r79", "r236", "r616" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r41", "r42", "r138", "r241", "r612", "r646", "r647" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax:", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r20", "r42", "r551", "r554", "r593", "r642", "r643", "r816", "r817", "r818", "r830", "r831", "r832" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r129" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r494", "r495", "r496", "r653", "r830", "r831", "r832", "r897", "r917" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholding for net-share settled equity awards", "terseLabel": "Share-based payment arrangement, decrease for tax withholding obligation", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to additional paid in capital", "label": "Adjustments to Additional Paid in Capital, Other", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r84", "r85", "r455" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to net cash provided by (used in) operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Advertising", "label": "Advertising Cost [Policy Text Block]", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r197" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advertising expense", "label": "Advertising Expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r501" ] }, "us-gaap_AirTransportationEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AirTransportationEquipmentMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Air transportation equipment", "label": "Air Transportation Equipment [Member]", "documentation": "Equipment used for the primary purpose of air transportation." } } }, "auth_ref": [] }, "usna_AllOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AllOtherMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Other", "label": "All Other [Member]", "documentation": "Related to all other." } } }, "auth_ref": [] }, "us-gaap_AllowanceForCreditLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForCreditLossMember", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r825", "r826", "r827", "r828", "r829" ] }, "usna_AmendedAndRestatedCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AmendedAndRestatedCreditAgreementMember", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended and Restated Credit Agreement", "label": "Amended And Restated Credit Agreement [Member]", "documentation": "Related to amended and restated credit agreement." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "usna_AmericasAndEuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AmericasAndEuropeMember", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas and Europe", "label": "Americas And Europe [Member]", "documentation": "Related to Americas and Europe." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets, total", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r72", "r77" ] }, "usna_AmountsReceivableFromCreditCardProcessorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AmountsReceivableFromCreditCardProcessorsMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts Receivable from Credit Card Processors", "label": "Amounts Receivable From Credit Card Processors [Member]", "documentation": "Represents amounts receivable from credit card processors." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofSharesnotIncludedintheComputationofDilutedEPSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r308" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia Pacific Total", "label": "Asia Pacific [Member]", "documentation": "Region of Asia Pacific." } } }, "auth_ref": [ "r919", "r920", "r921", "r922" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "verboseLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r182", "r240", "r268", "r317", "r332", "r338", "r353", "r390", "r391", "r393", "r394", "r395", "r397", "r399", "r401", "r402", "r545", "r547", "r567", "r609", "r679", "r776", "r788", "r853", "r854", "r903" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "verboseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "usna_AssetsAndLiabilitiesLesseeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Classification of ROU Assets and Lease Liabilities", "label": "Assets And Liabilities, Lessee [Table Text Block]", "documentation": "Tabular disclosure of lessee's assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r231", "r245", "r268", "r353", "r390", "r391", "r393", "r394", "r395", "r397", "r399", "r401", "r402", "r545", "r547", "r567", "r776", "r853", "r854", "r903" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "usna_AssociateIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AssociateIncentives", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Associate incentives", "label": "Associate Incentives", "documentation": "Expenses related to commissions and other incentives earned by independent associates. Commissions are earned based on direct and indirect commissionable product sales. Other incentives including bonuses and contests and promotions are based on pay-for-performance and earned when associates achieve the required performance measures." } } }, "auth_ref": [] }, "usna_AssociateIncentivesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AssociateIncentivesPayable", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Associate incentives", "label": "Associate Incentives Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred and payable for associate incentives." } } }, "auth_ref": [] }, "usna_AssociateIncentivesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "AssociateIncentivesPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Associate Incentives", "label": "Associate Incentives [Policy Text Block]", "documentation": "Disclosure of accounting policy for associate incentives." } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r793", "r794", "r795" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r793", "r794", "r795" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r793", "r794", "r795" ] }, "us-gaap_AutomobilesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AutomobilesMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Automobiles", "label": "Automobiles [Member]", "documentation": "Vehicles that are used primarily for transporting people." } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r108", "r111" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings", "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r164" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r540", "r768", "r769" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r92", "r94", "r540", "r768", "r769" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement." } } }, "auth_ref": [ "r544", "r820" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum amount of earnouts total", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid." } } }, "auth_ref": [ "r102" ] }, "usna_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValuePerArrangementHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValuePerArrangementHigh", "crdr": "credit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum amount per earnout", "label": "Business Combination, Contingent Consideration Arrangements, Range Of Outcomes, Value Per Arrangement, High", "documentation": "Amount of maximum earn-out per period." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)", "terseLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r1", "r101", "r543" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Business combination, contingent consideration, liability, current", "label": "Business Combination, Contingent Consideration, Liability, Current", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r101" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Business combination, contingent consideration, liability, noncurrent", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r101" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/BusinessCombinations" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r177", "r541" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price allocations to tangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r95" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price allocations to intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r95" ] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transactions [Line Items]", "label": "Business Combination, Separately Recognized Transactions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transactions [Table]", "label": "Business Combination, Separately Recognized Transactions [Table]", "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction." } } }, "auth_ref": [ "r93" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r91" ] }, "country_CN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CN", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China", "label": "CHINA" } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued purchases of property and equipment", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r53", "r54", "r55" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r50", "r234", "r743" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Axis]", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r234" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds included in cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r51" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r51", "r181" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r151", "r266" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r151", "r266" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid during the period for:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r151" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents, at carrying value, total", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r807", "r913" ] }, "usna_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities", "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]", "documentation": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities" } } }, "auth_ref": [] }, "usna_CashSettledRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "CashSettledRestrictedStockUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash-settled Restricted Stock Units", "label": "Cash-Settled Restricted Stock Units [Member]", "documentation": "Represents cash-settled restricted stock units." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r165", "r383", "r385", "r728", "r850" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r779", "r780", "r781", "r783", "r784", "r785", "r786", "r830", "r831", "r897", "r915", "r917" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par or stated value per share (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r128" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r128", "r667" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r128" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares, outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r21", "r128", "r667", "r685", "r917", "r918" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December\u00a030, 2023 and 19,206 as of December\u00a031, 2022", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r128", "r611", "r776" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r43", "r248", "r250", "r257", "r605", "r620" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive income:", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer equipment and software", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r58", "r60", "r118", "r119", "r346", "r727" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r58", "r60", "r118", "r119", "r346", "r648", "r727" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r58", "r60", "r118", "r119", "r346", "r727", "r802" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk, percentage", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r58", "r60", "r118", "r119", "r346" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r58", "r60", "r118", "r119", "r346", "r727" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r272", "r319", "r330", "r331", "r332", "r333", "r334", "r336", "r340", "r390", "r391", "r392", "r393", "r395", "r396", "r398", "r400", "r401", "r805", "r806", "r853", "r854" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r272", "r319", "r330", "r331", "r332", "r333", "r334", "r336", "r340", "r390", "r391", "r392", "r393", "r395", "r396", "r398", "r400", "r401", "r805", "r806", "r853", "r854" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation and Basis of Presentation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r104", "r750" ] }, "usna_ContingentConsiderationMilestonePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ContingentConsiderationMilestonePeriod", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration milestone period", "label": "Contingent Consideration Milestone Period", "documentation": "Contingent Consideration Milestone Period" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Contract Asset, Contract Liability, and Receivable", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r856" ] }, "us-gaap_ContractWithCustomerAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNet", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with customer, asset, after allowance for credit loss, total", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r430", "r432", "r443" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Contract liabilities at beginning of period", "periodEndLabel": "Contract liabilities at end of period", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r430", "r431", "r443" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease due to beginning contract liabilities recognized as revenue", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r444" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r144", "r601" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r804", "r824", "r892" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r804", "r824" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r176", "r528", "r534", "r824" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current", "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r804", "r824", "r892" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r98" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/LineofCredit" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r166", "r267", "r403", "r409", "r410", "r411", "r412", "r413", "r414", "r419", "r426", "r427", "r428" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r31", "r123", "r124", "r183", "r186", "r272", "r404", "r405", "r406", "r407", "r408", "r410", "r415", "r416", "r417", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r579", "r757", "r758", "r759", "r760", "r761", "r822" ] }, "usna_DebtInstrumentCovenantAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DebtInstrumentCovenantAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "crdr": "credit", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument covenant, adjusted earnings before interest taxes, depreciation, and amortization", "label": "Debt Instrument Covenant Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "documentation": "The amount of debt instrument covenant for adjusted earnings before interest taxes, depreciation, and amortization." } } }, "auth_ref": [] }, "usna_DebtInstrumentCovenantRatioOfConsolidatedFundedDebtToAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "pureItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DebtInstrumentCovenantRatioOfConsolidatedFundedDebtToAdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, covenant ratio of consolidated funded debt to adjusted earnings before interest, taxes, depreciation, and amortization", "label": "Debt Instrument Covenant Ratio Of Consolidated Funded Debt To Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "documentation": "The covenant ratio of consolidated debt to adjusted earnings before interest, taxes, depreciation, and amortization for a debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r38", "r272", "r404", "r405", "r406", "r407", "r408", "r410", "r415", "r416", "r417", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r579", "r757", "r758", "r759", "r760", "r761", "r822" ] }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation liability, classified, noncurrent, total", "label": "Deferred Compensation Liability, Classified, Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred compensation liabilities", "label": "Deferred Compensation Liability, Current and Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Prepaid Expenses", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred commissions", "label": "Deferred Costs, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r814" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r824", "r891", "r892" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r176", "r824", "r891" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "verboseLabel": "Net deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r509", "r510" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Deferred", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r176", "r205", "r533", "r534", "r824" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Gross deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r125", "r126", "r185", "r522" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 }, "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "negatedTerseLabel": "Net deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r509", "r510", "r610" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r153" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r810" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r824", "r891", "r892" ] }, "usna_DeferredStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DeferredStockUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Stock Units", "label": "Deferred Stock Units [Member]", "documentation": "Represents deferred stock units." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetDomain", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Asset [Domain]", "label": "Deferred Tax Asset [Domain]", "documentation": "Identification of the deferred tax asset for which a valuation reserve exists." } } }, "auth_ref": [ "r86" ] }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Intangible assets", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r523" ] }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGrossAbstract", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Gross [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Capitalized R&D expenses", "label": "Deferred Tax Assets, in Process Research and Development", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInventory", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Deferred Tax Assets, Inventory", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred taxes", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r889" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails_1": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r889" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating losses", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets, operating loss carryforwards, foreign", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets, operating loss carryforwards, state and local", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and equipment", "label": "Deferred Tax Assets, Property, Plant and Equipment", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credit carry forwards", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r88", "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity-based compensation expense", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accruals not currently deductible", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses", "crdr": "debit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Deferred Tax Assets, Unrealized Currency Losses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r524" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Intangible assets", "label": "Deferred Tax Liabilities, Intangible Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other", "label": "Deferred Tax Liabilities, Other", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r89", "r890" ] }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Prepaid expenses", "label": "Deferred Tax Liabilities, Prepaid Expenses", "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Property and equipment", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r89", "r890" ] }, "usna_DeferredTaxLiabilitiesWithholdingTaxOnUnremittedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DeferredTaxLiabilitiesWithholdingTaxOnUnremittedEarnings", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesSignificantCategoriesofDeferredTaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Withholding tax on unremitted earnings", "label": "Deferred Tax Liabilities Withholding Tax On Unremitted Earnings", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from withholding tax on unremitted earnings." } } }, "auth_ref": [] }, "usna_DefinedBenefitPlanCliffVestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DefinedBenefitPlanCliffVestingPeriod", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit plan, cliff vesting period (year)", "label": "Defined Benefit Plan Cliff Vesting Period", "documentation": "Minimum amount of service time before matching contributions will cliff vest." } } }, "auth_ref": [] }, "usna_DefinedContributionPlanEmployerContributionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DefinedContributionPlanEmployerContributionAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, employer contribution amount", "label": "Defined Contribution Plan Employer Contribution Amount", "documentation": "Amount of contributions made by an employer to a defined contribution plan." } } }, "auth_ref": [] }, "usna_DefinedContributionPlanEmployerMatchingContributionMatchPercentExceedingInitialMatch": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DefinedContributionPlanEmployerMatchingContributionMatchPercentExceedingInitialMatch", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, employer matching contribution, match percent exceeding initial match", "label": "Defined Contribution Plan Employer Matching Contribution Match Percent Exceeding Initial Match", "documentation": "The percent exceeding the initial matching percent that the employer matches contributions under the defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, employer matching contribution, percent of employees' gross pay", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, employer matching contribution, percent of match", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "documentation": "Percentage employer matches of the employee's percentage contribution matched." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, maximum annual contributions per employee, percent", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "usna_DefinedContributionPlanMinimumAgeOfEmployee": { "xbrltype": "integerItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DefinedContributionPlanMinimumAgeOfEmployee", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, minimum age of employee", "label": "Defined Contribution Plan Minimum Age Of Employee", "documentation": "The minimum age of employee required to participate in the defined contribution plan" } } }, "auth_ref": [] }, "usna_DefinedContributionPlanRequisiteServicePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DefinedContributionPlanRequisiteServicePeriod", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined contribution plan, requisite service period (month)", "label": "Defined Contribution Plan Requisite Service Period", "documentation": "The requisite service period of the defined contribution plan." } } }, "auth_ref": [] }, "usna_DepositsAndProjectsInProcessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DepositsAndProjectsInProcessMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deposits and projects in process", "label": "Deposits and Projects In Process [Member]", "documentation": "Represents deposits and projects in process." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r78" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r322" ] }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets (liabilities), at fair value, net, total", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments." } } }, "auth_ref": [ "r11" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r658", "r660", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r680", "r681", "r682", "r683", "r694", "r695", "r696", "r697", "r700", "r701", "r702", "r703", "r717", "r718", "r719", "r720", "r779", "r781" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, gain (loss) on derivative, net", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r896" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r109", "r110", "r112", "r113", "r658", "r660", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r680", "r681", "r682", "r683", "r694", "r695", "r696", "r697", "r700", "r701", "r702", "r703", "r717", "r718", "r719", "r720", "r749", "r779", "r781" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r894", "r895" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives Financial Instruments", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r22", "r105", "r106", "r107", "r114", "r271" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "usna_DirectSellingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "DirectSellingMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct-selling", "label": "Direct Selling [Member]", "documentation": "Direct Selling" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r857" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Equity-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r453", "r458", "r490", "r491", "r493", "r771" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r793", "r794", "r795" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction [Flag]", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r793", "r794", "r795", "r797" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r796" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r791" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Tax Authority", "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share, basic (in dollars per share)", "verboseLabel": "Earnings per common share from net earnings - basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r258", "r285", "r286", "r287", "r288", "r289", "r294", "r297", "r304", "r306", "r307", "r311", "r557", "r558", "r606", "r621", "r752" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share, diluted (in dollars per share)", "verboseLabel": "Earnings per common share from net earnings - diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r258", "r285", "r286", "r287", "r288", "r289", "r297", "r304", "r306", "r307", "r311", "r557", "r558", "r606", "r621", "r752" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock and Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r293", "r308", "r309", "r310" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r899" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total effective income tax rate reconciliation, percent", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r512" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory U.S. federal income tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r270", "r512", "r536" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net increase in valuation allowance", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign income tax rate differences", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All other, net", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State income taxes, net of federal tax benefit", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax position reserve", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Excess foreign tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit." } } }, "auth_ref": [ "r887", "r893" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued employee compensation", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r35" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, amount capitalized", "label": "Share-Based Payment Arrangement, Amount Capitalized", "documentation": "Amount of cost capitalized for award under share-based payment arrangement." } } }, "auth_ref": [ "r489" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, amount", "totalLabel": "Total remaining unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r492" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (year)", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r492" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, expense, tax benefit", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r488" ] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r790" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r790" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r790" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r798" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r790" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r790" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r790" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r790" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r799" ] }, "usna_EquityBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "EquityBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity based compensation expense", "label": "Equity Based Compensation Expense", "documentation": "The value of equity based compensation expenses under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r21", "r228", "r252", "r253", "r254", "r280", "r281", "r282", "r284", "r290", "r292", "r312", "r355", "r356", "r429", "r494", "r495", "r496", "r529", "r530", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r570", "r571", "r572", "r573", "r574", "r576", "r593", "r642", "r643", "r644", "r653", "r706" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities without readily determinable fair value, amount", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r350" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities without readily determinable fair value, impairment loss, annual amount", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r351" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in Equity Securities", "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change." } } }, "auth_ref": [ "r352" ] }, "us-gaap_ExciseAndSalesTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExciseAndSalesTaxes", "crdr": "debit", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued excise tax for repurchase of common stock", "label": "Excise and Sales Taxes", "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services." } } }, "auth_ref": [ "r256" ] }, "usna_ExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, aggregate intrinsic value", "label": "Exercisable, Aggregate Intrinsic Value", "documentation": "Intrinsic value of exercisable award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "usna_ExercisableSharesInShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExercisableSharesInShares", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, shares (in shares)", "label": "Exercisable, Shares (In Shares)", "documentation": "Number of equity instruments other than options exercisable." } } }, "auth_ref": [] }, "usna_ExercisableWeightedAverageExercisePriceInDollarsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExercisableWeightedAverageExercisePriceInDollarsPerShare", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, weighted-average exercise price (in dollars per share)", "label": "Exercisable, Weighted-Average Exercise Price (In Dollars Per Share)", "documentation": "Per share or unit weighted-average exercise price of exercisable award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "usna_ExercisableWeightedAverageRemainingContractualTermYear": { "xbrltype": "durationItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExercisableWeightedAverageRemainingContractualTermYear", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, weighted-average remaining contractual term (years)", "label": "Exercisable, Weighted-Average Remaining Contractual Term (Year)", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options that are exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "usna_ExercisedWeightedAverageExercisePriceInDollarsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExercisedWeightedAverageExercisePriceInDollarsPerShare", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised, weighted-average exercise price (in dollars per share)", "label": "Exercised, Weighted-Average Exercise Price (In Dollars Per Share)", "documentation": "Per share or unit weighted-average exercise price of award exercised in period under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "usna_ExpiredWeightedAverageExercisePriceInDollarsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ExpiredWeightedAverageExercisePriceInDollarsPerShare", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired, weighted-average exercise price (in dollars per share)", "label": "Expired, Weighted-Average Exercise Price (In Dollars Per Share)", "documentation": "Per share or unit weighted-average exercise price of award expired during the period under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r560", "r561", "r565" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r560", "r561", "r565" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r29", "r116", "r117", "r180" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r417", "r446", "r447", "r448", "r449", "r450", "r451", "r561", "r595", "r596", "r597", "r758", "r759", "r765", "r766", "r767" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r560", "r561", "r562", "r563", "r566" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r417", "r446", "r451", "r561", "r595", "r765", "r766", "r767" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r417", "r446", "r451", "r561", "r596", "r758", "r759", "r765", "r766", "r767" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r417", "r446", "r447", "r448", "r449", "r450", "r451", "r561", "r597", "r758", "r759", "r765", "r766", "r767" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r417", "r446", "r447", "r448", "r449", "r450", "r451", "r595", "r596", "r597", "r758", "r759", "r765", "r766", "r767" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Nonrecurring", "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r560", "r561", "r562", "r563", "r564", "r566" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r559", "r566" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r14", "r30" ] }, "usna_FinishedGoodsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "FinishedGoodsMember", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished Goods", "label": "Finished Goods [Member]", "documentation": "Finished Goods" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived intangible asset, weighted-average amortization period (years)", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Finite-lived intangible assets, accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r238", "r377" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r161" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r374", "r376", "r377", "r379", "r602", "r603" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived intangible assets, gross carrying amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r160", "r603" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r602" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r73", "r76" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsEstimatedAmortizationExpenseDetails", "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total estimated amortization expense", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r160", "r602" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized intangible assets", "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiscalPeriod": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiscalPeriod", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fiscal Year", "label": "Fiscal Period, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed." } } }, "auth_ref": [ "r103" ] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Authority", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign currency contracts included in other current liabilities", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Translation of Foreign Currencies", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r568" ] }, "us-gaap_ForeignExchangeOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeOptionMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Option", "label": "Foreign Exchange Option [Member]", "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [] }, "usna_ForeignOperatingLossCarryforwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ForeignOperatingLossCarryforwardsMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Operating Loss Carryforwards", "label": "Foreign Operating Loss Carryforwards [Member]", "documentation": "Represents foreign operating loss carryforwards." } } }, "auth_ref": [] }, "usna_ForeignWithholdingTaxes": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ForeignWithholdingTaxes", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign withholding taxes", "label": "Foreign Withholding Taxes", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax withholdings." } } }, "auth_ref": [] }, "usna_ForfeitedWeightedAverageExercisePriceInDollarsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ForfeitedWeightedAverageExercisePriceInDollarsPerShare", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited, weighted-average exercise price (in dollars per share)", "label": "Forfeited, Weighted-Average Exercise Price (In Dollars Per Share)", "documentation": "Per share or unit weighted-average exercise price of award forfeited during the period under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and fixtures", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on sale of property and equipment", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r10" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails", "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Goodwill as of beginning of year", "periodEndLabel": "Goodwill as of end of year", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r237", "r362", "r604", "r756", "r776", "r838", "r845" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill acquired during the year", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r366", "r756" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r159" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r361", "r373", "r756" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r15" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency translation adjustment", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r370" ] }, "us-gaap_GoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillGross", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Gross goodwill", "periodEndLabel": "Gross goodwill", "label": "Goodwill, Gross", "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r365", "r372", "r756" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, impairment loss", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r10", "r363", "r369", "r373", "r756" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.usana.com/role/IntangibleAssetsChangesinCarryingAmountsofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "usna_GrantedWeightedAverageExercisePriceInDollarsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "GrantedWeightedAverageExercisePriceInDollarsPerShare", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, weighted-average exercise price (in dollars per share)", "label": "Granted, Weighted-Average Exercise Price (In Dollars Per Share)", "documentation": "Per share or unit weighted-average exercise price of award granted during the period under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_GranteeStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grantee Status [Axis]", "label": "Grantee Status [Axis]", "documentation": "Information by status of recipient to whom award is granted." } } }, "auth_ref": [ "r454", "r456", "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "us-gaap_GranteeStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusDomain", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grantee Status [Domain]", "label": "Grantee Status [Domain]", "documentation": "Status of recipient to whom award is granted." } } }, "auth_ref": [ "r454", "r456", "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "usna_GreaterChinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "GreaterChinaMember", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greater China", "label": "Greater China [Member]", "documentation": "Related to Greater China." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r143", "r268", "r317", "r331", "r337", "r340", "r353", "r390", "r391", "r393", "r394", "r395", "r397", "r399", "r401", "r402", "r567", "r753", "r853" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22", "r549" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r793", "r794", "r795" ] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IntangibleAssetsNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [ "r821", "r848" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "United States", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r269", "r535" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r140", "r188", "r317", "r331", "r337", "r340", "r607", "r618", "r753" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesConsolidatedEarningsBeforeIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r269", "r535" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Axis]", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r17" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Domain]", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Axis]", "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r17" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Domain]", "label": "Income Tax Authority, Name [Domain]", "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxContingencyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxContingencyLineItems", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Contingency [Line Items]", "label": "Income Tax Contingency [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxContingencyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxContingencyTable", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Contingency [Table]", "label": "Income Tax Contingency [Table]", "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months." } } }, "auth_ref": [ "r18", "r90", "r174", "r175" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r270", "r505", "r513", "r519", "r526", "r531", "r537", "r538", "r539", "r652" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/IncomeTaxesIncomeTaxExpenseBenefitIncludedinIncomefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "totalLabel": "Total income tax expense (benefit)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r194", "r206", "r291", "r292", "r325", "r511", "r532", "r623" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r251", "r507", "r508", "r519", "r520", "r525", "r527", "r650" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Income Taxes Paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r49", "r52" ] }, "us-gaap_IncomeTaxesPaidNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNetAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash received during the period for:", "label": "Income Taxes Paid, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes receivable", "label": "Income Taxes Receivable, Current", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r121", "r811" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "usna_IncreaseDueToDeferralOfRevenueAtPeriodEnd": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "IncreaseDueToDeferralOfRevenueAtPeriodEnd", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase due to deferral of revenue at period end", "label": "Increase Due To Deferral Of Revenue At Period End", "documentation": "The amount of increase (decrease) in contract with customer liability due to deferred revenue." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of in-the-money equity awards (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r298", "r299", "r300", "r307", "r457" ] }, "usna_IncrementalTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "IncrementalTaxes", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental taxes", "label": "Incremental Taxes", "documentation": "The amount of incremental taxes for the reporting period." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r375", "r378" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived intangible assets (excluding goodwill), direct sales license", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r162" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r74", "r162" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Intangible assets, gross (excluding goodwill)", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r237" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r71", "r75" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r120", "r190", "r255", "r321", "r578", "r691", "r787", "r916" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r261", "r263", "r265" ] }, "us-gaap_InventoryCurrentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryCurrentTable", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, Current [Table]", "label": "Inventory, Current [Table]", "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/Inventories" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r357" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r158", "r746" ] }, "us-gaap_InventoryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLineItems", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Line Items]", "label": "Inventory [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "totalLabel": "Total inventory, net", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r243", "r744", "r776" ] }, "us-gaap_InventoryNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNoncurrent", "crdr": "debit", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails", "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent inventories", "label": "Inventory, Noncurrent", "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle." } } }, "auth_ref": [ "r809" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r196", "r233", "r242", "r357", "r358", "r360", "r600", "r751" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r158", "r748" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work in progress", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r158", "r747" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory write-down", "label": "Inventory Write-down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r359" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r146", "r320" ] }, "country_KR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "KR", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "South Korea", "label": "KOREA, REPUBLIC OF" } } }, "auth_ref": [] }, "usna_LaboratoryAndProductionEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "LaboratoryAndProductionEquipmentMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Laboratory and production equipment", "label": "Laboratory And Production Equipment [Member]", "documentation": "Represents laboratory and production equipment." } } }, "auth_ref": [] }, "us-gaap_LandImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandImprovementsMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land improvements", "label": "Land Improvements [Member]", "documentation": "Additions or improvements to real estate held." } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r858" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r586", "r775" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Supplemental Lease Information", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r901" ] }, "usna_LeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "LeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total ROU assets", "label": "Lease Right Of Use Asset", "documentation": "Amount of lessee's right to use underlying asset under lease." } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r164" ] }, "us-gaap_LeasesOperatingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOperatingAbstract", "lang": { "en-us": { "role": { "label": "Leases, Operating [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r585" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.usana.com/role/OperatingLeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturity of Lease Liabilities", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r902" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease, liability", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r592" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r592" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r592" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r592" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r592" ] }, "usna_LesseeOperatingLeaseLiabilityToBePaidYearFiveAndAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "LesseeOperatingLeaseLiabilityToBePaidYearFiveAndAfterYearFive", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028 and Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five And After Year Five", "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Five And After Year Five" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r592" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.usana.com/role/OperatingLeases" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r580" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r133", "r187", "r614", "r776", "r823", "r835", "r898" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r37", "r232", "r268", "r353", "r390", "r391", "r393", "r394", "r395", "r397", "r399", "r401", "r402", "r546", "r547", "r548", "r567", "r776", "r853", "r903", "r904" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "usna_LiabilityAwardMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "LiabilityAwardMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Award", "label": "Liability Award [Member]", "documentation": "Represents liability award." } } }, "auth_ref": [] }, "us-gaap_LicensingAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicensingAgreementsMember", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct selling license", "label": "Licensing Agreements [Member]", "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)." } } }, "auth_ref": [ "r99", "r504", "r886" ] }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Life insurance, corporate or bank owned, amount", "label": "Life Insurance, Corporate or Bank Owned, Amount", "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)." } } }, "auth_ref": [ "r354", "r808" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term line of credit, total", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r31", "r186", "r912" ] }, "us-gaap_LineOfCreditFacilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAbstract", "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "auth_ref": [] }, "usna_LineOfCreditFacilityAdditionalIncreaseInMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "LineOfCreditFacilityAdditionalIncreaseInMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, additional increase in maximum borrowing capacity", "label": "Line Of Credit Facility Additional Increase In Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity due to additional increase under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r822" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r34" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r34", "r822" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/LineofCreditNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit - short term", "label": "Line of Credit, Current", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r123", "r183" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r452", "r599", "r641", "r659", "r660", "r710", "r712", "r714", "r715", "r721", "r738", "r739", "r754", "r762", "r770", "r778", "r855", "r905", "r906", "r907", "r908", "r909", "r910" ] }, "usna_MinimumAmountOfIndividualClaimsBeforeInsuranceReimbursement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "MinimumAmountOfIndividualClaimsBeforeInsuranceReimbursement", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum amount of individual claims before insurance reimbursement", "label": "Minimum Amount Of Individual Claims Before Insurance Reimbursement", "documentation": "The minimum amount of individual claims required before insurance will reimburse." } } }, "auth_ref": [] }, "usna_MinimumAmountOfProjectedAggregateClaimsBeforeInsuranceReimbursement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "MinimumAmountOfProjectedAggregateClaimsBeforeInsuranceReimbursement", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum amount of projected aggregate claims before insurance reimbursement", "label": "Minimum Amount Of Projected Aggregate Claims Before Insurance Reimbursement", "documentation": "The minimum amount of projected aggregate claims required before insurance will reimburse." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r452", "r599", "r641", "r659", "r660", "r710", "r712", "r714", "r715", "r721", "r738", "r739", "r754", "r762", "r770", "r778", "r855", "r905", "r906", "r907", "r908", "r909", "r910" ] }, "usna_MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities", "label": "Mirrored Deferred Tax Assets Recorded in the U.S. to Offset Deferred Tax Liabilities of Foreign Disregarded Entities [Member]", "documentation": "Represents mirrored deferred tax assets recorded in the U.S. to offset deferred tax liabilities of foreign disregarded entities." } } }, "auth_ref": [] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r859" ] }, "usna_MovementInContractLiabilitiesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "MovementInContractLiabilitiesRollForward", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofContractLiabilitiesFromContractWithCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in Contract Liabilities [Roll Forward]", "label": "Movement In Contract Liabilities [Roll Forward]", "documentation": "Movement In Contract Liabilities" } } }, "auth_ref": [] }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInValuationAllowancesAndReservesRollForward", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r262" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r262" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r151", "r152", "r153" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "terseLabel": "Net earnings", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r141", "r153", "r189", "r230", "r246", "r249", "r254", "r268", "r283", "r285", "r286", "r287", "r288", "r291", "r292", "r301", "r317", "r331", "r337", "r340", "r353", "r390", "r391", "r393", "r394", "r395", "r397", "r399", "r401", "r402", "r558", "r567", "r619", "r687", "r704", "r705", "r753", "r787", "r853" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r259", "r285", "r286", "r287", "r288", "r294", "r295", "r303", "r307", "r317", "r331", "r337", "r340", "r753" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "usna_NonQualifiedDeferredCompensationPlanAnnualIncentiveBonusDeferredPercentage": { "xbrltype": "pureItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NonQualifiedDeferredCompensationPlanAnnualIncentiveBonusDeferredPercentage", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-qualified deferred compensation plan, annual incentive bonus deferral, percentage", "label": "Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage", "documentation": "Non-Qualified Deferred Compensation Plan, Annual Incentive Bonus Deferred, Percentage" } } }, "auth_ref": [] }, "usna_NonQualifiedDeferredCompensationPlanSalaryDeferredPercentage": { "xbrltype": "pureItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NonQualifiedDeferredCompensationPlanSalaryDeferredPercentage", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-qualified deferred compensation plan, salary deferred, percentage", "label": "Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage", "documentation": "Non-Qualified Deferred Compensation Plan, Salary Deferred, Percentage" } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration given to acquire businesses", "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r53", "r54", "r55" ] }, "us-gaap_NoncompeteAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncompeteAgreementsMember", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-compete agreements", "label": "Noncompete Agreements [Member]", "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party." } } }, "auth_ref": [ "r97" ] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-lived Assets", "label": "Long-Lived Assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r345" ] }, "usna_NonfinancialAssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NonfinancialAssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonfinancial assets, fair value disclosure", "label": "Nonfinancial Assets Fair Value Disclosure", "documentation": "The amount of nonfinancial assets measured at fair value." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r147" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "usna_NonqualifiedDeferredCompensationPlanPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NonqualifiedDeferredCompensationPlanPolicyPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Nonqualified Deferred Compensation", "label": "Nonqualified Deferred Compensation Plan Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy related to the Company's nonqualified deferred compensation plan." } } }, "auth_ref": [] }, "usna_NorthAsiaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NorthAsiaMember", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "North Asia", "label": "North Asia [Member]", "documentation": "Related to north Asia." } } }, "auth_ref": [] }, "usna_NumberOfActiveCustomers": { "xbrltype": "integerItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NumberOfActiveCustomers", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fiscal year-end 2025 active Customers", "label": "Number Of Active Customers", "documentation": "Number Of Active Customers" } } }, "auth_ref": [] }, "usna_NumberOfEarnoutPeriods": { "xbrltype": "integerItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NumberOfEarnoutPeriods", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of earnout periods", "label": "Number Of Earnout Periods", "documentation": "Number of earn-out periods." } } }, "auth_ref": [] }, "usna_NumberOfGeographicRegions": { "xbrltype": "integerItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NumberOfGeographicRegions", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of geographic regions", "label": "Number Of Geographic Regions", "documentation": "The number of geographic regions in which the company operates." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.usana.com/role/SegmentInformationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r834" ] }, "usna_NumberOfSubGeographicalRegions": { "xbrltype": "integerItemType", "nsuri": "http://www.usana.com/20231230", "localname": "NumberOfSubGeographicalRegions", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of sub geographical regions", "label": "Number Of Sub-Geographical Regions", "documentation": "The number of sub-geographical regions the company operates in." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r317", "r331", "r337", "r340", "r753" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r587", "r775" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/OperatingLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent expense", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r900" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "http://www.usana.com/role/OperatingLeasesMaturityofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease liabilities", "verboseLabel": "Present value", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r582" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails", "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r582" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r583" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r582" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r583" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r584", "r588" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails": { "parentTag": "usna_LeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ROU operating lease assets, net", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r581" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use asset amortization", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r821" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r583" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate\u2014operating leases", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r591", "r775" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term\u2014operating leases", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r590", "r775" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards, total", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r88" ] }, "usna_OperatingLossCarryforwardsNotSubjectToExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "OperatingLossCarryforwardsNotSubjectToExpiration", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards, not subject to expiration", "label": "Operating Loss Carryforwards Not Subject To Expiration", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws, that are not subject to expiration." } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r330", "r331", "r332", "r333", "r334", "r340" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r154", "r155", "r156", "r178" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r244", "r776" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r108", "r115" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r239" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r138" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax benefit (expense) related to foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r6", "r569", "r575" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income (loss), net of tax", "terseLabel": "Other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r8", "r19", "r179", "r247", "r250" ] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses And Other Current Assets", "label": "Other Current Assets [Text Block]", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "usna_OtherForeignDeferredTaxAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "OtherForeignDeferredTaxAssetsMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Foreign Deferred Tax Assets", "label": "Other Foreign Deferred Tax Assets [Member]", "documentation": "Represents other foreign deferred tax assets." } } }, "auth_ref": [] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Revenue", "label": "Other Income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r622", "r688", "r722", "r723", "r724" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Total other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35", "r776" ] }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrentAbstract", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current:", "label": "Other Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for other liabilities." } } }, "auth_ref": [ "r36" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "us-gaap_OtherLiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrentAbstract", "presentation": [ "http://www.usana.com/role/OperatingLeasesClassificationofLeaseAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent:", "label": "Other Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Noncurrent Liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r148" ] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other prepaid expenses", "label": "Other Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r813", "r836" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Miscellaneous receivables, net", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherSundryLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSundryLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "All other", "label": "Other Sundry Liabilities, Current", "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date." } } }, "auth_ref": [ "r35", "r80" ] }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments for contingent consideration", "label": "Payment for Contingent Consideration Liability, Financing Activities", "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PaymentsForHedgeInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForHedgeInvestingActivities", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments for net investment hedge", "label": "Payments for Hedge, Investing Activities", "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation." } } }, "auth_ref": [ "r264", "r819" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r47" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments related to tax withholding for net-share settled equity awards", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r260" ] }, "us-gaap_PaymentsToAcquireAssetsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAssetsInvestingActivities", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments to acquire businesses", "label": "Payments to Acquire Assets, Investing Activities", "documentation": "Aggregate cash payments for a combination of transactions that are classified as investing activities in which assets, which may include securities, other types of investments, or productive assets, are purchased from third-party sellers. This element can be used by entities to aggregate payments for all asset purchases that are classified as investing activities." } } }, "auth_ref": [ "r819" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to acquire businesses", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r45", "r542" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r150" ] }, "usna_PerformancePayoutAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PerformancePayoutAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Payout [Axis]", "label": "Performance Payout [Axis]", "documentation": "Performance Payout" } } }, "auth_ref": [] }, "usna_PerformancePayoutDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PerformancePayoutDomain", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Payout [Domain]", "label": "Performance Payout [Domain]", "documentation": "Performance Payout [Domain]" } } }, "auth_ref": [] }, "usna_PerformanceStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PerformanceStockUnitsMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Stock Units", "label": "Performance Stock Units [Member]", "documentation": "Performance Stock Units" } } }, "auth_ref": [] }, "usna_PermanentTaxDifferences": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PermanentTaxDifferences", "calculation": { "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Permanent tax differences", "label": "Permanent Tax Differences", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to permanent tax differences." } } }, "auth_ref": [] }, "usna_PersonalCareAndSkincareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PersonalCareAndSkincareMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal care and Skincare", "label": "Personal Care And Skincare [Member]", "documentation": "Related to personal care and skincare." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expense and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r815" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidInsurance", "crdr": "debit", "calculation": { "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/PrepaidExpensesandOtherCurrentAssetsPrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid insurance", "label": "Prepaid Insurance", "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r745", "r755", "r836" ] }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromCollectionOfNotesReceivable", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Receipts on notes receivable", "label": "Proceeds from Collection of Notes Receivable", "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ProceedsFromHedgeInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromHedgeInvestingActivities", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the settlement of net investment hedges", "label": "Proceeds from Hedge, Investing Activities", "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation." } } }, "auth_ref": [ "r264", "r800" ] }, "us-gaap_ProceedsFromIncomeTaxRefunds": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIncomeTaxRefunds", "crdr": "debit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax refund", "label": "Proceeds from Income Tax Refunds", "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r52", "r152" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings on line of credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r46", "r822" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of property and equipment", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r149" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r59" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r342", "r601", "r635", "r636", "r637", "r638", "r639", "r640", "r741", "r763", "r777", "r803", "r851", "r852", "r857", "r914" ] }, "usna_ProductReturnFirstTimeOrderDurationOfReturn": { "xbrltype": "durationItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ProductReturnFirstTimeOrderDurationOfReturn", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product return, first time order, duration of return (day)", "label": "Product Return First Time Order Duration Of Return", "documentation": "The duration of the return on first-time product orders." } } }, "auth_ref": [] }, "usna_ProductReturnFirstTimeOrderPercentageRefunded": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ProductReturnFirstTimeOrderPercentageRefunded", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product return, first time order, percentage refunded", "label": "Product Return First Time Order Percentage Refunded", "documentation": "The percentage refunded on first-time orders for product returns." } } }, "auth_ref": [] }, "usna_ProductReturnPercentageOfNetSales": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ProductReturnPercentageOfNetSales", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product return, percentage of net sales", "label": "Product Return Percentage Of Net Sales", "documentation": "The percentage of net sales that had product returns during the period." } } }, "auth_ref": [] }, "usna_ProductReturnPercentageRefunded": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ProductReturnPercentageRefunded", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product return, percentage refunded", "label": "Product Return Percentage Refunded", "documentation": "The percentage of refund on product returns." } } }, "auth_ref": [] }, "usna_ProductReturnPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ProductReturnPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Product Return Policy", "label": "Product Return [Policy Text Block]", "documentation": "Disclosure of accounting policy for product returns." } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r342", "r601", "r635", "r636", "r637", "r638", "r639", "r640", "r741", "r763", "r777", "r803", "r851", "r852", "r857", "r914" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/PropertyandEquipment" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r163", "r200", "r203", "r204" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "parentTag": "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r164", "r235", "r617" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r12", "r608", "r617", "r776" ] }, "usna_PropertyPlantAndEquipmentNetExcludingNondepreciable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "PropertyPlantAndEquipmentNetExcludingNondepreciable", "crdr": "debit", "calculation": { "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Property and equipment, net, excluding non-depreciable", "label": "Property Plant And Equipment Net Excluding Nondepreciable", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale, excluding non-depreciable amounts." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r12", "r200", "r203", "r615" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r164" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Useful life", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PublicUtilitiesInventoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilitiesInventoryAxis", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Axis]", "label": "Inventory [Axis]", "documentation": "Information by type of inventory held." } } }, "auth_ref": [ "r812" ] }, "us-gaap_PublicUtilitiesInventoryRawMaterialsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilitiesInventoryRawMaterialsMember", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw Materials", "label": "Raw Materials [Member]", "documentation": "Basic goods that are to be consumed directly or indirectly in the production of finished goods or services." } } }, "auth_ref": [ "r134" ] }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilitiesInventoryTypeDomain", "presentation": [ "http://www.usana.com/role/InventoriesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Domain]", "label": "Inventory [Domain]", "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale." } } }, "auth_ref": [ "r812" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r445", "r452", "r484", "r485", "r486", "r598", "r599", "r641", "r659", "r660", "r710", "r712", "r714", "r715", "r721", "r738", "r739", "r754", "r762", "r770", "r778", "r781", "r849", "r855", "r906", "r907", "r908", "r909", "r910" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r386", "r387", "r388", "r389", "r445", "r452", "r484", "r485", "r486", "r598", "r599", "r641", "r659", "r660", "r710", "r712", "r714", "r715", "r721", "r738", "r739", "r754", "r762", "r770", "r778", "r781", "r849", "r855", "r906", "r907", "r908", "r909", "r910" ] }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments on line of credit", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r48", "r822" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expense, total", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r122", "r503", "r911" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r502" ] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research Tax Credit Carryforward", "label": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r87" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesScheduleofAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Domain]", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r234" ] }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Restricted cash included in other assets", "terseLabel": "Restricted cash and cash equivalents, noncurrent, total", "label": "Restricted Cash and Cash Equivalents, Noncurrent", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r195", "r266" ] }, "usna_RestrictedCashDepositsInChinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "RestrictedCashDepositsInChinaMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash Deposits in China", "label": "Restricted Cash Deposits in China [Member]", "documentation": "Represents restricted cash deposits in China." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r56" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r130", "r167", "r613", "r645", "r647", "r651", "r668", "r776" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r228", "r280", "r281", "r282", "r284", "r290", "r292", "r355", "r356", "r494", "r495", "r496", "r529", "r530", "r550", "r552", "r553", "r555", "r556", "r642", "r644", "r653", "r917" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "verboseLabel": "Net Sales to External Customers", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r318", "r319", "r330", "r335", "r336", "r342", "r344", "r346", "r441", "r442", "r601" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r207", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r740" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.usana.com/role/OperatingLeasesSupplementalLeaseInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ROU assets obtained in exchange for new operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r589", "r775" ] }, "usna_RightOfUseAssetsObtainedInExchangeForLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "RightOfUseAssetsObtainedInExchangeForLeaseObligations", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for lease obligations", "label": "Right-Of-Use Assets Obtained In Exchange For Lease Obligations", "documentation": "The amount of right of use asset obtained in exchange for operating lease liability classified as a noncash transaction." } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "calculation": { "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/OtherCurrentLiabilitiesOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales taxes", "label": "Sales and Excise Tax Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r346", "r801" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r56" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r56" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Tax Expense (Benefit) Included in Income From Continuing Operations", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r173" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Taxes", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r172" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r833" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effective Income Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r171" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers by Products and Services", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r67" ] }, "usna_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Intangible Assets", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure for finite lived and indefinite lived intangible assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r73", "r76", "r602" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.usana.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r756", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Consolidated Income Before Income Taxes", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r824" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.usana.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r32", "r135", "r136", "r137" ] }, "usna_ScheduleOfMarketBasedAndPerformanceBasedConditionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ScheduleOfMarketBasedAndPerformanceBasedConditionsTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Market-Based and Performance-Based Condition", "label": "Schedule of Market-Based and Performance-Based Conditions [Table Text Block]", "documentation": "Schedule of Market-Based and Performance-Based Conditions" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash-Settled Restricted Stock Unit Activity", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.usana.com/role/PropertyandEquipmentCostofPropertyandEquipmentandEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenue by Geographic Region", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r69", "r142" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Markets Representing Ten Percent Or More of Consolidated Net Sales and Long-Lived Assets", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r68", "r142" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r68", "r139" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r64", "r65", "r66", "r70" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.usana.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Operating Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r64", "r65", "r66", "r70" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r454", "r456", "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock-Settled Restricted Stock Unit Activity", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r81" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock-Settled Appreciation Right Activity", "label": "Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year." } } }, "auth_ref": [ "r81" ] }, "usna_ScheduleOfShareBasedPaymentAwardPerformanceStockUnitsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ScheduleOfShareBasedPaymentAwardPerformanceStockUnitsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions", "label": "Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions [Table Text Block]", "documentation": "Schedule of Share-based Payment Award, Performance Stock Units, Valuation Assumptions" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Remaining Unrecognized Compensation Expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]", "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r170" ] }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "presentation": [ "http://www.usana.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Unrecognized Tax Benefits Reconciliation", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in unrecognized tax benefits." } } }, "auth_ref": [ "r774", "r888" ] }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccounts" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule II - Valuation And Qualifying Accounts", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "documentation": "The entire disclosure for valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r208", "r279" ] }, "usna_SecSchedule1209AllowanceSalesReturnsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "SecSchedule1209AllowanceSalesReturnsMember", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for sales returns", "label": "SEC Schedule, 12-09, Allowance, Sales Returns [Member]", "documentation": "Allowance for sales returns." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r789" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r792" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r314", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r340", "r346", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r381", "r382", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r756", "r803", "r914" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r344", "r345", "r655", "r656", "r657", "r711", "r713", "r716", "r725", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r742", "r764", "r781", "r857", "r914" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.usana.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r313", "r314", "r315", "r316", "r317", "r329", "r334", "r338", "r339", "r340", "r341", "r342", "r343", "r346" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails", "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "usna_SelfInsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "SelfInsuranceExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Self-insurance expense", "label": "Self Insurance Expense", "documentation": "The expense in the period incurred for claims for which no insurance coverage exists." } } }, "auth_ref": [] }, "us-gaap_SelfInsuranceReservePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SelfInsuranceReservePolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Self-Insurance", "label": "Self Insurance Reserve [Policy Text Block]", "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR)." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r145" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, General and Administrative", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption." } } }, "auth_ref": [ "r16" ] }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "presentation": [ "http://www.usana.com/role/BusinessCombinationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series of Individually Immaterial Business Acquisitions", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.usana.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r771" ] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercises in period, intrinsic value", "label": "Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Exercises In Period Intrinsic Value", "documentation": "The intrinsic value of award exercised under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r476" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited, weighted-average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r476" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r474" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, weighted-average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r474" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance outstanding, shares (in shares)", "periodEndLabel": "Ending balance outstanding, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r471", "r472" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value (in dollars per share)", "periodStartLabel": "Beginning balance outstanding, weighted-average grant date fair value (in dollars per share)", "periodEndLabel": "Ending balance outstanding, weighted-average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r471", "r472" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining contractual term, outstanding (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r168" ] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasedInPeriod", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation arrangement by share based payment award, equity instruments other than options, vested and unreleased in period (in shares)", "label": "Share-based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased In Period", "documentation": "The number of shares vested and unreleased in the period of non-option equity instruments under share based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r475" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r478" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, weighted-average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r475" ] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, outstanding (in dollars per share)", "label": "Share-based Compensation Arrangement By Share-based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price", "documentation": "Per share or unit weighted-average exercise price of award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average exercise price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r485" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r484" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r486" ] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitures", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, forfeitures (in shares)", "label": "Share-based Compensation Arrangement By Share-based Payment Award Forfeitures", "documentation": "Number of shares under equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodGross", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, grants in period, gross (in shares)", "label": "Share-based Compensation Arrangement By Share-based Payment Award Grants In Period Gross", "documentation": "Gross number of awards granted during the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r454", "r456", "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised (in shares)", "negatedTerseLabel": "Exercised, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance outstanding, shares (in shares)", "periodEndLabel": "Ending balance outstanding, shares (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r23", "r24" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r773" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average exercise price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "usna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedPerAwardExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedPerAwardExercised", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, shares issued per award exercised (in shares)", "label": "Share-based Compensation Arrangement By Share-based Payment Award Shares Issued Per Award Exercised", "documentation": "The number of shares issued per each one award upon exercise of award under share based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofPerformanceStockUnitsValuationAssumptionsDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofCashsettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledRestrictedStockUnitActivityDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Equity-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r453", "r462", "r481", "r482", "r483", "r484", "r487", "r497", "r498", "r499", "r500" ] }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedPaymentArrangementNonemployeeMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Nonemployee", "label": "Share-Based Payment Arrangement, Nonemployee [Member]", "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires." } } }, "auth_ref": [ "r454", "r459", "r460", "r461", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r484", "r485", "r486", "r487" ] }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearFour", "crdr": "debit", "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Four", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year four." } } }, "auth_ref": [] }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearOne", "crdr": "debit", "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year One", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year one" } } }, "auth_ref": [] }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearThree", "crdr": "debit", "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Three", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year three." } } }, "auth_ref": [] }, "usna_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountDueYearTwo", "crdr": "debit", "calculation": { "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails": { "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.usana.com/role/EquityBasedCompensationRemainingUnrecognizedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Share-based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount Due Year Two", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement to be recognized in year two." } } }, "auth_ref": [] }, "usna_ShareBasedPaymentArrangementPayoutPercentageOfTargetNumberOfShares": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementPayoutPercentageOfTargetNumberOfShares", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payout as % of target number of shares", "label": "Share-Based Payment Arrangement, Payout, Percentage of Target Number Of Shares", "documentation": "Share-Based Payment Arrangement, Payout, Percentage of Target Number Of Shares" } } }, "auth_ref": [] }, "usna_ShareBasedPaymentArrangementPerformanceConditionActiveCustomerGrowthRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.usana.com/20231230", "localname": "ShareBasedPaymentArrangementPerformanceConditionActiveCustomerGrowthRatePercentage", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "active Customer CAGR", "label": "Share-Based Payment Arrangement, Performance Condition, Active Customer Growth Rate, Percentage", "documentation": "Share-Based Payment Arrangement, Performance Condition, Active Customer Growth Rate, Percentage" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationScheduleofMarketBasedandPerformanceBasedConditionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price (in dollars per share)", "verboseLabel": "Target share price (in dollars per share)", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting rights, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r860" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value, outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, expiration period (year)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r772" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r483" ] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software and Software Development Costs", "label": "Software and Software Development Costs [Member]", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "usna_SoutheastAsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "SoutheastAsiaPacificMember", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Southeast Asia Pacific [Member]", "label": "Southeast Asia Pacific [Member]", "documentation": "Related to Southeast Asia Pacific." } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and Local Jurisdiction", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofSegmentReportingInformationbyOperatingSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r229", "r314", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r340", "r346", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r380", "r381", "r382", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r756", "r803", "r914" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r21", "r40", "r228", "r252", "r253", "r254", "r280", "r281", "r282", "r284", "r290", "r292", "r312", "r355", "r356", "r429", "r494", "r495", "r496", "r529", "r530", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r570", "r571", "r572", "r573", "r574", "r576", "r593", "r642", "r643", "r644", "r653", "r706" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.usana.com/role/SegmentInformationConsolidatedNetSalesandLongLivedAssetsDetails", "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r209", "r218", "r344", "r345", "r655", "r656", "r657", "r711", "r713", "r716", "r725", "r726", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r742", "r764", "r781", "r857", "r914" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r280", "r281", "r282", "r312", "r601", "r649", "r654", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r680", "r681", "r682", "r683", "r684", "r686", "r689", "r690", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r706", "r782" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r280", "r281", "r282", "r312", "r601", "r649", "r654", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r680", "r681", "r682", "r683", "r684", "r686", "r689", "r690", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r706", "r782" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails", "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails", "http://www.usana.com/role/EquityBasedCompensationWeightedaverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under entity award plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r21", "r127", "r128", "r167" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under equity award plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r83", "r127", "r128", "r167" ] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, remaining authorized repurchase amount", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "documentation": "Amount remaining of a stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchased and retired (in shares)", "terseLabel": "Stock repurchased and retired during period, shares (in shares)", "label": "Stock Repurchased and Retired During Period, Shares", "documentation": "Number of shares that have been repurchased and retired during the period." } } }, "auth_ref": [ "r21", "r127", "r128", "r167" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchased and retired", "terseLabel": "Stock repurchased and retired during period, value", "label": "Stock Repurchased and Retired During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)." } } }, "auth_ref": [ "r21", "r127", "r128", "r167" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.usana.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets", "http://www.usana.com/role/ConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r128", "r131", "r132", "r157", "r669", "r685", "r707", "r708", "r776", "r788", "r823", "r835", "r898", "r917" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' equity", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Share Repurchases", "label": "Stockholders' Equity, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income." } } }, "auth_ref": [ "r13", "r709" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r577", "r594" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r577", "r594" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareNarrativeDetails", "http://www.usana.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r577", "r594" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credit carryforward, amount", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r88" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward [Axis]", "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r87" ] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name [Domain]", "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r87" ] }, "usna_The2015PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "The2015PlanMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The 2015 Plan", "label": "The 2015 Plan [Member]", "documentation": "Represents the 2015 Equity Incentive Award Plan." } } }, "auth_ref": [] }, "usna_TheCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.usana.com/20231230", "localname": "TheCompanyPolicyTextBlock", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "The Company", "label": "The Company [Policy Text Block]", "documentation": "The Company" } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r191", "r192", "r193", "r347", "r348", "r349" ] }, "us-gaap_TradeSecretsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeSecretsMember", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product formulas", "label": "Trade Secrets [Member]", "documentation": "Information generally known to only a limited number of the entity's employees, such as a formula, pattern, machine, technology, and production process that may give an entity a competitive advantage." } } }, "auth_ref": [ "r100" ] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.usana.com/role/IntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade name and trademarks", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r96" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.usana.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.usana.com/role/SegmentInformationMarketsRepresentingTenPercentOrMoreOfConsolidatedNetSalesandLongLivedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China", "label": "UNITED STATES" } } }, "auth_ref": [] }, "usna_USANAFoodsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "USANAFoodsMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "USANA Foods", "label": "USANA Foods [Member]", "documentation": "Related to USANA Foods." } } }, "auth_ref": [] }, "usna_USANANutritionalsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "USANANutritionalsMember", "presentation": [ "http://www.usana.com/role/SegmentInformationScheduleofRevenuePercentageByProductDetails" ], "lang": { "en-us": { "role": { "terseLabel": "USANA Nutritionals", "label": "USANA Nutritionals [Member]", "documentation": "Related to USANA Nutritionals." } } }, "auth_ref": [] }, "us-gaap_UndistributedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarnings", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Undistributed earnings", "label": "Undistributed Earnings, Basic", "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed." } } }, "auth_ref": [ "r302", "r305" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails", "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "periodStartLabel": "Beginning balance of unrecognized tax benefits", "periodEndLabel": "Ending balance of unrecognized tax benefits", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r506", "r515" ] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Decreases related to prior year tax positions", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r516" ] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Decreases for settlements with taxing authorities", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities." } } }, "auth_ref": [ "r518" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued, total", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r514" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense related to interest and penalties", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r514" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increases related to current year tax positions", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return." } } }, "auth_ref": [ "r517" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increases related to prior year tax positions", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r516" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "crdr": "credit", "presentation": [ "http://www.usana.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded unconditional purchase obligation, to be paid, year one", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r384" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.usana.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r61", "r62", "r63", "r198", "r199", "r201", "r202" ] }, "usna_UtahStateTaxCommissionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "UtahStateTaxCommissionMember", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Utah State Tax Commission", "label": "Utah State Tax Commission [Member]", "documentation": "Represents the Utah state tax commission." } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences." } } }, "auth_ref": [ "r86" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://www.usana.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance, deferred tax asset, increase (decrease), amount", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r521" ] }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance - deferred tax assets", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward." } } }, "auth_ref": [ "r825", "r826", "r827", "r828", "r829" ] }, "us-gaap_ValuationAllowancesAndReservesBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesBalance", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "documentation": "Amount of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r273", "r278" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "crdr": "credit", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charged to costs and expenses", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDeductions", "crdr": "debit", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deductions", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "documentation": "Amount of decrease in valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r277" ] }, "us-gaap_ValuationAllowancesAndReservesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDomain", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "documentation": "Valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r273", "r274", "r275", "r277", "r278" ] }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesTypeAxis", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "documentation": "Information by valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r273", "r274", "r275", "r277", "r278" ] }, "srt_ValuationAndQualifyingAccountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsAbstract", "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "auth_ref": [] }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r208", "r273", "r274", "r275", "r277", "r278" ] }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureTable", "presentation": [ "http://www.usana.com/role/ScheduleIIValuationandQualifyingAccountsValuationandQualifyingAccountsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "documentation": "Disclosure of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r208", "r273", "r274", "r275", "r277", "r278" ] }, "usna_VestingAnnuallyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "VestingAnnuallyMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Annually", "label": "Vesting Annually [Member]", "documentation": "Represents vesting annually." } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885" ] }, "usna_VestingEachQuarterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.usana.com/20231230", "localname": "VestingEachQuarterMember", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Each Quarter", "label": "Vesting Each Quarter [Member]", "documentation": "Represents vesting each quarter." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding - diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r296", "r307" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.usana.com/role/CommonStockandEarningsPerShareScheduleofEarningsPerShareDetails", "http://www.usana.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r294", "r307" ] }, "usna_WeightedAverageRemainingContractualTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.usana.com/20231230", "localname": "WeightedAverageRemainingContractualTermAbstract", "presentation": [ "http://www.usana.com/role/EquityBasedCompensationSummaryofStocksettledStockAppreciationRightActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining contractual term", "label": "Weighted-Average Remaining Contractual Term [Abstract]", "documentation": "Weighted-Average Remaining Contractual Term" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "b", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "38", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-12" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(i)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Publisher": "SEC" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-27" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "66", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "325", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481612/325-30-25-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 101 0000896264-24-000093-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000896264-24-000093-xbrl.zip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䬱:B\-3E8-R:L9=5D>A4""9[3@'>WWP$"#%BG.I_(+M#\$K" M35G.!8&(7T?DQ? N9-SR4/#XV569+V9T*MU3D-?!TEU.\@6&4H*?K1;W578) M8U5T?MMM\+"&2[\F[+,D,XF4(+$!&KD$#VDY6M$= M?0\W<%$6>SZUCU?8*&G8XA67(@TI+!"BW>-!;1VJ$*I !L @Z"\CNK%##WB M_PIB#\+Z7#JGL:59V7R"A;Q,2\++RD9"&Q)'="%[4N0B1= FM'+*14U\NHF# M&G@^Z #PXV#B5C-ZC=H#['H [O@KS2,L>&1ZP8 MUD?C.!CZVDW6)&JK#4Z/@Z[X_0UNC._X\F2ZO2L;2L6T#&-0W;^1OOX$2"95 M>2WKN'VH)D+41U<=!IC(UGE397#O_U^XN':K@Y@O%8Z*5H97JJ^SH'48#T[N M>QB?ML\B7OI?P$'D^".MHL?1E/CC78K2[[@8NS4E;-([]9&M"='DOG9'Y*^> M-<1$^:84^0^/: 6S)'J3C+))-GJVGABNP(NYK3GBP1^P-0/=FIE^^O>L=\(B M_-_3P>'IAA^VGZHT01QTHKU<0S_U*)(*'[M1DSLX)A[5CU6[_5;2?K05:W!\ M,#CCS&)[&6X0W/W-GM/7?PG6X>;-^^#HZ-'+\]'3G3Q_*?(\'.[$>7#\<=*\ M<1;%UWVN^,=B&VR!.<7L(^6BF:9(9F&]F,^$'[)YTGRV?\<#?3],C(/UEFM+ M5,#P9'!RHPY8ZY!\ 5?=0P"F;-Y*G9WNSM+Z9^GT%NMP=Y8>XUGZAL[2M[O# MM-ZJG0WV/]-AVB3#C<_2MQ]GMO;#Z6R!V4JS_[6LJ'0_NTL(\#Y80ILGW$=G M][Y>[P*]=)-&Z%FN+=$(3P=/UU0(-YR++_)V_?RP7)NW4L>'NZ.TOJ6ZO[:E MNCM+7_Y9^N;X_I;JXSU,WSP=''VFP[1QMMK'6JJW^V\;-V4;2XVH>O 3\5VM M6V^T>9)_>';_R_<3>;;KK.>6Z)/3IX/#^WF^:PK7EWMY?WHRL"_AL-XU?[\[ MK&L/[A-H_V\VT27;;YP@:?Z2#**WLA[!TXW*!H!FZ E^4!WFT,;'93[/@ M6W*N"1CEHP)"GTP^O]QK=J<0[M6[].#U\3N%L%,(.X6P*4N]JTN^7V3^O@F? M+\-P[Q)>ALV"S'UQ.CCX*&"_GY(JF97%&,;?'OJ=0L6KL4HW?9AWA,L^&&XN M7/:]2-HV! 3R30C7FY?%I8<&KJ?9?([8N9B F,+_(7#A28KPP%F>,\9C:=@5 M&/"W0NQ21(!,$*W^*BT6B ))F+_)?)[#:2?H1L8DSFK">D;$][0@T.N$\:VK M,H=?Q HQ/R.&!L4%1E#/"J9M2!40LE*&85@E$H+79K!X>/\XS3/0.$O]13/- M*GAJ4C5+Y-6HLK0BU&F<.:*##J(WR9*)5Q!:'GX[IL\7!:V-'U%WYF.%(M4E M4'#]K!CEB[$B^J?1D]?$,C!:P+>+)LJS!!8W:[*T?A+AAD49,K?*ET>6(.8B MR1%Y%$:;IC#4#5T1 M60F2*'T3\9DD&:&TVCW5G;Q(X1@5!.C,&*)(V9O!(C#.?\Q3&XW2FE#%2P+^ M]$_1;XL@>BJNI"B0H4NAQV$KTFOX;Q)V?*3'AN97\&A54%ORB/CH+',@"/)* M(7=@ 11R!Y69RP*.;'!>$ @>=$&5X%G=HSG LB,;+3T:13>M9KH&H("4:(A& ME"#&];:IHA=(X 38@&T_"P$3$^2@R)6U"2?>:+<%,EUA()994D.FY,G8+7& MRJH#:UHO*CPES!6"RS=%!J9165O"'$2S9QJSWVNE#.N=(^!;0X;7(4 M(N>A69AQP>9>(R7,V(\(/_#9,'__9>A]Q6P0L/WKH ME:B ,([GC..77)(F=*HAIJ7P"R\J2O@$<#4F$U8HR!3CCK5, @Y#19LHRTL' M'>F-2B0YJ!=XHFO!$B; =E9SHR7,11"&*^(OV39I=?H %PO& F>O5O%4Q5:3 M6"% --,)E3.XQ5#_UG:US.])\E,4"ST::5$4*FK " M#5:-A9D,]4):BW#B?5HV?B"$YAP,C]7;+'D/SUO,F6 E^1,4/1PI$;^;5H!X M)N;)THTI'+&[049@_2<@%1<+$#90V7MZKD?P)CPY":=?? J6O/9D [42X:YKPA MQ'M\GE^69#1%GHT:N3VXG%IG-8B^;ZVXO_?XB7RU);EE0P@YG7 %A%O)/L+6Y@@7PL+ MA\>*KQT]7QQ*P Q. .V3??W=]X8.KB-H4B8D\U62SAN^M/T>%@SB M8/+J9.F4E6XZS848<)"X1R<+!XJ8P_0SX9^",>)T%QV"LW%):]&WUKP8G54@ M[E7]6H]2+8N^E4^8WTX7/&EY,<:H$]8NNGGAJV(ZB.BXRW?KKKVWS# 3BY0R M-6$RGF4%&D1$@.*---WKZ^12-.@%_&J2X3D9IW.PMI@ AA\R@Q43S1.C1B<% MJ2H\%4;_0I*_H:I&7$Y$7" MSTA\$#IZN,(ZP\9]96>?E$8.>X34!JCBRD(T6KW&"H&&-7KEQB7QM@6MZZ*J MO'0IHTY6P&W3L+N*:G:ZK,DQ WO,K1Z.=<%7%2I_8J]@T4Q'TP*DZ!+/Z*1* M8+ +9JD$H:T7<[8\%U7+TG1L&#?(\N/CRSD,UV+'E[/CR]D.]:YL;#ZB!_8H M7G==$DXVAS'JD8R\)6EC$7F)VD<\/N?QXB^<\_[[X.T ;N\<5"D%ZWATZ7A/ M:/!6^8L4@_$6!AK@GFV:0T'X>+8[Q(3 EX)65[\:'IC.U7\G2-Z8])N-)YBK MGXPQU(-YQN2@/AK9^A(%%?FT"E;1C!O+"'7 M=9J@?$\6;.&!]X+_A)_2_0,N83%6D2'RK,S%_#38@73:X/(Z((R M&6\MONE,5EXC_>BCF; <6!!$KIBEUY2Y(67L7N%>C9./*>="7]5X(WZ'#BS- M7?1"S(F#,;KPPO ]F^WSEU]A8Y4DB__BQ/QPB^2B5>X)_"++2L@ M!2TE@H);U*"#IM>.1E!,#%V^&E@\?=_S85_]D@MY]LL32GXMK-MX4[9"3WIU MXW[2V;_V"@ZV;9KF\Y5JR=^G;595Y$H$)VIOE?'%G+[D5";&XH+MWQ/;B\]2 M5M.]/''#1,%U6DYM*#A;&9&UH_?*VL-J- S#J$6)"^(WCRW]9;"W\B:PI;Q) M1%:=1F1L.A;#!%E3M[G5-6[A%XGC]_Z)LD"KC:WSVDXAV-!2S&14 V3GJ'KI MR!G&66%.SJ%OE+%1%"RR*R:5:*R6[J#Y_/+R?Y+9_/DY4[C/2ES!"E-C8"=/ MEBTAP/\R@F"GV;/]%)#Y;]^@C4@2/\I<3@*Z3**U[OZZ*]H4<_,ZOV78 M<8Z8C3N6/3QUP]/G==^C&@GVSM:S^4S90L?FTZTH5.9592J[=RE![M;O5@_S M(XS(T\TU(G_S*N"U5P%WOE"Z=4P/-(^W1)-*1A92=YE[5F:X;7FW!:I[6RYV9EO42# M02D6*'ZG]P0_)/&]VE=RTYQS"<]O?(G#H'^$W8N&^WO_(JN<[CX*GE<#-_,;1'&VQ]>T!/3BVJ!I__@C)G[;*G959+E'$0L)%#.!HT0V.,Q MN$XOZ@Q3PTTT;9IY_>R[[[)J@+S(R0#D,9)APMO<1IF?7%]?#^IT-+@LK]!_ M2IJV3PIGKP1GH]*+DNBPL2 +@_9E8,G?7?-NB)KZU=>R%:R%QBF7MXSAW)U] M3;6#7YV>#DXB>'M.6228\U=/#X:#??\G/O6ZM;C7N)2I>UA8-G>=V$HD"6]* MMB5!@S#/T^(2E5T*IDPYRT8@5E=951;D163HPA:N8@)9QCD-Y2HLIN#-78% MX2/&Z6659V:TD%, MJL)><.%CT>8=I\49#HZ^]OMH[2N935A\N"@FR57)$;O;XZ1&JKP8J/H@O8$Q MSL*40WYU .*G K9U'C(>*Q=6]G,_&^Q_3!([N>I34<7<[Q:)=SW("Q;$_.\8'\IQ_9!$-V;;[&K29O M?7AP5VWZ4(D1T&Z4,MTVK8]JFC-M%*[@A@QR;.$A["V-POA9D%F[3,O+*IF# M!0/*^5+#WBT#N^ZWL/?5<$8-WV]]/UNCFVD3>JRZPB@KJI<*=5&., M/KO1_LGGVA,^\?KOOOSCVFW M3KLQ??ECNOE)@HC3,M4/^#J\#RGI\"Z4K&R=/U##<<=^V _L![Q4?Z.;E RY M;RB!4V)<:%S?I6/]-B2 JKQ>]9/M6"G.YDE%/+KZM$YH9NQ6Y\D_WDA#!=ML MNQ4!>='HCHNDD<#4@;'^B->G)3&X-ND'E[B1Q:,_\P+V(9JU]/?PZ-'I[W?7 M:7Z51K]@"6H=_8#NSJ=G%_],7_O4F_AT2_=07=!(/=./W<'M7PAQP[=-E-> M\QFEZ?: @>_OMVAY[@=AQ',VD$[# ,_I(]"DMO?)FSNR;7SR;F2[D=UK9)^2 M =B'V3=4D_]4I=A=Q"U''X.&W(L@MW'3_>JCIKBQX'@TMZ/3XWC_Z4/0]-X? M9/UQ@([3]AP_$@1_FNPG1_#?J:)M4D7'^P?QT=E#B/M.%=UI>]:FZMJIHITJ MVDI5],W!:7QX=MK)6^VTT(/OS/'@^*_=EIT"VBF@!U! 8 L]/=LIH,W;F>&@ MB\#_Q2N@3Y2?V([PUMMRT4S3I&ZB.Z4L;F1-Z"[#ELCY\.0P/GNZ-@_*ZFW_ M'&KH+G'>+W1[3@=G#[ WFZ"+=L)QJW \W8^/3A]"/G9G]T[;,QCNSNY..%98 M_B?Q\=D:EO_NV/YEEO_1.J;_[L@^&L$XB@]/3W8G=O,V9C@KW[=.FF;L]P;1+9+R58N!..V\_N6?ST^&!W M=C=U>P8/41&W.[O;(!S?G,;'^VM8^[M3^U=MS,G@Z>/+S.WDXG8O,#X]/=H= MV,W;F./!X>,[L(^MU2]ZA_27'Y,]O[T-9XN$_O1H/SXZ/+Y?_N=N*[$%P<0O M:DO/]@='&[6?FZ#F=@+U,0(UC)\.UPWM[73$1F_IVMT3.QVQ$ZB;O-UA?'0V M7#N[M5,/&[F;I_=(5.XTPTZ6>BN(SN*3H_4KB'::82-W\VBP,4I^$S3#)RIN MV.SPR0Q^-TJ80N"'157.5R,B?IFAP>'9?GQ\NFZ49!>Y_>LJF'>P%#OA6"4< M)_')V>[L;NSV#$YW9W$ 6?8GVV)Q;ZZ4_(YHD#<8AMD3!L@K+>Z>B=COZ\ M.OKI67RR?T^X@YV.WNGHG8[>Z>B=CO[,Q2>G\?'3>V>9=^KYBU'/WYP.[ETW MLE/,.\6\4\R?'(;Z]&1]9)F=8O[B%//Q/:"G'JUBIA#T=T1&W\-U+]/;0Q7X M['1P0'21=QST3TF5S,IB#*-M#_2V<1[@.",WSO:H9DEUF16\'0YS)RO&:=$\ M.SQ99XSK+BP]\5G6P#:.[C %V]OW3*?S%^\YK^6[:1J-TU&5)G4:907HCJ)N M$J2$5>K<(@7!)G9J^#A@K8JNDQIIF&'98611 X^JTGJ1-U$YB1+Y$3P<7XL_ MYA]A/=Z[)+N&R5Y/TRJ-\A(.0-_[=%SC:']P\C7]\'#P].L8WS)/1TUVE>;+ M 4X!GG+=\RAY-XT\R?,(!OH^;>@_<;#]&,51O;C8JXB%.XYF)7Q:E'0,]&=O MIEF>S>?T8!S3^:)N*MCX)(8)9:-I-$W&-TZ*QP1K=' \..5YG0V.^N:USM9X M$"?:E_;(:;+1OTIXG!UG]%UL )?-O N>>%>Y$4R7A]81\>#(8@X_@$N#!: MTGYGG?[7L^(>,%M?6=?1FZJ<9,T&GH,;Q8S'/J>QPZZJ3CW8CRZ2&J1A7F8% MR%131F?[@[.O<:_<#L;18AY-JG*&GX$.!J% 3F"6.'T6_O72OH07(AK!7"_2 M*&F:*KM8H!3!.[Q2SXHK6)FR6D972;Y(&I#D*!G_"=IT!G^O6510!)6\?0)* M;9R"6H,[9^1?#T.?)O#QB 00?P*&W.44]!W]>IDF%8VWMC^A,S=/P/J"<[6$ M9T]JF//%,IK"RL$%-\-K+D.I!CV*RU!,DJNR(FW*;.ET0IS,IQ_XKU&%YX3' MGN.2P*CS%,R\!#Z#">8EO)G7]LX*]8%D_KRNRU$&TXE>%4A4#0>UWC;9]W/( MW!R,")YVS\#10?L,B- ?QB +((DH8M<9W*5'AX/CKU5-@DB6E96;C@7H!5!>$K\=CDK\5B &*(\P7]?@NELI@)RAJ(,-P/=^/<\'!LN MAV]A?N!KQ-%/:0'GB-?B?#S+B@P-+UKE'S[ HM7;)Y]N;I=F;DDXMU3F9G3W M\*0EN$[<0)*\X.+#O%Q]=3PXC& ..2I:-"@NP%\%\8M T\WJEM@ZW=ZKQ)U& MR]'*=&K-O3FT2,8ZA>Y;]?'N8/398ROKO/XR+RFA* DL6 MI:6X]-)B- .>]%$R)SOYOWS1@H(SWQ0E*8JM7%31.+O$KZ/* Z.9%$H&=V5P M"6S4'FVZ%H,[M)REX/E^V#XM)6-O<.Q&"\%1.#Q%#Q:$:5ZE>_!Y!/=) 6)H M+DTU( ]/P.J_X:MB5*:3"3L%^#JRIHR="7?W(K4A!SR,8GC)1(S$U)3Z 6\$/VD__U= M\H^.2/-J_^-_7U3?K?/AANK.EUE.=^\/JC'>@+'Q=@JF^+9I4C>3-V^->01J M[*O#P>&^*DU6F/"GXZ=6.69UZ$UTS3)GA:EN[5%VV?CO3VZ7M.'A_I.-E8>? ML_\LLG'6+"4>199-]%M:@^4RVK[K]8\TFB9PX<$&-R4&*#$B,8-=1$/LNJS> MHUTG]AO-6/]-%ARLPZ)"RQW6I$HI=()QC$6-OT)9&"7U-)J ;+!8B:E8%NP? MP%?'57*-7T:S$-ZH05^0-'CV('H-?X,KMQAE)QBC4>+'2?(Z2\!Y22A2!-\?IW2#UFR$7B3%>PZQI!5]!]Z(+Y$0 M:(R7?<6/Y"!, XM6E#YP4X$S#(O),Y6I)1=9C@.&=X-W5=03."ZX"+!N61-- M0"7#HLQ*7 OX=H97+7/8 G?Q%?DG6]P6'9"G6&GBX;+#_6%8@-@4XNV+R M?/,__^OLX&#_^=OS'W^@?PZ??RL!78[?=N;8T/AD*3E:)VYB=I7!.8#YDY!P MJ@:7J1,"QB@=[%6>+''$Z(3"DDPB'$-4@A#@OKC)RTS+"L?35.5X :\OX-C8 M)8!?R832#S!A7"G[,<>9X5"@!,L28.RPIL?"&'GW^F>#BI!BC7Y*/$+:E"K# M&$I+,L+'P>#FR7*-]9DE%-W)LQG]5ZP!*56:ZI!](NH"CI&3@'"Z5B, M2/U1E"N=S:<)3J^&-TTFV2@+!\O!E63>Z&Z[X%UZE60YN<^CLBAGV2@:P0:2 M\\&Z#3:&8WSPLT'T!QYKR5R ]YQBZ+M$:PP53S*"][$K %.8EU6S0-]9XC$L MN;PDE*D!K4$KE& @'/X79@/S_6.:Y9@9PE0.G(A%N:CQ7=D,5QG&"_L)>Y+@ MCUL3!)\>%^0"+P =UB7<)B%3@Y\,BXL&#_VW* MT7O8S3FH_BD&%36>3MHIO83E L,$YHR;25<9K:I;$1BRQO#I?I'AQC!6L&9Q MV1=TD(OD*KLD2:*GP[OR/"TN\0L-2;5S#O/E!OC[:V8?7Z!TL\$"__@!%N$J MR=F"WRZEX"9"YS7U$PEC U\='NX/CES$$<[GRW24SB[2BHO7#_=C"1&PN7MP M=G;CUX>Q6,(OG)H )8UJF6Y.;WW0T>03AYGPKT[W!R?NN7TY'YK'@G-2T00T M.]@ZX7/@QOQJ>#0XT,?$?O[Z.S[8?;\[&.SK[\ >&H\SMBCRY?II)3I7_?1L1RX[,%I-^\0 41X2!G9&Y\=3 X=@/;-B'$6-&D1*. U .M(%Q5)!2@ M/% :0?-A>$5O&31I5THNK(U$CL#$8/4%XRK'N!UC,,EAO9ZMH7%X/"Y"1%5B ML#)Y,J_39_J/Y^.LGH,=]2PK:'[TH^?R, DK82BE521&&\ ?^RC+8)\C+=(T M+&^6CP?PT7?=OY\.!T\/^S_:'PQ[_[[J42CC9_T_6?6HU7\_VC_Y=(,ZO/%1 MMS1:WUA=^;3SM9XR2([O/5"=7\=[WK]1?5- Z!M0/[^P3JB_[58$WG.M3"7K M74LF-WP5STFAT)+I/17IC7:7"O=;E^$QKZ-<]1^)B3"9[$]&6P5:&'B2=R]5 MYHD^TDZ&M2:_V178PY.G:Y.FK37_S]J0$!ZWNW7H["3W"Y%<<([6;E#_W)+[ M&&!N*1#Y,?A(7]JIZIOBII^=AZ&Y_33X8SM9VRI9.W@Z.'L867L,]OMYGDMZ M2;*%ZUZ&7_)IZ9OB9I^6HZ>#M4GF>H5V$XWNG:AMTMR.CAY*U!Z#E4STF='J MP.>:5^$.4>+S+LUF'U5*:][/AMIT4(F/L/-W9^(QGPG*W6_7F;@9X&*CBTA^ MS,MKZD9VQ0^OPZ+.MS!5Q#+ %O#?:ZY#P%]N6Y+_O([&63U:U%ACD5R45VDL ME8LWE:-BEX?4Z;F*LKI;4O9K4!M[:RE)@S8$5DT$Y212L]L@X_[R%E]8TJHF'FPB MELJ-$O&:O.O:R/="Y)N7M!CE"UR@I#"5=EJ^XZI=J(A.BMEP46$IM7H.A&A. MO_%=1M0"Q#5-M[7&T3/P2Z^*<98$XA86_OC2(:HX=8/ANITFJ]*HQ@8'(W?# MH9$[K%(AP=NV#;SOJ1ON'PZ>MH[=P68?.[O%\V2I/==)42RP>'\VS\MEFD87 M9;&H$0Z#BJ.3T:B"CVLK=8J4D"FR0,+?;F0IFBH9(YK!$B^SCQ UJI8[.#95 M>")F![NF.=\T=[)KFMN L>R:YM:V'7^6QIX7U-BS;1?'JP*4T8R;84B_"WZ0 MJNRP;4G;,";H<3 \5I,Z:^>O/U4;<';@ ESGV!P<'#[YQ_^Q!^5!( ZDQP8. M+OE^="7^R"7:<(E2I90V4XCI!YO]!J[CZ-6K.'H%GT9G*!:$EW7.5^]O*79E M*()51K\MJSDN%%_RL$8I%F#?O6%G8PXYM<7B#.6:_]*..9DJMA=E=](_^J0? M'H-=OCOI6W;27T\F>]\G.75TOIUBX]UY5:&G/]O&IJ)?06:W;P_>+F8PM.6V M+?:*MD[N$F*1 D^3>U;YKSTN,)Q3\49GV$M;1PDV49*E369ZGU5V#7XE*FO3 MG@G'?E1>R=>-=VWZW(LT'3M RK(:@U*H,,RWJ&IZN.MUU-X=;!.NTY3&(IVW MV*-\S6!:X$?CF4D0;A!>7 ?P2<555I4%1XTJF$A2-!F&&AL**F'[Y*)&S7); M#SXLC?/"34^97%;:!3^ VPH[2!<5'6-!=;@$U[DP[>74W-KWN#C*)NY9H.7* M13XF6 BW$["ZBQJ;Z1 ^%-NSP:=W'6<"_ 72,$/AX$90>1Q^&9;P??\T7)/4 M I0I;P(L!*P/?I@5A$)V[7OU+RMNT\(M=CW>[M-96EW"-K L^>99[,RNZ$U< M4H.=A11)>XMMJ>&2RI5 8UKP>,;I!6TA_@E!R0B4V,\%9]DL88H@_!3$&<"= ML32/E2NCN"KSJ[0.'M/Y+;XG*[ ;F6\HWK"*NGA(XI+4C>I00VP3NH^=8D/!T\/5FOC?(OZGWE W/ZJ_F*S;)+H=O8EODB4KOI>+-/I^ MB;!CH,%3?T;5R#Y MVD53?B8(^OL1_NW:B1]Q._%!_'1_;8[C72?\1FWBXQ3=T_AD?X?AL)/<[9/< MXWAXNM.Y.\G=/LD='FP<]LA.;G=R>^NL$;-[>/!\TV3W,70$3 M>D._I/O]323<=\5(V3S1/1S&IZ?K:MW-0:WYPG?G8!@?'3X0SLMN=VXU5_;C M@[.#W>YLYNX<[[3:AN[,_S??[=H7B4A^+@:;Q_=+H[%+M#L3L4WILZCH^.U_6F=H=B=RB^Z$-Q MNCL1NQ.Q.Q&?-M>RV1AUF]*^)*2T[2I (:B-+M,"/D"H).DIY6XYA\+5)!^P M^30KI"F2VY2(*C@MJ$N26BZQ\Q_[D;#W""$"RJ+.F-53&@2#;Q5E$[2-4R.I M&V!.E-K:QBH?<^\1@Y "3X:E&!X].0?/^U ";:K=5'/?CN[ MVCW\VK$[@I5=Y'AT]NB@OWJWI\AGR'&;C5@9!*2Y%Q6U"E_#R2ZX*T'X@W45 MN96XF>8I_)MT0UG5TVR.3>W)B+E_C4:)W:LLZAIU1E[Y?M[K-,+66NY(AC-_ M7M?E*"/.9]#8TR@OF;F=67X-=3B"L.$?Z0O4$5];?O40K4WFHF!Q6%N.;Z;& M>2J#YS[BJZ3*RD4=U5,0I3ULY'8]H=A17=9(ASZA'N[NS.XVJ]NUWN\@MX7K MJ'ZCP'*V+W>G!S\:ANGDR3_^M=.#]^UE/]G<7G8X7LQQOVU:_N?L?0HGNU@* M,L-E7EXP("H,QK&*@]F%RA9A"0QV0::31@@/I.I%MG)G=%V7%>@B)F%?D@+J M^S(^6B$EDAI?AAC;,*]1CR(%<@P#CBY!(' MCO?3I>AKT*9%C2+*&G $2M4QG_=/(Q;Q%W@+V#OW&>,/NY_QN$&G)PPM@0]G M%-NY@,LB*H1PMQ.,!TY8<$^/=G"<4P?'>;H:CG,=/?'4Z8D=B.<.Q'-3KH@7 M"!*#5N/Y:(3>*2J6-W !(ZP)Z:@?A,U]ZT!.7B^J-:T),ATJLAD8>>0B34F_ MSN$^H&\DL$C5F&($C #M%TT0XW.8P/_/WKMWIZTD>\-?1G?ZJJ6Q= 7 3"".BSSNPD@*16 M]:^JZUZQ#0+?\W$0>P2FQN\BTMHC>+D>T\ZE7?.]U"EIO[3;C]*>^5#2\#V2 MYUORF=%&@?CO<[_G6=WX81E>'LY8;CET],CW%6<(K' 07>@G+YPC1;3RL+\3 MJN8.$X+CD:B3PPUL9;.$K$?6=Y*='D2NL(; MD@G.9T[G*C:26KP"040/CC'1B$NV5\+SD3:3OS![(C1'ALVN95\: UVSN[) M5EVB]Q<7U)B,@H_@!=7)WDLWS\?VB5F.)1F%@PHEL&='$ MR4]T[D+SQW='/"#6Z5M 0"_2.E G0:4@?F?1-TW\C!JRA>85T"<2!0F$):A% MU!E0]W,F#=* *!KUH@H?&^KRN'$>>\,.0@,B58REZ+FR23B]%OUL>LY$X@EA MV[ 85>1Q;7SRR1K5_$GW/QP[IG/M/Y/^,V&!6H^%C>CH+K@,^GDOY6W'2<$W M^^I3W 6"PN?4'KW 'I1TB?\-C?,)=G#MN<\.;4)IE<&\4T$=+HB$+ZWI#^RP M/\0.=:!1,^0E]#RXA".&CMR1A0P(?\$>]5KLA! :]0![O0$&&? @\.8(^00E MEB.%2HBG@U,KW-XD#V47^]Z*LQI5$:&)H/:1NBEX MAOOP-W]@\7Z!5<(%4]! J?X/V##!6ZBI8R-:H?BB=A.I,CX&+WH?;6RS'G6(#ML)RV<(Y56T2<;'X5W=Q*H>)A$5)6VC8%K< M6AB;)0O=5#IG&78:QD <$XD'4>; G,3 UQ!CIZC'*A-C[ M#R8>S0PC*QX8040&%]UZ>NERP7["1 +*B77:*;HTQ3E_!D0FHA30*;S?&$S>M/*,ID%&*;$9 NW!P8VO$!BF^ *7" %!\*ET22K <8&[8B* MX9XO6'%DW:=:]@?'W'31[\,D#.X%F^<+0M(G$,1"N0Y$:IAOZC/K-=!_[*;5OZ M'GOAN+6(4Y@?\0_SQ0./\NP*TPD0N6A)O)!\PZB8=' E6'O,K+Y,GQ HQZ;U M2!*1+X'I)+X?SQT0PEZF9N0S&/XW0J&4LRAPU?J#XG[152#G3 93NA*(>Y"02L.]"G_SL'AK(/J33@W8@C_L6<& M23(O8F24?6/8!*F^O&727J0_,B0>Y@TF'N)K@XD]@$-P)- =1HSAD',]GO+NZ,KYT,HH1Q9H$6O"WRF&S-KDFV/,#]#XM6(SW" MBC@%M[?/I3Z;).@TYU!Z0'BDC?[\5VF]/.2EDJ?64$Q1R74 M0J12.Y79%P9/$C<+,_QHX OJN@D[.(X(R>$R0#_.@9]N9A\X[V26EAW>*11\ MZYR3VH-,\NWUF$\2EY+=@#,O>F(4BK 19&[PV.K](+% @UMC^^@U'%M@R=P^ MWQ<)AQQ>] >0=P@,*8V"R H1N7H_<10%14>X-3VP(=)8\*GXS(3!$DN'*?-V MC0?.W*S+Q1ALCX_DZ& 7_!6(DD#!P M;/<5=>F!E*]B@+#'F6W]028,Q@\XD.E#3UY@,7 M10K'& 3&3VG.4?#!\GS<*%W^#1-&1SP8NGT1)\8 *RBA9 V:SK>E*W KDQY*PO)BS/ODGJ.X0IJ#KW'6@QEE0549PDHK@D1.68$2G5^QPVO:^'_R;]$H2/ M0V.31$D!SA^:BK$^R=E1(#-P7UTU"YQ?C5IHHUW2_C'!*7Z!<-#@CL('=OCO&[#9;5[ M>(S^)@Z&;Y;_8['$WKO>M#BM#KUL@!<\'L,Q7-)C$F?XA"<&Z3(BKTODW _L M"6JI42A+G+"]MSBAPA-'+Y6X<% FY+]CC\S$D6G69&1$^4>6,Q1939A_[2*@ MHV0J"E!$WC)QVL*O1M&0!72GA2O!M/!HDI^>'!L9VD:@)[B^\)!XL(F)-;#0 MO],7JDF",^@+6ZQ!M0CK(0??B:%S&:O M,C@1YC/1\IY1Y7(2I4Z"79./(,^#9T4V(M;NT BVY$#.**]<%TDV8-L"EJ2' M7T\NAG("H]6 EC:QD\YCRI5Q9Y8 1DR?2Q]=N-"#,RZ^ *Y ]*N0VPCJ_O[ M-"]*VF].LS@&%0A$TP^6 M(P%E$F7L6PQEB]"5145;]!@'];Q=3LA$)[X=VF""N+Q_ 6_B@=*X2&Q%CC2,3L";=NUH+B&) M%9D;K,NR8GD"QZ__[+D^A4$&5C M.H5 ?>%P#(,49; B]H,[-/14Y!$0M_5Q M9J%'MW+X,TM>X >PX&?XY:*+NA(AKY1D.<'$U8ET%,W&AZ,P:6IBL&=6)+ EAHN2)P.>KA# MPM'=!]7? L*)DSQ$B/#3>CB&.)R!&RE#;W'H,3'Y4OI34M8>\X=!N'TW9)9XF* M. <8^<9T8CVY_C#RBW9Y%G0_;1^((=YP_BU Q!56L:+AP2!8W M=3_C0SD,2\N"71[-H\;\>CAD(_*%$B\LX$JR233"6$ T"&R13T\Z.OQ09KDG M(X[^;,$OL?-;LK8W4=,[D"=5]"XR.R)9X9:NCD1+B[,K* 8%]K-@"* :GZ-9 M*)0D8XBX6ZPQS"UG6KH*QL,ATHFWF?]MG%N!LF

FA M?9?L(!2/5",@7B)FP.1P9ID03-YZ=." 2)O(X*T<9QW&;,)YW$YR1G>4IS[& M=Q >^VBJ>0_=0H.)31G(MB62]M"_)Z9OHU@-T!81SF3;#N5\0DV-\$#:'E$1 M*>:(?'9Q-L9#VWLSX"HN8R_R\THKXAN*9-+#]NOG;2^=F$P:-\:H<4QW&.F1 M:>MT]L:!(#%_W$$-/*K[C\O^A0K@IEY!NRM^%78K /TP="92(@9"BU0?$2]\ MFV/D*>N,X$4%UM&B0=L)9'$^Q@F \1&Y3 1#NZXGBTV%BA9(/HP2-4:(LP%I'R$/)U+..TL/R&#-G=E MU KNRFB6%E=4=2:@T-*_D;PW+&#%E02+IYYG>+TXGZ_[)GB":$2A&7&>H TA MHC/H1O;)]=4+#0;1FN"?LC6!4=.Q#LE]W0(]S8*CIP7:>7R2(U%O+)^A9BG( M3 >++#-E%#9RDE6G>$&\/;'3[.!4R7O0$V+K;_,-KQE%W_"V#/N[MF"B1ZQ- MZJ.C<]T]V]/R;V-7.I[%,=:V?)VB0/!W+KH/B4X4T=OUDF\WCMXN]EZ"W0(Z MLDQ1=&+S+Q&6D!\DTIU%:9Q\C$ADP9/[-M3&V[U >CJBQ"+,!]'#4C;\JS\9 MH0WQ!_Y=^ JE9R21($(9*&$B4;1DU*XM2E.1/^O<7D>%H=XD]*N()#]A^+) M9$DGWPH3-'N]R6@B/3Y8KNN.1A/'BG(VX\+39!<.?-7KH<4'\,*@YY.6_X"V M'B@RYX^B*!SDV=R7'^@9XLI8[*5<.??E!_+!4KQ^C&8D%WY8+!4,#R=2+ 1V^2\+;[.0<(& M:(8,8?WD68Y02![_L7!#ZJ3!A1W]7,=^2P:@8IT.2T1[0-47N7RZ&[YR5$,: ME@D7V999E.L:FG,<*1-5R@%'P.N)0HE06?%D[Z-E^%R&P&1%:FBMP[4439%. MP#4DR[E(^J(D#N#/;\"/FE%A%T;MG'](I*XEA<6'65N$1]):!"XW>1U8H,Q1 M1$CJ8;HL!4WA=53>1)0WT5)Y$P58B\J;6"$+(^<(QD%0*H7I!^3!LV-QC\FK ML9].B$79URMNZD"VF1X5DZR0:J]<9G5&8A'OMM"K0JF0F,HP3FN($RJ$B?8@7X!*FE&^^#MV!+4\^RW,?1>]*&P[D<@MHEZR M3N-:N/0C'78^I6)A2(BTUB@C0V*2,!UG4(3Q2:E(ZW%*OO0#4V(D[$O.#8ZB M_D ?UF:'/1F'O\TWF!&-))$'[D+YQ[R>!-.2!BF;7MNB MFH'[V.;0\H>AG1":F/3O/I@6(JRZK@!>HAL.ENB&3RD\LOY#+5]TD*'LVD@R M==_(V1L_TY^,L<[!%QZ"*<;\B[^16)(QP"@-:OJ.GUU,8"9?!/:-=+TIBRJ9 M^R1*QAQND]47VD.IIE!L^\GBAA4R-XH+S[0 6TL$RJQEN0]AG&MYI[!$)9X? M=LU)MF":<5%LV/,&F:HP30^HBJ7^:7\1J&G:&-52#6GQ*-N6RH2!9#-\JL/& M'?3E46HY2;CU.5R(J6Q8CPU@D.%N>>;))DNSI>5B>T'3"H^TZ*3"^I>H7BUD MD,6=1]3&;[OQRP0(>6^FMVVFH&LJX#;&6 M(1W*U@'UE.3'-*#H/42:UXB%[J2T_HX3D$J>]0>+,)HX(@6$I;B>1>S2GBP* MM;M$[?2Q-Z84/P%&+_:/!C+; 6T8P,/$";>:4/;?B16JVA.?DVZ0$%8S>QUI M(5)V)3IXR+S'2-./<]'6XHJ#,QSOUM;#ALR/\[4IV2!,;5[_'E.ZG(Q3O+@V M9O0-)_ NL&>V]8Q-.T)__AA4H/"?6,TI6D:B[++96*HK42T5_HA<7'WWE3SI M[KLQ.>I^TX2^8<#E-8&G$W)[#0:REV?*GV7O65<7Y@L5)2-^KW( M$A.R0&#%9P/^/&&DTH29:K@X:KQ(?AV9646?HBD$-#R\G,;VO(=#0 *M+LQ% M[ FSAR%K=!/MWZ+O+5&'L?Y>ZP*+0G%(8#"6TV)_A!DBV_^DXG)&R/X%SW0: MZN#*1$1KM(9:L0&V#T[H3EONZ\8FR:*,OI^S5_6$,8R;[5-)N0S\I%FKHG!] M6;@HDVLVX4S5(C\JABI'[(-\\"D/WC-SDNH?_O@)T-S'+-?KJ+^+=G[]T'GX@*RR8U6)[GB) M$QRL7I8#6;JK+O"#9U'7\<5C(_[J>C_VF@YY;I:-2C+DA\V.DALK:K^%=R#< MT*GM3@GMI:%'SPC"5^;/^/@3&?5Q9][P/DF9N;ZCHB B).%3 Z6I+TH^9(]<=G-1 6)&E#!Q%^1A8S(]E+3] _ IC#(]VF_=%,>M4.@GO M#1UXS>>WJ/(B"KNJ>O&%2C O'9=0S M$-0H)C/-L>L=;3@LX@=_BYUI\?2I>,P?>;1H!3(ENT<9T6#T34@X")'4C@/) M4V["B(Y1(DX,)'%3Z3)G>#CBXB981<$%<"SOD#'G:8T[I0W7T4?P6S[ 6H!\:3.R*A$NU=(J<( MS7 "C7SAT LJR" \R72T3U_LX5Y&G=Q0;$G791^S,]VP?$K634S=.7Q+UJ-R MJOFL^+0WCMY.Q/=(3>]C\B(Z*>/-"ZNDX!9O23./3A;6Q[,2%RY0=X"-CIZ& M/%6H18!.EIK#>\KVS4"E:;,B;)BW.G8FWQOE:FB MGPDEGH8G.2A8ED-N$2?=LDW3)#*X2Y*C*<4J)71DAN?TA,M6.QIQ.0C77/1T MBF^H08I_#<*$$M0K<[RP2=NL,97TD>C?NGN#8BEU6 MB5J-Z50><3;!WKFRR>C(=:R ?%Y2'>>B1Z 4<-(*CK 9.05$3XX9%X!L?Q&6 M)\2VOY[HHQY-0*7\(14OW2E*;L1>BT:0(J3,@A!PM& M2G!'HW/MU<%6H&%N:)PA*.Y Q2:CN$7DS*D8]R*>'FN;DE7&,=PKLU$2,M&7 M1V[L!A&1?T0I"<:X_P*UA?%I",%,#FOR?C(KF,3?P>E5L[/NXH[/HE,F];N1 M1\&B R/12D4,/DX>7&%-B"3R4% PBU4.GR<1QR=B5C4))6$1:<; M^@6C7G>1RR%Y$J%O,)P1'U8_B?,J[7Y)2R#11R@^0#742NU0PH4-?B+TR&(E MT?8ZZ3J513J(MG!>2L*#C<'PR'I LT*.@!-"6$_NYM1!O> T_CV>6A!-\Z\%>.BBZ&#)NJ2UT[@/;APK^B<3=WL M(F^VS&Y(G[&V//^==8$R82;!K&-NNB/,&M$4Z3,7\7P"#PAV#SW8: 3V%U1. M3."@B#U4WV(/U:/P4"4:5WRQO-$F='KWP(XXPCN!V_LQ=.UH M(L!\-L?\T;>?%7_OM._;VJ^:=RGLA^(9\S$>8F_BG"+R ML&XE40&Q];ML%!MZ9I?LG&AEEVC_^!?M/.%$_;!]GE"B9#'* (J*EX0?N-A9 M.C0+Q3 ^:6G9.C)C9J]).])-GE/V%.5UB2[+Q!UZ%&,/NQW(M.F%:JL^7[<9 M)AM0+XBIC,*X <2,]9](+THF<@QE(E#HF.#]1"J' NNI@?5 Q#&EKR1ELIY6 MX$*UCG(P3/364L4)\9]0=1ZB3%"A-)Q/U?M^T,X?K]L/GS^D5$U/S66:+\=) MYPW11"SZU*!/S7!Z@1TF',5/243]Q/R]L<>'.+. .!5[!.KPFUC_"=V'Z!@* MWN8*J*FD$?M-R^6BOR.*U :@7/,+\#W6 Q[=Z==)(<^P.__BW,%!F]B])R<>7F.10.A]V?-@O4/>I0 +"24)G[[ MA7>]"99SF0U:?!4]29Y([ 483QRQ )H*E@R,NOY&Y2P%9)VC2)KOS58FS:7. MYY8M+T<:A>FP:3ZE.#TND2R6J/VE0VXT7W4?9P%?)JN^58:JRE!5&:HY9J@N M#H?PZ2FTV$U0QFU"9ZY#M5HZ CL*'LM9WUA:B:H'Q3%\$2^)VP.*KZ2\HL-^ M[4S1J+N9UG>YT,V9M!#B\^SPCJ6,>OAGRD-#"2"="@5YC74+#2)4+^\ZD@P' M;V1VR9XWTV4ETY9E(ITKPZ$]G5A3R6F;MT6);-"(-:,9%VQ!4EXR;2^R)4C_3\R(GFH1FLSYFXU0)<^E M!78*]0T9\#Z=P#Z'HTX,F8T&#,U$9>/FG\G)0W+C._'U^(NHQTRBIBN\);U3 M483$*K,/!X%,A*H6"=FU[3YZ43@-4&S&W\I=U,)NZ112I_8L(H]"T%U(>E=S MNZ1*I%;F,YI^]CKD%*G TA0$0I9-0Z M+)N4$#(G:L(3%6.S%#N#_P2&\J'. QE:02PU3V,IHQ M?;K1,9?P$!:%&S,>V3?8[#;MNCZ[VZ76W7W&K= MIC4TW7-S"JW?-$L[-SX@&^^\O9/*F8AR)DQ5256 M10P^V$_LGB#QFN]L(W5 MN?EAN=C-I4?8/EN"A2/4=M82+*(E?GM>64'/^!A;W;EJHZY5<[[AC%VKBNQ" M6>XPB8/*5I#>?4K/< 9C4C&ZGN0VQ6[RZ3IH..A!HR9WZ7]X+P(-(HY/32&9 M5N"!5>18K'#B!0V[B!M635L3D5\R,7$+UARFSR?BZ8D,SGC@,&$E4;6(0WO" M")ILF169C9&RX4X9 E%2MX62.&7LS5)$%"647ZS4=(V-EL7 MDPC%D)#H./1P%B$UHH @C"I\2UC_&3:DCSZ'6P5;NM+?5:O6R\DG U3PMD'YMH4T"RNP%E07EC5Z3I=!3")(S,"B^'&B*$T/1Q_+]@K3@]Y0[Z<&IHM( M$0-=FQWKPGVB")N?%H,8L/6W6U([9X0PY,44W[,48'H=I;2#@ M'J+W0SA!--I/&>".^S,.N3C8SI(P:5.LY8$&\88OGW:NP2,#W2C5@((#*VNA:&EE &X6DPR'RF!+\B"L_W(BW/V1X3CJ=I8Y:J!M)A.DFN[_;DJ'A4-X5D M!#U42IHDEV_8.:,UNQ^MO6V&L>MIZYEB<#/(%2!-&PJ=P<@/R(,7A2UPA/D% MIN1B1_'+\"^?T!-GL[=+RZ$UT46AF)"Q#N0B'+P%.J@MY25MHO@Z=OV7RL+] M'WCPOW[X9/EU";[Z./]YLUEJ5)NI7Y5+1NKGBV[5*I5KYM([?:25B=4! 9"2 M_WM6.8LC'[0'E^;XIV9,GP^X+;,T$*^_IW!'>=UPQ]0QP(6\_;3W!:X? S$: MS2VJ'V=C)1^#_@YV/R70YR$5TD5;I5PS!N;.J YRXV*][=_Q0N:V']TO67?> M6+"'BI4/D)6;QMG5=3+M];.LONE0]&45%8BLBA(5A=S+ MS41%=494=*9*Z*ZG2NCNJ(3N=,7'49SVN.-5Q<)'Q,*-I2S<2:EWO:5Z5\7( MA\W(L.\UQXBJ[ZXM603[:O\^/@BLP.[>BI M%/_H"?.G#FXD!.8=25[QD]VWJ$EF(ON(.H,M2H><34V:FI]%!,[)A@TS!764I%8O4W[C=+K]!^H60-5HXHZ?F 1Y5C!WR4]A,TR-PZ,RI^IZPJ-O) I=.?L U;NP1*_9)Z[-8VH M1LF,T)"M&.I04HTP/R@]HVA1IM'BSZOE>BXY2\UFR:A6BI:TM*OD3]HS*;/> M76E,6\VR$_Z>9$-FIT 9=T'N9X[;52S:W%!7X_%4[=AVWC*AY<[QOCM^_P.J M+ Y_8^K-WG/3Q5LK%^&F+L)A$(PO/WY\?7TMP3)+S^[+Q[;7&V)G[8^\_\R\ MC]@'\6.S53?KU8^P6K!U&C6S4JZ702^NM3ZRFE$Q*[4JO&'%* 4_X8AKCX3- MC,?X-TYEU'VMC=MF<]DE)U13\' _7ZRUP.$M1: &()OI,195OU]CPTS*<9P: M!MK$ @^A-+3'GF5K9@UM\')=3]X4T^GA/+YW2UKY NQ@H_ZAE+M_NW@<:RJ. M/3&.-5KP][I118YMU>#_JL"Q_S9*PP#.S ['1@):*N=^?J/N?._ IK\Q>!'0 MU)%-C5:2,\O&1:56-JLGP)M5=9J>$&^6JXUJO46\V2@W/C+3K#2:IOD'_WE1 MC9@3FUT#9XHT(.T:]XQJZT5W56QWZ89?KL>EU<5NU%MR]7JTWRQ\9L(A9K50J_S:;S#"[@G43 MQA_E\<4=:YN-*'SWZO?#&Q1,&HJ.W;9B? M0Y:=&7J!%>F#4SR C7*IJ?CX=/@XLF=KM7H-M6/XH]+D/XVRM&>)5V0]WX!CG_4JRD%#)L\"9Z_=U^$OMT*/T\>W\UT M]]=IL+[R@)T.ZTL/6 T-Z485/6!FK68TT0-FE$,7V+)9Q, [-5D-AQ^@+ #! MT'[%X9:/F#BR"[W[;Q.0 "+=$_W5BQ3O4V-<%592C"L8UYP^LT8C6WWC0,MXGYY!R00S%,6"!4E$)1 M((%0R4\@8%?H4"@D_&L'*1TJIRP=JDHZ*.E TJ$Z+1TP^<2S>D$D&G!(_3$J M!]539O^:8G_%_L3^M4W9_YA4@=HIRP*5.J-D@9 %]6E9<(,LYZV6!,^8%D/I MY?WP"I^NF#@8O@-^/29943]E6=%0LN* 986_28C?Q+^:AOF1U4RS48&/,#"X M3OKZ-4@"%!F1L!"=;1B)BO;D>>('LC+$+.^$B<-GB'EIY76"!2?!Q2K)[I"Y M.!L35RN-1K5E&L#.F"S+?_[;K#:KU;(\ZBT/&(2XESA4LMKF7"W*O43+%6-] MIOY+,KSOK1O>%T^KB(<)?A8)/881?K8ZL'\2'*\R\TZ0X\VZ8;20XROEJ8(=_.).H8Y32&3B]4.PE-W%0Y>B?/T=6M.+HM M)\9NDI/WCDQ.S'R:&XL\?K(O?\*B7>5@'K)HS^ADD5R :3OGU->.4W_ZD7U[)_E-^^4-VU2@4* &8"PNCJ.J+/YJF@2L MYD>?4@18Z)\*7/G!?%I0F%B0):E 3\L5DO&!XQ:UV>A\W$97-EKL.'JE*!U1 M6@;R%$44'Z;0XKBUP6RT"(>2G8"'+!MAPJ"_(HF2(2FT:"I:S,F09&,+19Z( M/(H62:AD3'!>.'E5#9:DP9+5&<*IP9)%<7,K:ME2 M0#&TZ]S8HI"#62FWFK)9P[7;)WEU&PRM'GE(ER4%9O&+K3 ,HI)@=M MSZ9TBW%"YEPZ=WK/E>,/EJB4WH/E77_2]:V^Q3R+^Q=R<698_)SX3LSWY8E! M(;J,7L0#>:C-N%G5S@67X'Q?'.)[ E7'III4>;@L,/$==@' K1AP"/T,>:!B MA(>1X]-H&]'I?\QI;'=B&([V..G:5D]K]WKNQ E@X^ 0@%/E_.^/O_VB??WZ M^.$$&0*HIQCB6!BB8H2\$ V(DV.C'CU0OJPQJ%1QX_P', MEBZIE,WP(.DPK\L<.'0>?MK\#;B'6,PLPR].DEU4LLGQL(NYDEV^6 Z#O\+? M%+MLP"ZF.EV.AUW,O$Z75KF^FEUTS6AJWTN=TG4)4[;H0@,,]=-D(W7J' \; MY77J*#;*QD8MU37P4)F(_[QH-2;P!/:S9[/7+NO]&.,\K[?5K4>NY>^U1[K@ M!'&/8TSO[CM[!O\^WOR.8I3:__W\[2N P0\8!AMNW-X$&?,1.8?NOVU_5]L]N_S6S>Q-;*%M?+>='E_DG M(0MN;K\H,,R"X88/+,#QVZV"P2P,'CV.\<-3 M.R#VG^=F$IVB-[YF 5P'Z Q8LNRQL6,)$7=#YPO1$+9.5G$C@T%AX> MP."3OF8YB6QXX\,\2!;F-<]G7^Z6$(V4O-6SJW\O_;^Y[-*9C;[ 7;ULA3MM M4<#]\J+U#J^3EH9[=O5_PA6__\,_3=&DBB2XX8X;P/V9!O<&K%'],6('\::Y M'OQ=]D)UO3=MC&WQX$/F>3&;\'O*=+Z\[=+_?MI^_?;CL+!4/JTJ5@KM3W)I@?$]$+ M#%=X_+\3RR,A1ZF)<6 "1:!1.^]_B"(;O#?Q0%K!8FY_]H8H&\/PAM&J5'5Y MOS#941O"@=W'H4D]-O'AB Z&EA]."136: MRV^UIB*>JK?6-]5;!<'WI+HNB72DF2@S"H-1$YC,0\O/^K/"KNA]K9Z]HN?S MVV4&';Z6A_]C]K?K)'V:TG[[+FOSN;1O'R1MB8!1U:_;_-]$G Q M\7:Y)+KCI14 %7KK6.U#BP]2,HS0)$?GC=5/^FG6+3!^;T,\74&Z80&_C"HT M_N=/1KW\28Z+JQZ;LK>F5A>K;:C2=3EW0LVMRVWW-=38!J!"N:^8S#\&S[KY^M M-DMF:WG][/LORJR6S'+M78MZWTDWF+,N5^0(=6!M+)AX_%UC2$?(/MZ_0!Q1B-,CY@E4L1(]&]1AH@Z3Z--!8X[H>,LL;,2=T@7YVF=<_6:7TU,^673/(R42,E1A> MIM-;=A>6I+5+VI>);>]1B]TK*6XLC_<"5^GPIR=GWX$#E*A5HO:C]C=WZ&A/ M@#*;C_9I*2I!JP3M_OSM"Y@@9^M&2=PB2=S]1D1+6J<'*]'NK9_NOF,\2O8J MV;L_V?LNG*!$;Y%$[[ZD[A>/ \]8/12_OUN.[\/BE7-!R=T3,_EV*H/U/ B],>[-Z/NW-FJJ] MV?NO1;4W6T++]/9FX;#?C/,;-Z'3.[(RO=J3Z(31"=S>CZ%K8X\Q*FN@M&Q\ MX_"L]K6"K'A)GZG+@E"<[KA6^QAZHX>QY="@'4?.FG;H9*=AU'&Q22> #T:" M!POQEDO?Z7>N#=D+U]BD;P74[ [^WNN),=K((+WD6W:930,P_"'GP5BF3HE6AR^)/#?K4#+OTV;2.J47Y$<'Q?KAT MCP^Q)3.\%@X,'W$=?A/SS?_\J6D:C4\:-I4)WG31D)?Y0VU@NZ\^30?GK#<, M"Q_>.//\L.5+ $*97^!'T]/#Y]Y"W#:Y9MG*%3X=1%B)EJ[YO2'O3T"&W]UI M%]H+LR>BC33^_K\3 .B =H,)R06D!(#8G+H.VV^".%-$27F&_Z$$^Z*Y$T]S M!9+7O$X;B\;6VH!9'CX-B,%L6QO!#SS\*7P]AK7XXG[Q+4*-*22EW/JL.Q]3 MTI_88I>Q[Z(+.T!$$E3%CW:PC7 %$ B[.0-8-)SW0[.PM&?NP.-M[.K8Z_$Q M-7J.CY6QJ$*SN3_?_Z>84H#9OCLE"L0VPRMY?>)Y>G4D'@[!Z<.I$[5BDJ=J MN+O)2KL7ZH4Y#.0Y=?[=(2E#,M+_H)T_7KJY':-+]'8BKDC'DZYA W9JS-3S+,*JQGVT#BP08-3&:,'?A&U_+ M-R9:&)^HQ_BS)PX:CXWXJ^O]T,[-LE'YL.,W6+I>S?+]"1X+;^$& I,$G!31 MSAC%BD56"Y@E,ASY8#.(JWR=Q1&VT0#[)MEWR:)TUQ37^$R42 M;BV\,^LCR'@HT\+3F0\&0CPZ\,L9 90=8D7AXHR ^LQ\2XA"J;L4Y#66J[I# M.&W6.)68Q\-C ;%F=2T;1?2"K8X[J)>T!X+8U%5 IL -@86PFH;36@N*I U" MF*2H7])0M,)"F3864C)Q2 QP=KP76R>1A"6I2,R E\KN=WW9?-A*F#9TA3Q] MPV9YH1A>(+WI\!I@(@@N/FZB9[-7/SIIV7@,:R6;T@.E1'P!*Y73C]*:\.$O MHD9\,4]'MZ1W*@H;K3H,8:_[DQYN=+R5ZQ^']*;:T]#UD]_*;82?,-@X+MKU M(W5 T'U0A >'X4[Z79Q0 1C3KNA.XQ9!C>^DU53@$TL 3 MHCG2VW"/PI_HT0W[$TZ\X'D@-^#_!QZL2C!-1(F>/4%]22Y=:#QN#S18 "-> M#(M%/B+VM/P?_L+'AD1;^08KUJ^X!+<&5I72>M,0$=,_#AZ M-_X3P.7 K71D:::!PA(@BUNP%/Z"W9IZU!@2-A>?1[LW$LHY+J5O^3W;]>4] MUWO'*2*30A:O1IH$X9/25$UM(H[$/K6YI,&P0&!8MC6BGI0CUN=X5L>B4$?5 MZ96#+@]_SCP"CT+4\L?)J3;K[A;)O2ZW+?XB$9]@)* VT@]HFH!W-SJJ$@9* M4>1%QF/W&F5B#PC2)G;^#>? > 5YE55'+ZG*M'@ABVB(#4T:&4TY^.-,\5@@S.!0_96YI7XE[KHD?*2,#DU&-=;_8LG/I:GG_B4;U( M%Q4'$ LNM7/C@[3&A8P*;6FX;Y);Z>$H+R.!)>^\AI2%9YV;'X!M7US[11X? M=#Q;9"K"\0A6N_-,4L6?=/\C5%0]G.5B\Y_:?R;]9\E#M!W1*TK^8PMVJ._" MVAT7EF[C/_&T BT ->P$0X7:\1KB-F _N(-R@8'D=6TN).RK4&?@.3J*DL3J MI-A(7QPA1I><3R8;Z!YCAB;-W-)2;X!RP4F*OOEM/HT#)E&(0#$AZQ!>^9Z\;FW"[O7:C*PG2844_'/=T*NUJ@Z+ M)X^0E&ZHYDBV=UPG_'3VVHINF,WP4I=TF/#"18XPCXO5@.0,:,EK[;60&*$! M()4A7!ZSWWS!(M1ETAJ\T9I#U8">L @\_&>/+&A/\V$1%R/@8.#?Q#OJ(=\) M745H?3QV8:*[3O[Z30C72%1)SQHN#$0#JMP:"DQ\ M=*5.L*MP='&? X#Z>OAOO C5;(D/TTQN'@R8+U *FWQ M+DH%;LI[1;H**DC/MMM%K9;N32M&.N CKX> K<4-P#=DM9,+8W^Y,!;'L55$ M6D6DBW/\@-4C):P5!M,V.[*GY&LL49)"*2&MA-4WY#:=>21V=*&ZI6I30NJ! M_.(]YM,9F"9&10AEE?1',Z!O84>]B1TD3'_A,1(!&RD^I5X;W)=L"5 MP0-"Q3=W@5D4<#Q-#9L(W9=@O^-,Q*0/ KU#XO 69@VLWPO=*0LV]/?HR)6X M@X,8!/>T]C?M[/:%MSO=+QZ>U_$Q3NOS234*T1C=*(QQAB;8%.;75E\B7V&? MPTI!4$_Y'%;!E6@0DPV="[ XKR&O&_-^V'X[XZFG UA[X"=X*R#VX(CY!/E+#(6YKL/_DI MW3:D/I:/O_VB??WZF&'FS#Z33N#R%S$@.949Y;G@6^AIQ6!GEEDZ^WBO#H,C M\"O[ >]"F27? S8LB&=O<3ZS,B\NS%S29)O&SM)D,\-<&2L[,%:*G7[7.]=WM_?5M1]?N[J]+6OO^1NM\_]RYN[EK?[M;,O^W*"]S_7#? M>?AZ=]-^NKW1/K>_MN%EM,ZOM[=/Q5_[.1D\[@3NT1?F&Q\'&B@[0MW[L,*8 M71=?V1250YDOUS!RFR1LF*5R,^OTMUU/A:-%+1]5M_.QLH4;!4:.>W= @$[: M(O0!VB.G.2$MG2Q&1!9SBBRKJM)8[\>SY\(1>2%7WQL,RH->UJ*T_=*CTTF> M (O1L/!M5Q?GK0#02CIN>GV&E67>Z@']7T&W>L%DFZD@VT9;/O/6F3=F5]?G MQ*D:_5DN^CYB4GY49($)'* %3=7'R"W-\O9E[1 @_.>M7C'Y:A[>M5#O]E?K MYZ7C.E\\)@*M$\<*OJ')-?'[9^0:AM73![V+ZID&1IHU8K;_OV<7 '2'C3C^ M\N*9L?$E(J3M]/&/VQ@>[>":>1Z6O?P3M>8S] Z.6 "V^,_@TIF,+OHNV7YX M6V =( LG)D)S?7!1:9U=54"#J)KEOWZ<7NJ5F(Z]S=Z$S+?V'N5SFB@..58. MJ;T_AU3+9U=FLUD@#LE)JSF,8_$N)1EK5K&12*KLK6BNXU<^N*LVJ7FEN M?<+O'&['%29;I"5C=YQ EOG\=V*-1;FOPQ^OL"I1:HYR7EG%@JNN1@V:%V-P0-+4R@:92;Q8$-*>@@-XY 7.> M+=FXB.JBE>ZY5: KI*=41B/W/PQ1XY4ZR0LB$Q[ZAM]!/[&?%&5E:H M@,Y1T:!U9ID&A!>I#HD&3TEUJMYL%46?4 KJ.PK17!!4)P0U6K6"(&A;C72M9/#MXYR%$\KKIXEG M>_GCX::U<@FRLD_C[*H.%EVCUBA\5%KE1E+I)55FL.&)C/38/CJACBH6AE[=7:POB9SFH MT^XK?$(M9CV.+8$O-'^(T_.P$ZT*!6YZ4B!1_8?!-=$TXHHYX!MG5XUF7B46 M!?"!*("L*SC3 9(4FP/K)^]?_,$]-P4XYMD5=;HU/Q4$/"=E(#Q,%0RO8_.I M>,TZ$;^O,24WU"0P<:+1%7,OC'UQO;I-T741P^K M/GA;X;I]\.6P.6:EGKHML]30=FOJS>K60?)#"/(IS.6A^FZ+N3I@KEK1FY6M MR]94'"SO)&*E#>\BDSC!,]GS0.N-LZNJ7JNI1+ACA%+6;.+MH-1$*)4;1D&@ M= JQ9>%ML%WG^0*=LGFIQ$?.%AG]#1LGB=8QG&?J1JTH]:'*C;M'C\/&,&I@ M#*RJ&]MW8BB60[?0DK43N+T?0]<&W=__"S6Z"=ZV2=C:=U;6WE.O%LU'-,R] M3=6[=DD1!*9'YCUX-.&[3TVU MXUM*AB]'#&\L%T2+%E/=R6+,LRL"\HX&S&AO-;C"8V.BMN^,#J65D]J$TP\ZO5 MFFX:>96;*T6U2'A:(6GSQU/U[*K2,O1ZI2@)^J>EW,;[%PYHTH#/BB S0GF_0"L3G'X1G/^]']W@)U@OK:?)92JDFM;HG)6/L%DP%9#-W/K@J\2M@\=W7Z"8^$3MK.T M19!O(1X^UTCG-!N&Y4F:X^'0]WYMY=:Y+\?M+&AO$\7$BHGSKHO* M@XE;Y=RZ!>Z9B>E(_AA@@YDPR6-1HF&E5(=M"S^B^\K/$H_K<=@5;WW _,(\ M-G*=/B!E%B1KI2!JTPDJB;6/F/=L.8)FY>T6F6O2Y-.0:ZR'#C?FO&%NF>,& M."S=@X\=S8*5/7L4=?8"3,L!:][GL$8P[7$.G5]:^,+R*=4:[I+K4VSLTN,V M"ZP7_NG5Z@?#D+$25TG$E>-+6!?P-0D67U( 2AHU6-.7B\I,>E+BO[A>9%:K MT2^7C2XW:N5ZM=KL]Q@K-WFO7"WS^J#&^[5_&^B-EE<-O1CZS_RBZW'VXX(- MX!TOF?W*WGSDF23( &%)NB\BV0P8%Q-L,-@9] 0'@$QS/48;#5*(>_@K6 XK MS%JTH8MK\^ M_:IUKN]N[Z]O.[IV=W]=$LU/OW_NW-W_WMYW[OYYBZ_W\-MMX=_GW') "+L3N$?? MUS7^L\?AG!US3^0,:WT6L ]IM]7!N_,DD"+%%_'JL?07"Y5Y[5^<>5,Z^C;$2%B_ZRKJ!:<29MZO4ZVU\G5/AUZF MHEAE9V.\H2B+O.>P8L^=+R]=T#IRTH^MT7%G&JF2L%^Y,^!?/':'1@W?\ MW0J&UQ,?7H][T:A0'(,!_]_/'NYO&6=7+=/0RT9>;;2/P0FMN.\DN*^^=^XS M@?M:3;V>4C&LN$]QWU%S7V/OW(==;G6C6=>K];S*0 J44'& +9JN79\"(:F: ML\KA7U=M1#(^#'!^/$5 N?=B];C?<>VLI>4M;.';J.OU5E':Z:A:D'=4@/+# M$6:MMRIZL[6UE:%P5$ S*-!J HZ)TBJ_>*[O:V// M'5C!-J5")YL@O.+<)OH^$GFS,D;C[*I1K>J5[8LV#\&05&#;_G#? FS-LZMF MN:HWC)/P6BBP;:\!; &VUME5J][4:_6MRX>5B9Y'%^4QQS0NYUGC/\?<\;E_ M>503>O=]_6D5I_N^V[-80&7HW,'D537M8 /UT6&7$2GO(DIFE+2P'NS44-7- MW,I5#NST/G+X+%0(3O#!CES8Q[1>%.ES4BVY M.MR&#Y]U[9D['(M2L!.).XO@K1MI]^>(NRMT*0S M(V15^\$C =VZ6L+FH#-P1DVYH=>-O)P#"G6'CKIU M]80M4&=@%GI9-UK'W_;R$#0%,4@[;!POG0D?-DL#*>K$UWU??U*QISOL6<#] M0&)*Q9DVU2OOG!<@(_:.$](V)&QFB8MUJ7J]4A1OK0H!O*.>F!N(*F=7%;VA M@I-'":(5:E]N(,)PI%XSYL>='$'&;5<">AG*X*OR!-+QW'7?:-[@$Z1@K+(@&J,R(W1Z/"Z;>K<),1K.B169% M2CN*]:6GPE,1\31WJKX+GLPRXJEYX.JG,QO10Q.;'\ZDG_:PXN//C M%VP[JE>:6P?T5+K9D2!OA9F<'_),;/I7WCX172'O2)"WP@[/8J>8E;.K:JWX MG91/*I^QRT%"1(/N _9SN]:2)\LG*SW<87Y/V++5V3X0H/BJ6 A3?+5M,&TKOL+0 MK5'7:^6\JD&4:RF7"-N8>_"2HQ%@PQ\R;W&=R!H$2&Q)!>C>=R==FV>;F[VK M(MTC6=HI!'\_,]_J;9-Y=Z3GT9&<.H_/:$BC0OZQ([^1#_)K9U>U4N/( MQDH6&L@WECT)>'^;0,.Q<6S:*QX?QV;3TB1,TGBV3GI:7NFV!0B#*NP?._:S MZ6E+L(^9)*7:UKUU%/85]HNIJ2W!?I-TM:),&3L%?]KO] _>UQBLBCWS*7>O MK[F3P ^8@Z^CAH&J8: Y^FQ/-3%,,%;&;)"02]N"2>\GHR[W'@8D3OV'F$>E M$9PQ^M;"-D2ZF5MY6P%T#H6N##D1.T57M2S1E=FQWMDK1S7)*904P2OY5J4?JLJJY( MA3C<<\-71>#+.*+0HL+7]L=[;OBJT@%?J>95\*\">*L1W7L+^ M&FH*2 &G@!0:1=O40AUS3."XLC?>LZZI6LNYKJD RH;BA&/EA%U6(E7K.5;7[2L;_J4Y9]H/B:V MX5KNPA-N@GATV^D_Q5O2CG9$M"5[8C\SR_,FMO$U6P5HN*Y@?LE]85#;CBZ1.:QV%W M>5\+7-S+G2DF1Y@Y\HYZR2P#$NO-!O?94QMLQ(FM7BD8JLC(*=1I2T6RJ M#H_'"+Q,(ZK>&7@5 ;RB2+Q3"(!F(^Y9G6GV2PT3](KGZ*_PG7*Z\^P6RRF6E5(&[E.'U R"Y 9?#1F\6$B/K2(T+-K'S'OV7($ MSK7XP#)DJ<95$7#F^A'4!7Y-@ M\24%H*11PR2ZB^HT,9+_Q?4BMUJ-?KEL=+E1*]>KU6:_QUBYR7OE:IG7!S7> MK_W;:((V+:\:>C'TG_E%U^/LQP4;P#M>,ON5O?G(,TF0 <*2=%]$LADP+B;8 M8+ SZ D. *'FBA&;ER"%N(>_@N6PPJQ%&WHHSO^T>N,:F,^ ,A+8!$>((GO\ M]2.[*K!(2!=BWSOM^[;VZVW[Z].O6N?Z[O;^^K:C:W?WUR6M?7^C=;Y_[MS= MW+6_W=UV%KY<45[F^N&^\_#U[J;]= LK?X(_?KN]?^IH#U_@7P_7?__UX>O- M[;?.__RI:1J-3]KM/[[?/?VK\&]U;CD@BMT)W*/O?T@3.QO@[.JO7>_CVG"% MB^BC3QT:.G<#M_5BC &=5 MG8KGOL[&V Z+'FU8+*I0S*;3Y)%9_0O+H;]?L[$5P.>*2E??>,#@PS[1Y79! M]?XI$J;=ZTU&$\K_)=I0O%2@)^DOH4_D:/9SC)W.1=I/D7A/[BQ[I4MIH[JI ME$XX5=?U 16<9J)USCJEDRM?^$0H]D]F3]894;NU!W2-M;^NF6W4L/3+T M:Y]W*7<^>WW<<:O3B4RMP#BA>^C:0!3_]K\3*WA+ R^VA,VKON(8(L**=TZ" M=UK9>2?CJ6!2,E5U^RF"BKF*!3/%7"M3%LL[YRZ<3=LT]48KKT;YBKT* K33 M9*]L=5SK%G+EP&@X"E>OF]L4Q2@.*Q;63I/#,C&8N?,#K'9V5:T:>CVW.4(% MJNDYP.KC9>V7*Q7"]5NH-[,J=V ZKM50+ 5J[5%O54LK)V"L2M<%A== MYO,^G=ZPSZ(7IVS>J2Q@I<0O.JIJR\5'W'?/?W+C+&),(+YS9.HPI=P0^JX3 MX/O& 9:^%? .]UZL'G^$EW'[WWC/?7;H+I2QEE6^-'"BD/25)C3AW\'EK=DB/9V MM"@>)*NS>6ZOJ]?J1":M]7Z]@O2E-:LPB(9U4;@;63]Z_ M^(-[;IKP;D:21SE6WW5,XZL5##%Q'5N$PG9A>M8%'>.:SX/ !G4GJ>ALIN,< M@EFCS**=^Y 2P9QO8A3HDPL0_#U&X!?76T>4K&$GM;!*J=;(H4I)V?[%N5XQ M68: Z:YYK%DN#(^=@B@)J8,M/1*:SZ\ ML4_7Q,D.UU2TX6L*4^^$J0TZ+V64(I6SJUI9+QM;5PLJB)O1ZJ5;V>$FU2J#M-U)D;M/*9!Q8V.ZCEE4.I0'7PH%HQTS(' M458'4=:JZ8:Y=7^HG:/N%%S/6[?7. 1WU:%??YSNMDR":47?GZU:%.! L'I+ MK^36\4>YJA5VUYXSNQUTFP6#[BEX@'??7.,0$C74]2K198[ MMSYHXKS?BFY6MPFIY93_HB"7*^3F#N-B(*Y5+@[B3L'LW4VCC4/0QY4^O[4M MNJ(G5-%JY5L&R99*):]I(LJ\+<[UBAU7F->%XT:S8-QX"A;[SCI7K*9%\9@K M:^<*,Y>2]+!SQ3Q#8!^#YGP,5[6JQYY[]"YXK!]BP>R M,1MWKE#D.KI T'$*G[QUL%TUVFBU9A2B9D"$?O7"08A1$)I^#G2?0%N>$]/NIR3ZMLTQFD MEW%\=+&9**O'9P4?Y=@9!#:(.H.8*9RR3]?/Z5:AKF.8K2AM-LN5/#J#9.7! MHC>Z/UU,;=!M)J,4J9Y=U6IZO;QU8;,"W;& ;M?M:,PRICVT#+U>F3^[%.J. M!W79W!)S#6D6%+GD@#^<@V#JC68.8Q 4\HJ(O"S 6R=*NQW<&F#25JIZM3&? MO% T<7<*_O2MNX<<@E/KT*\_3J=<%KE46=$K:YL6#&896S!4X @LRBC2(F%/ M87?K[H*[A&ZK8- ]!3_Q[KN''$+VB;I>9>]L:>96YD3CKGHYS E.HWQVU2JO M4;-V2.F."E+SA^W[(/0]"GE3Z^M2VYHARM8/T&3 .#VU6] MUIKO+*3,TT._7K'C"O.X<-Q8*1@WGH+%O;/N'X=8U9*U^T>ELLON'Z91!89H MSG>OW:S[Q^F:.4=3='>F40-VU*O5;7*&%:@*":IUYL7L"%28 M)%+6S7(.22)%0M6^KU>H7J7^[Q+4#0"UH==K\^,DE<_N$-MHK*9)\7AE%[K\ MMFTT3(/::,QG0:M^?N^@T1^VD^Y -N:H:SCW??UQ2LV.^E*81GY]*92' MLG!]*0IFU1P$Y^ZX#9 RXK*$5'==,V^6J8UL:YO>B,I34;CK%9-E")3NG,>, MPO#8*3A.4OM2E*DO164;(T963HEWNZP ]?ONI&MS43UUFETK*BL:0N79M<(4 M72N,RGSP-&_;]#V@D"IS"\=,?]YP.OEVI#E0'DE3]=:9$+"JM8>92VN/?,78 M/CQLBBT56^;$ECNOW#:K9U?UFEZO;SWV2O&MXEO%MY)O-^B4E9%O:V=7U6I- M-XWYY W%N(IQ%>-NZ/.VLQX]9ITF3M93>LV1WOF6W*P?J3B5_BS;[U<_17^$RY7WOT".>2R4JK#3H4? MT7WE9XG']3ALA+<^1GYA'ANY3A_ ,8N+&5@T9F%A(BRTB-"S:Q\Q[]ER!,W* MVRTR+R#3BI^&7&,]+&IESAO&DATW@+MC'!D68\'*GCUF:V/FB1X30^YS6",+ M.#G_2PM?6#ZE6L-=*U?+O#ZH\7[M MWT:K?!9>-?1BZ#_SBZ['V8\+-H!WO&3V*WOSD6>2( .$R34UZB6D_"*BS5GXJ]@.:PP:]&&'LKQ/ZW>N@9F9J"4!$:YQB, M&.2O']E5@85"NAC[WFG?M[5?;]M?GW[5.M=WM_?7MQU=N[N_+FGM^QNM\_US MY^[FKOWM[K:S\.6*\C+7#_>=AZ]W-^VG6UCY$_SQV^W]4T=[^*)=MSN_:E^^ M/OQ>_+K3M:1-%R+5H:65@Z)2>IQWE1"Y(\T= M<]26P6A$9\,+V&M\PSQC08KM@;>*R)M>?Q0K6_/02?IN9K7'HB%R64/IE-?: ML[]UO7=:Y&XM@G=TO3RJW]$IM M/BU3851A=&V,KIA7M15&*V7L75#7:^6,;<@*4LLGT-I*@2O]VP+SW DN+UKS M/JE][GZBQ$(+7,WCL.$]R^;4[CM4>O ;_';[H$-N?907L#3ZW8_R MAU#;_LJ9SXG*#X/O/F\CB9/<)4WSFV M:F=73;V\?>F&PE;QL+7B@-\YMNIG5RW=J!4%6Z=DM)__PM 1A-/B-.R)R42* MXMA#UQ!VB')$LZ@Q.IN4$;_MM">D-KI9'YP.4/IA\"CI_&@S)[@-Z9S&(]@C M-F,<0%E7AP"=N8,]=^A@$]5J7L72"CL%PLZZE7^;8P=#D$6!SBG9X)O/E3MY M;795S]-<.H]5RWE-7U(&4?$@M*H70CX0,H33O+*U?%40*AZ$5MC4.4%(3&0T M6UM/75>F\P;Q[@'W/,JDH)'K ?NY)'OB*'75G4Q$#NDJDI*>D*IMIP]_7L.' M5I Y1:E:.;LR]49UOLU;YIX5RO@I$J#6M9QS!Q3%68SF-N-Z%* *"*AUS>G< M 55#"=5JK#&[4MG8^6'CSGGA3N!Z;]JK9P4<-NE5!;.#KMHP$+Y8K =RJ].R6EP/63.,]S-?R>6:'GE7ZIA<3E>GZ>V:S:+C;Q02"XK\3GY@V9='Q58?AXF0]UP\>>= MDR!OYL.GA8IO)67\KU)=#AY1ZSJI5[(^4 M/*2##C\5_81O]WKP)H&OC=D;ML$]+:M\)ZDC\_P2$OE1T#@-_3B6R)Q/H#KH M*]UCB>*=<'<3Z31I4, MR)R6Q?U.!S11.:XPCJF=F4N:8".5]7)%&4E'!J[-C_+\P-7"$O5R?9M#76&K M@-C:_%#/#5MU:J&I5[?2&)7]G1DG]SGVQEQ#.]YB[&/A6"S?+MXX.^!1[L'G MM^\^)E9'C-6.B)^9KXRSJT99KV]?^IYI!P_ 4#M5**YNUKTK*&* J%S16]MW MW%18/ XLKF[*O2LL8FM%T]!-,Z_DD!W/?,TK,[3@\TIF)^A8S@OW\^C-7=3D MRWU??TJE3M]XCUOC@'I\B2F^'G[R-I MA0ZY-I[F<5.GJ2X%P%>R9TP&#(-9\'@L<3/"N2E@K>E:TULB>W+8@J2M.V/$XK1;-?E#'\ MCK6VFV)JC5.UBLWC:I5M*BP4HHHGI-;4S_(54OG%W)2394S&8J63FQVK"=M--84"66@T>T M22TM]59*&F/F0*.J53QT/*[;@6.'>*2J1;VRU8PLA<.Z73MVB,A.ZOGCD8N+L'M_3BM(-*.DG9C M\CX,KHFX':1M9J%<(Z6UUMIFU*\*$1002NMG[>8%)>SB6M,K*?,$%90.&DKK MY^SF!:4&2*5&0V]6-<$T/*#-[]:+F4:;W[P>MQF >]C]6/ ?FJO M5C 57;:LT-&68;]>K"H$!+X!]JN"OOM6G'O2NHVST+4]_X)+KB+;7 M2=*&XX3>OH19+,E4I7DNP9Z3%37#M/@HRO^(WQ1$ZUMJS:)9:@IE[]XC8?,!V'(G MB\%1Z/!(];%G;D@4>,:34-O6KDX#(M4&5'NE)49)WD M=C#@/1IZP7_VA@PT3PTT3JZ)OU/. *HLNE!<,"[Q GOI!+Y.;28\[@>>U'"0#_%_M_$&?(M(CU^TG?[T!XE?WCD]>X*T MO;'\L>LS^Q>@_QBN@'\+M].$]^700S Z,C-SY>S*U&OE;(U!H*US3%_?#]-95&L76C>QH?TO,X5B2>PQ[1 MW[ #Q\YUHB,T47*,[&S%L(^P>A?,&+&;-W)7(S9.B@8A+C*S;/WLJFKH+7/K MT7[*XCX..*^(,14$DM/R.V5AU=H.CYY=FSXM,'U:AEXQMZX[ M5*9Z\9!I[E+)WS$TC3) LUK1Z[5YIZ>"YL%#TS /&)H8ZC5J>BLE]^"@749' MI,%P^'BA[K)#JZ-H9/OSCM[]: 11]8#ED(G9TA7=K)Z$&TQQK>+:(["YC$IN M-I?BVD(!6''M,=NCU=SL4>70S*.1+>QIS[(MVDWJMY/!0, N 4-.58!(=>H< MT&4VN[DZ[-IW@ :J&*0 MXKQ:SC9@_@R"[;2;3<4@BD&*SR#KF%OY&LNF'6>QGQ_F0FW_D0J\9J'GWJ6H]XYYY"9 M$1_W8)9//"_[,,R*T<0\_.;V.;U9]_ D@%.&(\KU+P=XA&3H_36]BW9%1Z/ M"8^KM*K= =(L8P^YIFD< B!)$?D8L*[-X<^^]7+U5_A/N"9)_6H-MF?L^A:^ MQ27U<+5>^*=7JQ\,PZU)7"576HXO85U8\B18?$EBP3T@.??R!AB-$UR*,*,& M:_IR48^VAXB1_._0"Y_>J)>0 MAHM>?\2\9_@QQ1A@H8M??C#8SK7:[/<8*S=YKUPM\_J@QONU?X.%\X2XQJ@#-I,27EEV M-;W!BW?AT_N#LI%"B[.K[YWV?5O[];;]]>E7K7-]=WM_?=O1M;O[ZY+6OK_1 M.M\_=^YN[MK?[FX["U^N*"]S_7#?>?AZ=]-^NH65/\$?O]W>/W6TAR_:=;OS MJ_;EZ\/O'>U"@]\]W=U_O[TI_!N=@T$3#-T)W*/O?T@3'TLYG61O+#I)UL/2 M;3;V^67XET^A 6DYM "ZZ).\F92W*&!FY#R12'P=RYY26<@?:7[*)\NO2_#5 MQ_G/:\V24353ORJ7C-3/%]W*,$OE9OHEBVZU^/-JN7[DBZHNO=4*/\)2_=&H MS?TN10D4K+4?+7".WPBX_^+,TV[A0)A.&-V&% E5?-UH?[%I9);-RCJQ\95O M>S+D,A6YLI#+R,)[QQ#H?W(#9F_3[4!EV*D,N_?(9L_LKC!4>KIBPY-DPUVF MIV=F0U/EFRLV/$DVW&F^>68^K*@$\@+AJ#,9CVV.(P% ^^Y;?L]V_8F'[5A% M*KDVL-U7S7+$)B^;$G,Z:=<%7EJN0P_+Q88NI8:/&3![?^)ADQ:L91"5SBB3 M+C="ZI(C]:2O/Z5I67?H#X+S;IOV!4>F.:6]X='H1RO4HQ .CR!J[GG*W.V* M63V[JA>E;VH.IY,"^G$"?45WR#6 CN-!6PKH"NC%!OJ*YMQK +U^=F44I1G< M*4TROW-Z[HCC\/+M1I(==_+E2HT%B?B$-$2(9W;18!_>JFY6\^K#6P!_J,+. MVDK =MAI G9J>K.>EW=/8:= V%EYKFZ'G=;95:VEU\SY-LF%+)G+YO0X!&^: MQWO<>N&Y>M1R\H(>W?6GJ=4!Q ;P3DJUVW34O.?V.._[7SQW%(G;;T33S*&X M"LZ.U5MF42J4U5']CM/FE^)H'BH&0,50.MT1 F75P/B,0,%YJZVM2_.4 I=Y MS^]=YT(V GCA?H#J&V;-ILUZ5XJ<4N0V;#J!?[]P!Q<3G\O^$IK;#1C\D!I/ M1*-]01/1;!IGYW9AU:+9I-+Z,FM]#KLDFC\,OON\301_D/2^<\+)1%]<[RO2 M^B$F=69=L *VMUYO;1W<44=\\="U4!=\-W15"5W5HN@%"EWOH4"^&[IJB*Y* M8>Q8U6GK2!/#VKV>-P%%9SSQ +R^R)(=>^X8EOA&VC86K8TQFU;-B=MXXN[8 M"IA]^W/,G;X58"[RG>@4T_\\">[=X%\\$,&%>3F 07NC*,.(WKD5T7 N5< MV\U!TSB[JC>.**=)@69-S]8VH&F>756:19G(=TH."&PT!&N&$Y;&%EA].[9>N(,3#5@/SF"/:]V)#U>#UJG<#IN>Q=BCC?G#!^^1>8'\1QO)*]J.46/< MAX'0[-N"['UC6GL?6#]Y_^(/[KEI;-0Z Y9IFH;YJ2"JNS(,W^_0WA!=P:B"QT/SFVI4W='( MQ96YO1_*YM[PG+\E"K>=?@<8P*?\O31N,,^N:ENGYBE#J7CP6'%0I\)C?2%: MR4V(*NP4#SLKCN@ML5,M&G:6]W/>?X?;M&Z_9U=/0PYV,9R5\&P<::(Y;@!W M9V FPV(L6-FSQVQM#&H4'JK!D/O8,I4%U!G"+RWL$7N"#:P;BQM8XWH1N:M[ M)QLMD(K;M[UN59>VO99@OT#-[K)1,G&3Y$<$<_'9^W?#!DH6IAOV\K6\8S?L MJM*GNV5_N[MOWUW?MKXD^VH5_E:EN MV3H:3QR.N3$'(3-$>=]G 5O41%NL^.JO7>]C"F[7E6SUL]5HW^,^:^U0HQ * MQ?UD!#?KS5M,TXK,@_?,'.L/$A#7T M9XWQ(]" P)X%A02]UX]P<<\"=0B>]]D&RS56>&I"OZ(IS>U ?H:K@5NQ,>(, M;.*SJ\[WWWYK?_L7=G7OW/UR?_?E[KI]_Z2UKZ\?OF-?]U^T1X#Q-?'>U&O. M["M\)Q\GO.C1,O"1*0LQ(^5P)=D<=@EJQ[70.>B-WU+>MS[[9OL$3=:Q#:A6 MR1?,-O3 @GLX(-'K>WJI2'QS9@=#K0-@='H=10DONO %T-Q*28]O,*7"'=-*I@@?U@ 5L$+M]VQ3S^!]4X&H+A3 M:[$AK$/[[P2$9?"F@])/#[_H,I_W-6<2>*02PB/PPNAY/11>8\_M3WJ@D&J' M1F\!E<2<[2\B+QO>K!/IV=HY%MRA>#++G])^0%\9GSZ$P]ZH0(\)N2(([4:3 MW:4B'P)4UUZ'5F](.C]:1F-8 Q%8R"V1OKO0\//X,_Q[J5OI[O[+%/.#@.AR M[V'P"W?!N!C#P[_13:;M/Z!G#U.\7EVO#^N(;,!R+") LPI>W3G[3WN.;JR) MY?F7VKGQ06O[%M,>6<\:P#?XBN \@),E M)ND%[DYHTIET8[(P>T/"-($PH)_R>=+XD^Y%3!/K@_8+&!6@DVC70T"5#A_! M9QUW F_+_&"*#J+7-OP ?G'O CWHV\46X+O):+KC)4;LK=X:#)=\I\UT\%IU M1GQ<&,V]R0\ =O@6>S@#I^A2+U6J2(=9[G&%AE1\OFFMQSF2-VD;XN:0\3+TH>P^@$\%Q0@8>"*9KYK ^R*+?^$^KY\*_ M8=FC;BB=Y+5D(\H+_PY/Z[LC70,5!FQH7?N%@R*$QEYGS"PXUNX #_ O>C6\ MSV=N/UN3D;@AWNB>H\5CIXS66W?_=[';[R4N]P%1[7=.62OH])BRU\EQ"VK& MB!1(S<$Q;+A%',UZ87:7.2UJY7G MG8.U\KR7\I!\>8\>*.S6V!9%/5-D(&8A-R]^E73T'J(7:BH.O-HEE=W35-+: MMDU!91RT*3R"4U>"ZN;XPN3RM2%[X5J7-XKY^Y Z]AV[1$/I8/3XA8(9OQSE*0 M:^?20?>]U"EIO[3;CZ%7;M8K.TWV ISS^))#T] ?>H;_GL M^1EL:;%:V"1L?N$$KO>FO7JP?Q=]]Q6N&GCN2!/UIB1GPU\A9A <\)&$\U2? MC!!/O227Q&D14S,R,$EBAGI7VERP97U!_-WG#X-;/[!&B+]8]!ZTD/TNDC:C MUSI$^0DX'3,O MPZ$C1$O16\"5D4B0[ ,Z4EXZGOL&>Z L$]8C_@X _)1.(. M^& R&@LNH +&PQX+R" "E'(8TZ#A,Z+2*&-2FH6 M72.>@N\8B]A5KQUJF&EK\SCPWT2NAF,!%A;3)IH.)F0[28=0(,0D&;&W'6MQ M&2TJ;9]*91=.Q_Y_)C[1&8@#-FDD7Q/#>T!&8P6 !W1=/U( M5%9-[#[\5O-!'T&>A8($^!,%%PWO,?15Z]5 MC)(FB8+7^F2IZ/A?4V .A]QJKQR 6C/C9_A35]%%@":PY7@_V8WT;PS.6#CD M#5W\)/%DD1=:*:4)QCRF]DGF/-/,)8] M05#%P"?(C\0#%MW?^+""%^?TD!//V&PNSMA4N9Y,F;AI0^1R)]R![) M3]+MU^Z;AO'\9U!I$_<=6J#K>KVAS%.)\%GASP5J ]X; M.M9_T7*=8+8B6NIBT8D;@_87/\02-X.;][AXSFMH7$7-]N$NF%^)I3CT AIZ MSG"N)7JYT%?^U1L;2%9,8H6-7OUICA+.*(\\LT#C"Q4PA;@;.T40K7' MF^VQF=QC\GB[E,T*>^0LVO,X12W$2;2C;A=6^$)J-2+A_['WKLUM(TFZ\%]! M<';.NB,@-N\7>T,1M"1WZX0M^5CRSLZG#9 LBFB# <7RYI??S*S+@ (\ (2 ME$"IWGC/K)LB@:JLS*R\/)F9+^2@/&P!F46<."@09!I7_I<^\R.?>3MYYI&; M.#,*Z^&':^\I/'5PYB.167G$, ,>LT^W%IQNB.%!>V80H$!PCDB./&W@B1T5 MP&$11&GMB>8>[O1SK)6$/32]=;\Q#(("[> +-Y[KR_^D9"ZYC#EF8:> 65@5 M,VI$5^R:$!BR0G[LRA2H @2?HGVTU9*B>)TXV.F*G48A0T5B-!WL0-A=^);P M:?U'=C8\2S7Q6(K/-#F?WW"85VX87^-[CNI_D-)[@ MP9+GZ3RQ/?Q TA;G#QHFU:&B!MMA7,5&PC2[M17%(50!=H"@-*:!.UMM#E%Q M4JV) !C?4>6F2'8$1MN/[*3.3YGFUW1Y58&X[5='6^&![#*;9NN.WQ3)6IID M14G6SA/A0[OJO4PSO>T> NW[B^>R)^G%T?2NE/M/.#;$(H$MGXHC[]A7:3?V MR&U_53E2_<>1-O]"/;]VW'61IE_MP;;6VL$<7&[\/UM[L!L-\OJV+ZS7GN)-G-:ZK34):1N^%)2U]-2IZ7NC4I=IW$4J=O8][+; M+[OOI1:XBK">%KBM K=U0M01!&YP.@)7TKB72DO))\^'_W1%#<.$2OE"/)"T MU\H3W++0(9&H>BTC7W8DU[M"\M7:+%^"]A>"]!>2\C+#^I0K:EF1&M;.>]F1 MC+_M+$AZ($<5E7/[&,RSLY[N-:HVD4.S5[G*J?,LRJG7U,KI-+BG$/-T7U8Y MM:JFG)X[L5$E_+R $\P8#G2DUK3,#3B,.\]0Y)BT$Y\<]!+FHB3Q18+"2J"X MJ(4'%-%=;W%ECR0LS;KZLI-EM&\]:R& MY/'55E>KK9-AK3*MS*.JK5[5U%:A@5@:QETA<+)>E(9Q'Q_&W50P[EU@BAK& MK6'<&L9]TK35,&X-X]8P;@WC?G%2::3-5D]VR^#OHP%*>_W:>:O9-+MM#2C5 M4O?6I&[+R/3C2=U 2YV6NK#JI4"YP6N'(%[CC52AL%KE\> M/%##N#6,N]()[NZ6NJ3#P6[;+1VE!J6@\FIKY74RW%6(N5ZV1J5?'K3P1&'@U49Z:XQW85ORZ&#)?K=V MWC1[[4-*(LA>4RP9+]R8$G-6\]J11Y?;?6UVCH9UBK3A#RJVBJ] M%\6IA2H)1?X2+(*N@,U'H>+,7WLJ1ESO%JW$[N;_44R!;>:RC]@]G04!<-D8 M)V/#X^(57B07N,I[>6PU!'>W/.[#6XIT[;?BWEVOB8'.D;\NKEK MBW%_9.YJ:^XZ->XJ=O-ML?!+NODZ%;GY:#%4W M_O0>X3!\,6+,L&%=MD_3PB9SH"=-(9./AQ?FK30>IOD(>PSA?*?>HXMK28[C M/&0XEN2W0JIE;>L!UWH/GHS:!!]>MD^VJ1%KF&[!:W6MGOHIY MPB LB@A&@@J;Y_=57QVN&T)-1W?8"+U5K1KSLAW33^G3U2HM>KS/X(OV!*=T MXM_Y^%P?SPKC3L3ZM,)=?FQ8RZ7O_0(A#VFD(QQM+$!!>JROC=/)/3_D<1^P M=$#DZG2Z25J=&]G33_T]>?Z"ZAULT;#T IMXS6>.A?-EX\X,?T]+B"CF;L0_ ML<:!YT3A^I]D:A2?G[.:7<0YG@WSAI[S_YVKHN*E]<#.QCZS?IQ9,UCM>\MY MM)X"M,^2T@.B(YX^I&&?:[>?&@S:K[<2C^ MZM+X='TSNKFX'GTV[N[A@R]7-_?5W\H[&[6V%\$SIJ#)V:\) W<0?!70XFB4 M3ZW0^FU7IGS!XS!&(KQR]_W+E]&W?QJWGXR[ZS]NKC]=7XQN[HW1Q<7M]YO[ MZYL_C*]P8L" =\89GA]\]/WJ,D_=KKG>.UVTIPX<'@E&W$Q [)2!3H?D&/3#?-ZEN$:&+-(I>.$&PU M5::PQE>>B0T'T3BPI[;E8V0!O%3\+AQS]@E@6TV\R U]^F#J+>R)[9!'FCM= M648E\EZ#LAT*^E,>$IS<[_6[.CS5<2S?L!;XH@!]I07L>W[&X.&@'>:6"ZXT MG"4#E_L;.-P@ _1B]@LSU_#OR43\,OT&,<6;TP]>#++^8.=8ZA,^;7KIW Y"S\<@EEQUIHHD3/"A-?TK"D)N M7^/#X,G1(A)/@X\(#^BY&%8 \HK<+7SDLSEL'^Q1M,J]!2SM#PML=7XF'IP/ M[-'W%NHPTB\74D]O3.:&D20T,+[QX19?91HN"^F#YH?T2NC/XMW&.W$8O\EG MK'(>9J.Q](BV%83P?_B.T1_(VTR)H]9S J$9?WAXREI-;M!([O 4-9E@&L-R M4!FAE%(8,_)!"8"@+^&PV0JN06@<.>U](H)YJXH)_@[,,DWYC?S;W%-#JR,9 M306A'8%IR]6J\Y3RD85/&Q@/GC=]M!U'Z1*T90*E!4,O1(6:6NX#L+BKOJ^6 M.Y8GZ(&.6@WLBL?9>$+VS"8;'H12Q8EG^<\"_SL6=%A&0+H5G.QQQ%L8@GY; MI0)J R')I'QL#EI8#1P?)([Y99/K[(UA(VOY#!NG':FZH '<"C]XRJGV)&VYB ,-DA9AGPD1ZJ"\]?#?R^GL D2>KYJ! Q$F@N#-/3 MR3&'34+? M\B-$P^YIB7:<0^R-J4F>)Z*7(2.3L8,L.[6>E"8.8 5!TLK*"T86I#$QW M$"SZ/PIE6';HJI306J/PPO+])["<*?I>%((\! X9FNU^MJ4+;:S8RG?H3%/B MRENU\X$Y;'0R*S68##%EJRZ]V44=Y 7)%CR_T14$<\4#OX'>5,/Y&KSMTWM"1_PKWD M1: @EF1EH@,;^? H-&(I@0ZFGQ& "PC&X\3BSAOHJ8"MO)9[N $NS)*?&G/F MD%-KT8)P/1>@]2QN$(\MQW(G="=S3_D1]%0Q@=W2U&8;H^]?^3#LU,Y;YJ"5 MA;9L5+;F'DII2Q^1(^X1AXV#@LH6".?O4=P:R#; J9(%DDRK/)?ETK$GR@6; MPA\GP&3,<9#_X$_H0L E_$3?_F*[8$7Q&!*( BB^";]C\8]W& P ;VO!OZ2> M^86;5]_80R0B)>]$8.)N].6;"$G\)B_=K\Q;.DR%&[ZQ932&9= ;.]O[CG30 B0W&B9_M$U&!INZ/E/:UVBWBEK M<[F]$PRV)I9.UB&%L52P62E>!;H6Y 3]-%]9CGVO\F\$UB>"_PK21=: MH?".J8$.^X.!.47@433\\ GX4? $OL="@ID2*7$>&)G9?H!T,<6_O"@T%BR< M>U.N^%6XCF3=EGS%%RA3^;[UB"X84 34DVDXUMCSN;!@+&+.+'C83<&,@<3)&XAL!4.QLX?W$']HQ:4V"QH"0H*[+_(W]6MI" M1Z [")_(.A9<\BPB\QWH-(U 'TT9G/G4E/^-/UK"C>7"4_D6A0L'+^.Q'@S[ M&"+B#%<=BKNZ+'%ON'V,92)F"_1&Y(3\:XD@+NY1D3H+N..<>TXMY3>GZEZ4 MWPD4$%\\R3,0(>/XOQ%%AT&C2:A0= 'HR-A!0J =7%M.PD*9/$TPC9"TC<"C MAP.;$3?A;U:^C#=6MP4+9C_@E#8L;>( ]X&I$\>S:SQ4S>-E-0,W:M@@6"NQ MZO]/:!8;"#*H=S&6T0,5'U!),6)H+EL8B68H? M)+$AXNW<<^!V8VC]8!P8(]:@G)N,H\(]M C+^.&)(#B!B'TDD-OJVSQ:)P@+ M5V>\,8HPXJPZL/!,%9*1;TU^SWH@)Q6^(?\J,S%@]L+1N$'Z9'SVTV:/ :?H MAH/Q*;[C.T]PHXE-"\-;F/-42@-[GUW.?20PL"287K0HX$EY>BM(G,DL\6'@)_\AC9#M:! M9[[Z;&G9"J24S&HIAY7\$8FM6>>5Y"-H5GR34L-/B+^YMWZM#3^=- *0;\^ M_9U>_"D%D9'1+Q(1E2$GJ+>-I[<&T5SY6]Z."1 M"ENS JF)02]"JXK@"_X$>14>S4B*181V:L]FJ&NX!?^2*Z9H4*#"/C&ACS?N)J^A>7 M?DYV(:]/_)92F$$/D\]L 3<'IFR2NU]]\)A)W8-Z#FQ(%H8.$T$\!K^;A A9 MVN50@-96(H"%WW2L1Q["IQ/^-]=4Z:5+P"/N6N@S'F$DRM")3 G\F"*PQ%_" MBL?,93.>*N#7(87&4!'34O@MLWWY)UF?*B6285@T!JWYWEC*'-VX&#V5@BDD M15"-1V?#8"V%X%D_;3P2R^#O(*A6ZD[EMYDOY1?7D_>T1ZH'I6BU_8,Y]MSS MINGE66Y"F\3GZB;7/?5$U&\!ET_RTEMX/CNC)S^= 3.Y9_ EA1WU;0HRJZM6 MJ)M5JT%P:9!\O\ 1:[,A>+?9(0*R.>"7-I(0V1 7 3?'B:?8#^X4F)M N4E M?LG301BN!+/ HL"CAV8"< H'4D*-)#SR=PEJP[OV!B4 M)]_$-YG:45H>\)=C(^EC0<1AO_C=:=T6&HA#AI+0:@.CO8])QCQ QQR M2.A"H,G,G@%C+C$11RV@DLPP9KA9SA*H(Y>8WW1"7HL'HHWAP$T')RUUSKN@ M0AQ233R]3 HOPG+"U&698ETCDM8;.28." MY7;I%-1>3TW!IG;!Y"XR#B1FM.K&%W0&FZ3\%K^=76:3 M*2X37XC_GTXE(C8%NUW*%;B@MS %QR:8!GK"/V!; =+,]$&:/IU;YS35C\0:4 M&>C@,PUQ%:K-QE]-OJEN;.0K=%S%/A(]'>#N=+'=@X$E*+P_1\*ZF=C^)%I@ M!A/=L#(I??H7IB9,>O0L27*2])G2L]:>-@D0T%NXS(7_"GI>33M< OH MBQ-&%_SX/$>8?Y-X+<&9TEA)G!RW/D_:]H-+P@[IO@P47HNN0;C\SA"%&GBS M\)$BP]B^Q5N*L%" G4@$R)B 6TF4,?@.CO?$"% J2J@P^N+Q9N_(?OSW"=1* M$I:3?!/PY8/ 'L3*B,XB6CY@/)4_F[ESY%\NC;D^4"+IKD/O9>\Q41"J#EYNDU+NHI5H"CG9S9O\[F]A2XY?WL#$ZR=DZ( M7<%MN*>-9D1O=SOB.ZWD,RPDA=/"1;R',WK$FA'F2O.BTVC6SF?(_^@X!JNV MC:DPR#Z;.9S^<)$L+9^T1K[^HF(M- 4I,/@\\:+/#+07(XV^KHBCTVAE0O_P MV6D7"<62ITC)90;4:;D3DS[\B"V]>NN#NP(PW/F. ^@)\6M/X M'EISSJ3DGUD3&8* [^)B[SSPEHQ_(!;>-$812C-X^N(7KO&1V7_)@/*];;E_ M(8PI 2V5FI6N]6#E'77CR@(K3O7 FG _FYL %C@Z0H79@6BT,T'F=WCF6*$O M^-3D'PJ@5DBHQ%^$4?<"7[$@@1177VR8D*!L(;U$-B>Y;5G,F&14H8A'JJ*./9LKFZ 4:AC#OB/E;MNM@233\^HH/EMJ'# MPV"*6/$AX\Y% <**J9Y,=*9?X8U!.W(IHK*Z'_)APM(]OLB0:R+]-1-%^9$Y#A?I)U5Q04GY^/$4F)JR)?8' MHE@TQEC9+Q/^CQWR8/Y*@I_CR^ [JE9'+B6]7\+XGZVL4W7EP4"HB)H%X$+A MHN!5*E2:OTE2!+ E3L6Z\46$\/-<;D%I@7H3F0'16=BQ)W;("4'[![<*4W13 MC!6.64)AD'\&EJ7G,S.."6*PUPXXO(H> DHFQ4&K:X$S](DPX "//=_W'BDI M:"%,3/16SJG_0;4CX%U"ZC4(%0P*+U@\HM MVK)U,N&[0.B!/7AC7<1^85I'I"^ILRZA+&@7=/_PX#MXJ[ YD?-986'NOP8V M2+;EDY#(M 7_#XK6*SX7 0**C[KLT8S[1JF;<$8AVX"C^P@.(VB7:F.3D$E, M-QBR^M(*/)>23BH!+O/9\OF4RF:_F#^Q \$B?%G<7U<:FS+DB;;$7#1(;A)) MB7@M,7)( 1654HC)M;"044,.!4'6VR1EIK%T(B[A\LWBXIFDX]/4_4,%@_.1OG*F\N)Y!+W3#VJJ/7$M0'Z)9JPE:\BR$]=#_0K LM@;W@SAO9-+-Y6 M!C<"NGAE>:JAOV)3L>W#.^"EHYZ%LC1_B%9E(W=Z#7>Z^V##Y4WWG M)J1<*#NC5F!SG*!*[_):5S@8,@AA62Q(5-##>O%[($_83H-/.L&_H79 ;Q5V MB\;]"BX#_HL@?S.?$,AB%T1BNM.?M4H%.TAH(K*OTPJO;MPA7$Z5J>_30'7[-*4"OEMPCE3#URT*J$ M'P$%<0NJ JQ0TJ2UO$7)> &"1X(<)C1H$G_%SXTXC)DO5W]R?GH.&ML!9*.#R9E[E3N C M'!YOJ,N6H9C\P,^2@SA 23[P["=R9.R?$^PSP7O4[\*:S%F0*5=(1*@D$D1 ME.+&$Q)QLO8+<0L,T53X ?Q#S/OROA(I?UG@"#-.&ZT1>!=UAQ*9!08'L&@* M62:';CFZ;H<330T8DJ"K-(IXC6^;5OP9&5G?W?UOU?MWNQH)/CLM.W> M>,NBEGUP/GZ9JM6<# ;;3+1]2D8<,%X,-Z>#]@_\1. >92-:=# EIB>1 M1UFMP:/&?C/'>TR571"J4IIEJ\O?OK5* J/%4SP^1#&Q*GJ3F<2*XA> 9N): MAWV@(Y.@E(VUDYP9>(""C)E$$G+-9<=7Z<7'S#_ *9A+>4>K16ML4R%L4TMC MFS2V26.;*@H(TMBFMXUMZN5BF_H; I1D2.>8UZWJ&=2U\R_I- 7=]>KFCTT- M,?_WR8R3ZE0SNR%LI4R&A*D09]*DF1''M9+#@#^EXD")4)8,3)7A>SI'EXMS(1;'>[$[9#5/MY@JT[K/59 K#8 M:8 '#I-XI=W6M>J68 /:,$CIC/OT*?&>,5L9_074"ZTTZ0,^)4F7PJX$FQ3L M*DTD*"!GK!(]7F$;CQFPW!:.B\-PM[-LU$H>%YW6U2]!9AGHVAJT:\<1KD&Q M*.*V..MS+7M8;C3VF9;=;)03(MU!7LL*GO(1AWOF/P8TZ58%)4[.8@3L6=/53&&Q)X"M2=5^!=_ MI.K_'CD?*-SI-,$)2I,SALVQ;CYL:)MC68KIH@KQ)V2P4U%;A /&M) MXH"==3#&.;5%@M8!&G)LKKZMYQAY4FB#CV.P-4>2,2Y="K0L MT>I8:8P/.AL_G<7_Q<&&P'8VXK[=:0QS%>%W3,9R4C'+1]Q9T;*&2JJ@^]6. M.PEE)'J22)T!5$T:X;E?5_8QPRMX2 !@I<%,(FM8%G-NJ7+ MKW-4%NI&JC:2:/6$BE$3Z;#Z* @B[**#^S:W$!IVF$36Q#T<9;XFL38!"*+G M4HNC4:9-3"#[Q.#&W-5WXW9BP/SF U,MVY+H2KPSE$2DS?64UA8-^J94+Y;_ MFF2ZC&7NQATO0%A$$7W=V6*HEJ2O-UNI;1SWD:.F4W--4I[5.IE%*U0Y=.DB MDS5$3YY9JYA+U:T"[3JY%C[OVK>9G;.C=4]2A8_6*$0>!]1SRHUUHPK6@;? M2621J1XL;G@%]H'G_Z!A+[P9$@\> *.@J>?8L?4[96,$C_W$!G:AA(ZMC7NI M@%^0BD3/U@6'>?^N#(0LA1/;CK',&$NJ MB;3LV4S+M=[?>"[W;,&!D(V6 MT79A;D"Z!!N.\3C+VFC+()M<:PY.&[N6I$K3RD(C$/6_V:5/<4_5%XA?"B MZ6E+E%515\)?:E$G GAJW%$OJS3<"*>-;M3BK569^'_;9.(.VR,^R;]^Y3V- M85=*%9RU8@D9ULZ[V7#$WSF<';OKT1PW-_Q/GLKEO1>I).)W(.#S;HSKNVM9 M]OK1-*XH(78< M%S91A(A>3K,^H_%?U!M#>$&.92_4UQ(#!*GXG1=Z<^S]3]ZC8J5<6\8 ; Q9 M_:1D[86 ;$R_CD>E?.#!<(PAYLHT:V! MC'#ZTIGWB,8B-=.$I44^F:=+O&[PU9(!R"[]ECAV#,Q$B;I;"I\E:6WY=L#K M"*9TSIC[E ?M,V&,J]XKR(]R+*_H\+Y"9UF4#B\.:)P*/M;B*WU*G63.A 3) M9F*291R!7!D4B3\5'V&G9U$Y'#^KEIKRGEOGN1J&O(C3^;'J7-77J?DW*M A M3DE]2[67IO[6LD=H8NAF;8?Z;CD-<]\2U4RR=!3D0%PUI#4!:6UK2*N&M&I( M:T5QH!K2^K8AK=GJ+_QT4#V?N78.ZN6231@Z'O_G;\U>XT.[0=&T-MWS*W]J MRD";,FN9,.@IQYRP>POEFCN;0S[8#/U:VI$7GH_#L$)VZW^TW!^W:&KNEUAN M@5_<,H>]5GY>N= .NB^S@U;MO&GV6MD=R$+C/,-PQ8XM\Z3R?-#/LA_+A>JV M&,] +[SC=NV\;3;;_?P=FZ6>VO%WTZ'S:^>=7](I. 2&!>;[3+'>-X9YI+4X MJU:VS2A\=MJ1/]S_F2+ :XWRT2FENC.!;QS@ULD!QYXI/*@F6[]1P@KN<^K= M)$>$\(#>G%E..!?!B;3W3_WC1 M.+A=HE.7C C*K)+U\."S!\0&$(1%1GQ$$QI[,8Y\T3))ML5,$)E8HK_NLFV?]+4:;S QWCE(@9PW4[) /"M MJ6BBCN(4\4CLFHQ"8N8G:O1#+&G(D?\8"U MYP9S>YEHJIX^(8_R1[0/'+N&\AA:/R0>G1[$7^E:U,(#I_+B(_@T5OK[-&YN MRO\;CPN\FPEOO"_:,DL.A_\'#!GW[DH0(#VA,8':$L?,WF\ "Y#>H;K=:F.)Q+&M"+L%IU4D=XE(2%#T8WJ+7%G68FY)O=[ *566;1;;%;PE2E8;D:.7C MO>_5E4!:,A[ S5'/E'ODL&H=46,2 M W1EY0L]XAZO]33UI='MQK9Z$4R=(!'FJ,)XQ MOQ84O+*[K"8CN0V2I\*1W?%P#WAI$MTMWR?@I:HE;T(A)!E0W3R!N/_P72&6 MY1+G._:_(LXJ6S!3];>(]GF$K"2]>NUG(EB[=CX,FSW57BX7 >+3\> M)BRZ\*\*?>$P7.^YY*M#[#)L9S%N=>.C)YRFS"ZE];RB\'#J#(UFY@8SQY7E M7LVK_H^8,2)JG(H2:VL20Q+K#W@^ J!OW00!67&J=3%MUFUD9:QX#*BW!>Q= M_N)[M?..V>WF1%Y%3$A>?*VTQC"%_2_.RN*%#X4/*Q/T0F:!?QU_XQAPW;3Q MIJQB3!N=G*F3AB0:AM(@1--NQ463SA.W^-/^E\3MQ4)%$WFXKV2J0I.DG#SJ:+69K=ZII*7T3YX96R;NQ^XWEN[$ZC=M[O@T6<56,'Y>D@_; .@LX2=JN<4?PK6],YG-/.63/%00FI&%C/HNG MDCB4:<;_.Q$=150!@17!K>/SZ6X\D//1PRL)[Q$:).9A3&G3Q5(P/;?%JJ53 MB8_CJ^\]^-;BFYP.-%++C;_#A:A96(K K^PWS>:@E^,FV;P'VD_>A4VD7MDO M/A#.^D7M">.> Y374.0F1&"0"\]?&1^0/*-XC_=&\+8..^BS6&2\:]6@[Y[EOIQIOG&ATY\ M\KW%A5#\6!!Y$8$HP /6JK&0D6'+LM,A73:$)](!'@A0)%X=T9X[7O%O [YP@S/>%#S&2CNH] M56_$7$TF)/K:^E9@+9^0'7ABL&B0I'S&G[RS05:AL^#=*CYGR<:2.C.Z87* M3#JZS$27F>@RDXK69N@RD[=;9B+LM1PKKK46)LR+4/)*4X;5L_5JYV*BVAFW M&LB*B)$J0:J[C H_RD8RPMQ)]1*F"<8X,8>9W,TX T4EL\@!9JYC/R=IE_BQ M14G98-4!+.XLC18/^"LTWGP&YL!9$+(EFCOH]+S?3YGV6RN6Z5ES\&)GT?SM MY3)2:;(,Z[T^DD%.$YVD)CRNYJ(D(WQ8>P;5I7GK1&B>:'25*M>/Z\'I2$[Q M"-J5.X+,\$A>BJ?T(H^GG"*M.Y6CM0A!;2*T;.6QJPS@77."9].MW-DD+V5$ MN8J[&H,E/%:"\9'<0Z'2*/A7@-BPW1&8:4?GJ$$B>N)[#&S:DQT.YZN(_@A[ MY=2B7B-C8?W%^UJG.^$H%"\9;A32P;B2"B(1'H^&'2\]FT-%J1DSF7-S>[D4 M_4YB6S#.+LHX&HX/EW&J>+ZA_ FR$4X5Y2^?4A__Q-?"N>U/!5(Q+9D9QAJ;$[A/V],Q804['9F MB,.TUEI@IXQU5IPH ZV<(^56XR'0>#>+R.7$B[ 5NX6%(3CM1%6TN6MN$JIF M#!G\GGJ^XH1Q,64R,-6+,>3KB9Z@G&$"B@WS!?DLC'Q7E4[2*%%>>+*B)^O& MB.I#0*%)N'3^@M(;5F4!\3ALK&&AW3DYL6/>R8D&CO(A.O"X,4\<\2GEF*(F M>Q(G9./PHX!W@//3KA>%P9&]D#U%S^U1NOTZ+G %JQJ/[,80=Y1HX?2DY&O- MVE7#X;D-W.NKT0$@XM3.551))"#6B99)J?;S(M&4+%;)]J+?H>G3J4F/ .,G M4A.DFR3@ %ZBE&RRJ>X"&WXOG?4&5:*U-N=))224]\.Q:0IEM"J]8JX#7PL\ MB2!(2YYHK1O?$VE+_IF9O@R4 H_1%JGF_IF5B"1B^K4H%H]> K!NC"+X[);H M8\;7TT_VA)R+'.Q3@0T2=_6"H@0UJ@LS[TT9B4ZE5:E7,;PK8#AI/EQ'\E@6 M[%"0'[/#A-BQ',^E"CB'ZAGH'6(F0T)RJN MV2WOPD<3 #8_/=763LSQ2NPE_5K\8W)'_Y ED3S0+"['!(44+1(+]JAC:< ! M"#*;G[QK$\/(K!7MQ"O%D@,XK"!U-XL:%1&CS.6EU1U;R5)04=^>G'V6NPF^ MS@68?UA>'2:J0Q-U3&IDB+PFUY_3RJ'&V]R\3NZH2;4@7\-M[93V.#DU<(>> M!R%&L!4N_ _I1E3#/^,^\_'(/AKR*3R+I_T<"X&%5",]$)F2>%T@C?,%5T-! M*%$P6!.6K943Q;C<( E4&]/T4W<^/B.?'OS)JZTS\5-IS 6JX0.OTT(51YKT M!'F"U(V DQ.F D[C# LGA5F4/H148:6 /?#SH/&3]AS(+'P,Y0"2=7KCQ05E#[#!0U>PWA%6['GVAPA2\^ M?%IR5TT=M3 09BQ]@]&%(>[+. C"/:TQ@PT2%DZ-:^%0(\ZO/&8!NHA&FH(1 MX9)_HYXBOTTX[HGLZ$NM?ZAUM-!B>+& 8>[0TNB1\>VR0P"'<(0\"A3$EU4Z M>I.\H[(F*H$&L=4#4O&,]L"+@_FCY]S)CX&,JK. B@9L'6^L848K,*.NAAEI MF)&&&544FZ-A1F\79L3!07F0(1Q)O &;U,K%)K5K11MIV8%LAP?/OYT),XR4 M20ZNO5, P5X5$^T^A1X*Q90WD1R?-=T9X@1[)&_0=D-:+:? MTRW]\ (]_Z5A/[VTRX\[H1Q_$PX2Q@9&/OR_J7RS^',=_O1[]O/NH-[LM'+_U*@WR]O>7^,2Y_Z36;YQA6-CE)B%T\-H$7]-2" )*-Q%E R<$\?3HM(6!&7(L^^ MVWT[]&II>A6B5[.(^&7[N4QFL\9LLFG;Z%V\T*8SMD%C?>Q)<,NVC>YV\@WC M% CQ'T?:?'+3Y$A6:M M V[3!$D-JH5*"]7.PV@/$:H>"E6GFVV KH5*"]6K%JHM@ZH/$:H^"M6@E6T/ M4S6A(N/U=XJJ[-$OM+K)4AFI2L?M3BUKFEY],G&*S0<8@@.7H@:X[ MY2AVA7?DX,X@!6^X\4*VK6OGL3(Y6[IG/&M6:?-:=L\JM;!#ZI=D'NE%VF52 M*+[YP;AC#P2QN7:YUH)MO0;\@VPL8WP4$V5/39I5E__07@CX B(<"<48R%;; M!%U*M"5!V9W:LQDC]/;,]Q8KCZ XO!Q_O+"FI!OPN8EZD\<$R$#-+TAT$L7R M"N-=$@R[1.C=-%%;@-"(:429*?8;;Y2O?A_#V=\IF(4L_% /2CS]MZW(A.H? MYH:44SO!J\G9$!PRCI@4-1 OB5Q+ESC@)ZO$#&) )';/F?[DN.69PN-Q8$JR MCV$:MIUL?9G&:"ND.=X@LR3_/5*?JDVUA3117,*E=T&^T'CP+'U6\9H9*B7' M0:^M:J@5K6?(SFU*8.#"IZ4 P,7C1ZP$R$:6)BEP>D(<115.\N;-JP:(JW=D M1U^Y1(("I]]3>&S4EK:\>=VZJ TG]=O,&K8%>W]NZ357].W#VGFV1W)._]^P M> O60_HVKMW&R)VJ08UK4L7=QJM)%1,8'_E=F1V&-09EE+TH4-KI*HMYGQ?T MY;;+2-1F3=(3YW,?K ;.3R-?MO 5(RY>6W:ZWZP/V_E_>CV)X/;1$L'9KYU& M"DIJ, /TVG^-_=]WS7F^".GVG@Z*EVHO*Q"D: M)NWBY/.&.<@90%NU.*E./F@Y*U7.6EORY.4*6JMVWAR:O7;U!:WP92VF(YW2 M97WM3GR&C;LQH*;"0>F.$U8HY\(Q-W-E*\*TBA$F5WF9>RCF'5B6FOZV?GJ+9C+ZV);S)WN$=42!! >C C2 MMX'T4R_"D#]Y,6_3%R^3--56-D?.8>[OJ/=+=BS*.,L7AL2]??<)?XT:IA^EEY*M> M#?C7E"##SB?OIY$_M9X4^_4:M?-X!+L\#@.^$B3 +O'014*K83M?1MV_URHD MT!ECYF_TC%N[;NHK\S$%;SV ^\)?K500=KJ0.X%3 "V944!_5QVS"&)(?5+K MQL[G!;\B4$QJY]&2-]EBQA-6IRN *I]>.4O0ZV@DVI$HK2)$NY<#Y%CA9Z/XY)_VK[G M\J;HKIA'*'Y2-R[9DG'@)O5C%!@G/FY4@C=YWS%Y8H]6H$3)3/3$P_ZH NDK M0*-Q^^DD6-'VX=!MT#(6;]%*9R8;PR,&E7>#1RR7:(Q&[=74^^6HQ97NK!X< MK0?+B!N(BJ:-U%N2FG[*YMO ?M1H?$DG(L&B0!O"<1(NC 5X#]G!'):MNA/B MF=@L%\$IM:[H0PZO#"T<#4G#4W]1-V[GZ2!V;._"CK>S&Q;>(5OE,F2[=MZH M9V??_MTLNK)>V2OKX,JR9;9_Y_#@@JOKE[VZ[AJZ(>NJWK7(0'PX,N*!^,*Q M=-],M,ISGO9#?<+*%5]?J[ZXZ\R:7N^4#9A8@..=GEKA16X78]$ ."BW2;5I M.-AWLBH=G,N<\7S'VZO_P5SF6\[(G8ZF"]NUL44E4N1*T'.M&/1/60S$YDU# M;)].(4V 4Y,*M:6'Q):LU):R0O)H/8CNVF/XU8S&?DRQMSQRMJQ M!; F/:_ MZ0/4MZZH;8A"$;U--A;':+QH!VUB30OZHX'LTPS7]8R1'(E.K*:PE6CAPBP% MNQ/%!OYC"@]S/"J%44O?(@*Z!^I*#]2>[H&J>Z#J'J@5;1QZHWN@OHS!4)$> MJ,U&?A/49M&&IG=(XX\8"$"'&FY*'BRC&21@VREC_ZL#Y.$V76S*#4[9E+OZ M5V2'3V>T=R.Y^5,SX%:&^GG^E!P/M1\UXT1$5S_9KN5.L.;W+@3+BU<48S2' M<8KPL)"%TZA6"EH??"R^HY!>/)U%^BOX!+#"0F Z]$:"T,-!#"Y.:;+%^ [' M"W@Q,IIN8K;+FAF+Z#EYKGB*>+V,):JE\&!3[JKP>WR<%#X!2!N&CEH5QG^4 MI5&6%\-AE >-(-A6]AZ A M&&<&N,J":/R7F+"B=+7:>W)8NYA!@<:8W.XT'G7%AQ3RQ@J"^X5P+A@+$Z6M M:J5J>;ACK%5?K3U?(\CCB#A33BJ<&O^*+!\([_ !A9+$B5FWF9&B_F'I8[ 9[SW!<7KDAOF\V9(1VV8,@3_;\;L,/+Y@"'8XI.HPL%+E5:)!3@38X8$@4ZH#3&M;./U>F \[: M*[[,>-@HCE5<8/1B;> K)ZW=._&T=F+OKS69W>/)[$1 *IX5-IFCON>C*X5& MLRA&%OG)P3YJ4!C^%:>H234N)K/N$('+S&C-2WA9J%;(%K)]XC MHKU%T3']1NV\8_:[V>R-66RE6P# ):P4#K]K-KKMG)7B,15:[99.@R6L%I/; M+;,]'.8L]XB9,+[^;R(&"W[C91R!%5M9\1W[[:PV[+=/6QM^2\:@$Q1XK:J1 MSBN]ZV3DO;)Z5L:;[T;(81"01W>9CQL7E/._PVGQF9?!U(P23B MX^VC0,890BR4C/PG$5CA81X5O1&OPM.9LS-X%GLR<^.*M!5JH3=FS.4!"8S) M1.)3C%K07^P@B+!5H.R:Z?.Q\8;C!8$9[V)EZ4CCO, '1B&B4+71G<9D,G%4 MK!4%O!+?,P+/>/0B!Q/<(-.A?2:)5*;O")PWXG$,(.]7WW/AGQ,>D>52OE;6 M!SGFT^#4S2?,-1@Q08PT15Y![]K1U%LBOQV^QRTZ;VT9P7,IPVO7N)V$'JHQ M?ANF,P\) MP)=&U@?/009/NN]FET]Q'T))?\_*]^7U+P\EUM=/<=OGKCU>DU M9XV!:7Q$987HJPMO,;9=T9WTW;VW!($<-+J_O4\^$\.'JK)PQ+MKXAVN/ON\ MVJQ0_D4T*Y2E(D%>R.LYSJ$@#]9S(YHOSC!PD/((P7*"&\,74>0)_9M2(''S M8HK%TT64[<&*?\LMVW^WVDGV-_ETWD@7;A_!.9.8<^@O$\RJ46B=CES-/]S$ M#I+C>HW>;W7CNTB3X-V%Z&.XK$V1>!#[HR2 &*PNN[]0FHE\I1EX,W S3B5* M&[5(LO5E(+#J=#=.&7I/2!N%PY<=<@5I952^, WAUDYDN<0H;MH#QSA14J%N M)$\3,PID=J"%0:AQ/F%;3HV,FRT0AD@U9C6:76Y4TVH(7&\OU*]4N0@"Y]-/ M3+\^F*MKG"A,:++8,J=V#SGG'O $ IE6:"SX8G7)1*0UY6G!NG&%]%!F!1VS M"W*A*@>P>S=A^BF_Y!J+R GMI0.$M_U)M,#O312\3IE:O+DW/XL%?/N72 'Q M_^+V4L[*5Q(EXLX)YRSN,4[@UB25$DU2>?6-2/W@]U3+7#IKL6=5+B&W.+6G M<5]D$%P;7C^AS6+J+=5[>:;N@4!EH.LOFC&HH*]14*U?9V[+M&6!R2SCGPSN M.,X/%=SQ-H/BQOO)%0/WM\FB %-!&0K SL(0:)\U^J8:@/"-$-)($J&26X,& M& '7"Q0'01W0 OQKE(65O[RT P0M8%Z1"U52H%$C4>T3_%:DL?,X&WPGO WH M-JY]Q4R+_)DP,7Y 4NJVED MT4WRU^ Q@)/("X;23^)%<_(9F)9;L5@.=1';YB8?L>##.OQA";]1>% ^"U.> M8^12D1\X.KQD&34WN((6XN64FV13)F!AAR%&L9..&?Q%>.7P?28<2$%+X3Q5 M,E*SU@-\M!V'NW^%G;X3\D(4N^SBA0Q-@X^.-.ZM7TS%A/J=/ ]((073),OB$5Q&#L/:3VDH\F<)M"+ 8FV(+>^BJF+]]Z(+U6R"0O^ /4> M% 43#1JU\Y[9;>=CB296,-\##-7:O(<)==.3#?8)#% MG-&ZU>/2Q\'OM9F=[''!NRM1%'$B#I=0+<[30Q MJ\]F ?P-Y'/*OY)'D5;MO-]O9BF"'9\L]\&F1EGTZX+ O.?6^X?G3?'F+LSB;63Q1B_;_)!7LF5(4SK#QRO/+JY3.^\.TJ+P.3J*@6^!_;1> M,AUW0 MG$#FL M53Q+L?%-NN?ZYE.*F#<$WKR=(: 5_&1.NR!+/-"BBGA"1S5B,O8$&;-:"@&F M9^B 2Q<73,TE[SU9DMD#F]C=7ACY/O;](POI&_[K=G8;A>C#!_^-&!'8?^(K M?X+0Y*GD/JCDG*:,%')>V3 W*!;6+WL1+>(_%IZ(7)[)M(T$?-,%;]!![;QI MKJ4)J0(:UY[E_+HQ4G*QBLS9(A4(,+)6RMBK:(<.\^U0SAIQ^7)Z(QMWGE32 M\LL*YI,@XB,-)$?=8[L*%PT7SFI_ %[]GJSQ_VG9O&]J*I2&V!ZAPRTTQI9< M__]PO4=7H;#@K_ 1>X*?+J,PU9?5&V-!N7@NK9J7J$M$ML]$50WBPCYC(831 MEJEYI6-EV]V87'#)^%@]\52O(C1F2Y<_/+/\Z=['9G^4FYM"U*RLSMA.N'?Y6CIB^H6>VU.UI@B.YVMNT4FGG'@*6AG4%60:.. M$!T)>%R7NC"X9^3:/Z"H>^O]91[@7ZE:H-7B?]7(-4LB,FMQK=M*G##12R41 M+8QCA&0_XI)FCO<(IM7%CBOZA/)!%YOQ16)\K#&8G:>G*[[Z'K^743XBA]/$ M6XJ-!RNE*'%]HBH5424U>3>NB&K@[U5$5W2"7CVBO)X\6V.X;QP--5B/AMH] ME@VJLJ8Q5!I#I3%4E=C,V\90[79M\KUA;R5[]O226;8+D64KEF2[=K'3K^<_ M;4JM#5O9U-JPE4VM7=_\-S##+>?M+0FU DT1)W,VC1SPX]5B+W@VGC1+SG+; MF<++-1D\OHFW#3O!X[;L98!>R__\6%J!TO'>GIONW1H]*,/ MXF'BNL>+:F7<#_$5_W-\A]4;_!X38P7%F\6?Z_"GW[.?]YOU83O_3XUZ,_?S M=8]JMNJ-0?Y/UCUJ_>>=1J^\1;4W/FK+*,:-(SVS7\N92\:UV@M-XE1>3[#*"MLV M^C:G]A7;_.N9R[=ELJ:Z@X&EODB.NF$A3O3"X"%-P.%^A M(SOJP.BTAMAI@*86MCM/L][,!ZZH)VUN8HOT/S_\AFNP^ M^"S(7,T[C9?/V?>)C)<_QKV$)+UVO_K>!.AYF*STJ"]F(SMS;;^AL148WZSY MJ;#J+9&?^LA/K4%90XB?7<&>H./S"=M1XH1*Q!+NIUYS=OT*Q6%7]2H)BI#. M \5A4#MO]\Q!3GO<_4R1"ECWFJ$*Z]<2&6H(^K5I-EIE.9(O;<'NY#>F)]*_ M,;^QV.9?CW#MJJU!G@I*4;>!!3%-L]/ME&2FO'PX1HN5%JM2[ZQ]Q*H)8M4W M&X.#K9VCB]5;\ MN/%O3#SM>N MXJ[":J(%3I'9+,V$W?&,JI\,T?+U!N1KY_MW?_EJHWQU^F7%'(XH7W0-_TZ8 MH2S=D: $SITQ M^\WCG.26V3]EK+]/Z^_E%,EL/,E\6YE*WE9K8\1L*%X7P]L)9(9 [508,[8< M,:67,2J^R,R-RD*.=ZTQZ%:\7\[E7DA>HKD QO+&$1ED;+>1'50"GV6!O%^_ M77T=75\:5__S]>KF[NJ.H.NW]W]>?3,NOG_[=H7-&N_NKN[OC!)QOI=B'@#- M[;RPEM1L^]]L^M5GV'ELY$YIBWQO&^#*W<9P1_POW_LI7)J"!JKC(^D7WM]* MBJ9HV",TJ*J FGFB._3[ AU"-;I9HYNK#^C5Z&:-;B8J<'-CN:(C-.(%IN"S4$.>#[J1O,3EO6+BOO+2P(V2SGVV[ MJ)'-I\]&NZC=:ZP[+ MJJ>J@!&OV:>0*CV,?;JU\[[9;&5S2J<)63X%%2J#Z;8;1#YFF;1)NJ_^%*2\ MEI0LS/X]3(ZW6U4IB=*&Z#-JSX.9IX_,TQIJ\_/YCE\F:;%!^L(.:'JU-C_W M59_IE/>>%@3UIFX.JF)!: /T&55H*0PT),AQ]^ R=VV"[LP"U\FY>G&$5!NB M^T/OD: TUC$.;165A%:#H(ZMLDITM#5:)0[:"A M@X.:!/9M9P=%G*9)ND=N M5R"_5M'P.O-[*&E>CR3N%E00*>$T[G-/&Z?5 KGLFH/#,UXEGFBU,1I:CK4< MEQ+?*56.VR#' Y#C@V,^+RS'>Q=W[5KD,*AXD;75W MK6/@N\O9\^8^YBO#%5;F*#Q73_O\BH>+9#40SI6#=>( >21E>BS]VHH'&L;) M"P=YT1D63<"_FN]W'HUS*K40W4&]V6F]\EJ(2BZJ<[0"C6;W1(L2_@GB:ERY M4S8M4HFP8WW&SE=RQ8FT8]7*]NV^'7JU-+T*T:OYY@J!OKLXY(]/;=/U/V^N M-N'=,49:E ML))J@9)J@-G5/75LBL:8:050&050OK5[- 701@4P "NEK%(LK0"T GCS"J!\ M+^1H"@ 'F?<;9J]SZBCS0TQB>/2L.4QC"I/_._=CD-,#.QO[S/IQ9LU@N>\M MY]%Z"I#F21"B[P&TN)Q M.7P/[,U\_!8LQZK,6HRYCWKF;]LQU7WPA D+ZLT,U#/ ;^#X6N>[8DE7T+;U M7N:P^&?/S]/Y,.WO=Z.;D?'GU>CS_9_&W<7UUC;]=7=VMI4)7-(.;\SKB_-2YN;^YN/U]?CNZO+HU/US>CFXOKT6?C[AX^ M^')U!,^8!J;!?DT8J'BX[HQ@CC,9IE9H_58 X/SB)0 I'/X9 MGM#]] -_*!<"W:WN#]W$^A>>BE$L@/U@/HICE(W/9S [7 /?; M6>!^]4<,Q"7ILH.V\6[,M_E;:LZ'"/S-P-R2%$>PO:<,K@TS"#3P_A0Q[I5< ME ;>:^"]!MYKX'T%Z?7V@/>BG'<7/MD?G[6-@?9J,?565E822.TT,M:?&)#% M<@Y!!;RVX'+>%JL=)#Y*-8=05()!,@Y=7E2W5SO/">CNC@*O#K9)\_\I\7^) M6=(]N+Z?R_4G"^O3K']*K%](]6<2A.6I_@&8\[W.R^O^-P4WI.I=W5-X7TB< M8'.BXLB=?O8F.S+[$#1^:5/J*@!!T2Q3T#PHS#*=!NC'857Z!FN6>4;8S=XL MTZR==WM589FW%131)7REW*RJ:5N&VXO!Q3HMN' ;YK!9E?D5NGKJ!5SRLIBI M#'&W":F2K(3+O=QJ4Q4P07E=L.*W].\W&Y;1FT'"_4 M%/UI2\MN]_@:3%=A8>F"YFV:[<[!/?]/H5V,YK_2KOZR^ _S4SVSU3A866O^ M>R7\MYNU4!;_]E2J59I?#34LT6/7OB__^+<"DY+BV0W!2 M+XTYJMSOWU80+Q_9],I=Y:- @:0P"I*6=1T.P!PS&^WL;7B*B"'-5\6[E!Z) MKX:U\Z'9'&2]3,U7I\U7N^)7CL-7W0;IJX-:3EHVG4M%K MA2/+_YB0SB9-"C=Y/K'8R&OGGJ*7];[@T#D;C8)X]?Z8,44[(L@Q1[)YD=II5:?&JO9QG3(D=B:6Z.(V]V\\B^#5+ MG3Y+;(#)F:Q+EK:6&C^I6ER4W.$_)[/6SM_OK&J>D MF? 8WGE93#BHG??,83M;?J"9\.TQ85$?ORPF'*(F'+0/*2NM_$BK(J77NA7T M<4E3;9$M?1C$P0+::]3.VP.SURLK$E'U-NY:=K7LOG0 J"S9;8+L#LW6X6!4 M+;M:=K7L%AC!<+CLMFKGW8[9S''/3DMVUTQ/2,Y*V+,E]=5LQB8X0T&1_)L5 MLF\,'C"Q'9O:+Z_I2=UKGV!/ZOLY,YC<,[6F]F&_R%<&MG$U\7];IF&Y4_Q7 MT_ %)=C4"#UJ/1V$5AB%GO]D?*_?U0V!G8H?90>&%8@&U8%N3WV2G: KN2C= MGGI#>VHCIKV]_M1W:3-@)LR >(8M60,ZH[C-.0 K?LS\ MC7&YUJKYNHO1.I)M&=5!I;ZLO 6<\B(-V@[P,ES!+U]U6CEN__O1Z@NU(&P4 MA-Z+"$)7"X(6A&H)0O]%!*&G!6$G02@)[EWI'1,B/V'@L< T7!;B2+)9(@@D M)IQI,/C.]ETF_+N+-.?71[ @5XS[M?-&7&.5TR5=V*[U7E$4N/PRIF<> MN_<;R.Y5Z=6M*UR?Z2(NR"1-9)*#6UAK)JDFDZR[8 LR20N9I*P&@2\-;CZ% MB_/J%QP% ANH^(UNSXG/IG:XW\UYN@;E^I* 8_FZ\.$%)[4H/39Z'#/=S=6*A#+-33+/3Z6.APOW8W%NH""S7JA[0_TL[LSDQPPT(, M2/O,"C R;?RTG(C.RK 0?FB!]:3=VN/>S1=SRWV +\B:/OC2* A8&/RW/(N1 M/(I<><'J_W9I&2;M[52,P0Z_N0]EL#XP6#-'(6L&>Q4,=OB]?BB##>C&SQJ- MVA4_*U,=?CUOA=3->%.K[^R67TG<:4_VN%\[CFX;HXQT_[[ MGFEI0=%_Q 1=B\(8M"IEPFH?Z?GRTD6XI(TWK08OO%(FV9"7+L(DG=IYOS+1 MEK?@#'\'=]8--I^PR>]W._\/?I6I>'YJ;7-*S;-3T$SP:",?AP MC71T\^&..K]8.4YZD0SU5O[I:2#_*3'1H4GJ8ZNC?C[24.>JC\ +(\/3MTCIT?2O* @7S V#=.NLF?V+3<_^S7PO5RP&-="H@U:S]:$B M=JQV=HZ-*#M TV99+8>EAOD7MYYJ53E.>O8 ]2[\,VQ@0/JUP+WWM0"/UE_S MY+EPGPN3FX<1$.9VR7QBQ7S>PPZP_=+RMD?K(5DYBV^_7AE:5BKHJN\L*SB] MLE=O:5G1LO(:9&4?ZV9G66F#K#3UO5)&ZYG-O9%/NBTQ]AQ^PCZGC/J<7K() M0T[E3-)N4,?BMJH"0,%?+"T_[E>\_K=-WNVX;JQY>UQ9$!C3B!E+'P3!A\WC MHRV4G9GUT_.I:[$L"YQ$/@(0GPP;5C$)#2\#:3"LR<2/0*"HR3*N<$( 5*Q? MP/^"5_Q@H;&P?V%GG:6/+8Y_&6//^R'PCO5T2V4\[ D7.9*UU'$+(G>P([), M#;WWF6/A3N-&R']/]ZX6,M2(?V*-06*B-F@T_Q?OUOGN[8: M_Y ZK':]ESDL_MGS\W2FORPIQ^]WHYN1\>?5Z//]G\;=Q?75S<75G6E/=]>7UZ-OUU=U:&E1E,S>W]U=WQOVM<7%[8IU)5;1QIUK0Y.LQ!_ M8=-1*#_MU/:>T9 IS,#F0K8UMAVXG%BP9CS#L'.BXQDP%&W/P-AT0V,"=LB# MY\,N4=E-!2$X,M) 'GO-HQ;ZS?JPG?^GUS/5H'VTJ0;9K^5XJ!5LIRZM= ., M^_\:^[_OVK__E1.CJ8C1ROI_KSQW?IE0?*#R\ XXI _QX9,+]LJ7E;NRDK"- MIS&G_-K]";+I^4^'(%->Z6BU5SHBK;-Y1%K&*%0L4G1*VK!;.^^:W4%5RGU* M"'YKJ7BM4M%]-JGHH50,^F6ELBH"$3R-ZVXD0\2N%XJ0P-[+8K/Q+3-;[QT L,,\B *2T^_=MXS>P/=U^8ULEA1)7P<%AO4S@=F MKU65@KPWY8]<_2NRPZ>SL5T%?) @.$B2F(P=W&'7_ MB$>2_,*%%Q0>G#P,\26C6SOO]JB#?M1W] MDHJX$-^T:N?#UL'1"VT<[Q.L#RWW <,4VW(UVA8IJCK_\+SIH^TXP/TQF?F? M"ML8;8Q1M+L'-^O01FX%&:NH;BV3L3HE!;^T\5J<1SZM I%#'Y[FD">B3=C2 M]/!WUV>PQ7^#JR<(_=F#/Q27%9P78/9[.E#\&KFJJ!(NC:NPJ[[9Z1RX@SB2"W,IEC^9@^5RR7XRQQ,N M84&1P3D!;;/;UOVI7R-W%<=-E,M=@]KYT.PUJX(Q>E,F\;T:U6=,+-]_PK-[ MM/RI[BU<:I*.#\>Z0 I+ A<6DR$JX8[9:AS_LKZTIZ%^<4B;QSL!N ^&0PZ-MH-+T[RWDK3H*AXF)SCUP!QVJY)TUA;P M2^K>$OFJ13&NEHX'OP"+4'B6IVZ1GH4E %O=F*W#8PO:JJT@"Q76K'NQ M4(=8J)7MUGSZ)FQK4'$E^H M@I;.FY9<4'(H!=DO@)IS+W1R8S78VGO7LW/2FK&4, M^&I;^65L9:!]84$9@F@^M:#>"Z =SU9<'/CVXE MRQ5(JG9Y)[W*-HBJ[LK>PEC.5,LR)^Y6>;0^]R_Q^S>52=%EH<=S(1/M7#<4 M^16\89K4P6B83;IH9_*T^6IW\^0H?-5"ONKG9&*JYE;*_KVP1K:>#8_YK3<% M=/KJLZ4%1L\;!?L_Q]5 !!9-. I'YEMMQ*$,FEF/0\_?/FUNVO-".(R;.MBB M93C,HII.=7SR:6C9^* MX%>"WH6E!U/QS5SPE+:53YN]UBKJYV2O 6>OG((L;3SK:H J*M]-9LQ>@.[6 ML';>,8>=;-9=F\*GS4-[F<)[\5"[@:'HSK "[M2;0CCEU /LDN)]:Y"38VA> M-6H\(3N%Q:99.V\WP#DLP?S08*>3Y[P=]74IG-<"SFN9W?8AM[XN"S@F6C6K MOW=$/HF)J&W8^-2+,#Y-AW& 7%6.5KM/X2J3--56-<=$\R8TS1X0RW8;)\3T MVV4UP2[C,%_(/=$BK$7X9:#1!XIPAV.-RFKD^5(B3!;%[S1 ?/M\\BH-8\?9 M3IX+"Z$![&[&5L#\AF7\%?EV,+4Y]XRMP-;#V?5P]AW1UAM [96>1ZZ'L^OA M[$7*_0ZO'WG]1M;;,:.*1OOVKC-K=ZFO$.FD_1PO9FQ"RHH'-_86L MA^VM^SEYJ*K)V%LH/+=*SYE:2+ACI=I--%6H1/.%W4:;S:=)'8T$VT M@$.;G$+Z:$0I(QDCY@?0;I@&1LQ-(YPSX\);P+J>C+DUQ8.&'[ODKR6'%N3W^EV=WH;+@&7S.2>/\+-P#GRW\((PN2C\ MFL*!NC)QP[D4/\]2?)_#LB6/9B]P=6P^6[<*+:7&! M%_FP?YM<#KET#^3/ G)/X;, !%',9DD0U':-I<]^VEX4&$_,\H,TWTX]^+;K MA;!EQV8_X?DA/\ Q,RB'"2^!HP8"P,;RUDCD@1_)-P;X1@L/ZP%^C6],'[=X M3R!89ZO,)+F)B M@K99%$;P*" )\P.0)&0;]LL.0E'MQC?-%DO/MWR@CST#]8X/ <*!Z/[%B*_$ M4^3W^:&8B07A?I:.Y6)M#6@MI,R#C<_ !<9?H[VB[@9&@3>&*/\VK, M\F'[X1S>:WM^WNFA@K#="*GI&0M@EM BZL\B(-K/;+-<)!H>VC:JUXV<3KL\ M(3YE(?,7H"FGP!>X.8MXX\RQ?X!&.T-V.$-^XE-0^2,FO@T_LBV^>50+=(+1 MDC_>F(&PV/XD6@0AO:^^DG%'321V3,]-W2!";W M'._^Q*_$M=B(?V*-X1*,PO4_R>0SG_]N:G9Q2O09=GM,T2?QOW/5ZVYI/;"S M,1S'CS-K!LM];SF/UE. =W3R H;;5SQ^V*DC$=?M7Q@&9VCGON_76TAO\9'/ M$ZWXV7JBS&9'(PHW&^!:\WQBD/=@#C$?OP7+L2JS%F/NXXW^-[L_;32:8];L M-GJ=SF ZL:S&@$T:G0;KS;ILVOW?/DX^1#T!2NH"C0$7D[+6^:Y(E ^IPVK7 M>YG#XI\]/T]GLO%D;WV_&]V,C#^O1I_O_S3N+JZO;BZN[DSC^N8"[L^;2^/N M^\>[Z\OKT;?KJ[NU-*C*9FYN[Z_NC/M;X^+VYN[V\_7EZ/[JTOAT?3.ZN;@> M?3;N[N&#+U]U'$8 M5__G;X-6L_4!..KVRY5Q/_H?.*(S/*'[ZYOO5Y=Y"G7EUA$V".O(&G MHU!^VJV=@FN3M,E\U%)3N)&M@A[)X-E;@G=H$%EWF V5K[-W%K;O>QCIS0&X MQ#LG!@6G/# M%P.SQD#ZG)CYHS=IR?MZ6H90.+"?O_=Q3D_(.8DM?0I%%,98O3 9@+ ,T2^B! M\H"="U<>!9?<_E57'X,60(#ZCN3$KWNN@WK)(/^=7%3T9E$)N$J?" <3- E< M1.BIY"JBN?43:0&_LY9+QV;3NG$9ZR:'7.F9$42SF3VQ49_*((#\"K(FNO:K M\;L _?4)78*;W&<1\W.M#1N[\<*[:(SQHGOO"D68F*GP=G$4E=EK93L@XW:Y M?4(B@3+I2I%/\B6:Z;8WY5&XK.F!_^M-;(H54K"),[B((V(LM1"QRAM]_(D? M96&"]:E#Z##;]8A'G_+E>E:0)5K/;_ABOQVSD].RF'174B.JN'&(YF+VR#DK MX&V6QP^P+-!#P ]G\-E9+#YQ1/;E>(+L\I$[_>Q-\HDT!.60I5#JT@XP? X' MCOIN\SYS\QCMEKQ\^3\\;/K!+[DQC^?B"4C90QT_L]&I<)Y.[WY -@F]$&[X MB;<84\PW3WH*,\2@_>SBTVVL'TRVQ>!3PI*W=^6W!46=YRTW9G;+JU2Y '/L M@5V[^QG*74SQ##^YSY=#R@!M$: E6HC6&+YHKONF2E#YS&&429 F[=+W?MH!?AFU MF$B5<=,R_LTTFJ#5>&K"N#T7/8D6$<]W&!;Q!/X@.8')+:W2,+W MY [V;5?7;1'$,L=L%&R-6^!$>V24'UQ:\$Y+.% YL2'\*"8SB0O2 I2E8#@O M JIA&O4(E '+\SI^XSV^,&_3X.IW\K;\^G@_#F5B&I45=5^VF"C8+G'B/;BP M9%2_'\%!GMG%&]IV.VC#-?K9.B;TB6O4/PPL;_?A#!5K,L98PR]$B560P386 MZ^#JES.<#728D"XVV&P&W@>J Q6MLV=&_ P13\3Z:'"\*8=)2J]SQ,0!Y=.Z>8;3L3H ZV8F.,VV9% MG9=]3ZW@-LD/ZW1S_'0EH[EV5],4UD9:2:6P8UDUF=[#W60.U[S#;F=K=O/- MWE,UJN= MB\K0DKPPS6V5TEW[W?4'ZZX^Z*X^#UNUL:(\VP57N_!' M8(PK=UHZ^C0]:5VW>S\2::JM<4KL5E$2ZJ>_MA1T/R^BZI,:-GBT6G2UZ)X2 MZ+S?+0ETKD57BZX6W6>%L_=[)<'97UAV7\5TE53;U,D$6ZD$HLU,R'P6A-3# M8VN^"[S9*"?WVRC<,.,O7,Z>ZUZ@%69 M6>",:!K]'#UF-I)K-)GX$9OFD0LK MXP;Y33(W]QA9E;(UPHARNE8 7ZBSS)ZT&C1 ('+:L<2D>M$&,_ONJ@D"T\YF MTTOC@-W:N.@1+KD7H!SATEJACQ[AHD>XZ!$N5=G,C1[ADLN4KV>$R^D-:YG9 M#DO9N#X+(]\-8T)4MFZ(GIW" B7;MBD[_3LJ\_<^ G@JOH4:AR!L![V.. M9AS[!?MS.15G<2O? M#H((3/I=3 _DA.U*O-4$8ZK24O%)PM<+]3G=,;#YNUV^W7Z^^W?^3U/[5__M^_14U929. ML=KE+T=0^>,+]@!<';5/L-??!<[9 0E:BGV2J#.Y2=D2V?8-' RZ(+F( M C:+') YG+]I4YB$=PL,WN_<#EGW]-OE4;JGWS%Z^F6_=AK=Q+Y+N9LQXQW= M7QGXR%LA16P7-,S_&ON_[]K)[Y43HZF(D6[3]Q; O1\CV\'%K@?M[K#ATVL\ MN#%GEF_C#/H[&SE].(LXR*%>QUSQ](BFIEXW8PO8;' M,;WZM?.,W76V<27#QG%6,@"QW1R<.X0_= EKKFH>;D'^E*R:A\!M';.;,QU9 MUT._ F;:TK"T7&8"/73>;9B]?E4:-KR%6,G(%FDOA-Y8)5SCVVEP:D&2X>Y\ M7^1^!$V=O:G+CI"\\L+/0LJL_:S*K%4[;YG#G+)TW?[K%?#2%NAMR;S4KA8O MO04O%[$K$>).T@GPP)N%CY;/M(>[P[W9/R3= M^ZQA?F"=\V[+;&L/]W4RT[-&LH<8G&N;G7:V6$I[N,=BAT^1#PP0^8Q#5^&D MX-\'00/>S 5^G! UR%S1"QP6>YRE#,N]P;7WM%-Q:N,Y@]3]!E;CF>U668EZ M[8I7BYF>,TC=!]8%9FH.RQJNI7WQ'6+4$;S;&V.9BO:[MU_;S<91 M;]1FN/ M>[MSG*6TM>?]$JIV2Q7]-E6;U::=VGF_4Y7&QYI;RN66+=T)BG,+0BY;50G$ MO 7?^3.V/)U[SM2P%TO?^\E;G6K?>9=+^"C0^CX(5?%+>'"1!S;3S?'2U M.GQ6?V=0.V]VS';[X)&5VGNN(COO%3PW4U MF[N7^!>Y%T&DSIOE(+NTI[&;$GO6>#*V[FB;K9P1HMIM?0W,]*SQY&:+F.GP MVJ:*>+5;RNE?YO<[V'D'%#">-K\_)Y*QWT0D8[-EMEH'(R!.H6I6,^#A/?9+ M9L .-OT=FOUF6?ZL+B8]+, 8!-BJ.UI$O-/:E"U]AKUBD6W0<;$6'BSWW_3! MT6QH;38=^1H9Q4=\F3AA^+?#\!\@V*/$0:\5^L+RCJ,U6@-SF-.W6%OKI\]V M6RZ/%V,[G K1ZIC]3E4&!6N[_HV956L5LFNMMZEN6'CU:^)$2)@;SY67\=AA MA26@7SL?@&,[J+Z=I3GRA77U,W'D #BR8PY[!UL"VO(O*2MQRO9\XO17IS2] MMI 9A+BRU0\3;]ELES\;;=FPG8-F_90;<-VBY!P.V&IP!R\KV')$! MWP(B#5PWG,H3R-YC.$: &OW#ORIVLM"^V>!]6:N$-T!B4U7[RI;V#HUC,>_Y^Q]M2S_O5\WZ/E,?>1R&TX6Z! MRZ595N&*'MBM!?C-"_!S&H<=$."^V>^7[-3IJ=W[S)U*9N8VS)]ZM()29V G M7UN8@3"MW#"'C>P-8)8Z\OJ@16(2LFFVNWDSK@O/&M[2=>F@A?9IH;U>WD)G M8J9Z"S[' ^',TWNK^^^',SSYM#T<52EFZ$4+6"T\)""A MF3A6$-@SN#NDSE?)194R,K!:7D?^Q#>NMM_JO+N+E'Y[ MJU30(Q!SB5'V",2])@)63F%P>^HETV3;Z?A28,-7L;*W !Y"*]:3GHLP8KE5 M:QHN*V7^U*%9CJIIRS4!NN1+L9KYS/YU-K>GX-N\!U^HW=C^E2;X?N Q^.( M%.W3_Z>DDS@8[EXY5BX<-GZEX=\M^9MTG.(;ON1V]CU@=)T5#3BUP<%O]LU> M9:INM61HR=@W,5*N9+1!,H;F<'@P;J8B=2O)]_8KSO#W7F@YB0A=9;%L>_[^ MB)41E3M+/43XD *E4E19IZQ+_A0JD+1L:=G:K=2J%-GJEF4F/%'@%Y2K_?H7;A%);VNNHDUN2%XI3N:S,C3_KW;R$Z>Q'Y/F(CJA"&U;]_ ME4HOG_%N5U("3K64X.M("?2V?Z4O4P(3K@ER#V+__, !;M ;<'9>J4M3*#\@ MK9\G<145]F\&M?.^V>I7I4VUE@PM&>7D!PZ6#.K',!CJ6>3/QPPWGCO1)G7U M?J]-:FU2EV%2=[:C;#H*9>-X[L,9;'#Q?$:U^KUN/+"?%1HK\*+7;:=5.^^: MS4Y5>@]H;GIYR^T ;FJC6],;'-Q,JUK&VPF!.\JY1*MJ$.E^ +H?P M?M855 M(J)$6F:G659_<-W+0\ONFY?=_0R;PK+;I6F"W7Y9(X$KUL8CW;%@0V,/<4X= MK(JF]HCP@_<^\MYM)X"I'FR3MUVY>.'G3H2<=W^5SL! MB(,_0P7VOE]O)3[R.3@#/UM/I-GL:$3B[ ?"X_G$0.^!W9F/WX+E6)59BS'W M467\;7L?CC[8T-0^P)L9%ZAM:)*EM=)88M?#:M=[FW]OA^-[H9 M&7]>C3[?_VG<75Q?W5Q75]>C[Y=8[.--32HRF9N M;N^O[HS[6^/B]N;N]O/UY>C^ZM+X='TSNKFX'GTV[N[A@R]7-_?5W\H[ZI#A M1?",:6 :[->$@AVL:L=FXQSO"4X(/O5Y=Y M2G9]-Y76MHFKV1XT$&XII=+IY?IY7(:?5DFWF+IN:BB4%UQKY_]6C(7 M_N\C\[%:5?1N"73_E+?=JJ22BRJE?\J.?25ROX:]HE>^5[5<3S[P]I_,\HTK M;%-6I.E$&21+>/W[=*JH("UW[&-R>-N&UT.OU@[T>GM4:9;2 .:4\_;"^-!X M2XTJ*Z5[:CJ$AR9\X>@=3H@S&YVJ(,FT-&AIV+=-;PG2@-/IS%ZCK+GH6AJT M-!Q-&K;T@BY!&H8XO:<[Z%9$&LH$JL2AJHIR>1*I1FT;\ M.0T-,!Z8"XZ:XSSAR*6?]I09X=P*X_E+H?6+!:9ANT'DX[P//FQG8=D(OJ$! M(,(]" P$/N#8$)S!X[F!S0%]F/M.#!.I&W?19)[^D>N%\(*)$^%<'S%[)-/9 M>0''CIGT*,0=J>_Q;+@U]G[";WSY*34PP*LD<@G MVR3&VU:D5<6K&"I4W96]I1KR&-0U0;'X_^U]>Y/:2++O5U&P9^ZQ;Z@9/4%X M-HC W;2'>VS:Q^#=F+].J*%H=$PC5A+]V$]_,ZLD$$@") 044!L;'AN05,I7 M969E_G*$Y>/2R'.?UT/FTMO*\U#S0M.#%YKFRY6V^&Z_HXWUBY4VB'NT6N^SC"Z MBDV#=Q\#.SI<(6^#L3U](C3FFL*CUD]D#AA:B:K12[4B6SS-M9$T#Z$\=J;M M4!KO7:\DX!"S@:AZM<;>F#^BV%JHS8G=T2.J34VA:G-)8)1";2Y5;;;XK,=4 M&Q751M=X:70[U\*E[,H$=B49WMCPTO83U@!AE=+27Z5XR5BCD?CET/$'>*8@ M :?)HLPC+%CZ3S^16+VX,H>Z6M6US>?DHJ)@N2C]U!4%#5%0((Z"14'!G@4% MUY#<^>'1#G_S4C\=18ZZ2:?U9--ATHS-"=:(KRW&UA\15^F7 M?>"INN*AXC")3\.YAZ6K2Y]4JS35ZC(!$J&*2N^>OU:U*D3@!")@'D$$=+"+ M57UG$;B&24L)D[D2'I1I*S>1ACX?);Q+F3> M#^#==^(-Z,2,,#R_T9:*8%2:>G7_4>9EG#N=AB6_"1$^I B;AQ=A$T58X:*8 M@ <1S@!4C\.GY\2I]7U",O*!W^Q@[L%_,S!L:^>*89N9;J,5M^%+K[7XT2VR M_H>?/"=&Q%OX[1T9$-01)IBZ0ANH]$_2I:75++.JJAJ/&:S-B]HQ'<.7,[-NVQ45G8W)UVX8_^53%[( M-[C].'>E68W67M847LH_KB&R!D-ABBB#=\W"+;/_ZN96* O"#]E*Z?07I9L' M5*B:&/1[%@HU]DAN+(I:H])495WEJFCD\O>HNMBCSD&E[MVYEZ(T=06'>>Y= MGGB<72A*4,!"27:\6>Q75[(!6K2FJS\F'J'C_<1^>'SEG=J;-;?O?B;?;6=( MU=9Y(:WIL(6\BOZ]NC&.G#G@H6,,+WSJ0S9\DYWDV#VC#&Y@CX@>GW#UB M_%Q'L#Q#C?QP+)7\.8T*-,BP_3: G[8H0DR:"NJ5IF$E?<./>?>,'5DE@JQT MV?C.3A&E%WLR%W,%.#AR*),T?)NE$JU22:U!=8/Z!8:Z]U%$B5PLJ:=HO> B M.=$^?QE$\^^/WN\I$[^1G-LGB&MJO<+W2.8_H_ F5W7*%]<=OCJ3"816G6E@ M3Y\<8 -M:_.Q?FCB(C9:LC"E;C*A!X:082L(/\/;KY:K=+K]5O=+Y_/7MM3J M]=HXHGN=M7%^9(R'9G=.>9YV-@4Q88T+SOI&-4?7,? E>PIO.I&>0B:@6VD[ M'H6B"\"KE(9SC];0(.CTV/&&TK_FM@<>)U;#8.T+PZ-.WMO&'X)1L1%+F*(T M^'X$<$?LP5CRR,SU:!TJ&C*:"AD2K.FG, X4\1H^1E1K!-E^=CUR,W%^DV![WCM^ST#YJE(+:('P MQ_-)($LE @-$XMU9$/:KZ_MY\@:U4CNN]U\/F*&IF[#X2=3II2C1VJF%B-$) MXAX9N$]3$&$*V8&2%*%0:^OEVYLL;RCE!A9#S5S?H5C.'IE0L5O60/VVJJ7A M!J,L+[$?83N!>"KSDD2'T/$U635A3?+F"FQ5>/N&444B9KW_NF$+M]P;=!T_U:M:["./[1/X63:1 M1J.#$8D97= !UV/8WN!H$ ]_!<'A:/5F:A%MZCKH%%_ M_]U.\21V899>K268Q3X[OHRG.Q,_>ZUN2_JSW?K:_U/JW7;:W=MV3Y8ZW5LP MT]T[J??S_C:N6OUVW?2?:?;ZMYV M6E^E7A\^^-;N]OE_E0\4K]:=PSV&OHPX2P2<;=CS)7^,TS"&=F!_S%$*>W)' M->$;2C?(IGZG^[-]EV9EL[U#+=4[U,_..P2OP4UW$7&=(P<<#W3$7ECF,?36 M&0K747Q'O-G6E?AENY/;WWW5P\2[E.=A;O'HEI[\%,7^9QY(4>*YJ[I9:I>.0]3+342E.MRWJ-ES:,(QSH M"TW@Z=WR:(*VXZE/,570J"K4N%&%DMP;)N$-SD7\RR+VI(F A*^3Z>KD*Y2[ MKLK5'7>.W)JBE[5IY.UK/P7U4]?UGX5,I3--D&MW M8XZ3',GGK MKQ(]?&5*T8YU;>E2E)266J5I6A?6GWX>IO1V[GED.GB7 @_N,F&5%/;P?^=^ M@,>OA0SI^?:@Y^HV2EA2']8/?\M2AGO7@V=-(XKWEP3_8CM35OB95(UZI:G5 MDH/L=N\UXB<#)X1G@P$]B/!8E::58E>/+CRA25TK%%9-5AO [3D2ORN[AO:^ MQ1DG3?V1Z7!KTN_4[?)%KK^NP&WC6:7PKW?M&=SO1*-!DV>JPHO#+4*SZ0)H0RLJ-LA[H8+^A ME5P-QC&TQ(Z-(5,[UA5R3UM3*&1"U*?R%=M4UCMI,J9Z-/1DNUI#3X(GG$%# M22?1EP,OYCO^HEML,0CDXH;?&D95-_,-OSV_YA&QJ%T791ZLS48US[2UI+4R MM4>*!O:<;J#*E4VN9P)C\Q_C>'$ \&\^?YQ [(D%*0.4! 1UCB MO^EYC*#F[M3LDJ"@0%YD\]WZS-"()$O9P@]FM(Q"^H")'__C(:K N X26XP> M:5W@5]_X)E8FF@4W*D_?LX>$1K$4&2' ?T*,]"NA.J);ZE*31*I:WYPFNL_. M8!0[-#(J34W6+).3!BK12WAEVI&OJF\/]8@%!ZV8UY:F$SAEV=!/7YDEE.'* ME.%8N@"A7>Z-HH:#RAI&66>"'.A&2;5YW(I1QD$)RLVNDO+3)Z/YY*LS6AV% M @L;?!K./8QREQ)2!PE1,D&CKZX1ZKOG#N>#@-(-]IWL %B41:FJ=62W%XNO M9TZ/J++CTT\L+D^9?F)."6M0"=/VZ0X1PG5AMHKZ7>NB8BE*I6D:%VB) M]DMNUJ ERI_ :SS,2$,E^\@AY9B-V M1&8KRZ!IRK[.5])JU4 F:_4+#!@O4U[R>5=[",S.1YR6@KEZ*^F@B]P4=])S M+.')R$U9X"%923_[_&W-=26G4# .XA\U=O2/(G(4@Y$5UW-R_3741'>V M#LC:IS3ZU,6\XOIK+EF^![E>R/?IY5L5\EVJB[53-?%J9X] 0SD0:2['3FR! M+DI-A>YO&S0(5A595??N=BF1J6>4!RGS>F%*A"DYB2GIDF!_0Z*#D]&0&^K> M3L:5&Y+R0)^V'X[$3D3:;S.,4],QGRS5R('N="X02)99556-1S2>S8O:$2:& M?T//E@8VQ?6H#'X"]2 >_JK2;/L!6)J #*6XE$JAF.XR,WA_R W^-H'#35+B M6$PJ.-3;*#LCO/>Y*'=4RNTU7:?WDV]#[,)]^Z]D\D*^P4/&N2M_59/696J\ MG!=?PR0&,!?FP88NB(1FJ?KU%[&]_JN;6ZUH[[6Z?X]022G-*]F%:P<[EQ65 M2N6KU=@C)$UWZI5FK<'+-(TKV9#J8D,Z'\VY=^=>FN)@Y9^YMR>,% =^FZ8X#6"E5E9F6.PXVZ6@/R8>L4-0W#?;6[6(HT]-!Q_<^I#15$?B6HJ M-<.PA@/;5BPR4 R%U$8F&9K_4P>7C)Z)NR/I%FT.[1&VFZMRL"NS]&HMP2SV MV?%E/#$:@$Y6^MEK=5O2G^W6U_Z?4N^VT^[>MGNRU.G>5J56]T[J_?SY#O]V3^@_2[4.W]_"U<]?JM^^D^TZWU;WMM+Y*O3Y\\*W= M[?/_*A^9%C/T2BQ)CO_*,_5+IV"]-C/TZ$OV_B+%?Y8_]B@]ED@0AQ<0O,?'K?6%R>2AI*H=4KS;K<2 '+%:C*W G7L60K'559LT!4 M5.L"3=&5H2KG$(5\:H? M,=,KKT$S2Y_II1MBIM2#WJ"Y&>HGK"U]_#47/8J3755U_5*2\QTNM"Y;LAY+M4%TO@20D\J?+MQ)8\Q6%&>AD*GAG*BK(W M-O:53^(1ID28DG,U)66,]#+42E/79$,O"RK\6@U)!D)>)B+>.O87?5,'7,II M\$FO'0%W*2&N%'>I]?3DD2<;ST3C@,=8>]&/Q-E26/^#,R0%#(R7MU#=DK59OPX=N1^30$ MUN4:ZJP30IWEF_OW %3UOCKVHS-Q H?X=XX_F+C^W$L9[V>83#R ?F38"L+/ M\)ZK0_\>^G^V?TBW/W_\:'?[TM=.ZW/G:Z=/(?PRSD8BR+6QY8N]CR M,P83&K7$8,)T"#?V/N=@9BD!I &C@#19D@ IYSM^@!8756;D3B;N*^XT.0#[ MS@*EKJY6&WKZ5Y>#O:8?#'OM7-&%EJ!KBDR!A' CN%:HI3@"740,[1 E>5R' MC>!ON ,'?4YGBDR"W7]W))B=H78N/XR^GD YL[)Z:G]:2%-G(4S?[7?UK] M$N'4A"AML;$EBU*MTJS)5J.L&D#AMN[22SEPGXGP6_@ZO:FDPD%\OIA&-:V#%%\O6 M*MY[":<)>#BER89(I%ZD*&US3,L4I1H>3)ERO;3R@%,[IGD&UHBVL<.2YG)4 M].?9;K MG4IY.L5TSCO%_E^A3K$[\AALZ@ZKZ[ [[VNFVI8=[Z?9'^Z[3W]H2 MEM:DQ6Z;\C#M/%JWIE)K_C3W071-VL"HR+13Z]9]AM6\2[8O@?1[[BOQ6&?C M $39=E@/;>!+H+7P8'LB^?-'WQDZMH=M7W#5T]SV[&G@>KXLT585!K#FTKOW M"!!L*+6>6?@7 K>'6\M2#SO5 MD&325URG1]?YE03P,GB?<"T=WY]'Q,&5TNA=FM K?&EF>\$[?NZ1P*U*2W*K M2M0O&B?W1DI1:A2B8"7SN\I'67H=.X.QY)'9Q!Y@\0'''Q(L\-FG_YYY[HOCXR0/1GZ\,-*9N"QG6MUC"3D8!Q<;DYZDWMCU M@IL^O (3EK\<,AE*B'WT)GG8LY.V_F,M\T.%3^KU/O]5^;C6O\R_9>NC6JUK M A79(3P$F[AMK%9T)R]X,#Q@OYPXSPX=_2=-7'AVI&V1>LYG^$D^E !M2]_Z M5UCYPXBM]-X>T).O;_:;\SQ__DPM+RSOUI[!-\%[;D?)J#3KI@R$3K:QIYC5 MZ/&1::R"9DCHX> 58 ,"9N!F$8A"C#3,0L F\+^(.PA$BO8)-%/T>G_5TCW; M[T#^?\W!,.'/G2EP ,_F\3?V K9AX#X#0RCKYM0$!TNN1JL-N6(OEPK;45D\ MFMJI#&HMGM0)%]Z9EL8T$^ONE%2NG:,6>H1B:^S!D$[W?I/6K!)XY+R1X>FT;96:4[=I#*X\P VR"GZ\O#]_Y'Z"])L0H9/)+H'>*U.@&Y6 'XN?ACI MUXK?M:Z3L[GGSVWF-=CH,\P]^A:@JM_9[1=+J$JKHK41[B5DL8$=]3/7IZKP MBB'+1OK?5EW@,+I2EI?8CQ!+S8/L2Q(-S\<78]6$-=W?:+4U^L3^'"]0 MM&?V$[EY!(/PZ\8>P7(_V9-7^]W'4"^NJZ"HX>T;1A6)F/7^ZUH=QILWF#CY M5*]JL8\\%FKA9]E$&HT.1B1F<4!I78\*S"8I5=K"6:QSXXOX^GQ^,]>J]N2_FRWOO;_E'JW MG7;WMMV3I4[WMBJUNG=2[^?G7N>NT_I!T5,R:,#+RV!RH2?U'Z3;AV[OX6OG MKM5OWTGWG6ZK>]MI?95Z??C@6[O;Y_]5/CBX%[ESN,<0@^FW 9F!)PM;B3_& M?6-H!_;'7862AUS/:M9%ND$>]3O=G^V[-!.;G7G/:MS#-S!^<9 #/SLX?_._8#Y"2-B!^ S^!+B3#DCAV8.4CT,YIP, MW!%J;)Z#9$W;8X M&4=SFKRA#B>&3"DD9M0#9H'O!W_'P)3XF*,!0=]=U^:AV15EF1%$/1J"DGAU=6J$D6@!*@*M"3V8"R%\LGD M.^%7#UU0CJD;8'PYF0\AM)QBV GOZ0Q"'YW)[C"&6,^/?/1064CO'T&X1VB!8 M)PIJ:%:&R# @*27WHSVQIP/"* TF+6'EID 9N#QD;@!K1#8\HVD+OX]2U(IF MGC69GFW$G71 ["8NR+Z$OZ916YA^L@>(IPS"-QH1BJ4&[_0+P2F!G"P\A'AO M-'(&#G[YZGJ_:.Z*Q8;@I6V(3EGV9847!%LA4M>1&PMSRZ$]1NM^%*XO#OV2 M5K51:=:MY%"K4K$3:YR?B/U7H1.QVT6B#)N5;BEUGLATL 5&L:XDSZ[J2O*@ M[/;AV[=.G_K+-!9@'ML7"!%V@5),\]_H4T[*@S1UW13$_IPNST;SP&&P'6T7MQ\/0*=UU[ M2 _P)?#2SG2$]OL0S[2E#]=W9Q^#.1JT8?F&."KIIX*0Z4XS465S[ M8GN..P>?S7[UYQ#-R=)@8CO//COSBL[[G\!B@; '>.H_\MQGYLCB 2+]+Y,\ MQR=1I RJY4Q!2T KYYY/PN!P.!]0Z_8X]]%G@F>PR 4_B^[.UH:?8&@Y\UR\ MB/XR(),)"#L&B_#Q#(S@NPP>XVPV<6"-S'2"$1T[,_CY$ L>G,D,HN\QC;FK2+!# *.BU:XR#L1] M,@SOC+]8_[7][,Z!7M'FLQ9J1[\:S3'QM7YH=4:6.L*]DC[#5C2"F.L[[*+" M8N=*K%))^(DSRX92#^N;UFH,_!FF7SPT7$L4P,>0WC.@=YA[[1'F+1F*^N'7 MQ^@4E>:QT \-873@MD-JF-!JX<683<4) O[^#IVJ4D"'4"@@2 [0_>^T=-< M.>^FR3F:8\7-G1ILN!5*RS=GB@4'K2?R,(K$:3>?:YEQJ^.$AA1OD@TW $J M_:*FF9J89X+:O6MDFKWR'Y@F\H%O/>:V?X<;N.3V,Z)<+OMUH2SJ8- .=Y-R,7;J W$>GG)?W27(8GK_@<,I+ MUBBS-[YDY%PXP-]@L;?%L3[9KN3X2U['JBR6US)WKB1*9)?^D",R) 7I4NCTO2=MQ+H$JOEPPMH923=$=H_.KW6 M6FG@>F4?FEG03 @Q!AZAB0,:Z,1,[:/M [G1YH:'1RMV>K&F5#L-2YTXHY'T M@L>J=E!@0PJ=+N3&+=[J'Q@%3)]R[$.64FD&KR[;*!/[$) IW(KHV5!LY<_V MD*S[M"&)J5/AI'@U!3)7F<.IMANF^.18:J6IR8:9!$PK:UC54=X" M\0]E,Z5!L,SA54=Y$YV^B9)\DZ+#K,XN6(C[@&,[[K0[4YHX 4\_3#L/D,3> M2HZ!>OK,:8B205'=PXI10PUFALQGZNRS>"!L+V'WH(9O/@N##9K$P#MB.\?CQ/''9%CJX5B#\\.QK\7:Q18G8%C+L-SD0LSI6]\7]&WGQGI0!^\K3,,I*G99:1/"UK__?/3O^OF\^M7AN/RKY];W=[K7[G MH5OHI(P](>6YYU'_U'>Q;AGE.WB_8<*_XIR3-_P[D5ZY;'XI;2@DV/DVI0&5 ML;@4MAD!QC]( /W M:0JR-&2>-K6\MZQ\!3^-W)LD$2#Z]YSZ78(4:*@LADHB"\DD/+!04C7 MG>*A#SR)A@K4.";S= UC/2-W#GDR/*QW(0A[I=7-;.C]V'UE@#P>P=X1_&8> M(T]Z)LVE%7<>N:'1DNT[(=S)9"(%[S/6Z#$/Z1@FYL+0:P4'81O6@>.'JTQI MLEI4U;$4!2W6DIX\VGI(L^IX2/A() ?!DX:YRKA"RD3^'$5F&R!4TM: V:@HL*^7_E!583Y1B)0:/CG\N@I? M_9[\W#*K==5*_4JIJJF?9]U*U:J*I6V\U34 8X/4&?L Y%X:_F3:*UX.CN2F MD>B)DYJ6YV$!*?YU=7]@.T;P%PF6"2V6NKJ;D[^([3U,\P>S)AW@5-M_M@(G M*,[GH!;8^"G&BIQ:6_JO;FYMJ6%+3T-,.SNNLM0**/$%4-+YH+%WG) =:F+O>74ZG+OSKTTA; J39.;P:O[[AX[8>Z'UPC,_<.2 MY@HT-,>9WWI>#6NVDKFW5?W-O;DUP-@:LEG:_!O.0/O7(?KY3S?F22K:C^X+ MYNOH!X.PBH,B_BRNPR)9R9;88\GPQH9_8_L8*\_ 9&*^E/#!))<5M=R[7O@1 M_DY-K?K'JJI(@!L*#G"JUA/%_K3TZNQPB>+M%O^)E6.J*;'*-:DSQ=,FBH2/ M1*6MJ0POND)_AO^N?*0=58MF9MH,/<5>X&5?)2M:7LTPXW%1E/7%%2QNB/EI MS'9'%>DT6XQ"$U5_P7>5\6NK,71LRQ12OLT $B8?O_V0EO MST'JXMOC7U8 R1<")6JV6S!9'6CRVAXQAU.!A:\@"#S0FRE$);WZ9WN(> M%B8.VRN6F)$^'>[4']O3!V9A5ZF7FW"T:*QA)*=XLVZXG:W^QJ;>+*)MP4;B MEF@&V@==2Y:X,Z)E;#E@(":^NQED";Z%#0=;.99^W.[TW%3F7YB8X,"-B$,! M<',3"D]Q9+6>S$M'_@&5F_#$>J&B(_9$,MQ'(;=4H>Z]R2QG4R2WFR0A,$&? M+,Q<&J?%=G+*RI@A!8*!/2GR>5@W-FVS9?N>_6([$UH9@/XC.IC4_TJQI3Q@ MQM [?J+5](-=O!UJZWJAK:/_DEIQ6_>#VCJ!'E.P(73NAV.O/D]L)/1@[$[0 M[69^Y0PL)H7?$@H,L:ELHOH;M>!"B3.8D&HFVX\[$PI]$L+QZOQWOM? = MG.D2$0][?ZC9Y]/!VUC7#ML?-5Y)Z[EM,,RQMN9_AHQK,;[1+^] *.Z!?_] M]B7!=AH*MG(UJHT4GV9KI7\V1:QSI@@"?M>K:I(BIS1F*1U(.,0(_RC&HL;Y ML&C+**48ZQKIHY2*F2SM_%(0.=\3,0G#S S5]I7D#,,#&.-$!G!?9I[[[-)[ M(.[W')Q,6XH:5F3\@4VA8R;OU-DA;PX%+XECND#8%M#&4CM T5 MQ\?M$ONX+K'TCQ!NA;DM(=(-R&,*H$U#5(WA#>XD\&^6" M6 X1T?<9O.3;S%GJ<$86&G>8DMZUC<^C/]X ++.28E;52M.HFNDIYA!6=$S8 M&\$[TO=;TYR"5=?I]H4*>6A*T$"P-P?O^IE]EEZ W5"31>'P61(HX0S4/*TL M.\P+,Y\QX<'92_*LCG_SF14 $40)+K \;(=%L%# M!PS9]-+JJTVKJAJ;BZ)SU5>G7Y)UJ^S/#:5VX8LR]JE$3RN$6/Q,-1._2RE? M8'U0)SJL3S3.4,G%^A6I3:&35HZP]R%&K*IDUW-LSJF$<6EFG56>U[T>>FF" M7KGHI>91OXNH]6U'Q1@O+G:^4\CU#^K'? M_-&P^WOK8%04)F>+R;&X-#E&I6GH5:WD6LU+-#G7T"3QP_%_W8P\0AA6*B84 M/!7+H')D436#.5VP1_HEK?6[?+:*O@08,+*FYNIV&[ MXO-'J:*NP2ZT$A;BV [ SA:B5FDJ53U9&'2E%N*J<@D39P0[NYZ]LQ_PQ=/! MKZAXG%:=#W]:N,EA[Q/O>8<.%;6.&WO*\6&BQ/\4P?)5['N'I]5EZ8_%E?Y8 MN?3G&B*_Q:Y !U&2Z5!Z=\AD*'TP1.3'3^07<>DN9%*F7]= ORYE;-R5^G4B M\A.1WW5$?KM:"$T1%N+:(K^H+'A1PD;>B#=PZ#1KG*;ZP4SL]7N#2'%'A&N% M7LRL6C?40U6MI]LG)G+?4>)2RLTUM=(TK6J]K#/P?4% ^(D'^1.W \3.PMY< MOKW1N+(W6J5IF565%WN3 CH4R_6LS'E0K;7R^1O\Y$3U\[%JM.,_?G7^1:VJ M&TB'E=9/+(/X-P)G.'[@>DCZ>"U=V$<2>#:%FF'N4-CG.7"?G]TI*]+/[E[B MF#,:=YS)*C-P_.6\:#H=N=JK2GV/V/[<>P\34H.Y]T*D5R<81]U[4;,X63G8 M"%E*&]S/DFTZ=VR[(V"-J8(LQMH"]Y[]%5K+P#Q&_5=7>B;!F$YL&&3U;5K",=4K#9:"/1HI\I9@19#Q)NH72Z2\3*=;"I M-7"OZ5"RI?'[#-&KZ#XFC=T),YVT*8EV+WYPG(_T9K[S/)NPT7],(,Y2'PUN M^)RVP2U9.F&3KW%0Q\QVAI192_PV]A5#;P-%G-GOBXQ_XNPC&^QP-S:E#Y,) M.P13^@:U4[$VEO=(S*+CA=D;J*GA\C;1EKO> MP^2\SN$[/[Q.P^,;OOV*\B9O<=!<[H+&?WZ:FS^XSBL_O2 M4W0412(.6,: /Q@>"*+L0 B1@22A)9<(GYTEDD1+\N?/SS%TDO58:C?P!\D. M*8;.G.V'X!3^IXO#>#",JFYNAALX?S@%L:A=%V4>#'@B^3/>.M[33UD8O*>T MPU';1;[^EJH%09:0+(LI#W]_]'YOXF:*)UES>T*3M-=*IM;3DT>>Z.$"$,29 M^N#F4!BF_WMUY3\/\:&_P0+_6=)5"OVVM$8UC@<3'-LVUF3T1^0]WBX=1^RF\K=W M4VDUG)>E)\X+CUP:*&S\)=OX8DY7(33?;4JT""DZ441!BPYCNK457COFI-4K MS3#AS;WU+ZD/DFF@PKD*?F& NZ+YV\\..%=-:M&L/)K*13:"5=]ORS'1S3ZZZD4[FLI-.QPB%E M>'4QW_;TY3D;O,Z]XR;NE'7W6HJT5SQ3_2H(^,9351RX#\V:7K4N\4#WTC!D M"X'GGT^%FXZ%!56ME HW87NOP/86 MK%Q9AU<9NG-LO\TUI/=LPKQSO_X:PM30PZ)-X <*4\/^\"QQO\I0=7G:CY1G MW;N=:2^\3<*F&@KXN7MGKW*S1<27PL&U$L'8PI"S638DLU_Z^4"0^!J$M#,H(;#A%]B4)C.J,1\B_3W!WK';>* M=(Y"G(.>OT3^-02CWZG)6-^;DGL0CH=.BNE) 1ASDKIQ+J2N@U5(,PE;3=26 M<7/\O'/<]9G.GV^&+@7?Q76F$03/7!19UY, -C+>BFY0Z-V#@0 [-Z1;#]ME M&-'@;^J:1966]FAD.UY^4T1WT!?B!]=@C Y]5/;43089D?_JY]AIJM(: M,6-RH\4$9@#!NNU,)?(\F[CO!)Y!)FR>3N""- T(B))D2U,(3.UGV)<"N@8& M*+H8XK,(&'/LA/!,>M2 ST%Z^Z/WU) QL-_HL*9H/HS[.'&>Z)WH;HPR 5M6 MOAR,L44>6L/_G?L!Y>,/G#9!0+?[]ML_E\NX=[UTH-CW6:J>FW_ /1@.&?O"<**23#\._B .!X'S*8TL&<.]0E7[327#E[,I)[2 MKZ$;%Y<$ N-X2L(PPYP]X.IH:5%ZQT\HU\Y@AW7_ %_(<^C.06'\);I!^B<- M]<_-_XG1,-PX6=XUG+NVMK?2N5RV/UY\X*U?CE;9ES&_2XTD)IYC7[ 136RG M3]MYW='( ?> 36O[1=Z7/@+S.(=D1#QO]6'Q>X()O8DND88.> "!ZX%CDGA+ M=B7.&(E=G?UTYG>,X88X)&[FN<]N9)O]^6 ,WDHT^(E.D;.GTSD=:H;6F;PY M/DVGSVP\I'#@A8/P=9[(E'CTAQB?9WL4T[#(?WV3JV_/Z!:ISZ-_8* !JV;C M,"#:0)QL^VD96-UHRUVN!L8U60WRFT1LH UUJT.O#0@#SIWGQR9-4/K3HX9J MJ+_X33%&[TU0BQ."UC<1]%]S$"3BR?1H@TP'U$5E]!TYGL^2/>SP)DYO-HPC M\L]'#GH3+VQ-BU,9C[PX[MP/)Y!*/U'JP]_(=%PB:D?"XTXW MD*BVH'+^_0 MBV,^?^CC[WB\9.<.RHS&09H(PFHIWY\3/'MA<7QJ+$8/^$'V7B$,\[&"/,RF.U^(\1>H'TX&9+["@Z6(\+=,3 M? J[SYA,AC)+00ZC\\+H%"X\2PP/XY@\+B21I3%7$Y@9:Z6'F C_3\\Q5V;K M)D0B?#2[?.7)JS,!I=L=B60/!AAQPC=HNB'*FSCV(YVW?#.8V+[/)H+&1HK& M7@D6[H&@X.#?Y0X7G;0N?R=+KV,'U#B<=Q@;;9A\&QF)3)5^[506UNA,E@-L M\6:+/3J(5';COC>:3R8W;.&AWH7\7*&>Q7$5,ICY(I.KF3Q95ZL-/?VKRYFGJ(MYBF*>8OSU M$X,#EUG#6&0MIN/M.AWOZN88[9PC-)535?9TW2FKTLN$]*DIE:9N)?/"8FJ1 MF%ITA![)5=4HLZ9I=]U8:ZVCLS/N8!=(%OXM<^HUM=*TS*J5K%2^Y&%%=A7+F1ID]G;U=+^M/L M+0[%-I-^?P)TNC1T(H$(S8/!716,0@;7I :WL3?:2$E T]?DX&Z?+G-I+NX9 MV=P%FMC"V_>YY\ QTNFO- MDFL<9\DMG-"23/:=*$N^E^!<=@Y]/]*RFMUQY<8_L;2_A+:;2F]?3^?()W=[#?8Y>>6"[[.[%1%ZB5 M#V/"U#?OL;$.YK[;6E#C.Q"C,[UE[<%4R_/"0M3QF%E6&LG9,7+>5S!.]0HJ M^ !R7:EE>@>,PB2".F>2H2:B@%9CUITPMB@^"_1J&UL7U09VQ!8]UKR^*] MC#X?V*#0RMO,T,!_6,-2V/TDC;#6[_RP1[*0G3*L:@S(B4LKMQTHD:,$4)DX M.G6]TFS(6B,-6^A\@)S,VD7P L]*--E2TD"-"IC?BT :J].!D[)>/QS24\'R M]T780:FTI;J]7KO$ZO;M_;NBN%T4MU]R=;4M+^9*"5 MVY/V]3JZ;;SD[*\Z*W^->?<=<'_XR[K7K4K3,JKUO6<\B[IV4==^O%WH9'C1 M6^O:ZXW4@A]1[W,$"]PXD07>OZC=4FB-I;6W&>:KX.EJGWG21 6=[,;A:M] M6=8_7V'][H)K\":X5YR=%P7WA]E3:AS#TEAFI:EQD[L7]?:BWG[7K7!5J\XE M[V_5( :RJG555-N?OKP':SA?UP_P5\LY-T'(N\O.M3.MZ=QI^+5R+JI5!]4Z MJWF<.PW[/AORXXEFLN!\A\+-+#)HZEG2 ?NIDF)X-4,Y^RNC1U)GR$3!![SQ M?!IV)&$7$Y=6-+"QMC.WSY_= W_0H=@L2]N:#G\N"+LAC]]0"D0SV7V./+T9 MX@9N']6XJ8(Z5$CMM!L(KB(WB_2S8)%6::I;#.62(6FCU;<.^$WK"JB=0=O* MQKFDC;QS8%?%X1S?..\$V=K)( [*>N/"LV=3-]Q8]QFVZ:6Y'3M/$.7%SPA; MI1?3OJ/>C,5$JMQ6+Z(=! 5 M!F./D!O<3]:3%.% -$:2]8%Y"ZV17IW)1'K!/J!'$KP2,LT]G;)F9F2K5C;D MZ(67Y(!/W'FPG#CY,.J#.I* )73#$21^VAS*!L1C22"5WW!T2]ZUUXZ^]@9. M?$Y;_%AA-Q=E6%:(- $_BY)@' 8 MZKEM;JF9R=36(GS1;0.;PRV_>#YP;6\\IQ)/4"0L5E.J2C(WM5L0D>4NU$^& M][/N+^QZW ZTT H$_-8YOJB^FP.]H^YH.!F8,@"B>512D.F3HC>%WB4.566FGHV+9+MX9.93 M=^YJH7YU=$]29K7%)3 VV78YK TM"1/AY6:5WM4.I#$30^7P0US&V76[4Q=B M.6B<\L>9#B;S(6'CCA,[TLIN'@O!YBR?*X$D#=!+8/O[;IL6E1-JD2,5'"Y! ML:+YQ4 L9X"BM[ZUKQ]"BLF\(8?#R;RZ(B;SBLF\8C*OF,Q[[%<1DWG%9-ZL MR;SA#-Z4;T-GBBN G(99-4PC+SZ.95:51FGX.'5U\ZTN&XHF(7S4X_@+#PS; M], P#^#*CK0H5+S,(942)=Y;R!-I#7C5))LZZ[^ZAC+Z]MN,(6+&,IT?U.PN MR!VZ&/>H=#ZCLMZL\^\>"=3\@G$PYBX!7J56:>KV: ML )GB 4-[PZ9#*4/ M^EH4>O'(%-W?6TD16.WMB$5?*^D@U5I+7]_@)R?*7\=\K^,_?C5-5JOJ!M*A M'T^*HY_Q;WC>V/$#UT/NQSW'\, Z\&PZ3H&=H<.'F!,?N,_/[I2ER;,+M3CF MC,8=9[*V<<=?K3'Y6>U5I;Y';'_NO8 M'V4>%W%\;+=>'(-B_ P?."NPU5'!%#NL"V@QEC28N+3\)UZZ S=8!VTUY:V' MV-G5(SN@%GS'!Z>>Y%L,HBL9?E6ESBBU-"A\>U86NJSJ([8WS3Z@EME@B]FB M7&UAD1F=EO?)O('C+T\\AZMF!*L"T$\ T031FDC@-;RB^:"10^6V]>5'Y>,: MR/A_^@P['#Z8PV.>L9ASY+G/TLA!*M'Z^!L2-BF@8*=\;H;%GK02;^4%Z5P6.SOE(6Q@E-SP1[N;98:$%HS:F MT4A+MFE(U:PW.%J5#N&KFN]7A%Z76JXI1RI%$@0"2HZ-. M&E!]6]N/=HXG-QY%-"Z15-_3['0Y]-KPLZ))CD)G0/RR)#T=T(]Y!+GE"?3Z@L2D^^+".NW6&2UC!E9C)5"\J)'9N=7CI"%AU4DHU#? ?PI M,Z.@*ED9A8.AQ5\10_.>"M;5@MV%2\]Q$3'3&70D,LM?:(8 3_Z6/8BI9X"J M6FDFI\W^)J3A@-(P")FT11[BG2\@$%'KZ"JC_=UF*L9-@ 8FP#)D):7)5+#] MC(Q T19C$ &]TE33>HP/?1S.(;L*;L+:/INP4>HF?'B/E$.VY=8R_?1;K5EI M)FMMBFVU@N>[;:B9\#]E;JB(:ZJ;Y6VH@KF'5.@]MDT<]FB6OFUN+P3ED%T% MM\T=L!2RM\W,T_!3NJWGQ;;<6E84NZ?$;;.1.F+UI"'JA3 ]>]\TC[!O:@KB M@5O("5+E35J5!A4 MV(B6@]F)BK2H:BNL]Z*=T?4_?.G.\<@ LLA:^^ H1/7GWMI%6N:G@*3H^E)F)Q>^PO"&4B=[OW#CV]A M._TZJS(*J3/,81K[LIK-V9+25JJEG#N>M/97J?^V6@X]\\!F>/",4-W@*;3@ M\VGB/MH3:;BJDM-YX(4Z#[_VW2G\9$SL23"FFO,*/YL2G[8>T+M36)XA>0'U MFS'E@L7/1V /<":8-(9%2?^:V]C*((/9<@@8EAM6/[IXE#V1(W1&]L !*S%Q MA_-!X)\G2M^ZY4N8.@:IBM7F03@])%Z$.G9?I4?$7T1:4^,*E"+L&E@?^!BL MFIV\4%"J984M%MR.8D_#+<.G:(SV+S"F'W!!FO+'[<,=56]-_0.,ICOWI-OV M RL*QJ_"9[""\&@=P*0)J"^5(. M7#0@\"'>V$]YHB^OK'!U:T$P;Q!!XCYY M]FP,5L4C3[A*^#BLVE[4&$^QZ BVNQ"@=E%"_/0$U] ;8RO,<,O.XB]>?74/ MBHB [1[N!K _=I>$Q[@% B_:W9DU1/.7I664#,&TFT2ML:HNC^$Z=VR+2](1M[&SJ,3(*BG,[$]:>).GVZP"ER" MC1_XZ("NQKF*_![;X =$%Q @E_N,FP9XP+!BT"2)N?*EC4!C,L.^;'LHZ,:=@)$=F,UF3"@&H7YH*ZD?&+1VO>-$(_ M@H9,'"9M\,F"3EF$A OHR2ZUYWX _V&+A&MQ51X9DZF/;C8\%#Q;%-M-+I# MN%O#N%,%QIW N!,8=P+C[MBO4BK&78H%X2%+D!*A2S?21N"WTF-T+3U&US? MR&D+&+EC]\/!5E%5V':1IR'.M*IJ6>FF"7KGHI1ZZ.)4[N+5N%$Q_VJ>,['!-<(=OHCN#E954 M[L5@[Q3.)7(UB;H/0%PJSA]W[_L?>[TBW]!GN6:RU#//]UF:\P=Y(1"1W'ON M,R8A\)[_=()Q=%;>CDZL6[Y/\.2[;[_M=OP?&\6BU7 4BREKJLH#8F'QPJ*X M51(Z<[DZ4^= 9^J@,PU35HSD"".A,]S(E="92&JR:5I"Q"Y2Q#(1#TH2L911J7'I4BO-J *8#_FZJG32;;P8 MB(YHS>M7A8FZ\$Q2AQID$PKJFR MHB;[5XJ%%67PF-,@7FBVT.S=-)N#U+2N8YK-DFM*6:EIH=E"LZ]>LSE(H.M& M^\/Y/9TAB#1TQR6R_!<2;VI-%V_/G]^]AUU]K M.NP1[\49$#^E\4-/:_S0TQL_XL,<)'_^C,V0_PY;V^S9S'/?'.QP69_P@1%7 MU(,H>6S-E$;8+)?>,,7:9K"EYI&0*5V@YSS.@\3\BV7KS+(%TI?A[N[03VN% MQ$_\7\YTI2\RP3"0/@>[\X;;&D.R:F%U[D8JBQK9,UN4J)$5-;*B1E;4R')( MK^NKD67M8-V8CW'86EG>1*$<4"AK,YPM1%?XDJQ+$:='+F&@U%3$)[U6:5IU MOK!.KY:W64"917E;%[SEAK>;\33S\]8"WFX;!W#L2?V%NM0PW[4)ET2I9%G'0#E]^\H4SF:EF:P%$I[DX1A8<@K3J D&'I>!)>.7#T>I=T"++_V?B_3$BU%0@UTUBKWP%OZ?R&)IQN9L(J()VJ5 T= MR==AR*A^:N$+&W>P/)N2\*8YX$N/!I-/[_C)"8#B@QWJKWID0@98\'._ $B. ME3Z=&#;I=@RAT#Y $9?6S9CVBI?3E:@VC-/W M)1J-2M.HF[)R2>!+0FN"B&KY\Z#,;']0-HI9-F$*)="ADM$E&MP !IA:I6F"DIC M-N( UD4(64S(.( I-G40LH8B&_6]L3&%D'$I9!P@_)I&I:G5&K*E\((? M?U49IJ[K!6.Z]0LH[$Q%T10.<(I-K/=45-DP+BBV%$(6$S(. $1-K$E5++EA M:D+(+E+(- Z$#.MFM8;'>W#!#-V2: 41X4U6JWZ:OF!Q_355L='&%MNG^ [MN>?.LM$= M1#Y54S@X3JVI$%Q9BFS6R_((SVQ[O7@AX^#XL8;'CXV:7+.$D%VFD'%P_%C3 M*TU-TV6M7I:GQM7)$.]IHCU&IZVV!(@Q+ 78&PY./FI&::/32N0QIR6? M0K.%9I_-Z+2:6=KH-*'90K.%9G,S.JU6*W%TVHEU.V-TVLKXJ4U8/B$?#40> M2<(?+0!'?EM%?@E?4UE>8C_"2\V#[$L2K?#'EU751'28&WT)$L#H%?MSO,B: MS^PGY68LT]M"D_,VI#Q5%?22J M"=ZX80T'MJU89* 8"JF-3#(T_Z=>:?8I1(\[DM"J@/SY?__=7IO,MBNS]&HM MP2SVV?%E/!V8CYV[3NM' MI]W+I $O+]-]Z+=[4O]!NGWH]AZ^=NY:_?:==-_IMKJWG=97J=>'#[ZUNWW^ M7^6#,Y6"L3N'>^"L0?(V(&#R9P2,SACAL(=V8'\L)I1;K,7!.21]H_!RVA^] M]A=D!@C;_<./;ZU^YZ$KW2#O^IWNS_9=FNG-&HFHZ> ?9']-XOI7EP."I1\,!"OYL_. W[DC X* HY*NR']_]'[?%>_IPHFA+HBQ"N9T#>!$ M7UVTY^!Y#W&$, D$'-%5E$M<*NA/F0=?=5J+@]!'0_EU#0KFN0KD.GEVP M4+GJLE;C7[E*"?1**MN*O>5ZW]*I*\KR+.T:ZD.I"U-"::B([469IRCS%&6> MHJRMK#+/HCY+H]+4U(9'5-<4$(@"SC(*.(M* M/F)]@N0KO-3=B;K-H]9M%A4;'!ZH<32M2I1KBG+-TLLUBRJ'"(L:D :E69- MU^3Z_MUK @]>**M0UIVJ0@LJ:T.I-,U&33;W]Q+Y!'A?!71?07Q/#LE9)6EO M,";#^80\C$*P?1_1]MMO ?&F]B1"VO=;TR'"47Y%-$K&A<_O7XC[Y-FS,:ZT MY1';I[#:?7C8YXD[^!6C/SR5 %MF\-S FY/-6.B4&LYT2*;!)[UV!!SCA-A2 M'./^F("<32;N*S!,8M#!,\]]<8;PC-'<"\;$DYPI$T64:_@_O,HO((WDD9E' M?(),@4O)%%&=$695NUW*3LXA^##?Q';D]I@?X9Y M$(=W3:+MNC5P3J0=T:GW1QV^''II@EZYZ*5>'>!W-_("/ET]TC>_*[NF6M!\ M?0V[IJ2Y>\W=H_:T5[R6T.K- T-&SH,![.Z&T:E:2HU654N$8R'=\^2=AE)_^5Z1/3- M7D_#H+:EY>4H>F\RV-']"UKYZ1(0*G.Y*K.E5^8H*H,CLF&KU!NB+UWHS!GH MS)::GZ/H#(*[::9L<3-%X)H2ES]!/,A0Z@5V0!+82"*PO%S-WU) =!3-M\#! M-.6&PLL$'9&+$2JS066V-',=164:S,%4K+)F00B=$3IS0)W9TLUT!)V!58/. MJ(JLUWEI?1(]D1Q??PT]F5^7=;.L1KE8'/TUG4\4"R!%ZNCL=_8# MCP!1%16B0UU6!<2GT(=ST(W%![M;\Z,2K->E^O[3QT1 MB2RA#X?7ART%.?OK@PG;NRXW]+(@O3C0A^+7YV2.7GQ[KVW>WI,MY,N.\;26 M\EB+<2AL!O8#SUS?P1]\\LC$QN;D91OP;ZM-WF$3L;*\Q'[TWP4M^LB>O]KN/HA;OZW:FT:(:1A5)GT6U M]6[Z4 !OT 9_JE>UV$<>Z[_#S[)).QH=C+1,:\%XN!X5LT^@/L3#7\%R;&[6 M(HT]5,B_;>=PO=*D$ C8WH]Y?Y!:_^^_V\U=V_57F:57:PEFL<^.KQF))DT* MD?"SU^JVI#_;K:_]/Z7>;:?=O6WW9*G3O:U*K>Z=U/OYN=>YZ[1^=-J]3!KP M\C+=AWZ[)_4?I-N';N_A:^>NU6_?2?>=;JM[VVE]E7I]^.!;N]OG_U4^.%,I M&+MSN,?0ER7R-B"P4\X(&)VQ[1%I: ?VQS23MA%)XE1,D;K_YV^6IFI_Y ,V M:=O>%!3'_TZ\'KYU$I=$5>ILSX5]C@Q;0?3A30*NY/;AV[>'+HC P^U_4E[^X?4^[/UHYW<1./D7=M08RN AYT#&LIGVP>2DY"F,5GZ@,S1 ME#_:WWOT;^H?'R7\_-'VR1 Q48(QD=BMR?#&!K\,-CP)/,='N 7827H77W+G M@1^ N")@"KB8\*3!&)_BN,.JU&._"<9V((WA%M(C(5,$69E[@S%]#J*F>"1P M//C[<.Y1V!5X+KN!+R%VBC-RX,M',G%?8S=QIG@4"U\X;*7@,@[FDQ#0940_ M6JXU\1I^;&'XTNMOD7+'1TI(H-8JA0)@%O[E'1ZR=B-8F3U]7Q#CSD&O:4AO ML4+H38OY,'"?9_0RNJ\M5_&1D@ZNGKFX73GV9/(N#?$1X,V%MUQE -YZG6K# MV)IB[^N'3Z,OB !!<^\=!!=T4'HF8*"&T8TD\J^Y$[Q+]JOM#5>>

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end XML 102 usna-20231230_htm.xml IDEA: XBRL DOCUMENT 0000896264 2023-01-01 2023-12-30 0000896264 2023-07-01 0000896264 2024-02-23 0000896264 2023-12-30 0000896264 2022-12-31 0000896264 2022-01-02 2022-12-31 0000896264 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2021-01-02 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2021-01-02 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-02 0000896264 2021-01-02 0000896264 us-gaap:RetainedEarningsMember 2021-01-03 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2021-01-03 2022-01-01 0000896264 us-gaap:CommonStockMember 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 0000896264 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-02 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-30 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000896264 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000896264 us-gaap:FairValueMeasurementsNonrecurringMember 2023-12-30 0000896264 usna:AmountsReceivableFromCreditCardProcessorsMember 2023-12-30 0000896264 usna:AmountsReceivableFromCreditCardProcessorsMember 2022-12-31 0000896264 usna:RestrictedCashDepositsInChinaMember 2023-12-30 0000896264 usna:RestrictedCashDepositsInChinaMember 2022-12-31 0000896264 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-30 0000896264 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-30 0000896264 us-gaap:OtherAssetsMember 2021-01-02 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-12-30 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-02 2022-12-31 0000896264 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-03 2022-01-01 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-30 0000896264 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SubsequentEventMember 2024-01-25 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-04-03 2022-07-02 0000896264 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-07-02 0000896264 us-gaap:PublicUtilitiesInventoryRawMaterialsMember 2023-12-30 0000896264 usna:FinishedGoodsMember 2023-12-30 0000896264 us-gaap:PublicUtilitiesInventoryRawMaterialsMember 2022-12-31 0000896264 usna:FinishedGoodsMember 2022-12-31 0000896264 us-gaap:ForeignCountryMember us-gaap:ResearchMember 2023-12-30 0000896264 usna:MirroredDeferredTaxAssetsRecordedInTheUsToOffsetDeferredTaxLiabilitiesOfForeignDisregardedEntitiesMember 2023-12-30 0000896264 us-gaap:StateAndLocalJurisdictionMember usna:UtahStateTaxCommissionMember us-gaap:ResearchMember 2023-12-30 0000896264 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2023-12-30 0000896264 us-gaap:ForeignCountryMember 2023-12-30 0000896264 usna:ForeignOperatingLossCarryforwardsMember 2023-12-30 0000896264 usna:OtherForeignDeferredTaxAssetsMember 2023-12-30 0000896264 us-gaap:OtherNoncurrentLiabilitiesMember 2023-12-30 0000896264 us-gaap:OtherCurrentLiabilitiesMember 2022-12-31 0000896264 us-gaap:OtherNoncurrentLiabilitiesMember 2022-12-31 0000896264 us-gaap:BuildingMember 2023-12-30 0000896264 us-gaap:BuildingMember 2022-12-31 0000896264 srt:MinimumMember usna:LaboratoryAndProductionEquipmentMember 2023-12-30 0000896264 srt:MaximumMember usna:LaboratoryAndProductionEquipmentMember 2023-12-30 0000896264 usna:LaboratoryAndProductionEquipmentMember 2023-12-30 0000896264 usna:LaboratoryAndProductionEquipmentMember 2022-12-31 0000896264 us-gaap:AirTransportationEquipmentMember 2023-12-30 0000896264 us-gaap:AirTransportationEquipmentMember 2022-12-31 0000896264 srt:MinimumMember us-gaap:ComputerEquipmentMember 2023-12-30 0000896264 srt:MaximumMember us-gaap:ComputerEquipmentMember 2023-12-30 0000896264 us-gaap:ComputerEquipmentMember 2023-12-30 0000896264 us-gaap:ComputerEquipmentMember 2022-12-31 0000896264 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-30 0000896264 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-30 0000896264 us-gaap:FurnitureAndFixturesMember 2023-12-30 0000896264 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000896264 srt:MinimumMember us-gaap:AutomobilesMember 2023-12-30 0000896264 srt:MaximumMember us-gaap:AutomobilesMember 2023-12-30 0000896264 us-gaap:AutomobilesMember 2023-12-30 0000896264 us-gaap:AutomobilesMember 2022-12-31 0000896264 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2023-12-30 0000896264 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2023-12-30 0000896264 us-gaap:LeaseholdImprovementsMember 2023-12-30 0000896264 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000896264 us-gaap:LandImprovementsMember 2023-12-30 0000896264 us-gaap:LandImprovementsMember 2022-12-31 0000896264 us-gaap:LandMember 2023-12-30 0000896264 us-gaap:LandMember 2022-12-31 0000896264 usna:DepositsAndProjectsInProcessMember 2023-12-30 0000896264 usna:DepositsAndProjectsInProcessMember 2022-12-31 0000896264 us-gaap:TrademarksAndTradeNamesMember 2023-12-30 0000896264 us-gaap:TradeSecretsMember 2023-12-30 0000896264 us-gaap:CustomerRelationshipsMember 2023-12-30 0000896264 us-gaap:NoncompeteAgreementsMember 2023-12-30 0000896264 us-gaap:LicensingAgreementsMember 2023-12-30 0000896264 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0000896264 us-gaap:TradeSecretsMember 2022-12-31 0000896264 us-gaap:CustomerRelationshipsMember 2022-12-31 0000896264 us-gaap:NoncompeteAgreementsMember 2022-12-31 0000896264 us-gaap:LicensingAgreementsMember 2022-12-31 0000896264 us-gaap:LineOfCreditMember 2023-12-30 0000896264 us-gaap:LineOfCreditMember usna:AmendedAndRestatedCreditAgreementMember 2023-12-30 0000896264 us-gaap:LineOfCreditMember usna:AmendedAndRestatedCreditAgreementMember 2023-01-01 2023-12-30 0000896264 usna:LiabilityAwardMember 2023-01-01 2023-12-30 0000896264 usna:LiabilityAwardMember 2022-01-02 2022-12-31 0000896264 usna:LiabilityAwardMember 2021-01-03 2022-01-01 0000896264 usna:The2015PlanMember 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember usna:The2015PlanMember 2023-01-01 2023-12-30 0000896264 us-gaap:RestrictedStockMember usna:The2015PlanMember 2023-01-01 2023-12-30 0000896264 us-gaap:EmployeeStockMember usna:The2015PlanMember 2023-01-01 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember 2023-01-01 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember 2021-01-03 2022-01-01 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-01-02 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember usna:VestingAnnuallyMember 2023-01-01 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-01-01 0000896264 us-gaap:StockAppreciationRightsSARSMember 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-30 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember usna:VestingAnnuallyMember 2023-01-01 2023-12-30 0000896264 usna:DeferredStockUnitsMember us-gaap:ShareBasedPaymentArrangementNonemployeeMember usna:VestingEachQuarterMember 2023-01-01 2023-12-30 0000896264 us-gaap:RestrictedStockMember 2023-12-30 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-30 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2023-12-30 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-30 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2021-01-03 2022-01-01 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2022-01-02 2022-12-31 0000896264 us-gaap:RestrictedStockUnitsRSUMember 2021-01-03 2022-01-01 0000896264 usna:CashSettledRestrictedStockUnitsMember 2022-12-31 0000896264 usna:CashSettledRestrictedStockUnitsMember 2023-01-01 2023-12-30 0000896264 usna:CashSettledRestrictedStockUnitsMember 2023-12-30 0000896264 usna:DeferredStockUnitsMember 2023-01-01 2023-12-30 0000896264 usna:DeferredStockUnitsMember 2022-01-02 2022-12-31 0000896264 usna:DeferredStockUnitsMember 2021-01-03 2022-01-01 0000896264 usna:PerformanceStockUnitsMember 2023-01-01 2023-12-30 0000896264 srt:MinimumMember usna:PerformanceStockUnitsMember 2023-01-01 2023-12-30 0000896264 srt:MaximumMember usna:PerformanceStockUnitsMember 2023-01-01 2023-12-30 0000896264 usna:PerformanceStockUnitsMember 2022-01-02 2022-12-31 0000896264 usna:PerformanceStockUnitsMember 2021-01-03 2022-01-01 0000896264 usna:PerformanceStockUnitsMember 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A100OfTargetNumberUnitsMember 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A100OfTargetNumberUnitsMember 2023-01-01 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A150OfTargetNumberUnitsMember 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A150OfTargetNumberUnitsMember 2023-01-01 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A200OfTargetNumberUnitsMember 2023-12-30 0000896264 usna:PerformanceStockUnitsMember usna:A200OfTargetNumberUnitsMember 2023-01-01 2023-12-30 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2023-01-01 2023-12-30 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2022-01-02 2022-12-31 0000896264 us-gaap:OperatingSegmentsMember usna:DirectSellingMember 2021-01-03 2022-01-01 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2023-01-01 2023-12-30 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2022-01-02 2022-12-31 0000896264 us-gaap:OperatingSegmentsMember usna:AllOtherMember 2021-01-03 2022-01-01 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-30 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:USANANutritionalsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-30 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:USANAFoodsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-30 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:PersonalCareAndSkincareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-30 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-02 2022-12-31 0000896264 usna:AllOtherMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-03 2022-01-01 0000896264 usna:GreaterChinaMember 2023-01-01 2023-12-30 0000896264 usna:GreaterChinaMember 2022-01-02 2022-12-31 0000896264 usna:GreaterChinaMember 2021-01-03 2022-01-01 0000896264 usna:SoutheastAsiaPacificMember 2023-01-01 2023-12-30 0000896264 usna:SoutheastAsiaPacificMember 2022-01-02 2022-12-31 0000896264 usna:SoutheastAsiaPacificMember 2021-01-03 2022-01-01 0000896264 usna:NorthAsiaMember 2023-01-01 2023-12-30 0000896264 usna:NorthAsiaMember 2022-01-02 2022-12-31 0000896264 usna:NorthAsiaMember 2021-01-03 2022-01-01 0000896264 srt:AsiaPacificMember 2023-01-01 2023-12-30 0000896264 srt:AsiaPacificMember 2022-01-02 2022-12-31 0000896264 srt:AsiaPacificMember 2021-01-03 2022-01-01 0000896264 usna:AmericasAndEuropeMember 2023-01-01 2023-12-30 0000896264 usna:AmericasAndEuropeMember 2022-01-02 2022-12-31 0000896264 usna:AmericasAndEuropeMember 2021-01-03 2022-01-01 0000896264 usna:GreaterChinaMember 2023-12-30 0000896264 usna:GreaterChinaMember 2022-12-31 0000896264 usna:SoutheastAsiaPacificMember 2023-12-30 0000896264 usna:SoutheastAsiaPacificMember 2022-12-31 0000896264 usna:NorthAsiaMember 2023-12-30 0000896264 usna:NorthAsiaMember 2022-12-31 0000896264 srt:AsiaPacificMember 2023-12-30 0000896264 srt:AsiaPacificMember 2022-12-31 0000896264 usna:AmericasAndEuropeMember 2023-12-30 0000896264 usna:AmericasAndEuropeMember 2022-12-31 0000896264 country:CN 2023-01-01 2023-12-30 0000896264 country:CN 2022-01-02 2022-12-31 0000896264 country:CN 2021-01-03 2022-01-01 0000896264 country:US 2023-01-01 2023-12-30 0000896264 country:US 2022-01-02 2022-12-31 0000896264 country:US 2021-01-03 2022-01-01 0000896264 country:KR 2023-01-01 2023-12-30 0000896264 country:KR 2022-01-02 2022-12-31 0000896264 country:KR 2021-01-03 2022-01-01 0000896264 country:US 2023-12-30 0000896264 country:US 2022-12-31 0000896264 country:US 2022-01-01 0000896264 country:CN 2023-12-30 0000896264 country:CN 2022-12-31 0000896264 country:CN 2022-01-01 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-12-31 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2023-01-01 2023-12-30 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2023-12-30 0000896264 us-gaap:AllowanceForCreditLossMember 2022-12-31 0000896264 us-gaap:AllowanceForCreditLossMember 2023-01-01 2023-12-30 0000896264 us-gaap:AllowanceForCreditLossMember 2023-12-30 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-12-31 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-01-01 2023-12-30 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-12-30 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-01-01 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2022-01-02 2022-12-31 0000896264 us-gaap:AllowanceForCreditLossMember 2022-01-01 0000896264 us-gaap:AllowanceForCreditLossMember 2022-01-02 2022-12-31 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-01 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-02 2022-12-31 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2021-01-02 0000896264 usna:SecSchedule1209AllowanceSalesReturnsMember 2021-01-03 2022-01-01 0000896264 us-gaap:AllowanceForCreditLossMember 2021-01-02 0000896264 us-gaap:AllowanceForCreditLossMember 2021-01-03 2022-01-01 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-02 0000896264 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-03 2022-01-01 iso4217:USD shares iso4217:USD shares usna:region pure usna:period utr:Y usna:customer usna:segment 0000896264 FY false 2023 P3Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent 10-K true 2023-12-30 --12-30 false 001-35024 USANA HEALTH SCIENCES, INC. UT 87-0500306 3838 West Parkway Blvd. Salt Lake City UT 84120 801 954-7100 Common Stock, Par Value $0.001 per share USNA NYSE No No Yes Yes Large Accelerated Filer false false true false false 699225000 19240514 <div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant incorporates by reference into Part III (Items 10, 11, 12, 13, and 14) of this report certain information contained in its Definitive Proxy Statement to be filed with the Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year ended December 30, 2023, in connection with the registrant’s 2024 Annual Meeting of Shareholders to be held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 6, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div> KPMG LLP Salt Lake City, Utah 185 330420000 288420000 61454000 67089000 25872000 28873000 417746000 384382000 99814000 97773000 17102000 17368000 29919000 32432000 13284000 9799000 54892000 54795000 632757000 596549000 10070000 11049000 786000 0 107989000 132784000 118845000 143833000 4552000 4071000 12158000 14173000 0.001 0.001 50000000 50000000 19130000 19130000 19206000 19206000 19000 19000 65661000 55604000 445217000 391636000 -13695000 -12787000 497202000 434472000 632757000 596549000 921010000 998601000 1186464000 176693000 193890000 217898000 744317000 804711000 968566000 394257000 434793000 519267000 256989000 262304000 279107000 651246000 697097000 798374000 93071000 107614000 170192000 9637000 3789000 2515000 262000 192000 57000 7000 -2590000 -2008000 9382000 1007000 450000 102453000 108621000 170642000 38665000 39271000 54137000 63788000 69350000 116505000 3.31 3.60 5.78 3.30 3.59 5.73 19250000 19254000 20146000 19345000 19310000 20343000 63788000 69350000 116505000 -1298000 -15126000 2203000 -390000 -1881000 -1880000 -908000 -13245000 4083000 62880000 56105000 120588000 21038000 21000 62460000 382794000 -3625000 441650000 116505000 116505000 4083000 4083000 14298000 14298000 1844000 2000 23173000 154662000 177837000 199000 0 3575000 3575000 19393000 19000 50010000 344637000 458000 395124000 69350000 69350000 -13245000 -13245000 13331000 13331000 288000 0 3031000 22351000 25382000 101000 0 4706000 4706000 19206000 19000 55604000 391636000 -12787000 434472000 63788000 63788000 -908000 -908000 14595000 14595000 180000 1446000 10207000 11653000 104000 0 3092000 3092000 19130000 19000 65661000 445217000 -13695000 497202000 63788000 69350000 116505000 12702000 13393000 13036000 7693000 8017000 9157000 -10000 -141000 -61000 14595000 13331000 14298000 -2749000 -7183000 -2970000 2601000 6082000 4200000 -2353000 -15797000 14701000 -110000 3304000 2331000 -428000 -2656000 -4572000 -30034000 -9066000 -11456000 70641000 103902000 121227000 0 0 116000 3775000 4555000 0 1271000 0 1555000 0 6532000 0 15000 7000 15000 14494000 10400000 12763000 -11975000 -12370000 -14187000 11599000 25382000 177837000 1542000 11000000 0 750000 11000000 0 3092000 4706000 3575000 338000 0 0 -14237000 -30088000 -181412000 -2503000 -13777000 2088000 41926000 47667000 -72284000 291320000 243653000 315937000 333246000 291320000 243653000 330420000 288420000 239832000 2826000 2900000 3821000 333246000 291320000 243653000 68000 49000 10000 44247000 45863000 59524000 1922000 113000 191000 5699000 5641000 5322000 117000 679000 383000 0 886000 0 54000 0 0 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Company</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asia Pacific</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">North Asia – Japan and South Korea</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Americas and Europe </span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)</span></div><div style="margin-top:10pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We commenced operations in this market near the end of the fourth quarter of 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principles of Consolidation and Basis of Presentation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“U.S. GAAP”). </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the consolidated statements of cash flows. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be adjusted as more current information becomes available, and any adjustment could be significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2023, 2022, and 2021 were 52-week years. Fiscal year 2023 covered the period January 1, 2023 to December 30, 2023 (hereinafter 2023). Fiscal year 2022 covered the period January 2, 2022 to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023 and December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,319 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,319 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,137)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,137)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial assets or liabilities between levels of the fair value hierarchy for the periods indicated.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s non-financial assets, which include long-lived assets, are not required to be carried at fair value on a recurring basis. However, if an impairment charge is required, a non-financial asset would be written down to fair value. As of December 30, 2023 and December 31, 2022, there were no non-financial assets measured at fair value on a non-recurring basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023 and December 31, 2022, the Company’s financial instruments include cash equivalents and restricted cash. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Translation of Foreign Currencies</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 30, 2023 and December 31, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Amounts receivable from credit card processors as of December 30, 2023 and December 31, 2022 totaled $9,379 and $8,904, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Cash</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,826 as of December 30, 2023, and $2,900 as of December 31, 2022. This deposit is required for the application of direct selling licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Noncurrent inventories are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventories are classified in the "Other assets" line item in the Company's consolidated balance sheets. Noncurrent inventories are anticipated to be consumed beyond our normal operating cycle, but prior to obsolescence.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for credit losses regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain internal-use software development costs, consisting primarily of employee salaries and contractor costs, during the application development stage. Costs incurred for upgrades and enhancements that are expected to result in additional functionalities are also capitalized. These development costs are amortized using the straight-line method over an estimated useful life of <span style="-sec-ix-hidden:f-400">three</span> to five years, and are reflected as part of Property and equipment, net on our consolidated balance sheets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities are recognized based on the present value of the unpaid lease payments over the lease term at the commencement date for leases exceeding 12 months. Unpaid lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. During 2023, 2022, and 2021, no impairment of goodwill was recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. During 2023, 2022, and 2021, no impairment of indefinite-lived intangible assets was recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment in Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are remeasured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2023, the Company evaluated an observable price change related to equity securities without readily determinable fair values. No adjustment to the carrying value of the securities was necessary based on the observable price change. During 2022, no such observable price changes occurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2023, 2022, and 2021, no impairment of securities was recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified Deferred Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the consolidated balance sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the consolidated statements of comprehensive income. As </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of December 30, 2023 and December 31, 2022, the trustee held total assets of $2,962 and $1,622, and deferred compensation liabilities of $3,137, and, $1,632, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Self-Insurance</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance for the United States markets on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,292. A liability is accrued for all unpaid claims. Total self-insurance expense was $14,501, $13,413, and $12,349 in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2021, the Company entered into and settled a European option with notional amounts of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$81,343 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$98,684, respectively</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company entered into and settled a forward contract with a notional amount of $98,930. Both the forward contract and the European options were designated as net investment hedges. The Company realized gains of $2,504 and $4,555 in 2023 and 2022, respectively, and realized a loss of $1,555 in 2021. These gains and loss were recorded to FCTA within AOCI. The Company assessed hedge effectiveness under the forward rate method, determining the hedging instruments were highly effective. As of December 30, 2023 and December 31, 2022, there were no derivatives outstanding for which the Company has applied hedge accounting. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December 30, 2023, on January 25, 2024 the Company entered into an option contract designated as a net investment hedge with a notional amount of $77,345.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock Share Repurchases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 30, 2023, $71,186, inclusive of accrued excise tax, is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the contract with a customer;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the performance obligations in the contract;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">determination of the transaction price;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">allocation of the transaction price to the performance obligations in the contract; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">recognition of revenue when or as a performance obligation is satisfied.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders becomes remote.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,177 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disaggregation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregation of revenue by geographical region and major product line is included in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7d001be1506448dcaa08ec040e6f5ed5_232" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">M</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Segment Information.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. The Company typically does not have contract assets based on the payment terms included in the Company’s contracts and the balance of contract assets was $0 at December 30, 2023 and December 31, 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to deferral of revenue at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to beginning contract liabilities recognized as revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,875)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,635)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Return Policy</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. Product returns totaled approximately 0.6%, 0.7%, and 0.6% of net sales in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Incentives</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General and Administrative</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity-Based Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. The grant date fair value of each performance share unit is based upon a Monte-Carlo simulation in order to incorporate market conditions. Equity-based compensation expense for restricted stock units and stock-settled stock appreciation rights are recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Equity-based compensation expense for performance stock units is recognized based on the achievement of certain performance and market conditions by specified target dates, subject to continued service through the applicable vesting dates. The probability of the awards meeting the performance condition is not included in the grant date fair value, but is estimated quarterly for expense recognition. The Company recognizes an adjustment to compensation expense based on revisions in probability assessments. The Company accounts for forfeitures as they occur. Further information regarding equity awards can be found in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a href="#i7d001be1506448dcaa08ec040e6f5ed5_229" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">L</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Equity-Based Compensation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Advertising expense totaled $4,756, $5,053, and $12,399, in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. Research and development expense totaled $11,446, $11,563, and $11,112 in 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. The Company adopted the provisions of ASU 2021-08 during the first quarter of 2023 and the adoption of the standard did not have an impact on its consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is intended to provide financial statement users with more disaggregated expense information about a public entity’s reportable segments. ASU 2023-07 requires incremental disclosures related to a public entity’s reportable segments including allowing the disclosure of multiple measures of segment profit or loss, </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requiring the disclosure of significant segment expenses, and requiring the qualitative disclosure of other segment items. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024, and should be adopted retrospectively unless impracticable. Early adoption is permitted. The Company is currently evaluating the impact </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adoption of the standard will have on its consolidated financial statements.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard is intended to benefit investors by providing more detailed income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adoption of the standard will have on its consolidated financial statements.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other recent accounting pronouncements had, or are expected to have, a material impact on the Company's consolidated financial statements.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Company</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures high quality, science-based nutritional and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements (the “Financial Statements”) include the accounts and operations of the Company, which are grouped and presented in two geographic regions: (1) Asia Pacific and (2) Americas and Europe. Asia Pacific is further divided into three sub-regions: (i) Greater China, (ii) Southeast Asia Pacific, and (iii) North Asia.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asia Pacific</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Greater China - Hong Kong, Taiwan, and China. Our business in China is conducted by BabyCare</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand, Indonesia, and India</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">North Asia – Japan and South Korea</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Americas and Europe </span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Americas and Europe – United States, Canada, Mexico, Colombia, and Europe (the United Kingdom, France, Germany, Spain, Italy, Romania, Belgium, and the Netherlands)</span></div><div style="margin-top:10pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We commenced operations in this market near the end of the fourth quarter of 2023.</span></div> 2 3 3 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Principles of Consolidation and Basis of Presentation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements include the accounts and operations of the Company. All inter-company accounts and transactions have been eliminated in consolidation. The accounting and reporting policies of the Company conform with accounting principles generally accepted in the United States of America (“U.S. GAAP”). </span></div>Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the consolidated statements of cash flows. <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be adjusted as more current information becomes available, and any adjustment could be significant.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal years 2023, 2022, and 2021 were 52-week years. Fiscal year 2023 covered the period January 1, 2023 to December 30, 2023 (hereinafter 2023). Fiscal year 2022 covered the period January 2, 2022 to December 31, 2022 (hereinafter 2022). Fiscal year 2021 covered the period January 3, 2021 to January 1, 2022 (hereinafter 2021).</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023 and December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,319 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,319 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,137)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,137)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds included in cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,539 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts included in other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration included in other current liabilities of $(338) and other long-term liabilities of $(548)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 258319000 258319000 0 0 62000 0 62000 0 3137000 0 3137000 0 211539000 211539000 0 0 3150000 0 3150000 0 1632000 0 1632000 0 338000 548000 886000 0 0 886000 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div>As of December 30, 2023 and December 31, 2022, the Company’s financial instruments include cash equivalents and restricted cash. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature. <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Translation of Foreign Currencies</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of the Company’s foreign subsidiaries is the local currency of their country of domicile. Assets and liabilities of the foreign subsidiaries are translated into U.S. dollar amounts at month-end exchange rates. Revenue and expense accounts are translated at the weighted-average rates for the monthly accounting period to which they relate. Equity accounts are translated at historical rates. Foreign currency translation adjustments are accumulated as a component of other comprehensive income. Gains and losses from foreign currency transactions are included in the “Other, net” component of Other income (expense) in the Company’s consolidated statements of comprehensive income.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates the purchase price consideration of the assets acquired and liabilities assumed based on the acquisition date fair values. Additionally, the Company records goodwill for the excess of the total consideration given for the acquired business over the fair value of the identifiable net assets of the acquired business. Transaction costs attributable to the acquisition are expensed as incurred.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. Cash equivalents as of December 30, 2023 and December 31, 2022 consisted primarily of money market fund investments and amounts receivable from credit card processors.</span></div>Amounts receivable from credit card processors and other forms of electronic payment are considered cash equivalents because they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. 9379000 8904000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Cash</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain cash deposits with banks in certain subsidiary locations for various operating purposes. The most significant of these cash deposits relates to a deposit held at a bank in China, the balance of which was $2,826 as of December 30, 2023, and $2,900 as of December 31, 2022. This deposit is required for the application of direct selling licenses by the Ministry of Commerce and the State Administration of Market Regulation (“SAMR”) of the People’s Republic of China, and will continue to be restricted during the periods while the Company holds these licenses.</span></div> 2826000 2900000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value. Cost is determined using a standard costing system, which approximates the first-in, first-out method. The components of inventory cost include raw materials, labor, and overhead. Net realizable value is determined using various assumptions with regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning, and market conditions. A change in any of these variables could result in an adjustment to inventory.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Noncurrent inventories are inventories not expected to be sold within the normal operating cycle. The Company has defined the operating cycle as 52-weeks. Noncurrent inventories are classified in the "Other assets" line item in the Company's consolidated balance sheets. Noncurrent inventories are anticipated to be consumed beyond our normal operating cycle, but prior to obsolescence.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts Receivable</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for credit losses for expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers’ financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. The Company reviews its allowance for credit losses regularly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Accounts receivable is included in the “Prepaid expenses and other current assets” line item in the Company’s consolidated balance sheets.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the differences between the financial statement assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in income in the period that includes the enactment date. Deferred tax expense or benefit is the result of changes in deferred tax assets and liabilities.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the probability of realizing the future benefits of its deferred tax assets and provides a valuation allowance for the portion of any deferred tax assets where the likelihood of realizing an income tax benefit in the future does not meet the “more-likely-than-not” criteria for recognition. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the Financial Statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. The Company recognizes interest and penalties related to unrecognized tax benefits in income taxes.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life, are charged to expense as incurred. Depreciation is provided in amounts sufficient to relate the cost of depreciable assets to operations over the estimated useful lives of the related assets. The straight-line method of depreciation and amortization is followed for financial statement purposes. Leasehold improvements are amortized over the shorter of the life of the respective lease or the useful life of the improvements. Property and equipment are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain internal-use software development costs, consisting primarily of employee salaries and contractor costs, during the application development stage. Costs incurred for upgrades and enhancements that are expected to result in additional functionalities are also capitalized. These development costs are amortized using the straight-line method over an estimated useful life of <span style="-sec-ix-hidden:f-400">three</span> to five years, and are reflected as part of Property and equipment, net on our consolidated balance sheets.</span></div> P5Y <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the Company’s headquarters in Salt Lake City, Utah, and its facilities in New South Wales, Australia, and in Beijing and Tianjin, China, the Company leases its facilities. Each of the facility lease agreements is a non-cancelable operating lease generally structured with renewal options and expires prior to or during 2027. In connection with the production facilities in Beijing and Tianjin, China, the Company has prepaid land use rights, which represents a lease with the associated prepayment recorded as a Right-of-Use (“ROU”) asset. The Company also utilizes equipment under non-cancelable operating leases, expiring through 2026.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company determines whether an arrangement is or contains a lease and whether the lease should be classified as an operating or a financing lease. A contract is or contains a lease if the contract conveys the right to control the use of the identified asset for a period of time in exchange for consideration. Control is determined based on the right to obtain all of the economic benefits from use of the identified asset and the right to direct the use of the identified asset. ROU assets for operating leases represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities are recognized based on the present value of the unpaid lease payments over the lease term at the commencement date for leases exceeding 12 months. Unpaid lease payments include only the fixed lease component of the agreement, as well as any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Non-lease components are accounted for separately from the fixed lease component for all leases. Most of the Company’s leases do not provide an implicit rate that can readily be determined. Therefore, the applied discount rate is based on the Company’s incremental borrowing rate, which is determined using its credit rating and other information available as of the commencement date and is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms may include options to renew, which the Company factors into the determination of the lease term when it is reasonably certain that the Company will exercise that option. The ROU asset is measured at the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense is recognized on a straight-line basis over the lease term and is included in “Cost of sales” and “Selling, general and administrative” line items in the Company’s consolidated statements of comprehensive income. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases is recognized on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company monitors for events or changes in circumstances that require a reassessment of its leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the ROU asset unless doing so would reduce the ROU asset to an amount less than zero, in which case the remaining adjustment would be recorded in the consolidated statements of comprehensive income.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div>Goodwill represents the excess of the purchase price over the fair market value of identifiable net assets of acquired companies. Goodwill is not amortized, but rather is tested at the reporting unit level at least annually for impairment or more frequently if triggering events or changes in circumstances indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Some of these qualitative factors may include macroeconomic conditions, industry and market considerations, a change in financial performance, entity-specific events, a sustained decrease in share price, and consideration of the difference between the fair value and carrying amount of a reporting unit as determined in the most recent quantitative assessment. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a quantitative impairment analysis is performed. This analysis involves estimating the fair value of a reporting unit using widely accepted valuation methodologies including the income and market approaches, which requires the use of estimates and assumptions. These estimates and assumptions include revenue growth rates, discount rates, and determination of appropriate market comparables. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized in an amount equal to the excess of the carrying amount over the fair value of the reporting unit, not to exceed the carrying amount of the goodwill. 0 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets represent amortized and indefinite-lived intangible assets primarily acquired in connection with business combinations. Amortized intangible assets are amortized over their related useful lives, using a straight-line or accelerated method consistent with the underlying expected future cash flows related to the specific intangible asset. Amortized intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Measurement of the amount of impairment, if any, is based upon the difference between the asset or asset group’s carrying value and fair value. Fair value is determined through various valuation techniques, including market and income approaches as considered necessary.</span></div>Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Initially, qualitative factors are considered to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying amount, a quantitative impairment analysis is performed by comparing the indefinite-lived intangible asset’s carrying amount to its fair value. The fair value for indefinite-lived intangible assets is determined through various valuation techniques, including market and income approaches as considered necessary. The amount of any impairment is measured as the difference between the carrying amount and the fair value of the impaired asset. 0 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investment in Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities (“securities”) without readily determinable fair value that are not eligible to be measured in accordance with the net asset value practical expedient qualify for an election to initially estimate fair value using the measurement alternative at its cost. During 2020, the Company entered into a strategic collaboration and made a minority investment in a privately held company, which totaled $20,000 and is included in the “Other assets” line item on the Company’s consolidated balance sheets. The Company, at the time of the investment, elected to apply the measurement alternative, which may be applied to an equity interest on an instrument-by-instrument basis. Dividends received are reported in earnings.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the securities are remeasured to fair value if the securities are impaired or if observable price changes occur. These events are continually monitored and assessed at each reporting period. If a readily determinable fair value becomes available for the securities or observable price changes for the identical or a similar investment of the same issuer occur, the securities are remeasured at fair value as of the date the observable change occurred. Any resulting gains or losses on the securities for which the observable price changes occur will be recorded in net earnings. During 2023, the Company evaluated an observable price change related to equity securities without readily determinable fair values. No adjustment to the carrying value of the securities was necessary based on the observable price change. During 2022, no such observable price changes occurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting period a qualitative assessment is made to consider impairment indicators to determine whether the securities are impaired. Impairment indicators may include but are not limited to earnings performance, business prospects by the investee, cash flows from operations, working capital, and noncompliance with debt covenants. If this qualitative assessment indicates impairment, fair value is determined and an impairment loss equal to the difference between the fair value of the investment and its carrying amount is recognized in net income. During 2023, 2022, and 2021, no impairment of securities was recorded.</span></div> 20000000 0 0 0 0 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified Deferred Compensation</span></div>In 2021, the Company created a non-qualified deferred compensation plan for a select group of management and highly compensated individuals. The plan permits the deferral of up to 50% of a participant's base salary and/or 80% of a participant's annual incentive bonus. The deferrals are held in an irrevocable rabbi trust (the "Rabbi Trust"), which has been established to administer the plan. The Rabbi Trust is intended to be used as a source of funds to match respective funding obligations to participants. The assets of the trust are subject to the claims of the Company's creditors in the event that the Company becomes insolvent. Consequently, the Rabbi Trust qualifies as a grantor trust for income tax purposes. The Company makes periodic payments into company-owned life insurance policies held in this Rabbi trust to fund the expected obligations arising under this plan. There are no contractual restrictions on the Company's ability to surrender a policy. The assets and liabilities of the plan are included in "Other assets" and "Other long-term liabilities" respectively in the consolidated balance sheets. Changes in the deferred compensation balances are recorded to compensation expense and reflected within the "Selling, general and administrative" line in the consolidated statements of comprehensive income. 0.50 0.80 2962000 1622000 3137000 1632000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Self-Insurance</span></div>The Company is self-insured, up to certain limits, for employee group health claims. The Company has purchased stop-loss insurance for the United States markets on both an individual and an aggregate basis, which will reimburse the Company for individual claims in excess of $175 and aggregate claims that are greater than $13,292. A liability is accrued for all unpaid claims. 175000 13292000 14501000 13413000 12349000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Financial Instruments</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s risk management strategy includes the select use of derivative instruments to reduce the effects of volatility in foreign currency exchange exposure on operating results and cash flows. In accordance with the Company’s risk management policies, the Company does not hold or issue derivative instruments for trading or speculative purposes. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. When the Company becomes a party to a derivative instrument and intends to apply hedge accounting, the Company formally documents the hedge relationship and the risk management objective for undertaking the hedge, the nature of risk being hedged, and the hedged transaction, which includes designating the instrument for financial reporting purposes as a fair value hedge, a cash flow hedge, or a net investment hedge. The Company also documents how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically uses derivative instruments to hedge the foreign currency exposure of its net investment in foreign subsidiaries into U.S. dollars. Initially, the Company records derivative assets on a gross basis in its consolidated balance sheets. Subsequently the fair value of derivatives is measured for each reporting period. The effective portion of gains and losses attributable to these net investment hedges is recorded to foreign currency translation adjustment (“FCTA”) within accumulated other comprehensive income (loss) (“AOCI”) to offset the change in the carrying value of the net investment being hedged, and will subsequently be reclassified to net earnings in the period in which the hedged investment is either sold or substantially liquidated.</span></div> 81343000 98684000 98930000 2504000 4555000 -1555000 0 0 77345000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock Share Repurchases</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock repurchase plan in place that has been authorized by the Board of Directors. As of December 30, 2023, $71,186, inclusive of accrued excise tax, is available to repurchase shares under this plan. The excess of the repurchase price over par value is allocated between additional paid-in capital and retained earnings on a pro-rata basis. There currently is no expiration date on the remaining approved repurchase amount and no requirement for future share repurchases.</span></div> 71186000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, control of a promised product or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. Revenue excludes taxes that have been assessed by governmental authorities and that are directly imposed on </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue-producing transactions between the Company and its customers, including sales, use, value-added, and some excise taxes. Revenue recognition is evaluated through the following five-step process:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the contract with a customer;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">identification of the performance obligations in the contract;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">determination of the transaction price;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">allocation of the transaction price to the performance obligations in the contract; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">recognition of revenue when or as a performance obligation is satisfied.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of the Company’s sales are for products sold at a point in time and shipped to customers, for which control is transferred to the customer as goods are delivered to the third party carrier for shipment. The Company receives payment, primarily via credit card, for the sale of products at the time customers place orders and payment is required prior to shipment. The Company does not recognize assets associated with costs to obtain or fulfill a contract with a customer.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s product sales contracts include terms that could cause variability in the transaction price for items such as discounts, product promotions, credits, or sales returns, which are a reduction of revenue. Accordingly, the transaction price for product sales includes estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. At the time of sale, the Company estimates a refund liability for the variable consideration based on historical experience, which is recorded within the “Other current liabilities” line item in the consolidated balance sheets.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial product orders with a new customer may include multiple performance obligations related to sales discounts earned under the Company’s initial order reward program. Under this program, the customer receives an option to apply the discounts earned on the initial order to two subsequent Auto Orders, which conveys a material right to the customer. As such, the initial order transaction price is allocated to each separate performance obligation based on its relative standalone selling price and is recognized as revenue as each performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives represent consideration paid to an Associate for distinct services provided in the sale of the Company's products and include all forms of commissions, and other incentives paid to our Associates. The Company may provide Associate incentive promotions which are earned by Associates for distinct services rendered. Associate incentive promotions are recorded as the incentives are earned by the Associates. With the exception of commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales, Associate incentives are recorded as an operating expense. The amounts paid to Associates are commensurate with the fair value received for the distinct services rendered by Associates and are recorded as an operating expense when revenue for the goods is recognized.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling activities are performed upon delivery to the third party carrier for shipment. The Company accounts for these activities as fulfillment costs. Therefore, the Company recognizes the costs of these activities when revenue for the goods is recognized. Shipping and handling costs are included in cost of sales for all periods presented.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to will-call orders, the Company periodically assesses the likelihood that customers will exercise their contractual right to pick up orders and revenue is recognized when the likelihood that customers will pick up orders becomes remote.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenue</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other types of revenue include fees, which are paid by the customer at the beginning of the service period, for access to online customer service applications and annual account renewal fees for Associates, for which control is transferred over time as services are delivered and are recognized as revenue on a straight-line basis over the term of the respective contracts.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,177 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disaggregation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregation of revenue by geographical region and major product line is included in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7d001be1506448dcaa08ec040e6f5ed5_232" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">M</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Segment Information.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the timing of our provision of goods or services is different from the timing of the payments made by our customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance).</span></div>Contract liabilities relate to deferred revenue for product sales for customer payments received in advance of shipment, for outstanding material rights under the initial order program, and for services where the performance obligations are satisfied over time as services are delivered. Contract liabilities are recorded as deferred revenue within the "Other current liabilities" line item in the consolidated balance sheets. <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Other Revenue for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,177 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3177000 3452000 3825000 0 0 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balances during the period.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at beginning of period</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,635 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to deferral of revenue at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to beginning contract liabilities recognized as revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,875)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,635)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 20875000 19635000 13910000 20875000 20875000 19635000 13910000 20875000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Return Policy</span></div>All product orders that are unused and returned within the first 30 days following purchase are refunded at 100% of the sales price. All product orders that are unused and resalable are refunded up to one year from the date of purchase at 100% of the sales price. This standard policy differs in a few of our international markets due to the regulatory environment in those markets. Depending upon the conditions under which product was returned, customers may either receive a refund based on their original form of payment, or credit on account for a product exchange. The Company monitors Associate activity to ensure that all such practices are in line with established Company policies. P30D 1 1 0.006 0.007 0.006 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Associate Incentives</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associate incentives expenses include all forms of commissions, and other incentives paid to our Associates, less commissions paid to Associates on personal purchases, which are considered a sales discount and are reported as a reduction to net sales.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General and Administrative</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include wages and benefits, depreciation and amortization, rents and utilities, Associate event costs, advertising and professional fees, marketing, and research and development expenses.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity-Based Compensation</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense in the Financial Statements for equity-based awards based on the grant date fair value, which for restricted stock units is the closing market value of the Company’s common stock on the date of the grant. The grant date fair value of each stock-settled stock appreciation right is based upon the Black-Scholes option pricing model. The grant date fair value of each performance share unit is based upon a Monte-Carlo simulation in order to incorporate market conditions. Equity-based compensation expense for restricted stock units and stock-settled stock appreciation rights are recognized under the straight-line method over the period that service is provided, which is generally the vesting term. Equity-based compensation expense for performance stock units is recognized based on the achievement of certain performance and market conditions by specified target dates, subject to continued service through the applicable vesting dates. The probability of the awards meeting the performance condition is not included in the grant date fair value, but is estimated quarterly for expense recognition. The Company recognizes an adjustment to compensation expense based on revisions in probability assessments. The Company accounts for forfeitures as they occur. Further information regarding equity awards can be found in Note </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a href="#i7d001be1506448dcaa08ec040e6f5ed5_229" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none">L</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Equity-Based Compensation.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Advertising</span></div>Advertising costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. 4756000 5053000 12399000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development</span></div>Research and development costs are charged to expense as incurred and are presented as part of the “Selling, general and administrative” line item. 11446000 11563000 11112000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share ("EPS") are based on the weighted-average number of common shares that were outstanding during each period. Diluted EPS include the effect of potentially dilutive common shares calculated using the treasury stock method, which include in-the-money, equity-based awards that have been granted but have not been issued. When there is a loss, potential common shares are not included in the computation of diluted EPS, because to do so would be anti-dilutive.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities (deferred revenue) acquired in a business combination in accordance with Revenue from Contracts with Customers (Topic 606). Under this approach, the acquirer applies the revenue model as if it had originated the contracts. This is a departure from the current requirement to measure contract assets and contract liabilities at fair value at the acquisition date. ASU 2021-08 is effective for annual periods beginning after December 15, 2022 and interim periods within those annual periods. ASU 2021-08 should be applied prospectively to business combinations occurring on or after the date of adoption. Evaluation of this new standard is dependent on multiple circumstances including the timing and complexity of completed business combinations. The Company adopted the provisions of ASU 2021-08 during the first quarter of 2023 and the adoption of the standard did not have an impact on its consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The standard is intended to provide financial statement users with more disaggregated expense information about a public entity’s reportable segments. ASU 2023-07 requires incremental disclosures related to a public entity’s reportable segments including allowing the disclosure of multiple measures of segment profit or loss, </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requiring the disclosure of significant segment expenses, and requiring the qualitative disclosure of other segment items. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024, and should be adopted retrospectively unless impracticable. Early adoption is permitted. The Company is currently evaluating the impact </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adoption of the standard will have on its consolidated financial statements.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard is intended to benefit investors by providing more detailed income tax disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid by jurisdiction. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently evaluating the impact </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adoption of the standard will have on its consolidated financial statements.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other recent accounting pronouncements had, or are expected to have, a material impact on the Company's consolidated financial statements.</span></div> BUSINESS COMBINATIONS<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, the Company acquired assets in business combinations for an aggregate purchase consideration of $6,532 in cash and $886 in contingent consideration. The final purchase price allocations were $771 to tangible assets, $6,065 to intangible assets, and $582 to goodwill. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary reasons for the business combinations are to augment and expand the Company's core competencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability associated with the business combinations in 2022 was based on the achievement of certain milestones over a three-year period, and the seller's continued employment with the business. Under the terms of the purchase agreement, the contingent consideration consisted of three earn-out periods capped at $500 per earn-out period. The maximum earn-out was $1,500 per the asset purchase agreement. As of the acquisition date, the contingent consideration had a fair value of $886. The estimated fair value of the contingent consideration liability as of the date of acquisition was determined using an option pricing method based upon available information and certain assumptions known and contains key inputs that are unobservable in the market, which represents a Level 3 measurement within the fair value hierarchy. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the contingent consideration had a fair value of $886. During 2023, the employee resigned from the business, which consequently terminated the employment relationship and the remaining contingent consideration of $548 was forfeited. This non-cash gain on contingent consideration is included in the change in "Other liabilities" line item on the Company’s consolidated statements of cash flows. Contingent consideration is included in Fair Value Measures above. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results of operations have not been presented because the effects of the acquisitions were not material to the Company’s Financial Statements.</span></div> 6532000 886000 771000 6065000 582000 P3Y 3 500000 1500000 886000 886000 -548000 INVENTORIES<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,454 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,089 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent inventories</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>As of December 30, 2023, noncurrent inventories consisted of $2,051 of raw materials and $1,077 of finished goods inventory. As of December 31, 2022, noncurrent inventories consisted of $1,711 of raw materials and $1,768 of finished goods inventory. Noncurrent inventories are included in the “Other assets” line item on the Company’s consolidated balance sheets. <div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,454 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,089 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent inventories</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,128 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 19848000 21776000 4707000 4285000 36899000 41028000 61454000 67089000 3128000 3479000 2051000000 1077000000 1711000000 1768000000 PREPAID EXPENSES AND OTHER CURRENT ASSETS <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consists of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,069 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,089 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consists of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,069 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,089 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,873 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 9069000 9089000 6172000 5183000 6096000 7121000 2325000 2293000 1181000 3157000 1029000 2030000 25872000 28873000 INCOME TAXES <div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated earnings before income taxes consists of the following for 2023, 2022, and 2021: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,988)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,996)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,017 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,453 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,621 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,642 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) included in income from continuing operations consists of the following: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,340 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,208 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,937)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,665 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,271 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for 2023, 2022, and 2021 reconciled to the statutory U.S. Federal tax rate is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent tax differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax rate differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the year ended December 30, 2023 increased compared to the year ended December 31, 2022. The effective tax rate increase is due primarily to an unfavorable foreign currency impact on withholding tax accruals and the change in the market mix of pre-tax book income.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant categories of deferred taxes are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,588 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals not currently deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,359 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry forwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,673 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,259 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax on unremitted earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,732 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred taxes on a jurisdiction basis are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,732 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023, the Company had foreign tax credit carryforwards of approximately $128,695. If unused, these carryforwards will expire between 2026 and 2033. The Company has generated excess foreign tax credits since the Tax Cuts and Jobs Act of 2017 was enacted on December 22, 2017. This is due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. Although the Company can claim foreign tax credits against U.S. source income due to overall domestic losses generated in previous years, the Company does not believe it will be able to use more foreign tax credits than it generates in a single year. The Company believes these foreign tax credit carryforwards will expire unused based on available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, available tax planning strategies, and available carryback opportunities. Similar with prior years, the Company continues to maintain a full valuation allowance on its foreign tax credit carryforwards. Valuation allowances are determined using a more-likely-than-not realization criteria and are based upon all facts and circumstances. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a $1,591 valuation allowance on mirrored deferred tax assets recorded in the United States, which offset deferred tax liabilities of foreign disregarded entities. These mirrored deferred tax assets represent future foreign tax credits. This valuation allowance is necessary because the Company is limited in its ability to utilize future foreign tax credits due to the U.S. tax rate being lower than most foreign taxing jurisdiction rates where the Company operates. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also had $1,908 of Utah research credit carryforwards, and $3,602 of Federal research credit carryforwards as of December 30, 2023. If unused, the Utah research credit carryforwards expire between 2027 and 2037, and the Federal research credits expire between 2036 and 2043. Utah research credits are limited to Utah tax due and the Company has a history of generating more credits than it can use. Federal research credit carryforwards can only be used in a year when U.S. taxes are owed after foreign tax credits have been applied. Due to the lack of sufficient evidence to the contrary, the Company has placed a full valuation allowance on these credit carryforwards. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company had $6,100 of foreign operating loss carry forwards, $1,627 of which have an unlimited carryforward period. The deferred tax asset associated with these losses was $1,893 and a valuation allowance of $1,423 has been applied against this deferred tax asset. The 2023 deferred tax asset for state-tax-loss carryforwards was $63. If unused, some of the state-tax-loss carryforwards will expire between 2032 and 2042 and others can be carried forward indefinitely. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total combined valuation allowance was $137,252 as of December 30, 2023. The 2023 valuation allowance represents a $19,116 net increase from 2022. If the Company determines that there is sufficient evidence to remove the valuation allowances addressed above, the valuation allowance will be released and the provision for income taxes will be reduced. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023, the cumulative amount of undistributed earnings of the Company’s non-U.S. subsidiaries held for indefinite reinvestment is approximately $4,000. If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $400.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023, the Company reported $1,074 in "Other long-term liabilities" in unrecognized tax benefits that would impact the effective tax rate if recognized. This compares to $66 of unrecognized tax benefits in "Other current liabilities" and $1,384 in "Other long-term liabilities" for a combined total of $1,450 reported as of December 31, 2022. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciliation provides the changes in unrecognized tax benefits for the years presented:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance of unrecognized tax benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance of unrecognized tax benefits</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for interest and penalties associated with unrecognized tax benefits as a component of income tax expense. For the period ended December 30, 2023 and December 31, 2022, the Company reported $66 and $201, respectively, as income tax expense related to interest and penalties. As of December 30, 2023, the Company recorded $180 of "Other long-term liabilities" associated with interest and penalties for unrecognized tax benefits. This compares to $64 of "Other current liabilities" and $239 of "Other long-term liabilities" associated with interest and penalties reported as of December 31, 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States and foreign jurisdictions. In general, the Company's tax filings are subject to examination for years ended on or after December 31, 2019. However, statutes of limitations in some markets may be as long as ten years for transfer pricing related issues.</span></div> <div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated earnings before income taxes consists of the following for 2023, 2022, and 2021: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,988)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,996)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,017 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total earnings before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,453 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,621 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,642 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -19988000 -23996000 13017000 122441000 132617000 157625000 102453000 108621000 170642000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) included in income from continuing operations consists of the following: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,340 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,208 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,937)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,665 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,271 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -42000 42000 -264000 469000 297000 567000 40913000 45869000 56668000 41340000 46208000 56971000 -4031000 -9180000 -4088000 -59000 -331000 -40000 1415000 2574000 1294000 -2675000 -6937000 -2834000 38665000 39271000 54137000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for 2023, 2022, and 2021 reconciled to the statutory U.S. Federal tax rate is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent tax differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax rate differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign withholding taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.210 0.210 0.210 0.005 0.004 0.004 0.007 0.003 0.001 0.164 0.166 0.109 0.130 0.119 0.106 0.087 0.095 0.018 0.106 0.097 0.079 -0.004 0.005 -0.003 0 -0.005 0.011 0.377 0.362 0.317 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant categories of deferred taxes are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,588 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals not currently deductible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,359 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry forwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,673 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,259 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax on unremitted earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,732 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred taxes on a jurisdiction basis are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,732 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5588000 5872000 6680000 8627000 2580000 2746000 771000 922000 6359000 6680000 1760000 1448000 13537000 9618000 134205000 115539000 1956000 1720000 3237000 3223000 176673000 156395000 137252000 118136000 39421000 38259000 5897000 5723000 1819000 2990000 6359000 6680000 11673000 11639000 4941000 5499000 30689000 32531000 8732000 5728000 13284000 9799000 4552000 4071000 8732000 5728000 128695000 1591000 1908000 3602000 6100000 1627000 1893000 1423000 63000 137252000 19116000 4000000 400000 1074000 66000 1384000 1450000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciliation provides the changes in unrecognized tax benefits for the years presented:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance of unrecognized tax benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases for settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance of unrecognized tax benefits</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1450000 1008000 1528000 30000 107000 21000 363000 0 330000 409000 468000 424000 452000 133000 635000 1074000 1450000 1008000 66000 201000 180000 64000 239000 PROPERTY AND EQUIPMENT<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of property and equipment and their estimated useful lives is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,803 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,071 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and production equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air transportation equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,717 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,939 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,287 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,969 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,720 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,723 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and projects in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,814 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,773 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of property and equipment was $10,904, $11,351, and $11,661, for the years ended 2023, 2022, and 2021, respectively.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of property and equipment and their estimated useful lives is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,803 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,071 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and production equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air transportation equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,717 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,939 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,287 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,969 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,720 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,723 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and projects in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,814 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,773 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P39Y6M 77803000 78071000 P5Y P7Y 54502000 50679000 P5Y 2952000 2952000 P3Y P5Y 52302000 53436000 P3Y P5Y 6323000 6198000 P3Y P5Y 744000 722000 P3Y P5Y 14337000 14388000 P15Y 3263000 3271000 212226000 209717000 128939000 124748000 83287000 84969000 6720000 6723000 9807000 6081000 99814000 97773000 10904000 11351000 11661000 OPERATING LEASES<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU operating lease assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-730"><span style="-sec-ix-hidden:f-731">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ROU assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-736"><span style="-sec-ix-hidden:f-737">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-740"><span style="-sec-ix-hidden:f-741">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,419 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,042 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,755, $8,258, and $9,830 for the years ended 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental lease information:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents weighted-average remaining lease term and weighted-average discount rate for the Company's operating leases:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term—operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99 yrs.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate—operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s lease liabilities as of December 30, 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,900 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,419 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of ROU assets and lease liabilities in the Company’s consolidated balance sheet:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU operating lease assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-730"><span style="-sec-ix-hidden:f-731">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ROU assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-736"><span style="-sec-ix-hidden:f-737">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-740"><span style="-sec-ix-hidden:f-741">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,419 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,572 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 17671000 19997000 17671000 19997000 7278000 6892000 5141000 7680000 12419000 14572000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,042 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These leases generally provide that property taxes, insurance, and maintenance expenses are the responsibility of the Company. Such expenses are not included in the operating lease amounts outlined in the table above or in the rent expense amounts that follow. The total rent expense was approximately $8,755, $8,258, and $9,830 for the years ended 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental lease information:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents weighted-average remaining lease term and weighted-average discount rate for the Company's operating leases:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term—operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99 yrs.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate—operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 8042000 8606000 9585000 8042000 8606000 9585000 8755000 8258000 9830000 8227000 7924000 9506000 5699000 5641000 5322000 P1Y11M26D P2Y4M20D 0.0397 0.0304 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s lease liabilities as of December 30, 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,900 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,419 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7609000 3858000 1312000 121000 0 12900000 481000 12419000 INTANGIBLE ASSETS<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test during the third quarter of 2023. The Company performed a qualitative assessment of each reporting unit and determined that it was not more-likely-than-not that the fair value of any reporting unit was less than its carrying amount. As a result, no impairments of goodwill were recognized in 2023 and 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also performed its annual indefinite-lived intangible asset impairment test during the third quarter of 2023. The Company performed a qualitative assessment of the indefinite-lived intangible assets and determined that it was not more-likely-than-not that the fair value of any indefinite-lived intangible asset was less than the carrying amount. As a result, no impairments of indefinite-lived intangible assets were recognized in 2023 and 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,102 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/> amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct selling license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,115 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,919 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Amortization Expense:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>amortization </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct selling license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,004 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,432 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate amortization of intangible assets was $1,835, $1,723, and $1,182 for the years ended 2023, 2022, and 2021, respectively.</span></div> 0 0 0 0 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill are as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,102 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,368 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 17368000 17668000 17368000 17668000 0 582000 -266000 -882000 17102000 17368000 17102000 17368000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/> amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,942 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct selling license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,115 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,919 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>amortization </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average<br/>amortization<br/>period (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name and trademarks</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product formulas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct selling license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,004 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,432 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> 2285000 343000 1942000 P10Y 8480000 8426000 54000 P8Y 3314000 1243000 2071000 P4Y 467000 184000 283000 P4Y 25569000 25569000 40115000 29919000 <div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Estimated Amortization Expense:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1223000 1154000 692000 253000 229000 799000 4350000 2285000 114000 2171000 P10Y 8701000 7983000 718000 P8Y 3313000 414000 2899000 P4Y 467000 61000 406000 P4Y 26238000 26238000 41004000 32432000 1835000 1723000 1182000 OTHER CURRENT LIABILITIES<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Associate incentives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,688 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,231 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,784 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consist of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Associate incentives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,688 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,231 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,892 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,784 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 45665000 55688000 16198000 17334000 13910000 20875000 9231000 11234000 7278000 6892000 3297000 4973000 12410000 15788000 107989000 132784000 LINE OF CREDIT<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2020, the Company as borrower, and certain of its material subsidiaries as guarantors, entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. On August 10, 2022, the Company entered into the Second Amendment to the Second Amended and Restated Credit Agreement ("Restated Credit Agreement"), which replaces the Eurodollar Rate, and LIBOR terms and provisions with the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bloomberg Short-Term Bank Yield Index rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">("</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSBY").</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement provides for a revolving credit limit for loans to the Company up to $75,000 (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the Credit Facility up to an additional $200,000.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no outstanding debt on the Credit Facility as of December 30, 2023. The obligations of the Company under the Credit Agreement are secured by the pledge of the capital stock of certain subsidiaries of the Company, pursuant to a Security and Pledge Agreement. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on revolving borrowings under the Credit Facility is computed at BSBY, adjusted by features specified in the Credit Agreement. The covenants require the Company’s rolling four-quarter consolidated EBITDA (as defined in the Credit Agreement) to be $100,000 or greater and its ratio of consolidated funded debt to consolidated EBITDA to be equal to or less than 2.0 to 1.0 at the end of each quarter. The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases by the Company. Consolidated EBITDA and consolidated funded debt are non-GAAP terms.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will be required to pay any balance on this Credit Facility in full at the time of maturity in August 2025.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains local lines of credit across different markets to secure sufficient working capital. As of December 30, 2023, the balance on these local lines of credit was $786.</span></div> 75000000 200000000 0 100000000 2.0 786000 COMMITMENTS AND CONTINGENCIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unconditional Purchase Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unconditional purchase obligations relating to IT-related services and advertising agreements were $8,018 and $7,163, as of December 30, 2023 and December 31, 2022, respectively that are generally paid within one year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving its products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company records a liability when a particular contingency is probable and estimable. The Company faces contingencies that are reasonably possible to occur; however, they cannot currently be estimated. While complete assurance cannot be given as to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, liquidity or results of operations. It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the Company in the future. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Benefit Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Company sponsors an employee benefit plan under Section 401(k) of the Internal Revenue Code. This plan covers employees who are at least 18 years of age and have met a one-month service requirement. The Company makes a matching contribution equal to 100 percent of the first one percent of a participant’s compensation that is contributed by the participant, and 50 percent of that deferral that exceeds one percent of the participant’s compensation, not to exceed six percent of the participant’s compensation, subject to the limits of ERISA. In addition, the Company may make a discretionary contribution based on earnings. The Company’s matching contributions cliff vest at two years of service. Contributions made by the Company to the plan in the United States were $2,451, $2,589, and $2,509 for the years ended 2023, 2022, and 2021, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has employees in international countries that are covered by various defined contribution plans. These plans are administered based upon the legal requirements in the countries in which they are established.</span></div> 8018000 7163000 18 P1M 1 0.01 0.50 0.01 0.06 P2Y 2451000 2589000 2509000 EQUITY-BASED COMPENSATION<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total equity-based compensation expense w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $14,965, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$13,485, and $14,706 for fiscal years 2023, 2022, and 2021, of which, $370, $154, and $408, was related to liability-classified awards, respectively. The related tax benefit for these periods w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $2,507,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2,556, and $2,813, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 30, 2023. This table does not include an estimate for future grants that may be issued. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining unrecognized compensation expense above is expected to be recognized over a weighted-average period of 1.7 years.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's 2015 Equity Incentive Award Plan (the "2015 Plan") is currently the only plan under which equity awards are issued. The 2015 Plan allows for the grant of various equity awards including stock-settled stock appreciation rights, stock options, and restricted stock awards which include restricted stock units, deferred stock units, performance stock units, (collectively "restricted stock awards") and other types of equity-based awards to the Company’s officers, key employees, and non-employee directors.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the inception of the 2015 Plan, 1,750 shares have been authorized. As of December 30, 2023,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 4,267 awards had been granted under the 2015 Plan, of which 2,942 were stock-settled stock appreciation rights, and 1,325 were restricted stock awards. Also, as of December 30, 2023, a total of 1,174 options and grants had been forfeited, of which 73 awards have been a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dded back to the number of shares available for issuance under the 2015 Plan. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Settled Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock-settled stock appreciation rights. The weighted-average fair value of stock-settled stock appreciation rights granted in 2023 and 2021 were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $19.92 and $27.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. There were no stock-settled stock appreciation rights granted in 2022.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-settled stock appreciation rights granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, generally vest 25% each year on the anniversary of the grant date and expire 4.5 years from the date of grant.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average assumptions the Company used to calculate the fair value of stock-settled stock appreciation rights that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price (5)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Depending upon the terms of the award, one of two methods will be used to calculate expected life:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exercise price is the closing price of the Company's common stock on the date of grant. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled stock appreciation right activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining<br/>contractual term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 30, 2023 and December 31, 2022 was $53.60 and $53.20, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock-settled stock appreciation rights exercised </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $0,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $50, and $10,337, for the years ended 2023, 2022, and 2021, respectively. The total fair value of stock-settled stock appreciation rights that vested </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $1,009, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$983, and $3,868, for the years ended 2023, 2022, and 2021, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended 2023, there were no exercises of stock-settled stock appreciation rights. During the years ended 2022 and 2021, certain employees elected to receive a net amount of shares upon the exercise of stock-settled stock appreciation rights in order to satisfy the Company’s tax withholding obligation. There was no reduction to additional paid-in capital for the years e</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nded 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards include stock-settled and cash-settled restricted stock units, performance stock units granted to the Company’s officers and key employees, and deferred stock units granted to non-employee directors. Restricted stock units are granted to officers and key employees upon hire or promotion to such a position, or annually for existing participants, and generally vest 25% each year on the anniversary of the grant date. Awards of deferred stock units granted to non-employee directors generally vest 25% each quarter, commencing on the first vest date anniversary following the final vesting of the previous award. Upon vesting, holders of stock-settled restricted stock units and deferred stock units are entitled to receive shares of the Company’s common stock on a one-for-one basis. Holders of cash-settled restricted stock units are entitled to receive cash payments equivalent to the number of units held, valued at the closing market price on the vest date. The fair value of restricted stock units is determined based on the Company’s closing stock price on the date of grant. Cash-settled restricted stock units are accounted for as liability-classified awards and fair value is remeasured to the current fair value, which is the Company's closing stock price, at each reporting date until the award is settled at vesting. Restricted stock units are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates. Performance stock units are granted to officers and key employees. The ultimate number of shares to be earned depends on the achievement of certain market and performance conditions, and continued service through the applicable vesting date, and do not have expiration dates.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.35 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended 2023, certain employees elected to receive a net amount of shares upon the release of restricted stock units in order to satisfy the Company’s tax withholding obligation. This resulted in a reduction to additional paid-in capi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tal of $3,092, $4,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $3,575 for the years ended 2023, 2022, and 2021, respectively, reflected as a financing activity in the Company’s consolidated statements of cash flows. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock units that vested</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $9,293, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12,808, and $11,378, for the years ended 2023, 2022, and 2021, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s cash-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.09 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.71 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of liability-classified awards outstanding</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $69, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$85, and $79 for the years ended 2023, 2022, and 2021, respectively. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of deferred stock units vested and unreleased to</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taled 8, for the years ended 2023, and 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 19 for the year ended 2021, respectively. There were no deferred stock units that vested in 2023, 2022, and 2021.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company granted 84 performance stock units to officers and key employees. The performance stock units are subject to a cliff vesting at the end of a three-year period. The number of units that vest will vary between 0% - 200% based on the achievement of market and performance conditions, over the three-year service period. The fair value of the performance stock units is determined using a Monte-Carlo simulation model. A Monte-Carlo simulation model uses stock price volatility and other assumptions to estimate the probability of satisfying the market conditions and the resulting fair value of the award. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of performance stock units granted in 2023 was $40.05. There were no performance stock units granted in 2022 or 2021. In 2023, there was unrecognized compensation expense of $913 related to unvested performance stock units that are not probable of achieving the performance condition.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average assumptions the Company used to calculate the fair value of performance stock units that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"><tr><td style="width:1.0%"></td><td style="width:85.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market condition is met if the Company achieves the target closing stock price on December 31, 2025, of $59.84. If the market condition is met, the number of earned performance stock units, as a percentage of the target number of performance stock units, is calculated based on the compound annual growth rate ("CAGR") of the Company's active Customers from fiscal year-end 2022 to fiscal year-end 2025. The payout as a percent of target shares will be determined based on the active Customer growth rate achieved by the Company as of fiscal year-end 2025, as illustrated in the table below. If the active Customer CAGR growth rate does not meet the performance condition according to the table below, the corresponding payout will be zero. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.393%"><tr><td style="width:1.0%"></td><td style="width:22.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market condition</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance condition</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target share price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">active Customer CAGR</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year-end 2025 active Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payout as % of target number of shares</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on active Customer count of 490,000 at December 31, 2022. For purposes of this performance condition, "active Customer" is defined as active Customer in the Company’s Direct-selling operating segment (discussed further in Note M – Segment Information below), excluding customers from mergers and acquisitions.</span></div> 14965000 13485000 14706000 370000 154000 408000 2507000 2556000 2813000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 30, 2023. This table does not include an estimate for future grants that may be issued. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 11697000 7934000 4426000 531000 24588000 P1Y8M12D 1750000 4267000 2942000 1325000 1174000 73000 19.92 27.12 0 0.25 P4Y6M <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average assumptions the Company used to calculate the fair value of stock-settled stock appreciation rights that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 yrs.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price (5)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Depending upon the terms of the award, one of two methods will be used to calculate expected life:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span>Exercise price is the closing price of the Company's common stock on the date of grant. 0.3989 0.4328 0.0378 0.0033 P3Y6M P3Y6M 0.0000 0.0000 58.79 85.19 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled stock appreciation right activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining<br/>contractual term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 30, 2023 and December 31, 2022 was $53.60 and $53.20, respectively. 147000 82.16 P1Y3M18D 0 18000 58.79 0 0 4000 81.59 49000 115.45 112000 63.88 P1Y2M12D 0 65000 64.84 P0Y8M12D 0 53.60 53.20 0 50000 10337000 1009000 983000 3868000 0 0 0 0 0.25 0.25 1 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.35 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 385000 85.80 274000 59.23 155000 59.94 14000 79.23 490000 71.35 3092000 4706000 3575000 9293000 12808000 11378000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s cash-settled restricted stock unit activity is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.09 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.71 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 12000 84.72 14000 59.82 4000 61.09 0 0 22000 68.71 69 85 79 8000 8000 19000 0 0 0 84000 P3Y 0 2 P3Y 40.05 0 0 913000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average assumptions the Company used to calculate the fair value of performance stock units that were granted during the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.454%"><tr><td style="width:1.0%"></td><td style="width:85.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.84 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company utilizes historical volatility of the trading price of its common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company historically has not paid and currently has no plan to pay dividends.</span></div> 0.3784 0.0409 59.84 <div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.393%"><tr><td style="width:1.0%"></td><td style="width:22.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market condition</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance condition</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target share price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">active Customer CAGR</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year-end 2025 active Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payout as % of target number of shares</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on active Customer count of 490,000 at December 31, 2022. For purposes of this performance condition, "active Customer" is defined as active Customer in the Company’s Direct-selling operating segment (discussed further in Note M – Segment Information below), excluding customers from mergers and acquisitions.</span></div> 59.84 0.06 584000 1 59.84 0.09 635000 1.50 59.84 0.12 688000 2 490000 SEGMENT INFORMATION<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company primarily operates as a global direct-selling nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating segments are identified according to how business activities are managed and evaluated by the chief operating decision maker (“CODM”), our CEO. The CODM manages the business, allocates resources, makes operating decisions, and evaluates performance for a geographic region or market based on net sales. The Company aggregates its direct-selling operating segments (“Direct-selling”) into one reportable segment, as management believes that the Company’s Direct-selling segments exhibit similar long-term financial performance and have similar economic characteristics. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Company’s acquisitions during 2022, the Company has operating segments that are not material to the Company’s net sales. These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s consolidated statements of comprehensive income. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct-selling</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,043 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,010 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Associate accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue for our Direct-selling segment that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Foods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care and Skincare</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________________</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes the Company’s Active Nutrition line</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selected Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information, presented by geographic region is listed below: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales to External Customers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,435 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,192 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,685 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,157 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,894 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,618 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632,757 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,549 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,938 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 1 These operating segments are included as a component of (“All other”) and are included for purposes of reconciliation of net sales to the Company’s consolidated statements of comprehensive income. <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct-selling</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,043 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,010 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 915211000 995043000 1186464000 5799000 3558000 0 921010000 998601000 1186464000 The table below summarizes the approximate percentage of total product revenue for our Direct-selling segment that has been contributed by the Company’s nutritionals, foods, and personal care and skincare products for the periods indicated. <div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USANA Foods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care and Skincare</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">______________________________</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes the Company’s Active Nutrition line</span></div> 0.87 0.87 0.86 0.07 0.07 0.07 0.05 0.05 0.06 0.01 0.01 0.01 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information, presented by geographic region is listed below: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales to External Customers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,435 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,192 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,685 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186,464 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,157 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,894 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,267 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southeast Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,618 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632,757 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,549 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 475099000 502486000 563469000 163890000 190478000 269803000 101446000 108952000 129920000 740435000 801916000 963192000 180575000 196685000 223272000 921010000 998601000 1186464000 79418000 86051000 17504000 15226000 2235000 3617000 99157000 104894000 96480000 92373000 195637000 197267000 219781000 250786000 57820000 51880000 21807000 22952000 299408000 325618000 333349000 270931000 632757000 596549000 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,938 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 427265000 453134000 506103000 99108000 106391000 125835000 95906000 106087000 110379000 93181000 89150000 77767000 83938000 COMMON STOCK AND EARNINGS PER SHARE<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,505 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,250 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,254 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,146 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of in-the-money equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,345 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,310 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended 2023, the Company repurchased and retired 180 shares for $11,653 including accrued excise tax of $54. During the years ended 2022 and 2021, the Company repurchased and retired 288 shares, and 1,844 shares for an aggregate price of $25,382 and $177,837, respectively.</span></div> <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,788 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,505 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,250 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,254 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,146 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of in-the-money equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,345 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,310 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,343 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.31 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.78 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share from net earnings - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 63788000 69350000 116505000 19250000 19254000 20146000 95000 56000 197000 19345000 19310000 20343000 3.31 3.60 5.78 3.30 3.59 5.73 <div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that their effect would be anti-dilutive: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td></tr></table></div> 319000 354000 60000 180000 11653000 54000 288000 1844000 25382000 177837000 <div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to costs and expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,552 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,252 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,562 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,958 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance - deferred tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,958 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 572000 5552000 5704000 420000 363000 112000 54000 421000 118136000 19116000 0 137252000 547000 6562000 6537000 572000 504000 6000 147000 363000 99958000 18178000 0 118136000 819000 7213000 7485000 547000 372000 148000 16000 504000 81401000 18557000 0 99958000